Development of porphyrin-antiangiogenic antibody immunoconjugates for photodynamic therapy by Bullous, Aaron
  
 
 
 
 
 
THE UNIVERSITY OF HULL 
 
 
DEVELOPMENT OF 
PORPHYRIN-ANTIANGIOGENIC ANTIBODY IMMUNOCONJUGATES FOR 
PHOTODYNAMIC THERAPY 
 
 
A thesis submitted for the Degree of Doctor of Philosophy in the University of Hull 
 
by 
 
Aaron Bullous, MChem 
 
 
December 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 ii 
      
Acknowledgements 
 
I would like to convey my deepest gratitude to my supervisor Dr Ross Boyle, for his 
advice and support during my research project. My thanks go to all the students and 
personnel I have shared laboratory space with throughout the project, for general advice, 
encouragement and interesting conversations. Among them, I would especially like to 
express my appreciation to Dr Cristina Alonso and Dr Chris Welch, for their continuous 
help and support. I would also like to thank Dr Steve Archibald and Carol Kennedy for 
providing chemicals, glassware and equipment throughout the project. Finally, I would 
like to acknowledge the generous funding of this project by the European Commission 
(FP6-2005-LIFESCIHEALTH-7).  
 iii 
      
Abstract 
 
Photodynamic therapy is a novel cancer treatment, involving the combination of light, 
photosensitiser and molecular oxygen to produce cytotoxic species. Currently, 
commercially available photosensitisers, including Photofrin
®
 and Foscan
®
, only exhibit 
a passive selectively towards cancerous tissue. Therapeutically, this results in a variety 
of unfavourable characteristics, obstructing PDT from becoming a more viable cancer 
treatment. Research has been directed towards improving the pharmacokinetic and 
biodistribution profiles of photosensitisers, which can be achieved by conjugating the 
photosensitiser moiety to a biomolecule which has affinity for the diseased tissue; these 
3
rd
 generation photosensitisers include photoimmunoconjugates.  
 
Three synthetic routes were developed, with the aim of producing novel bioconjugatable 
porphyrins, which could be subsequently conjugated to cysteine residues expressed by a 
suitable monoclonal antibody (SIP(L19)).  
Two cationic, thiol reactive photosensitisers were synthesised and successfully 
conjugated to SIP(L19) in a reproducible manner, affording well defined 
immunoconjugates, which retained both the immunoreactivity of the antibody moiety 
and the photoactivity of the photosensitiser. The effect of the length and hydrophilicity 
of the linker connecting the photosensitiser and bioconjugatable group was investigated, 
and it was observed that the photoactivity of the immunoconjugate was enhanced using 
a longer, hydrophilic chain.   
Synthetic routes leading to the production of bioconjugatable porphyrin dimers, and 
photosensitisers from symmetrical porphyrin, were developed, but failed to yield final 
products. 
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Chapter 1: Introduction 
 
1.1 Photodynamic therapy  
 
Photodynamic therapy (PDT) is a therapeutic concept, which combines a light activated 
drug; known as a photosensitiser, visible light and molecular oxygen, leading to the 
formation of reactive oxygen species (ROS), which can adversely affect surrounding 
cells.
1,2 
PDT has been utilised for the treatment of certain cancers, including lung 
cancer,
3
 tumours of the head and neck,
4
 as well as some non-malignant conditions such 
as macular degeneration,
5
 microbial infections,
6
 atherosclerosis
7
 and psoriasis.
8
 
The PDT treatment involves the administration of the photosensitiser to the patient, 
topically, orally or via intravenous injection, depending on which photosensitiser is 
being used, and the condition being treated.
4,9
 The photosensitiser distributes non-
specifically around the body, and is preferentially retained within rapidly dividing 
tissues including neoplastic tissues and skin.
10,11
 A time interval is therefore required for 
the photosensitiser to accumulate in the target tissue and reach the optimum tumour to 
peritumoural ratio. The time period is dependent on the biodistribution and 
pharmacokinetic profile of the photosensitiser used, for example, it typically takes 48-
72 hours for the maximal tumour to peritumoural tissue ratio to be achieved for 
Photofrin, whereas it takes 96 hours for Foscan.11 The photosensitiser is then 
activated with a wavelength of light which corresponds to an absorption peak of the 
chromophore. Once activated, a photochemical reaction occurs between the 
photosensitiser in its excited state and molecular oxygen, leading to the formation of 
cytotoxic ROS. Oxidative damage to a variety of cellular components occurs, which 
adversely affects the structure and function of the cell, ultimately inducing cell death.
2
  
The PDT therapeutic effect is dependent on the light dose, the photosensitiser 
concentration within the target tissue and the availability of oxygen. To achieve cell 
death the potency of PDT effect must surpass a certain threshold level. Patients remain 
photosensitive until the photosensitiser has cleared from the body, and this time period 
is dependent on the photosensitiser being used.
12
 Following treatment, if there is 
damage to surrounding healthy tissue, it usually heals within 2-3 months.
9
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1.1.1 Photochemistry 
 
The photochemical processes which transpire during PDT, can be illustrated using a 
modified Jablonski diagram, as depicted in Figure 1.
2,10
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f g
h
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a = absorption                                                                   
b = fluorescence                            
c = internal conversion                  
d = nonradiative decay
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3
O2
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e = intersystem crossing
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h = Type I reaction
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S0
 
Figure 1: Modified Jablonski diagram illustrating PDT photochemistry.
2,10
 
 
Photosensitisers are administrated while in the singlet ground state (S0), and once 
irradiated with a wavelength of light corresponding to one of its absorption bands, the 
chromophore absorbs energy (a) and reaches a short lived (10
−12
-10
−9
seconds) excited 
singlet state (Sn). The excited photosensitiser can then lose the absorbed energy by 
relaxing to lower energy levels. The excited chromophore can return to its ground state 
by a variety of mechanisms: by simultaneous emission of a photon, a process formerly 
known as fluorescence (b); by collisions with surrounding molecules and/or vibrational 
relaxation, a phenomena known as internal conversion (c); or by colliding with other 
molecules, causing either the release of thermal energy or the molecule dissociating or 
fragmenting (d). Another process by which the photosensitiser can lose some of the 
absorbed energy is by a mechanism known as intersystem crossing (e), which involves 
the excited singlet state being converted into an excited triplet state (T1), by inversion of 
the spin of one electron; a process which is formerly forbidden by the spin selection 
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rule, as it involves a net change in spin for the transition. The photosensitiser in the 
excited triplet state can also lose its energy radiatively by emission of a photon, a 
mechanism called phosphorescence (f), or by interacting with other molecules within its 
sphere of influence. Since the lifetime of the excited triplet state is considerably longer 
than the excited singlet state, 10
−3
-10
−1
seconds as opposed to 10
−12
-10
−9 
seconds, there 
is a greater probability that the photosensitiser in the triplet state can diffuse to, and 
interact with other molecules within its immediate vicinity, leading to the generation of 
cytotoxic species, via either a type I or type II reaction.
2,10,13
  
Type I reactions occur when the chromophore (T1) interacts with an organic substrate, 
causing a redox reaction, resulting in the photosensitiser being reduced, and the 
substrate oxidised. The reduced photosensitiser can interact with molecular oxygen, 
producing super oxide anions, which are subsequently used to create the highly reactive 
hydroxide radicals. Additionally, the excited photosensitiser can also react with super 
oxide radicals, generating super oxide anions, which subsequently produce hydroxide 
radicals 
2,12,13
 Generally, Type I reactions are prominent if there is a high photosensitiser 
concentration, low oxygen concentration, a high singlet state acceptor substrate 
concentration, and polar surroundings; due to inhibition of the reverse redox reaction 
and stabilization of the radicals produced.
13
  
The type II photochemical reaction occurs between the excited photosensitiser (T1) and 
ground state oxygen (
3
O2).
 3
O2 has two outer electrons which are unpaired and are 
located in the π2px* and π2py* anti-bonding orbitals. When a magnetic field is applied, 
these electrons can be parallel; aligned up or aligned down; or anti-parallel, giving 
ground state oxygen three possible electron configurations, known as a triplet state.
2
 
Oxygen has low lying excited states, 95 and 158 kJ mol
−1
 above the triplets state, thus 
the chromophore (T1) can transfer sufficient energy to 
3
O2, causing a change in the 
electronic configuration of the π-antibonding orbitals.14 The increase in degeneracy 
causes an inversion of one of the oxygen outer electrons, causing both of the outer 
electrons pairing up in the π2px* orbital. Oxygen in this excited state only has one 
possible electron configuration, a singlet state (
1
O2).
2
 An individual photosensitiser can 
typically afford 10
3
-10
5
 molecules of 
1
O2 before it is degraded via photobleaching or 
other processes.
14
 
1
O2 is thought to be the primary cytotoxic agent in PDT and is so 
highly reactive that its lifetime is only 10-100 µs in organic solutions, however in an 
aqueous environments the lifetime was estimated to be 2 µs, as the energy of waters 
oxygen-hydrogen stretching is approximately the same as the excited state energy of 
singlet oxygen.
2,12
 Due to the high reactivity and short lifetime of singlet oxygen, the 
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oxidative damage is restricted to an area equivalent to the thickness of a cell 
membrane.
2
 Type II reactions are favoured in hydrophobic environments, due to the 
increased solubility and longer lifetime of the singlet oxygen species.
13
  
The cytotoxic species produced during PDT can cause photo-oxidation to nearly all 
proteins, and certain cellular structures, including: nuclei, endoplasmic reticulum, 
lysosomes, mitochondria or plasma membrane. Oxidative damage to these cell 
organelles can disrupt the normal functioning of the cell, inducing cell death by either 
apoptosis or necrosis.
2,12,13,15,16
 ROS can also target the tumours neovasculature, causing 
thrombosis, haemorrhaging and blood stasis, depriving the tumour of oxygen and 
nutrients, resulting in infarction.
2,17
 Furthermore, when the tumour is exposed to 
oxidative stress, an influx of phagocytes, including neutrophils and macrophages 
occurs. The accumulation of macrophages in cancerous tissues can induce PDT-
mediated lysis and enhances the accumulation of tumour necrosis factors, increasing the 
concentration of nutrophils in the blood. Neutrophils can aid damage to tumour stroma, 
making the cancerous cells more susceptible to cytotoxic species, as well as being a 
source of immunoregulatory factors, which induce inflammation.
18
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1.1.3 Photosensitisers 
 
Photosensitisers can absorb light of a specific wavelength, transforming it into energy, 
which is transferred to a substrate or molecular oxygen, leading to the production of 
ROS. Thus a good photosensitiser should absorb light efficiently, forming a high 
quantum yield of photosensitiser in the excited triplet state. The excited triplet state 
should also be relatively stable, increasing the probability of reacting with either oxygen 
or a suitable substrate. Compounds that have the ability of to form excited triplet states 
generally posses conjugated systems, hence porphyrin type structures have been utilised 
as photosensitisers.
19
 
Porphyrin derivatives are aromatic tetrapyrrolic macrocycles consisting of four pyrrolic 
subunits connected by methine bridges. The porphyrin nucleus has a total of 22 π 
electrons, with 18 π electrons in direct conjugation in compliance with Hückels 4n+2 
rule of aromaticity.
19,20
 Free base porphyrins have a UV/visible spectrum consisting of 
one intense absorption band, referred to as the Soret band, at 380-430 nm, and four less 
intense signals, known as the Q bands at higher wavelengths.
21
   
The optical properties of different porphyrin derivatives are dependent on the functional 
groups that are present on the porphyrin core.
22
 Porphyrins absorb photons efficiently at 
wavelengths corresponding to their absorption peaks, leading to high excited triplet 
state yields, which efficiently produce ROS.
2
 
The first generation photosensitisers were derived from hematoporphyrin, e.g. 
Photofrin, shown in Figure 2. The synthesis of Photofrin was achieved by treating 
hematoporphyrin derivative with 5 % sulphuric acid in acetic acid, under ambient 
conditions. Following neutralisation with aqueous base, a complex mixture of oligomers 
and dimers were produced, which were connected by ether and/or ester linkages. The 
active oligomer forms (Photofrin) were isolated by either high performance liquid 
chromatography (HPLC) or size exclusion chromatography.
12
 Due to the nature of the 
synthesis, Photofrin exhibited inconsistent batch-to-batch preparations, leading to 
inconsistent biological studies.
23
 Furthermore, patients remained photosensitive for 4-6 
weeks post treatment, and the optical properties of Photofrin were not ideal. 
Therefore, second generation photosensitisers were developed to circumvent these 
unfavourable characteristics.
24
 
While irradiating a photosensitiser, light can be absorbed by endogenous chromophores, 
such as haemoglobin, or by microscopic cellular structures, including cell organelles, 
resulting in the loss of direction by the light beam.
15
 Human tissue transmits light most 
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efficiently in the red region of the electromagnetic spectrum (> 600 nm). A 630 nm light 
source will penetrate tissues up to 0.5 cm, whereas at 700 nm this increases to 1.5 cm; 
thus the second generation photosensitisers, such as Foscan (Figure 2), had longer 
activation wavelength (652 nm).
4
 In comparison to Photofrin, Foscan also exhibited 
other favourable properties: chemically purity, reduced photosensitivity (2 weeks) and 
increased photoactivity; Photofrin had a singlet quantum yield of 0.5, whereas 
Foscan had a yield of 0.87.24 
 
 
 
Figure 2: Photofrin and Foscan.19 
 
Although not fully understood, first and second generation photosensitisers exhibit a 
passive selectively towards cancerous tissue, an effect that has been attributed to the 
morphology of the tumour neovasculature, and subsequent retention of the 
photosensitiser. Non-covalent interactions between photosensitiser and serum 
components, including low density lipoproteins have also been implicated.
17,25
 
Therapeutically this results in a variety of unfavourable characteristics; the time 
required to reach the optimal tumour to peritumoural ratio is extensive; the tumour to 
peritumoural ratio for photosensitisers is low, potentially leading to damage to the 
healthy surrounding tissue; and a high dose of photosensitiser is necessary to obtain a 
satisfactory therapeutic.
12,19
  
Research has therefore been directed towards improving the pharmacokinetic and 
biodistribution profiles of photosensitiser and thus addressing these undesirable features 
preventing PDT from becoming a more viable cancer treatment.  
Passive targeting vehicles such as oil dispersions, hydrophilic polymer-photosensitiser 
conjugates, or encapsulation of the photosensitiser inside a drug delivery vehicle, such 
as nanoparticles or liposomes, attempt to enhance the retention of the construct, and 
Photofrin Foscan 
 7 
      
thence photosensitiser, within the neoplastic tissue.
13,26
 Another method for augmenting 
the desired selectivity involves the formation of bioconjugates; in this case the 
photosensitiser is covalently attached to a biomolecule that is metabolically associated 
with, or recognised by, the diseased tissue. The biomolecules used to produce these 
“third generation” PDT agents include albumin, lipoproteins, transferrin, insulin, 
epidermal growth factor and steroids.
26,27,28
  
This particular research project involves the production of photosensitiser bioconjugates 
formed from another class of biomolecule, antibodies and antibody fragments. 
 
1.2 Antibodies and associated fragments 
 
Certain antibodies and antibody fragments,
27
 (Figure 3) have the ability to bind to 
specific antigens associated with cancerous tissue, thus the production of 
photosensitiser-antibody bioconjugates or “photo-immunoconjugates” is an attractive 
targeting strategy. 
 
 
Figure 3: Schematic representation of antibodies and related fragment.
27
  
 
Hydridoma technology developed by Köhler and Milstein
29
 enabled the production of 
monoclonal antibodies (mAb), specific to a selected antigen. The procedure involves 
production of a hydridoma cell line, via the fusion of spleen cells from immunised mice, 
with murine myeloma cells. Screening of the hydridoma cells identified the antigen 
positive clone, which was subsequently propagated to afford the desired antibody.
30
 
Another screening method, phage display, produces antibodies with a higher antigen 
affinity. Once the antigen positive phage has been identified, the isolation of the DNA 
from the phage genome and recombinant DNA technology generates the antibody.
31
 
The different antibody formats can be produced from either proteolytic cleavage of the 
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intact antibody, or using recombinant DNA technology.
32
 These techniques have 
facilitated the production of numerous antibody forms, each with their own unique 
characteristics.
33,34
 
Intact IgG, the largest antibody format (160-170 kDa), contains more lysine residues, 
available for conjugations, than the associated fragments; therefore the loading of 
photosensitisers should statistically occur more in areas remote from the antigen 
recognition region. In contrast, single chain fragments (scFv; 25 kDa), the smallest 
antibody format, contain more limited lysine sites for conjugations, thus photosensitiser 
loading is more likely to occur at the antigen binding region, hindering 
immunoreactivity.
27
  
The pharmacokinetic profiles of different antibody formats are significantly different in 
vivo.
35,36
 The intact mAb exhibits slow blood clearance, leading to accumulation in vital 
organs. Additionally, due to the size of the mAb, in combination with the physiological 
barriers of the tumour,
37
 poor diffusion of the mAb throughout the tumour mass results. 
Conversely, the smaller scFv format has a rapid blood clearance; therefore it does not 
accumulate in organs so prominently. The small immune protein (SIP) format has 
enhanced tumour retention, faster blood clearance and reduced accumulation in vital 
organs, compared to the whole mAb. Once conjugated, the biodistribution profile of the 
antibody, or fragment, should be transferred to the photosensitiser.  
Tumours are highly heterogeneous in nature, with the expression of antigens being 
inconsistent throughout the tumour mass, therefore immunoconjugate can also be 
unevenly distributed, resulting in an inconsistent photodynamic action throughout the 
tumour.
28
  
Immunoconjugates using internalising antibodies represents another strategy for 
enhancing the photodynamic effect. By delivering the photosensitiser directly into the 
tumour cells, reactive oxygen species are formed closer to sensitive organelles within 
the cell, resulting in an enhanced phototoxic effect.
38
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1.2.1 SIP(L19)    
 
Generally, immunoconjugate enhanced selectivity is only observed for a particular 
condition, as the target antigen is usually specific to a certain malignancy. Hence, it 
would be desirable to produce a range of antibodies targeting antigens which are 
expressed by a variety of cancerous tissues. The formation of the tumour neovasculature 
by the proliferation of new blood vessels is a process associated with many solid 
aggressive tumours. Therefore, if an immunoconjugate bore an antibody targeting 
antigens associated with angiogenesis, it could enable the treatment of a variety of 
cancerous conditions. A recent example of this strategy involves the L19 antibody, 
which targets the extra domain B (EDB) of fibronectin. EDB fibronectin is expressed 
during the angiogenic process and is undetectable in most normal tissue, except during 
tissue remodelling.
36
 
A study was conducted over a 144 hour period, evaluating the pharmacokinetic profiles 
of radiolabeled L19 antibody in the (ScFv)2, SIP and IgG formats, employing SK-MEL-
28 tumour bearing mice. The SIP(L19) exhibited a 2-5 fold more favourable % ID/g in 
tumours, in comparison to the (ScFv)2L19. The % ID/g for the IgG(L19) consistently 
increased throughout the experiment, reaching 11.22 % ID/g after 144 hours. However, 
the % ID/g tumour-organ ratios showed that IgG(L19) accumulated to a greater extent 
in the organs tested, and SIP(L19) exhibited the most favourable tumour-peritumoural 
ratios, thus the SIP format was deemed the most suitable for producing conjugates.
36
  
The 80 kDa SIP(L19) is a homo-dimer composed of two scFv fused to the human ϵs2-
CH4 domain of the human IgE, with the two CH4 domains covalently attached via a 
disulphide linkage.
39
 It has been reported that the mild reducing agent: tris(2-
carboxyethyl)phosphine hydrochloride (TCEP), can reduce a C-terminal cysteine 
expressed by an engineered scFv, without destabilising the fragment by reducing the 
intra-domain disulphide bridges.
40
 Therefore, TCEP could be used to reduce SIP(L19) 
disulphide linkage, leading to the expression of two thiol groups remote from the 
antigen binding site, which could be used for site-specific, stoichiometrically controlled 
conjugations. The reduced SIP(L19) fragment was selected for this research project.   
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1.2.2 Strategies for conjugating photosensitisers to monoclonal antibodies 
 
Antibodies and related fragments express certain amino acid residues and 
oligosaccharides that can be used to form covalent bonds with photosensitisers 
exhibiting complementary functionalities. Once conjugated, a successful photo-
immunoconjugate must at least retain, or ideally enhance, both the photoactivity of the 
photosensitiser moiety and the immunoreactivity profile of the antibody.  
Conjugation of a photosensitiser to an antibody can however be problematic for a 
variety of reasons. Lysine residues are heterogeneously distributed throughout the 
antibody, thus conjugations are not regioselective, resulting in possible binding of the 
photosensitisers in close proximity to each other, and potentially quenching excited 
states. Conjugation may also occur in the recognition site, thus inhibiting targeting 
activity. Furthermore, the amount of photosensitiser per antibody cannot be accurately 
controlled, often resulting in a complex mixture of photo-immunoconjugates with 
inconsistent batch to batch preparations; although using consistent reagent 
concentrations and reaction times can lead to a certain degree of reproducibility. 
Cysteine residues within the antibody are connected together in an oxidised form, and 
some of these disulphide bridges can be reduced using mild conditions; yielding 
reactive thiol groups in specific regions remote from the binding site. Due to the 
relatively low percentage of cysteine residues, only a limited amount of photosensitiser 
can be directly loaded on to the antibody in this way. As an alternative to direct 
coupling to lysine or cysteine residues, oligosaccharide moieties present in the Fc 
domain can be oxidised, producing formyl functionalities which can then participate in 
conjugation reactions. The reactions associated with these formyl groups; reductive 
amination or formation of a hydrazone linkage, are however relatively slow reactions. 
Additionally, as with coupling to cysteine residues, the photosensitiser loading is 
restricted due to the limited availability of the formyl functionalities.  
The structural features required of the photosensitiser can also represent challenges for 
the bioconjugation procedure. Antibodies are generally stable in an aqueous 
environment and become denatured when exposed to many organic solvents. Hence the 
photosensitiser must be sufficiently hydrophilic to facilitate the conjugation reaction 
and preventing substantial aggregation of the photosensitiser under aqueous conditions. 
Rendering the photosensitiser hydrophilic also reduces non-covalent binding to 
hydrophobic regions of the antibody. Additionally, some photosensitisers derived from 
naturally occurring porphyrins, such as hematoporphyrin and chlorin e6, contain 
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multiple functional groups, in this case carboxylic acids, leading to cross-linking and 
inconsistent preparations. Considerations of all these potential problems need to be 
addressed, in order to synthesise successful photo-immunoconjugates. There has been a 
variety of coupling strategies reported for synthesising photosensitiser-antibody 
conjugates: 
 
1.2.2.1 Carbodiimide coupling 
 
The carbodiimide strategy relies on activation of carboxyl groups present on the 
photosensitiser using a carbodiimide reagent, and subsequent coupling with amino 
groups expressed by the antibody. An innovative report by Mew et al.
41
 investigated the 
potential of photo-immunoconjugates by conjugating hematoporphyrin to mAbs, 
including anti-myosarcoma M1 (anti-M1) targeting DBA/2J myosarcoma. 
Hematoporphyrin is a relatively hydrophobic molecule; therefore a mixture of 
dimethylformamide and water was used as an appropriate reaction medium. A 
carbodiimide reagent, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-HCl (EDCI) 
was added to the hematoporphyrin solution causing activation of the carboxyl 
functionalities. Anti-myosarcoma mAb in distilled water was subsequently added, 
resulting in coupling between carboxyl groups present on the photosensitiser and amino 
groups present on the antibodies; the environmental pH was monitored and maintained 
between 6 and 7 (Scheme 1). Monoethanolamine was used to quench the residual EDCI 
and the mixture was dialyzed against phosphate buffered saline (PBS). The conjugate 
was freeze dried, re-dissolved in PBS and passed through a Sephadex G-25 column 
using PBS as eluent, thus removing unbound photosensitiser which was retained at the 
top of the column. The final conjugate did however possess extensive non-covalently 
bound hematoporphyrin, indicated by thin layer chromatography (TLC), due to 
hydrophobic interactions between photosensitiser and mAb. In vivo studies of the anti-
M1-hematoporphyrin conjugate with mice bearing M1 tumours showed significant 
reduction (95 %) in tumour growth upon irradiation with broad band light, whereas the 
tumour was unaffected by individual treatment with hematoporphyrin and mAb. 
Experiments using a different tumour type (C57BL/6J lymphoma EL4) with the anti-
M1-hematoporphyrin conjugate and a non-specific antibody-hematoporphyrin 
conjugate with M1 tumours, demonstrated that the antibody conjugates were only 
selective towards complementary antigens.  
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Scheme 1: Hematoporphyrin carbodiimide coupling.
41
 
 
These findings prompted further studies from the same research group.
42
 
Hematoporphyrin was conjugated to the CAMAL-1 (mAb which specifically targets the 
leukaemia related CAMAL antigen), and L1210 (irrelevant antibody) mAbs, via an 
EDCI methodology. The concentration of hematoporphyrin (mg / mg of mAb), was 
determined spectrophotometrically, and found to be CAMAL-1-hematoporphyrin (0.26) 
and L1210-hematoporphyrin (0.172). In vitro experiments were preformed using three 
cell lines; antigen positive WC4 and WC6 expressing CAMAL, and antigen negative 
WC2. Fluorescence microscopy was used to confirm that the CAMAL-1-
hematoporphyrin labels the WC6 cell line while L1210-hematoporphyrin does not, by 
comparing the fluorescent spectra of the cell line pre- and post-labelling. The photo-
immunoconjugates capability to kill these labelled cells upon irradiation with light was 
then analysed. It was found that CAMAL-1-hematoporphyrin had the ability to 
eradicate a substantial number of cells when the hematoporphyrin concentration was 1.2 
ng/10
6
 cells, whereas concentrations of 240 ng/10
6
 cells for L1210-hematoporphyrin 
and 120 ng/10
6 
cells for hematoporphyrin were required to obtain a similar therapeutic 
response. The cell lines were also treated with each of the conjugates; when the 
concentration of hematoporphyrin was 12 ng/10
6
 cells; the antigen positive cell lines 
were destroyed, while the WC2 control cell line was not. The carbodiimide strategy was 
utilized to couple hematoporphyrin to the monoclonal antibody 45-2D9, which has an 
affinity towards the cell surface glycoprotein expressed by 45-342 cells.
43
 A pre-
activated hematoporphyrin solution, formed by the reaction of hematoporphyrin with 
EDCI dissolved in dimethylsulfoxide, was added to a solution of antibody in PBS. After 
a short time period, the reaction mixture was placed on a gel permeation column and the 
product was eluted with PBS. The conjugate exhibited a certain degree of precipitation, 
which could be problematic for characterisation and activity studies, therefore the final 
purification step involved passing the conjugate through a 0.22 µm filter to remove 
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precipitate. Spectrophotometric studies revealed that there were considerable batch to 
batch variations as the number of hematoporphyrin molecules per antibody molecule 
varied from 4.2-39.5. In vivo kinetic and toxicity studies using nude mice bearing 45-
342 tumours were performed. The kinetic experiments involved treatment with 
hematoporphyrin and hematoporphyrin-45-2D9, then harvesting the tumour and skin 
tissues after 24, 48 and 72 hours. The mice treated with hematoporphyrin exhibited no 
photosensitiser accumulation in the skin and the optimum concentration was observed 
after 24 hours corresponding to 0.09 ng hematoporphyrin/mg of tissue. The 
hematoporphyrin-45-2D9 conjugate had a maximum concentration of 0.98 ng/mg of 
tissue, after 72 hours. The conjugate also accumulated in the skin, to the level of 0.23 
ng/mg of tissue after 24 hours and 0.42 ng/mg of tissue after 48 hours, but the conjugate 
was absent after 72 hours. The carbodiimide (EDCI) approach has also being used to 
produce hematoporphyrin conjugates with a-PNAr-I mAbs, targeting gastric cancer 
cells.
44
 Purification of the immunoconjugate was attempted by dialyzing the reaction 
mixture against 0.01M PBS, pH 7.4, at 4 
o
C for 48 hours followed by passing the 
resulting solution through a Sephadex G-25 column equilibrated with PBS; despite the 
purification attempt, TLC revealed the presence of non-covalently bound 
hematoporphyrin. The immunoreactivity and photochemical properties of the conjugate 
was not significantly compromised, as indicated by ELISA and comparison of the 
generation of photoproducts following He-Ne laser irradiation between 
hematoporphyrin and hematoporphyrin-a-PNAr-I. In vivo studies involving the 
administration of hematoporphyrin and hematoporphyrin-a-PNAr-I at a concentration of 
0.2 mg/kg body weight to nude mice bearing a human gastric cancer xenograft in 
combination with light irradiation was conducted. Tumour regression of 10 % for 
hematoporphyrin and 90 % for hematoporphyrin-a-PNAr-I was observed, thus verifying 
the enhanced potency exhibited by the conjugate at a concentration of 0.2 mg/kg of 
body weight.  
An article by Linares et al.
45
 has demonstrated that the carbodiimide conjugation 
methodology can also be used to synthesise chlorin e6 conjugates by a modification of 
the Mew et al.
41
 procedure. The antibodies selected for conjugation were anti-IL-2R and 
anti-IL-2R Fab, targeting the multichain interleukin-2-receptor (IL-2R) associated with 
various cancers including cutaneous T-cell lymphoma and T-cell leukaemia. The report 
describes the synthesis of immunoconjugates using either hematoporphyrin or chlorin e6 
conjugated to anti-IL-2R mAb, in addition to hematoporphyrin conjugated to anti-IL-2R 
Fab. UV-visible spectroscopy was used to determine the photosensitiser/antibody molar 
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ratios: the hematoporphyrin-anti-IL-2R (14.5) contained more photosensitiser in 
comparison to both chlorin e6-anti-IL-2R (3.43) and hematoporphyrin-anti-IL-2R Fab 
(5). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) revealed 
that each of the antibody conjugates contained less than 1 % unconjugated 
photosensitiser, while the anti-IL-2R Fab conjugate contained up to 4 %. In vivo 
photolysis experiments with TIB-152 T-leukaemia cells expressing the IL-2R receptor 
verified that chlorin e6 conjugate was more effective than the analogous 
hematoporphyrin conjugate. There was fewer photosensitisers per antibody for 
hematoporphyrin-anti-IL-2R Fab in contrast to hematoporphyrin-anti-IL-2R, thus a 
higher concentration of hematoporphyrin-anti-IL-2R Fab was required to reduce TIB-
152 cell viability, even though the hematoporphyrin-anti-IL-2R Fab conjugate diffuses 
to the receptor more efficiently. These findings illustrate the importance of loading 
multiple photosensitiser units on to antibodies.  
The carbodiimide strategy has been used to conjugate palladium(II) coproporphyrin 
(Figure 4) to rabbit anti-human ferritin antibodies.
46
 The photosensitiser was dissolved 
in a dilute potassium hydroxide solution and hydrochloric acid was used to adjust the 
acidity of the solution to pH 6. EDCI was dissolved in water and sodium phosphate 
buffer was added. The activated photosensitiser was added in either 50 or 200 molar 
excess, relative to the antibody, in a sodium bicarbonate solution (pH 8.3). The crude 
conjugate was then loaded on to a Sephacryl S-200 column and eluted with sodium 
borate (pH 8.5). The loading ratio was dependent on the molar ratio of photosensitiser 
used: 50 molar excess of photosensitiser produced conjugate with 0.3 porphyrin 
molecules/antibody and 200 molar excess created conjugate with 1.0 porphyrin 
molecules/antibody. 
 
 
Figure 4: Structure of palladium(II) coproporphyrin.
46
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Although the versatility of the carbodiimide coupling strategy has been demonstrated, 
and produces conjugates with promising biological results; carbodiimide coupling has 
the disadvantage that it requires the in situ formation of a reactive intermediate, and can 
also result in substantial loss of photosensitiser as the N-acyl urea derivative.
47
 
 
1.2.2.2 Activated esters 
 
Due to inherent problems with direct carbodiimide coupling to form photo-
immunoconjugates, research involving carbodiimide agents has been directed towards 
derivatising photosensitiser as activated esters, which can be isolated and purified 
before conjugation. The most common method involves the transformation of carboxyl 
functionalities present on the photosensitiser into N-hydroxysuccinimide esters via 
treatment with N-hydroxysuccinimide (NHS) in the presence of 
dicyclohexylcarbodiimide (DCC), and subsequent coupling with amino functionalities 
expressed by the antibody (Scheme 2). 
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Scheme 2: General NHS activated ester strategy for bioconjugates involving chlorin 
e6 or Verteporfin®. 
 
Martsez et al.
46
 investigated both the direct carbodiimide (previously described) and 
activated ester strategies for conjugating palladium(II) coproporphyrin to a mouse 
monoclonal antibody IgG2a and rabbit anti-human ferritin antibodies. The palladium(II) 
coproporphyrin bearing NHS activated ester was dissolved in dimethylformamide and 
added in a range of molarities between 5 and 100 excess, to the antibody in sodium 
borate buffer solutions of differing pH (7.4, 7.8 or 8.5), while ensuring that the overall 
dimethylformamide concentration was 13 % in all the conjugation mixtures. Glycine in 
sodium borate buffer was added to quench the reactions and each resulting mixture was 
passed through a Sephacryl S-200 column and eluted with sodium borate buffer (pH 
8.5). The conjugation reaction produced both the monomeric conjugate and aggregates, 
with yields of both increasing directly with increasing photosensitiser/IgG molar ratios. 
The pH of the conjugation medium also influenced the reaction, increasing the pH from 
7.4 to 8.5 resulted in more covalently bound photosensitiser, however the formation of 
aggregates was also more prominent. Thus the optimised conditions to synthesise 
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monomeric conjugates, was addition of a 10-40 molar excess of photosensitiser to the 
antibody in a buffer solution at pH 7.4. The monomeric conjugates did not contain any 
significant amount of unbound photosensitiser as indicated by gel permeation 
chromatography. A study to establish how the direct carbodiimide coupling and NHS 
activated ester methodology influenced the binding efficiency of monomeric conjugates 
to the target antigen, revealed that the immunoreactivity of the conjugates formed by the 
carbodiimide reaction had been compromised. However the conjugate formed via the 
activated ester exhibited enhanced antigen affinity, which was attributed to an increase 
in the conformational mobility of the derivatised antibody.  
Synthesis of a chlorin e6-anti-EGFR mAb (C225) conjugate was achieved using a NHS 
activated ester strategy as reported by Soukos et al.
48
 Chlorin e6 was treated with NHS 
and DCC in anhydrous dimethylsulfoxide and the resulting chlorin e6-NHS ester was 
reacted with C225 dissolved in a sodium bicarbonate buffer solution (pH 9.3). The 
conjugate was dialyzed against phosphate buffer to remove the unconjugated 
photosensitiser and stored in the presence of horse serum to prevent conjugate 
aggregation. The loading of chlorin e6 was limited by the tendency to form aggregates 
when more than 5 molecules of photosensitiser were added to an individual mAb; the 
loading ratio was 4.8 molecules chlorin e6 per C225 as calculated by UV-visible 
spectroscopy. The chlorin e6-C225 conjugate was tested in vivo employing hamsters 
expressing papillary tumours; following a typical PDT treatment, the expression of 
EGFR was reduced, as indicated by immunophotodiagnosis. 
Fabbrini et al.
49
 have used bis(triethanolamine)Sn(IV)chlorin e6 to form conjugates with 
SIP and scFv formats of the L19 antibody, which shows affinity for the EDB domain of 
fibronectin. The bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19 immunoconjugate was 
produced by two different methodologies. One procedure involved isolation of 
bis(triethanolamine)Sn(IV)chlorin e6-NHS and progressive additions of the activated 
photosensitiser to the antibody in carbonate buffer (pH 8.5). The 
bis(triethanolamine)Sn(IV)chlorin e6-NHS was synthesised by DCC mediated reaction 
between NHS and bis(triethanolamine)Sn(IV)chlorin e6 dissolved in anhydrous 
dimethylformamide; the reagents stoichiometry relative to the photosensitiser was used 
to control whether monoesterification or triesterification of the photosensitiser occurred. 
To terminate the conjugation reaction, tris(hydroxymethyl)aminomethane was used to 
quench un-reacted bis(triethanolamine)Sn(IV)chlorin e6-NHS ester; dialysis and gel 
permeation chromatography was used to purify the immunoconjugate. The other 
procedure used to produce bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19, as well as 
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the scFv(L19) conjugate, involved in situ formation of 
bis(triethanolamine)Sn(IV)chlorin e6-NHS ester, resulting from carbodiimide coupling 
(EDCI) of sulfo-NHS to bis(triethanolamine)Sn(IV)chlorin e6 suspended in phosphate 
buffer (pH 6), followed by the addition of antibody in phosphate buffer (pH 8.5). 
Exhaustive dialysis and gel permeation chromatography yielded the purified conjugate. 
The conjugates formed by the in situ production of bis(triethanolamine)Sn(IV)chlorin 
e6-NHS ester exhibited an average loading ratio of 2:1 (photosensitiser:antibody) for 
both conjugates as determined by UV-visible spectroscopy, with no detectable non-
covalently bound photosensitiser, as indicated by SDS-PAGE. Affinity chromatography 
showed that the immunoreactivity of the conjugates was mostly retained after 
conjugation, at 84 % for bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19 and 82 % 
bis(triethanolamine)Sn(IV)chlorin e6-(ScFv)L19 in comparison to the corresponding un-
conjugated antibody fragments. In vivo experiments treating mice bearing FE8 sarcoma 
with bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19 and 
bis(triethanolamine)Sn(IV)chlorin e6-(ScFv)L19 conjugates, once they had reached 
comparable tumour:blood ratios, demonstrated that the 
bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19 reduced tumour mass to a greater extent 
in comparison with bis(triethanolamine)Sn(IV)chlorin e6-(ScFv)L19. Further in vivo 
studies comparing bis(triethanolamine)Sn(IV)chlorin e6-(SIP)L19 as a single PDT 
treatment, with a three dose PDT treatment on nude mice bearing FE8 using the same 
conjugate, revealed a substantially increased time delay in tumour growth for the 
multiple dose PDT treatment. 
The activated ester approach has been applied to produce conjugates of benzoporphyrin 
derivative conjugated to an anti-EGFR antibody (C225), which had been previously 
conjugated with a 10 kDa-branched polyethylene glycol (PEG) chain.
50
 The 
benzoporphyrin derivative-NHS ester was prepared by the EDCI catalysed reaction 
between NHS and benzoporphyrin derivative in dimethylsulfoxide. The activated 
benzoporphyrin derivative-NHS ester was then added to the PEGylated C225 dissolved 
in a dimethylsulfoxide-aqueous solvent system. The dual solvent system was used to 
avoid photosensitiser aggregation and possible non-covalent interactions; additionally 
the conjugation medium did not exceed 50 % dimethylsulfoxide to prevent precipitation 
and denaturing of C225. The conjugation mixture was then centrifuged and passed 
through a Sephadex G-50 column to yield the purified conjugate. Depending on the 
stoichiometry of the benzoporphyrin derivative-NHS ester relative to the antibody, 
immunoconjugates with loading ratios ranging from 2-11 were prepared. The purity of 
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the conjugates was analysed using SDS-PAGE and it was found that there was 
approximately 5 % non-covalently bound photosensitiser for the conjugate with a 
loading ratio of 2, increasing to 10 % for the conjugate with a loading ratio of 11. The 
final yield of the conjugates was also influenced by the molar loading ratios, a yield of 
75 % for the conjugate with a loading ratio of 2, decreasing to a yield of below 45 % for 
the conjugate with a loading ratio of 11. Phototoxicity experiments were performed by 
incubating benzoporphyrin derivative-C225-PEG with both A-431 (EGFR expressing) 
and NR6 (non-EGFR expressing) cell lines prior to light activation; the selectivity of the 
conjugate was realised as the A-431 showed a substantial reduction in cell viability (90 
%), whereas no significant phototoxic effect was observed on the NR6 cells. Research 
concerning the benzoporphyrin derivative-C225-PEG conjugate was extended by 
conducting mechanistic studies.
51
 It was found that the immunoconjugate was less 
phototoxic than benzoporphyrin derivative alone, on a molar basis. However, the 
conjugate did selectively target EGFR expressing cells, whereas no selectivity was 
observed for the free benzoporphyrin derivative. Savellano et al.
52
 used a similar 
protocol for the conjugation of pyropheophorbide-a to the PEGylated HER50 and 
HER66 mAb targeting the anti-epidermal growth factor receptor HE2 expressed by 
ovarian and breast cancer. The activated photosensitiser was conjugated to the 
PEGylated antibody in PBS (pH 7.4); purification using a Sephadex G50 spin column 
afforded the immunoconjugates. SDS-PAGE revealed that the conjugates contained 
unbound pyropheophorbide-a ranging from 2.3-20.9 %, dependent on the preparation 
and antibody used. In vitro studies indicated that phototoxicity could be improved by 
increasing the photosensitiser loading ratio, and by using multiepitope targeting; namely 
the administration of a mixture of immunoconjugates in a single dose. Benzoporphyrin 
derivative and pyropheophorbide-a, have also being conjugated to an anti-HER2 scFv 
(C6.5).
53
 The photosensitiser was activated using NHS in the presence of DCC, with 
pyropheophorbide-a dissolved in a mixture of anhydrous tetrahydrofuran-
dichloromethane (9:1) and benzoporphyrin derivative in anhydrous tetrahydrofuran. The 
pyropheophorbide-a-NHS ester was isolated by removal of the dicyclohexylurea 
precipitate by filtration, then precipitation of the crude product using hexane over 
chloroform followed by column chromatography, whereas benzoporphyrin derivative-
NHS ester was purified more simply by column chromatography. The photosensitiser 
dissolved in dimethylsulfoxide was added to C6.5 in PBS containing 6 % acetonitrile 
and the resulting conjugate was dialysed against PBS. On average, each C6.5 was 
loaded with 10 photosensitisers, of which up to 20 % were non-covalently bound. 
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Cellular uptake experiments, using HER-2 positive SKOV-3 cells and HER-2 negative 
KB cells demonstrated the selectivity of the pyropheophorbide-a-C6.5 conjugate. 
Additionally, enhanced retention with SKOV-3 cells was observed for the 
benzoporphyrin derivative-C6.5 in comparison to unconjugated benzoporphyrin 
derivative. Bhatti et al.
54
 extended this research by synthesising a library of conjugates 
consisting of pyropheophorbide-a conjugated to C6.5, MFE-23, D1.3, F1, GP6 and 
HuBC-1 scFv‟s, as well as the benzoporphyrin derivative-C6.5 conjugate, illustrating 
the versatility of this conjugation methodology. The final pyropheophorbide-a conjugate 
concentrations were limited to approximately 0.25 mg/mL due to the hydrophobic 
nature of pyropheophorbide-a, resulting in aggregation, whereas the more hydrophilic 
sulfo-NHS-pyropheophorbide-a, produced conjugates with C6.5 at higher 
concentrations. The conjugates were more potent than the corresponding free 
photosensitiser when tested with an appropriate cell line, both in vitro and in vivo. 
Carcenac et al.
55,56 
have utilized the activated ester approach to synthesise 
immunoconjugates involving derivatised aluminium tetrasulfophthalocyanine (AlPcS4). 
The sulfonic acid groups expressed by AlPcS4 were converted into sulfonyl chloride 
functionalities by treatment with thionyl chloride, to which, aliquots of a solution of 6-
aminohexanoic acid and sodium carbonate in suitable stoichiometry were added, 
yielding the monosulfonamide product (AlPcS4A1). The carboxylic acid thus 
introduced, was converted into the activated ester by treatment with sulfo-NHS and 
EDCI in sodium phosphate buffer (pH 5). Chromatography on reversed-phase C18 
preparative plates using phosphate buffer/methanol as the eluent and subsequent 
lyophilisation purified the AlPcS4A-NHS ester.
57
 The first exploratory paper involved 
the coupling with a radioiodinated 35A7 mAb, which targets a carcinoembryonic 
antigen.
55
 AlPcS4A1-NHS ester in phosphate buffer (pH 5) was added dropwise to the 
35A7 mAb contained in sodium bicarbonate (pH 9). The resulting mixture was passed 
through a Sephadex G25 column using PBS (pH 7.4), which contained 0.01 % azide. 
The immunoreactivity and biodistribution of the conjugates, measured using the 
radiolabel, was comparable to the 35A7 mAb. This research was then extended to 
produce conjugates with 35A7 mAb, targeting the non-internalising carcinoembryonic 
antigen, FSP77 mAb, that has an affinity towards the internalising ErbB2 antigen, and 
an irrelevant PX mAb.
56
 In vitro experiments were performed on a SKOv3-CEA-1B9 
cell line which expressed similar levels of both ErbB2 and carcinoembryonic antigens. 
Following activation by light, the AlPcS4A1-35A7 conjugate reduced the cell lines 
growth by 68 % when incubated for 20 hours at 2.5 µg/mL; in comparison the 
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AlPcS4A1-FSP77 caused 96 % growth inhibition after been incubated for 8 hours at 
1.25 µg/mL, thus demonstrating the enhanced potency of internalising conjugates.  
An exploratory article by Halime et al.
58
 has used 5-(2-N-triphenylmethylaminophenyl)-
10,15,20-tri(2-aminophenyl)porphyrin (TrTAPP),
59
 for conjugations with IgG and Fab. 
The hydrophilic succinyl groups were introduced to TrTAPP by treated with ethyl 
succinyl chloride in the presence of triethylamine. The trityl protecting group was 
removed by trifluoroacetic acid hydrolysis to afford an amino functionality, which upon 
treatment with succinic anhydride yielded a carboxyl group that was subsequently 
converted into the NHS activated ester. The derivatised porphyrin dissolved in 
dimethylsulfoxide was added to the antibody in a sodium phosphate dihydrate buffered 
solution (pH 6) and the purified conjugates were obtained using a Sephadex G25 
column (Scheme 3). The same strategy was also applied to derivatising the antibody 
with an activated ester to facilitate coupling with an amino functionality present on the 
porphyrin moiety. Reduction of the disulfide bridges of an IgG antibody using 2-
mercaptoethanolamine yielded thiol groups, which were reacted with the bi-functional 
crosslinker N-succinimidyl(4-iodoacetyl)aminobenzoate (SIAB) in a sodium tetraborate 
decadihydrate based buffer solution to introduce an activated ester. The coupling was 
also performed in a sodium tetraborate decahydrate based buffer solution and Sephadex 
G25 column chromatography was used for purification (Scheme 4).  
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Scheme 3: TrTAPP conjugation to an antibody by the NHS-activated ester 
approach.
58
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Scheme 4: TrTAPP conjugation to modified antibody.
58
 
 
Vrouenraets et al.
38,60,61,62
 have utilised an alternative activated ester method, based on 
tetrafluorophenol (TFP), for successfully producing immunoconjugates. A reaction 
between the commercially available photosensitiser 5,10,15,20-tetra(m-
hydroxyphenyl)chlorin (Foscan
®
, Temoporfin
®
) and iodoacetic acid resulted in 
enhanced hydrophilicity via tetracarboxymethylation of the hydroxyl groups. The 
carboxylic acid groups formed were subsequently converted into activated esters by 
EDCI mediated coupling with TFP and the intermediate was purified by HPLC. Partial 
hydrolysis of the activated esters using stepwise additions of sodium carbonate in buffer 
solution produced a mixture of completely hydrolysed esters, mono-ester, and trace 
amounts of di-ester; the antibody in buffered saline (pH 9.5) was then added to the 
mixture. The conjugates were purified by gel permeation chromatography (Scheme 
5).
38,61
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Scheme 5: Modification of Foscan
®
 and conjugation to mAb using TFP activated 
ester strategy.
38,61
  
 
This approach was used to form conjugates with the internalising 425 mmAb and the 
non-internalising cmAb U36 antibodies, which target antigens associated with 
squamous cell carcinomas. Conjugates with a molar ratio of up to 4 photosensitisers per 
mAb were prepared. SDS-PAGE revealed that the conjugates contained a minor higher 
molecular weight impurity, which was ascribed to oligomers formed by trace amounts 
of di-ester in the conjugation mixture. The Temoporfin
®
-U36 conjugate was 
radioiodinated to enable pharmacokinetic studies in mice bearing head and neck 
squamous cell carcinomas. The conjugate exhibited an enhanced selectivity towards the 
tumour, although this was not as prominent as expected based on the distribution of the 
unconjugated U36, furthermore the conjugates with a higher molar ratio of 
photosensitiser were cleared from the blood more rapidly. Both the Temoporfin
®
-U36 
and carboxymethylated Temoporfin
®
 showed significant accumulation in the liver, 
however skin photosensitisation was lower for the conjugate 48 hours after 
administration. In vitro studies were also performed comparing the internalising and 
non-internalising conjugates, with the internalising conjugates being more phototoxic.
38
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The research was further developed to enable conjugation with AlPcS4. Thionyl chloride 
facilitated the conversion of the sulfonic acid groups into sulfonyl chloride 
functionalities, which in turn were reacted with glycine to produce 
carboxysulfonamides. These transformations were performed in dimethylformamide, 
however glycine is insoluble in dimethylformamide therefore N,O-
bis(trimethylsilyl)acetamide was required to form a disilylated intermediate with 
glycine so the reaction in dimethylformamide could occur. The carboxyl groups were 
then treated with TFP in the presence of EDCI, leading to the formation of the activated 
esters. Partial hydrolysis of the activated ester was not required as the esters are 
sufficiently labile under aqueous conditions. The photosensitiser in acetonitrile was 
added to the antibody in buffer solution (pH 9.5) and the resulting conjugate was 
purified by gel permeation chromatography.
60,61
 Conjugations with the mmAb E48 and 
425 as well as the cmAb U36 were achieved using this methodology. In vitro 
experiments employing an A431 cell line demonstrated that the internalising 
AlPc(S02NGly)4-425 conjugate was 7500 times more toxic than the un-conjugated 
photosensitiser. The AlPc(S02NGly)4-425 conjugate was also more toxic than the 
unconjugated Temoporfin
®
.
60
 Vrouenraets et al.
62
 have coupled a novel photosensitiser, 
5-[4-[5-(carboxyl)-1-butoxy]phenyl]-10,15,20-tris-(4-methylpyridiniumyl)porphyrin 
iodide,
63
 to the mmAb E48 and 425 as well as cmAb U36 using the TFP activated 
strategy as previously described. The selectivity of the conjugates was illustrated and 
the in vitro studies revealed that internalising conjugates were phototoxic to A431 cells, 
but that the non-internalising conjugates were not at concentrations up to 1 µM.  
   
 
 
 
 
 
 
 
 
 
 
 26 
      
1.2.2.3 Reductive amination 
 
Reductive amination involves the reaction between formyl and amino groups leading to 
the generation of an imine, which is usually reduced in situ to form a stable amine 
linkage. 
Yarmush and co-workers
64,65,66,67
 have used a reductive amination approach for 
synthesising Sn(IV)chlorin e6 monoethylenediamine photo-immunoconjugates with 
IgG,
64
 PO37,
64
 α-ICAM,65 and PR2D366,67 mAb. The general procedure involves DCC 
coupling between a chlorin e6 carboxylic acid group and ethylene diamine to yield a 
short chain extension terminating in an amino group. The core of chlorin e6- 
monoethylenediamine was then derivatised by the insertion of tin using stannous 
chloride, affording Sn(IV)chlorin e6 upon air oxidation. For the Sn(IV)chlorin e6 
monoethylenediamine precursor possessing axial ligands, excess triethanolamine was 
added to Sn(II)chlorin e6, yielding bis(triethanolamine)Sn(IV)chlorin e6 
monoethylenediamine. Sodium periodate was added to the antibody solution causing 
oxidation of an oligosaccharide moiety present in the Fc domain, ethylene glycol was 
added to quench the oxidation process and the oxidised mAb solution was purified by 
gel permeation chromatography. The photosensitiser in PBS and modified antibody in 
phosphate buffer were then mixed, leading to the formation of an imine, which was 
reduced using sodium cyanoborohydride dissolved in water (Scheme 6).
64
  
 
 
Scheme 6: Reductive amination reaction between derivatised chlorin e6 and oxidised 
antibody.
64
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Radioiodated Sn(IV)chlorin e6 monoethylenediamine-PO37, targeting P. aeruginosa, 
and Sn(IV)chlorin e6 monoethylenediamine-IgG conjugates were prepared, both with 
and without the triethanolamine ligands. The photosensitiser to mAb ratios, which were 
determined spectroscopically, ranged from 1.6-10 and was dependent on the molar 
excess of photosensitiser used for coupling. Batch to batch preparations were 
considered to be relatively reproducible, although some preparations did contain 
immunoglobulin dimers and other aggregates, as determined by HPLC analysis. The 
singlet oxygen quantum yield of the conjugates had slightly diminished, in comparison 
to the Sn(IV)chlorin e6 monoethylenediamine precursor, possibly due to structural 
changes in the photosensitiser and/or aggregation. In vitro assays confirmed that the 
phototoxicity of the conjugates increased concomitantly with photosensitiser loading. 
The immunoreactivity of the conjugate was retained, indicated by a competitive 
inhibition radioimmunoassay. In vitro biodistribution studies showed that 
bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine had a significant effect on 
retention of the conjugate; Sn(IV)chlorin e6 monoethylenediamine conjugates were 
cleared promptly from the mice. The presence of triethanolamine ligands also 
considerably enhanced the stability of the conjugate in human plasma.
64 
This strategy 
was then utilized to produce conjugates with the α-ICAM mAb specific to cell surface 
antigens present on melanoma cells. In vitro experiments on M21 cells consisting of 
administering bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine-α-ICAM at 
various concentrations, and using different light intensities, were conducted to 
investigate the mechanics of photo-induced cell membrane damage resulting from PDT. 
A fluorescent integrity probe and microscopy was used to monitor the reactions. A time 
lag was observed before a point rupture at the cell surface resulted in cell lysis and the 
time lag was inversely proportional to the reactive oxygen species which had diffused to 
the cell membrane.
65 
This methodology was used for the production of a 
bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine conjugate with an anti-
fibroblast antibody (PR2D3), for the treatment of hypertrophic scars.66
,
67 In a 
preliminary article the bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine-
PR2D3 conjugate was synthesised; the loading ratio was determined spectroscopically 
and found to be, on average, 1.3 photosensitisers per PR2D3. An in vivo experiment 
was performed using mice implanted with human hypertrophic scar tissue; the 
conjugate was administered to the mice and, after a 24 hour time interval, the 
photosensitiser was activated with light. Treatment employing the 
bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine-PR2D3 conjugate caused 
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considerable growth reduction in the implants in comparison to the un-treated controls. 
An irrelevant conjugate was also tested in vivo, but no noteworthy phototoxic effect was 
observed.
66 
The research was extended to produce a range of 
bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine-PR2D3 conjugates with 
loading ratios of 0.5, 1.0 and 2.0 photosensitiser/mAb, with the purity of the conjugates 
being confirmed by HPLC. Phototoxicity experiments using a cell line consisting of 
fibroblasts cultured in a fibroblast-populated collagen lattice (FPLC) were performed; it 
has been postulated that wound contraction resulting in severe scarring is facilitated by 
fibroblasts and myofibroblasts. The phototoxicity of the 
bis(triethanolamine)Sn(IV)chlorin e6 monoethylenediamine-PR2D3 conjugate was 
found to be dependent on the photosensitiser concentration and intensity of light used 
for activation. A correlation between increasing rate of lattice contraction and number 
of viable fibroblasts was observed.
67  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
      
1.2.2.4 Isothiocyanate conjugation 
 
The isothiocyanate functional group enables conjugation with lysine residues via an 
addition reaction, thus no by-products are produced that could potentially contaminate 
the conjugate. Additionally, no activating agents or reagents are required. Boyle and co-
workers
68,69
 have synthesised a range of porphyrins (Figure 5) bearing hydrophilic 
substituents, such as hydroxyl or quaternised pyridyl groups, and a single isothiocyanate 
group for bioconjugation; thus eliminating the possibility of antibody cross-linking 
during the coupling procedure. 
 
 
Figure 5: Hydrophilic photosensitiser bearing an isothiocyanate group. 
 
The hexahydroxy porphyrin (A) was synthesised from a porphyrin precursor possessing 
one protected amino group and six methoxy groups. The methoxy functionalities were 
demethylated using boron tribromide and the single amino group, after deprotection, 
was transformed into the isothiocyanate functionality by reacting it with 1,1-
thiocarbonyldi-2,2`-pyridone (TDP).
68
 The cationic compounds (B-E) were derived 
from porphyrins bearing a protected amino group, and one or three pyridyl groups for 
B-D, or a dimethylamino group for E. TDP treatment yielded the isothiocyanate 
functionality and hydrophilicity was introduced via methylation of the dimethylamino 
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or pyridyl functionalities. The cationic compounds were treated with amberlite IRA 
resulting in chloride ion-exchange and enhanced water solubility.
68,69
 In a study by 
Boyle et al.
70
 the porphyrinic photosensitisers (A and B) were coupled to the 
internalising FSP 77 and 17.1A (IgG2a) mAb and the non-internalising 35A7; the 
antibodies were radioiodinated prior to conjugation to enable biodistribution studies. 
The conjugation procedure involved A in dimethylsulfoxide or B in water being added 
at various molar excesses (20, 40 or 60) to the antibody in sodium bicarbonate buffer 
(pH 9.2). The conjugates were passed through a Sephadex G25 column using PBS as 
the eluent, and the purified conjugate loading ratios were determined spectroscopically. 
The loading ratios calculated ranged from 1.4 to 2.5 and variations occurred between 
the different photosensitisers and antibodies used. Generally, the loading ratio increased 
when higher molar excesses of photosensitiser were used for couplings, except for 
conjugations between A and FSP77 mAb, where a decrease in photosensitiser loading 
was observed, possibly due to reduced solubility in PBS for the photosensitiser at higher 
concentrations. The behaviour of the conjugates was generally comparable to the 
corresponding unconjugated mAbs, as indicated by flow cytometry, in vitro binding and 
in vivo biodistribution. However a decrease in tumour uptake occurred for conjugates of 
B with higher loading ratios. The in vivo biodistribution also showed that tumour to 
peritumoural ratios were favourable; for example, for A-35A7 this was found to be 
33.3:1. The SKOv3-CEA-1B9 cell line was used to compare the phototoxicity of the 
conjugates; an enhanced phototoxic effect occurred for the internalising A-FSP77 
conjugate, but no phototoxicity was observed for the non-internalising A-35A7, 
whereas both B-FSP77 and B-35A7 increased in phototoxicity. The absence of 
phototoxic effect for A-35A7, but not for B-35A7 was thought to be caused, at least in 
part, by the greater inherent phototoxicity of B, as unconjugated B was up to 3 times 
more phototoxic than A. The internalising conjugates were more phototoxic than the 
non-internalising conjugates, which is in agreement with previous work by Carcenac et 
al.
56
. The research was extended to produce conjugates between C, D and E (Figure 5) 
and anti-EpCAM or anti-CD104 antibodies.
69
 The loading ratios were in the range of 
0.3-1.74 photosensitiser/mAb and the variations were dependent on the photosensitiser: 
E>C>D, as well as the mAb: anti-CD104>anti-EpCAM. Pharmacokinetic studies 
indicated that the binding efficiency of the conjugates was similar to the corresponding 
unconjugated antibody. The enhanced phototoxicity of the conjugates was also 
demonstrated using CORL23 and LoVo cell lines, both of which express the EpCAM 
and CD104 antigens, however the LoVo cell line expresses 10 times more EpCAM 
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antigens. The phototoxicity of the anti- EpCAM conjugates on the LoVo and CD104 
cell lines was similar and did not seem to reflect differences in antigen expression 
between the cell lines, thus suggesting that the biology associated with the antibody 
and/or antigen influences the overall photodynamic effect. Boyle and co-workers
71
 then 
utilized the isothiocyanate approach to produce conjugates with an irrelevant anti-NIP 
scFv, and LAG3 scFv which targets antigens associated with colorectal malignancies. 
Various molar excesses of A and B (Figure 5), ranging from (2.5-60), were added to the 
scFv in sodium hydrogen carbonate buffer (pH 9.2). The final loading ratios differed 
substantially for the different photosensitiser used: for A loading ratios varied from 4-20 
while B only loaded between 0.67-1.2 molecules of photosensitiser per scFv. Flow 
cytometry assessment of the immunoreactivity of the conjugates showed that antigen 
affinity of the A conjugates had been severely compromised, possibly due to non-
covalent binding and/or the photosensitiser coupling in the scFv antigen recognition 
region. The conjugates of B retained binding reactivity, with the binding efficiency 
diminishing with increasing molar loading ratios. In vitro cytotoxicity experiments 
illustrated that B-LAG3 scFv had a selective cytotoxic effect on Caco-2 cells, causing 
cell death primarily via an apoptotic pathway.  
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1.2.2.5 Maleimide conjugation 
 
Milgrom and O‟Neill 72 have synthesised a maleimide substituted porphyrin by a series 
of modifications to a synthetic, unsymmetrical porphyrin, 5,10,15-tris(4-
methoxycarbonylphenyl)-20-(4-hydroxyphenyl)porphyrin, which was subsequently 
coupled to a thiolated B72.3 mAb (Scheme 7). The hydroxyl group was modified to 
present an amino group by treating the hydroxyl group with N-(2-
bromoethyl)phthalimide in the presence of sodium carbonate, and secondly, converting 
the 2-phthalimidoethoxy group into an amine by treatment with an ethanolic solution of 
methylamine. A heterobifunctional crosslinking agent, N-succinimidyl-3-
maleimidopropionate (SMP), in the presence N-methylmorpholine, was used to 
introduce the maleimide group onto the photosensitiser. An aqueous buffered solution 
of the antibody was treated with 2-iminothiolane hydrochloride (Traut‟s reagent), 
resulting in the lysine residues expressing thiol functionalities. A thiol assay using 4,4‟-
dithiodipyridine indicated that approximately 1.58 thiol groups had been introduced to 
each antibody. The photosensitiser dissolved in dimethylformamide was added to the 
thiolated antibody solution leading to the formation of a precipitate, thus indicating that 
this solvent system was not optimal for conjugation due to the hydrophobic nature of 
the photosensitiser. The conjugate was finally purified by gel permeation 
chromatography.  
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Scheme 7: Coupling of thiolated antibody to a maleimido porphyrin.
72
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1.2.2.6 Acryloyl conjugation  
 
5,10,15-Tris(2-(3-(ethoxycarbonyl)propionamido)-phenyl))-20-(2-
aminophenyl)porphyrin has been derivatised to present a thiol reactive acryloyl group.
58
 
The amino functionality was converted into the acryloyl bioconjugation handle via 
treatment with acryl chloride in the presence of triethylamine. The photosensitiser 
dissolved in dimethylsulfoxide was then added to the reduced IgG in sodium phosphate 
buffer (pH 6). Finally, Sephadex G25 gel permeation chromatography afforded the 
conjugate (Scheme 8). 
 
 
Scheme 8: Bioconjugation involving the acryloyl functionality.
58
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1.2.3 Conjugations using polymeric linkers 
 
Polymeric linkers used for bioconjugation are generally water soluble molecules that 
posses multiple functionalities, which can be used for coupling with mAbs and 
photosensitisers. The possibility of loading multiple photosensitisers to the polymer 
before attachment to the mAb, and thus potentially enhancing photoactivity, is 
attractive, providing the targeting efficiency of the construct is maintained. Due to the 
availability of many conjugation sites, photosensitiser will load in a statistical manner. 
At higher loading ratios this can lead to conjugates bearing photosensitisers in close 
proximity to each other, and potentially result in quenching of excited states and loss of 
photoactivity. The relatively large size of the polymer can also present problems if 
conjugation occurs near the binding site, which can lead to loss of immunoreactivity. 
Polymeric linkers are generally a mixture of different lengths with average molecular 
weight, and conjugation will result in this property being transferred to the conjugate, 
producing conjugates that are ill defined structures.  
 
1.2.3.1 Dextran 
 
The glucose polymer, dextran, which contains multiple hydroxyl groups, is fully water 
soluble and non-toxic, and has been used to couple multiple photosensitiser units to a 
variety of antibodies; including anti-Leu-1,
73,74
 anti-BSA mAb 9.1,
73,74
 anti-melanoma 
2.1,
75,76,77
 and anti-lymphoma 2.130.
75,76
 In preliminary studies, chlorin e6 
monoethylenediamine was prepared by converting one available carboxyl group in to an 
anhydride using a stoichiometric amount of ethyl chloroformate in the presence of 
triethylamine. Subsequent addition of ethylene diamine introduced the amino 
functionality required for reaction with dextran. Sodium periodate was then used to 
oxidise the dextran and a 5- molar excess of ethylene diamine was added, followed by 
addition of a 75-molar excess of chlorin e6; the imines formed during this step were 
reduced with sodium borohydride. Finally, purified dextran-chlorin e6 
monoethylenediamine conjugate was reacted with the pre-oxidised antibody, and the 
resulting imine was reduced with sodium cyanoborohydride (Scheme 9). The conjugate 
was passed through a Sephacryl S-300 column, eluted with sodium phosphate. 
The conjugate exhibited high loading ratios, up to 36 chlorin e6 molecules for each 
antibody, as determined by UV-visible spectroscopy. The conjugate also retained 
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approximately 80 % antigen binding activity, as indicated by assays using appropriate 
antigen positive cell lines; furthermore increasing the photosensitiser loading ratio did 
not appear to influence the binding activity. Phototoxicity studies showed that 
photoactivity had been retained; the singlet oxygen quantum yield for the conjugate 
being identical to the unconjugated photosensitiser. In vitro assays determined that 
phototoxicity was dependent on light intensity, conjugate dose and was further 
enhanced in the presence of deuterated water, thus suggesting the involvement of singlet 
molecular oxygen. The conjugate also had a significant phototoxic effect on antigen 
expressing cell lines, whereas the unconjugated photosensitiser was ineffective at 
concentrations 100-fold greater than that of the conjugate.
73,74
  
 
 
Scheme 9: Synthesis of dextran immunoconjugates.
73,74
 
 
The synthesis of dextran photo-immunoconjugates was further developed so that the 
dextran carrier expressed a single bioconjugation handle at its terminus, enabling site 
specific conjugation between the dextran carrier and antibody.
75,76,77
 The terminal 
glucose unit of dextran (35 kDa) was reduced with sodium cyanoborohydride enabling 
in situ reductive amination with adipic dihydrazide. The derivatised dextran, now 
bearing an amino group, was then reacted with a novel linker; bearing an activated ester 
and trityl protected hydrazide at opposite ends of a short alkyl chain. Treatment with 
ethyl chloroformate in the presence of triethylamine resulting in the formation of an 
activated ester located at the centre of the glucose moieties. Hydrazone was then added 
to the derivatised dextran, resulting in the formation of multiple amino groups, which 
were subsequently reacted with various concentrations of Sn(IV)chlorin e6, pre-
activated with EDCI / hydroxybenzothiazole (HOBt). Capping of the un-reacted amino 
groups was achieved via a reductive amination reaction with acetaldehyde and sodium 
cyanoborohydride. Acid hydrolysis of the trityl group yielded a single amino group 
which participated in bioconjugation with an oxidised antibody; to achieve this the 
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dextran carrier, dissolved in water, was added to the oxidised mAb in acetate buffer (pH 
4.75) leading to the formation of a hydrazone linkage. The reduction of this hydrazone 
was performed, but did not influence the stability of the conjugate, therefore this step 
was not included for the optimized conditions. Once the reaction was complete, 
potassium phosphate was added to increase the basicity of the conjugation mixture (pH 
7.5). The crude conjugate was then applied to a protein G-Sepharose column, to remove 
the unconjugated photosensitiser-dextran, and eluted with a glycine solution (pH 2.5). 
The conjugates had formed as postulated, which was indicated by SDS-PAGE, with 
HPLC analysis revealing a signal for the pure conjugate in molecular weight range 200-
240 kDa, and also a minor signal (< 10 %) corresponding to 2 mAb coupled to a single 
dextran. The number of Sn(IV)chlorin e6 molecules coupled to the dextran carrier was 
dependent on the concentration of Sn(IV)chlorin e6-HOBt used; various loading ratios 
were prepared ranging from 1-10 Sn(IV)chlorin e6 units per dextran. The number of 
photosensitisers present on the dextran slightly reduced the conjugation yield, but had 
no influence on the number of dextrans conjugating to each mAb; approximately 2 
dextran carriers were conjugated to each mAb. Competitive inhibition assays using 
antigen positive cell lines, indicated that the binding activity of the conjugate was 
reduced, but still remained similar to the unconjugated antibody.
75
 A series of 
Sn(IV)chlorin e6-dextran-anti-melanoma 2.1 conjugates were then assessed in vitro
76,77
 
with the SK-MEL-2 cell line. The selectivity of the conjugate was shown by in vitro 
photolysis experiments; the Sn(IV)chlorin e6-dextran-anti-melanoma 2.1 conjugates 
were considerably more phototoxic to SK-MEL-2 cells, in comparison to Sn(IV)chlorin 
e6-dextran-anti-lymphoma 2.130. Additionally, phototoxicity was enhanced by 
increased photosensitiser loading with a higher dose of light.
76
 A competitive inhibition 
assay confirmed that the immunoreactivity of the conjugate had slightly reduced, but the 
immunoreactivity was independent of photosensitiser loading. The singlet oxygen 
quantum yield was also calculated and showed the conjugate had a reduced singlet 
oxygen yield, attributed to a reduced triplet excited state, determined by time resolved 
absorbance spectroscopy.
77
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1.2.3.2 Polyvinyl alcohol 
 
Polyvinyl alcohol (PVA), average molecular weight 10 kDa, was deemed a suitable 
polymeric linker due to the presence of multiple hydroxyl groups; giving PVA 
hydrophilic character as well as facilitating the introduction of multiple photosensitisers. 
This polymeric carrier has been used for couplings involving benzoporphyrin derivative 
and T48 mAb.
78
 PVA was pre-activated with 2-fluoro-1-methyl pyridinium toluene-4-
sulfonate (FMP) and subsequently reacted with 1,6-diaminohexane. An EDCI mediated 
reaction resulted in conjugation of benzoporphyrin derivative to the derivatised PVA, 
which now bore amino functionalities. The PVA carrier was modified further so it 
expressed thiol groups; this was achieved by EDCI coupling of 3-mercaptopropionic 
acid to available hydroxyl groups. The heterobifunctional crosslinker sulfo-m-
maleimidobenzoyl-N-hydroxysuccinimide ester (SMBS) was then used to modify the 
antibody; the activated ester reacting with the mAb lysine amino groups resulting in 
introduction of the thiol reactive maleimide group. The reaction conditions were 
modified so that 2-3 SMBS were added to each antibody. The benzoporphyrin 
derivative-PVA and modified antibody were then reacted in acetate buffer (pH 5.5) and 
the reaction monitored by TLC (Scheme 10). The conjugation mixture was dialysed 
against PEG and then, in the presence of low molecular weight PVA, was applied to a 
Sepharose CL-4B column equilibrated with acetate buffer. After purification SDS-
PAGE confirmed covalent attachment had occurred and revealed two peaks at 75 and 
105 kDa, attributed to cross-linking between one heavy chain and the photosensitiser 
scaffold, and the PVA carrier cross-linked between the mAb heavy and light chains 
respectively. Jiang et al.
79
 investigated these PVA conjugates further by coupling the 
benzoporphyrin derivative-PVA to a mAb targeting a glycoprotein on human squamous 
carcinomas of the lung, 5E8 mAb. The benzoporphyrin derivative-PVA carrier was 
synthesised with a loading ratio of 25:1 and the carrier was coupled to the mAb with a 
ratio of 1:1. Once conjugated, ELISA analysis determined that 80 % of the binding 
activity had been retained for benzoporphyrin derivative-PVA-5E8, and the 
benzoporphyrin derivative-PVA-T48 did show enhanced binding in comparison to 
benzoporphyrin derivative-PVA. A phototoxicity study employing the antigen positive 
A549 cells, demonstrated enhanced potency of the benzoporphyrin derivative-PVA-
5E8, which was 10 fold more phototoxic than the irrelevant conjugate. Additionally, the 
phototoxicity increased in the presence of 10 % foetal calf serum. The irrelevant 
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conjugate was found to be more cytotoxic to A549 cells than the unconjugated 
photosensitiser, probably due to benzoporphyrin derivative associating with serum 
proteins; the association is less prominent once benzoporphyrin derivative is 
conjugated.  
 
 
Scheme 10: Synthesis of immunoconjugate using polyvinyl alcohol as a polymeric 
linker.
78
 
 
Further in vitro studies were conducted by comparing the phototoxic effect when the 
conjugate remained on the cell surface or was internalised; if the conjugate was 
internalised an increase in phototoxicity was observed.
80
  
The biodistribution of the conjugates was then assessed in vivo with DBA/2 mice 
bearing M1 tumours and nude mice with A549 tumours. The photosensitiser was 
labelled with 
13
C, and the conjugation was performed using 2 equivalents of 
benzoporphyrin derivative-PVA to 1 equivalent of mAb, the final photosensitiser:mAb 
loading ratios were 50-70:1 as indicated by UV-visible spectroscopy. The 
benzoporphyrin derivative biodistribution in the different mice was similar, except for 
the tumour (less benzoporphyrin derivative detected for nude mice) and lymph nodes 
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(more benzoporphyrin derivative detected in nude mice). The conjugates remained in 
the blood of the nude mice for a longer time period than the unconjugated 
photosensitiser and generally the conjugates were retained in all tissues to a greater 
extent, and for a longer period of time, than the unconjugated photosensitiser. The 
kidneys, liver, lungs and spleen contained the highest concentrations of photosensitiser. 
The free photosensitiser clearly had a completely different pharmacokinetic profile to 
the conjugates, thus the conjugates were assumed to be relatively stable in vivo.
81
 
Hemming et al.
82
 studied the potential of benzoporphyrin derivative-PVA conjugates by 
comparing the biodistribution with unconjugated benzoporphyrin derivative and 
cytotoxicity against the commercially available Photofrin II
®
. An anti-EGFR IgG1, 
which has an affinity for oral squamous cell carcinomas, and anti-CEA IgG1, were 
coupled to benzoporphyrin derivative-PVA by the method previously described.
78
 A 
hamster contralateral cheek pouch model containing squamous cell carcinomas was 
employed. The tumour to peritumoural ratio for benzoporphyrin derivative (2:1) was 
considerably less favourable than the benzoporphyrin derivative-PVA-anti-EGFR IgG1 
(26:1). The 1 month cancer free survival of the hamsters showed that the therapies with 
benzoporphyrin derivative were more effective than that with Photofrin II
®
; 67 % 
survival for benzoporphyrin derivative but only 27 % for Photofrin II
®
. However the 
benzoporphyrin derivative-PVA-anti-EGFR IgG1 conjugate was significantly more 
cytotoxic than the free photosensitiser; 80 % of the hamsters survived with a twentieth 
of the dose in comparison to the benzoporphyrin derivative treatment. 
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1.2.3.3 Polylysine  
 
An alternative polyamino acid carrier, polylysine (average molecular weight 25 kDa), 
has been used for synthesising cationic and anionic bioconjugates with OC125 F(ab‟)2; 
83,84,85,86
 targeting ovarian cancer antigens, 17.1A, mAb;
87,88,89
 which bind to colorectal 
cancer associated antigen (EpCAM) and an irrelevant rabbit IgG.  
The initial study investigated the effect of charge on the activity of the conjugates, as 
cationic character has been reported to enhance the rate of endocytosis. Firstly, the 
chlorin e6 was converted to its activated ester form using a DCC mediated reaction with 
NHS, which was subsequently reacted with polylysine in the presence of N-
ethylmorpholine. The heterobifunctional crosslinker pyridyldithiopropionic acid-NHS 
ester was then used to introduce a disulphide bioconjugation handle to the polymeric 
linker. The lysine required further functionalisation in order to produce the anionic 
immunoconjugate; the addition of a large excess of succinic anhydride resulted in 
amino groups being converted to amide groups bearing carboxyethyl groups. The 
cationic character was provided by protonation of the lysine amino groups, whereas 
deprotonation of the carboxylic acid groups resulted in anionic properties being 
expressed. The antibodies were treated with mercaptoethylamine in phosphate buffer 
containing ethylenediaminetetraacetate (EDTA), causing partial reduction of the 
cysteine residues in the hinge region. The reactive thiol expressed by the antibody could 
then participate in a disulphide exchange reaction with the disulphide bioconjugation 
handle, resulting in covalent coupling. Conjugations were performed by the reaction of 
a 3-fold excess of the derivatised lysine in dimethylsulfoxide with the reduced antibody 
in phosphate buffer (pH 7.5) (Scheme 11), a Sephadex G200 column was finally used 
for purification. SDS-PAGE confirmed the conjugation had occurred. The loading ratio 
was calculated using UV-visible spectroscopy, and was found to be 15-20 
photosensitisers/antibody. The immunogenicity of the conjugates was maintained, 
relative to the unconjugated antibody, as shown by ELISA competition assays on an 
antigen positive OVCAR-5 cell line. Cellular uptake studies revealed a six-fold 
enhancement of cationic conjugate uptake, in comparison to the anionic conjugate, after 
a 6 hour incubation time, increasing to a 17-fold enhancement after a 24 hour incubation 
time. Furthermore, raising the temperature of the cellular uptake assays also improved 
uptake of the cationic conjugate, these findings indicated that an active uptake process 
was occurring. Phototoxicity studies confirmed the enhanced potency exhibited by the 
cationic conjugate.  
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Scheme 11: Cationic and anionic lysine based immunoconjugates.
83
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These photo-immunoconjugates were then tested in vivo, using mice bearing ovarian 
tumours.
84
 The biodistribution of the conjugates was analysed 3 hours and 24 hours post 
administration by harvesting the vital organs of the mice and calculating the tumour to 
peritumoural ratio. The cationic conjugates were significantly better at delivering 
photosensitiser to the target tissue in comparison to the anionic conjugates. After 3 
hours the cationic chlorin e6-polylysine-OC125 F(ab‟)2 conjugate had caused less 
photosensitiser accumulation in the liver, kidneys, intestine and skin in comparison to 
the corresponding anionic analogue. However after 24 hours, the cationic conjugate 
showed a greater photosensitiser accumulation in the intestine and skin. Ovarian cancer 
can become resistant to cisplatin treatment, therefore a study was conducted to 
determine whether chlorin e6-polylysine-OC125 F(ab‟)2 could be used for a PDT pre-
treatment to overcome the resistance.
85
 In vitro assays were performed comparing 
cisplatin, PDT, and a combination of the two treatments with various cisplatin sensitive 
and resistant cell lines. The combination of the two treatments generally enhanced the 
overall cytotoxic effect, with the enhancement being less prominent for the cisplatin 
sensitive cells. The photodynamic effect caused by anionic and cationic chlorin e6-
polylysine-OC125 F(ab‟)2 conjugates to mice with ovarian cancer xenografts was also 
investigated.
86
 The experiments involved injection of the non-conjugated 
photosensitiser or conjugates, followed by a 3 hour interval before the application of 
light; this procedure was repeated 3 times for each treatment. All PDT treatments 
caused a reduction in tumour size compared to the control, with the mice treated with 
the cationic chlorin e6-polylysine-OC125 F(ab‟)2 surviving longer (44 days) than the 
mice receiving the other treatments (36 days). 
The polylysine conjugation method was then utilised for the synthesis of conjugates 
using the 17.1A mAb which has an affinity towards colorectal cancer cells.
87,88,89
 An 
ELISA binding assay showed that the anionic conjugate binding activity had been 
compromised, whereas the cationic conjugate exhibited an enhanced targeting 
efficiency compared to the unconjugated antibody. Furthermore, the cellular uptake for 
the cationic chlorin e6-polylysine-17.1A mAb conjugate was 4 times greater than the 
anionic analogue, although both conjugates were more selective towards antigen 
positive cells than the irrelevant conjugates and the unbound photosensitiser. Photo-
killing studies using an antigen positive cell line showed that the cationic conjugate was 
the most potent.
87
 The biodistribution of the conjugate and precursors were then 
assessed in vivo. Mice were injected with HT29 cells, inducing the expression of 
tumours on the liver. Post 3 hours and 24 hours photosensitiser administration, the 
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biodistribution was determined by quantifying the fluorescence spectra for each of the 
tissues analysed. After 3 hours, the anionic conjugate had delivered five times more 
photosensitiser to the tumour compared to the cationic conjugate; which delivered 
approximately half the quantity of photosensitiser, compared to the unconjugated 
chlorin e6. Accumulation in the bladder was noted for all the photosensitisers and a 
significant amount of photosensitiser was present in the lungs for the cationic conjugate. 
Additionally, the cationic conjugate was cleared from the blood more rapidly and was 
not significantly retained in the skin, in comparison to the anionic photosensitiser and 
chlorin e6. The anionic conjugate also exhibited a slightly more favourable tumour to 
peritumoural (liver) ratio (2.52:1) in compared to the cationic conjugate (2.2:1), 
however the most favourable ratio was observed for the free chlorin e6 (3.61:1). The free 
chlorin e6 had accumulated substantially in the skin, with a tumour to peritumoural 
(skin) ratio (1.94:1) in comparison to the conjugates and precursor (38-81.4:1). After 24 
hours, the quantity of photosensitiser present in the tumour had reduced, although a 
substantial quantity was still present in the target tissue for the anionic conjugates, 
furthermore the tumour to peritumoural ratios were less for the liver (1.54:1) compared 
with the skin (87.1:1). Mice treated with the cationic photosensitiser still had significant 
accumulation in the lungs, whereas the anionic conjugate caused substantial 
photosensitiser retention in the bladder.
88
 Due to the promising biodistribution results 
obtained for the anionic conjugate, phototoxic in vivo assessments of the long and short 
term benefits and survival rates following PDT was made, employing mice with 
colorectal tumours of the liver. Short-term tumour response indicated that the conjugate 
reduced tumour growth substantially more than chlorin e6 and the control. The median 
survival results correlated well with the enhanced phototoxicity observed during the 
short term experiments; the mice treated with the conjugate (102 days) survived longer 
than the treatments with the chlorin e6 precursor (77 days) and the control (62.5 days). 
Increasing the light dose was also found to enhance the cytotoxic effect, with the laser-
induced hyperthermia of the target cells being a contributing factor to the overall 
cytotoxic effect.
89
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1.2.3.4 N-(2-hydroxypropyl)methacrylamide 
 
N-(2-hydroxypropyl)methacrylamide (HPMA) based polymers are both biocompatible 
and hydrophilic, and as such have been selected as a suitable polymeric linker for use in 
bioconjugation.
90
 
Kopeček and co-workers,91 have described the synthesis of HPMA copolymer-chlorin 
e6 monoethylenediamine-immunoconjugates, using either OV-TL16 IgG or Fab‟ 
targeting antigens related with ovarian carcinoma. A radical precipitation 
copolymerisation procedure was used to produce two different co-polymers using 
HPMA, and either N-methacryloylglyclphenylalanylleucylglycine p-nitrophenylester 
(co-polymer 1) or N-methacyloylglycylglycine p-nitrophenyl ester (co-polymer 2). The 
first immunoconjugate bearing the unmodified OV-TL16 IgG was synthesised by 
reacting co-polymer 1 dissolved in dimethylsulfoxide, with chlorin e6 
monoethylenediamine, in the presence of triethylamine. The subsequent polymeric 
precursor in dimethylformamide was added to the OV-TL16 IgG in PBS, with the pH 
being maintained at 7.2 for 2 hours, which was then increased to pH 8.3 over a 3 hour 
period (Scheme 12). Purification of the immunoconjugate was performed by, firstly 
using a Sephadex G-25 column to remove the low molecular weight impurities, 
followed by a Superose 6 (HR16/60) column to collect the desired immunoconjugate 
fraction. The polymeric immunoconjugate was characterised using a combination of 
techniques, including UV-visible spectroscopy, refractive index detection and Lowry 
assay. The approximate molar ratio was calculated, and found to be: 
protein:polymer:photosensitiser 1:4:9.     
 
 
Scheme 12: Synthesis of chlorin e6 monoethylenediamine-HPMA-co-polymer 1-
IgG.
91
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The remaining two conjugates were prepared using the same polymeric precursor; co-
polymer 2 was treated with chlorin e6 monoethylenediamine, in dimethylsulfoxide, 
followed by the drop-wise addition of hydrazine hydrate in dimethylformamide. The 
polymeric precursor was dialysed against ethanol/water, dilute hydrochloric acid, 
followed by water, in order to remove un-reacted hydrazine. The immunoconjugate was 
prepared by oxidising OV-TL16 IgG, using sodium periodate, which was subsequently 
added to the polymeric precursor in acetate buffer, pH 5.2, leading to the formation of a 
stable imine linkage (Scheme 13). The crude mixture was applied to a Superose 6 
(HR16/60) column and the relevant fractions collected. The approximate molar ratio 
was again calculated and found to be: protein:polymer:photosensitiser 1:2.5:4. 
 
 
Scheme 13: Synthesis of chlorin e6 monoethylenediamine-HPMA-co-polymer 2-
IgGox.
91
 
 
The remaining immunoconjugate used a OV-TL16 Fab‟; OV-TL16 IgG was 
enzymatically cleaved using ficin, the F(ab‟)2 fragment was isolated and subsequently 
treated with dithiothreitol affording the Fab‟ fragment. The polymeric precursor 
dissolved in anhydrous dimethylformamide was treated with the heterobifunctional 
linker 4-(N-maleimidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester 
(SMCC) in the presence of triethylamine, furnishing a reactive maleimide group. The 
derivatised polymeric precursor in a sodium phosphate buffer (pH 7.4) containing 
EDTA was added to the OV-TL16 Fab‟ in the same buffer solution, resulting in the 
formation of a thioether bond (Scheme 14). Purification using a Superdex 200 (HR 
16/50) size exclusion column afforded the immunoconjugate. The approximate molar 
ratio was calculated and found to be: protein:polymer:photosensitiser 1:1:1.5. 
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Scheme 14: Synthesis of chlorin e6 monoethylenediamine-HPMA-co-polymer 2-
Fab‟.91 
 
An immuno-assay was performed employing antigen positive OVCAR-3 cells, enabling 
a comparison between the native antibody and immunoconjugate affinity constants. The 
affinity constant of OV-TL16 IgG (8 × 10
−8
 M
−1
) was compared to chlorin e6 
monoethylenediamine-HPMA-co-polymer 1-IgG (1 × 10
−8
 M
−1
) and chlorin e6 
monoethylenediamine-HPMA-co-polymer 2-IgGox (3 × 10
−8
 M
−1
); both conjugates 
exhibited a substantial decrease in binding efficiency, with chlorin e6 
monoethylenediamine-HPMA-co-polymer 1-IgG showing the lowest affinity constant, 
due to polymer attachment to the IgG around the antigen binding region. The chlorin e6 
monoethylenediamine-HPMA-co-polymer 2-Fab‟ (3 × 10−8 M−1) also showed a 
decrease in antigen binding activity compared to the F(ab‟)2 (6 × 10
−8
 M
−1
). 
The HPMA co-polymer 2 has also been used to facilitate the formation of an 
immunoconjugate bearing chlorin e6 monoethylenediamine and OV-TL16 IgG, as 
shown in Scheme 15. HPMA co-polymer 2 was reacted with chlorin e6 
monoethylenediamine, leading to the formation of an amide linkage, and the resulting 
polymeric precursor was purified by chromatography. The OV-TL16 IgG in a 
phosphate buffer containing sodium chloride (pH 7.2), was added to the polymeric 
precursor in dimethylformamide, and after 2 hours, the pH was slowly increased to 8.3 
over a 3 hour period. A competitive immuno-assay was performed, employing the 
OVCAR-3 cell line and immunoconjugate, in the presence, and absence of the native 
antibody; the presence of the native antibody significantly reduced cellular uptake of the 
conjugate, thus demonstrating the conjugates antigen targeting ability. In vitro 
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cytotoxicity studies were also conducted, evaluating the IC50 doses for the 
immunoconjugate (0.38 µM), HPMA- chlorin e6 monoethylenediamine precursor (290 
µM) and free photosensitiser (0.34 µM). The immunoconjugate exhibited an enhanced 
potency in comparison to the chlorin e6 monoethylenediamine precursor, however the 
free photosensitiser was the most potent, an effect which was attributed to diffusion of 
the free photosensitiser into the cell being more efficient than the pinicytosis 
mechanism required for the HPMA derivatives.
92
  
 
 
Scheme 15: Synthesis of chlorin e6 monoethylenediamine-HPMA-co-polymer 2-
IgG.
92
 
 
In vivo studies have been performed using chlorin e6 monoethylenediamine-HPMA-co-
polymer 1-IgG and nude nice bearing OVCAR-3 xenografts. The immunoconjugate 
accumulated in the tumour considerably more than the precursors, and following 
activation of light, the chlorin e6 monoethylenediamine-HPMA-co-polymer 1-IgG 
treatment caused a notable reduction of tumour volume, whereas the free photosensitiser 
had little effect. The article also described the synthesis of a doxorubicin 
immunoconjugate, and the benefit of combining targeted chemotherapy with PDT was 
demonstrated, relative to treatment with the individual conjugates.
93
   
A biodistribution study comparing chlorin e6 monoethylenediamine and chlorin e6 
monoethylenediamine-HPMA-co-polymer 1 showed that the HPMA conjugate 
exhibited a substantial accumulation of photosensitiser in the liver and spleen, both of 
which were greater than the same parameter for the tumour.
94
  
HPMA has also been copolymerised with polymerisable Fab‟ and chlorin e6 
monoethylenediamine fragments, bearing methylacryloyl functionalities. The 
polymerisable Fab‟ was prepared by firstly derivatising methylacryloyl chloride, using a 
series of synthetic steps, leading to the introduction of a spacer terminating with an 
amino group. SMP was added to the derivatised polymerisable fragment, resulting in 
the introduction of a maleimide group, thus enabling the subsequent addition of the Fab‟ 
fragment. The polymerisable chlorin e6 monoethylenediamine fragment was prepared 
using a methylacryloyl precursor, containing an enzyme cleavable tetra-peptide chain 
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terminating with a p-nitrophenoxy group; the activated ester was then used to form a 
stable amide bond between the polymerisable precursor and photosensitiser. The 
polymerisable antibody and photosensitiser fragments were copolymerised with HPMA, 
using an azo initiator (VA-044), leading to the formation of the immunoconjugate, as 
illustrated in Scheme 16. In vitro cytotoxicity studies revealed that treatment using the 
immunoconjugate led to an increase in internalised photosensitiser, which localised in 
the lysosomal compartment, and as such, was more potent than the native 
photosensitiser and a copolymer employing HPMA and the polymerisable 
photosensitiser fragment.
95
 
  
 
Scheme 16: Formation of HPMA co-polymer immunoconjugate.
95
 
 
Lu et al.
96
 utilised the same methodology to synthesise a polymerisable Fab‟ fragment, 
containing a PEG spacer. The presence of the PEG chain enhanced the solubility of the 
fragment, resulting in a higher polymerization activity in comparison to the previously 
reported polymerisable Fab‟ fragment.95
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1.3 Cysteine reactive functionalities 
 
The reduced SIP(L19) fragment selected for this research project expresses two thiol 
functionalities which are available for conjugating to the photosensitiser moiety, thus 
the photosensitiser must posses a complementary functionality to facilitate the 
conjugation. It has been reported that porphyrins bearing maleimide
72
 and acroyloyl
58
 
functionalities have participated in conjugations with antibodies expressing thiol 
groups. Additionally, it has also been demonstrated that an antibody bearing a thiol 
group can be modified with SIAB to express an activated ester, which can subsequently 
conjugate to a porphyrin bearing an amino group.
58
 A variety of other conjugation 
strategies involving the thiol group have been reported. A range of proteins have been 
modified to express either N-iodoacetyl or divinylsulfone functionalities, enabling 
selective conjugation to sulphydryl groups expressed by a peptide.
97
 A similar approach 
has been used for the synthesis of a phospholipid-peptide conjugate, with the 
phospholipid modified to express an N-bromoacetyl functionality.
98
 Disulphide 
exchange has also been utilised for conjugations involving thiol groups. The disulphide 
exchange reagent pyridyldithiopropionic acid-NHS ester has been used for synthesising 
a photosensitiser-lysine-antibody conjugate as previously described.
83
 An 
oligonucleotide which posses an activated disulphide bond, has been treated with a thiol 
expressing peptide, leading to the generation of a disulphide linked oligonucleotide-
peptide conjugate.
99
 The literature suggested that the maleimide functionality was the 
most commonly used group for participating in conjugation reactions involving 
sulphydryl expressing antibodies, and was therefore selected for this research project. 
 
1.3.1 Maleimide      
   
During the research project, Endo et al.
100
 reported the transformation of an amino 
functionality, expressed by a pre-formed porphyrin, into a maleimide group, as 
illustrated in Scheme 17. A solution of 5-(4-aminophenyl)-10,15,20-tri(4-
sulfonatophenyl)porphyrin tris-tetrabutylammonium salt dissolved in anhydrous 
acetonitrile, was treated with maleic anhydride for 5 hours at reflux. The solvent was 
removed under reduced pressure and the intermediate was subsequently treated with 
acetic anhydride in the presence of sodium hydrogencarbonate, resulting in 
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cyclodehydration of the maleic acid and formation of the maleimide, with an overall 
yield of 90 %.  
 
 
Scheme 17: Synthesis of 5,10,15-tris(4-methoxycarbonylphenyl)-20-(4-(2-(3-
maleimido)propionamido)phenyl)porphyrin.
100
 
 
A porphyrin bearing an amino functionality can be further modified to possess a 
maleimide group by using a hetero-bifunctional cross-linking reagent, such as SMP, as 
previously described.
72
 In addition to SMP, SMCC is another hetero-bifunctional cross-
linking reagent which has been used to incorporate a thiol expressing antibody into a 
HPMA immunoconjugate, as previously discussed.
91,95
 The versatile SMCC has been 
utilised for production of an array of conjugates, including: glycogen phosphorylase b-
thyroxine,
101
 DNA-bisbenzimidazole,
102
 ethidium homodimer-B72.3 mAb,
103
 glucose 
oxidase-IgG,
104
 and cholera toxin-liposome.
105
 A variety of different reaction conditions 
have been reported for the addition of SMCC to an amino bearing compound, with the 
reaction being performed in dimethylformamide;
101
 and in the presence of 4-
dimethylaminopyridine (DMAP),
103
 diisopropylethylamine (DIEA);
102
 in 
chloroform/methanol (9:1) with the addition of triethanolamine
105
 and in sodium 
phosphate buffer (pH 7).
104
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Although not applied to porphyrin chemistry, a Mitsunobu type reaction can be used to 
convert a hydroxyl group into maleimide functionality. A triphenylphosphine/ diethyl 
azodicarboxylate (DEAD) catalysed reaction between phenethyl alcohol and 1H-
pyrrole-2,5-dione in tetrahydrofuran, afforded the maleimide derivative in 24-92 % 
yield. The reaction conditions were evaluated and it was observed that yields were 
improved when the reaction was performed at −78 oC, gradually increasing to ambient 
temperature; with a slight excess of the initial alcohol and in the presence of neo-pentyl 
alcohol.
106
 
The maleimide functional group is susceptible to nucleophilic attack; therefore it would 
be feasible for conjugations to other amino acid residues, such as lysine, to occur. The 
nucleophilicity of the amino acid residues can be controlled using the environmental 
pH. When the pH of the surroundings is close to or above the amino acids pKa, 
deprotonation occurs, and the residue becomes more nucleophilic. If the conjugation is 
performed in a buffer solution of 6.5-7.5 pH, the maleimide reacts exclusively with thiol 
groups, as the pKa of cysteine (8.8-9.1) is slightly lower than lysine (9.3-9.5). Above 
the 6.5-7.5 pH range, the maleimide functional group would also react with lysine 
residues.
107,108
 
Under basic conditions, the maleimide group can be hydrolysed, and once the 
maleimide ring has opened it renders it inactive towards thiol functionalities. The 
hydrolysis can also occur after thiol conjugation. The rate and degree of hydrolysis is 
dependent on the functionalities to which the maleimide is attached. Aromatic systems 
enhance maleimide hydrolysis, whereas unconjugated systems such as the cyclohexane 
ring of SMCC, increases stability. The steric hindrance provided by the cyclohexane 
ring could also be a contributing factor to the enhanced stability of SMCC.    
As porphyrins are aromatic, and it has been reported that maleimides are more 
susceptible to hydrolysis when attached to a conjugated system, it seemed appropriate to 
employ an unconjugated linker in-between the porphyrin and maleimide functionality. 
SMCC was therefore selected to further modify the porphyrin moiety.         
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1.4 Synthetic overview 
 
As part of a collaboration project with the research group of Professor Dario Neri at the 
Swiss Federal Institute (ETH), the aim of the project was to synthesise a 
photosensitiser-SIP(L19) conjugate for PDT. The photosensitiser/porphyrin moiety 
would be synthesised in Hull, which would then be sent to Zurich for subsequent 
conjugation to reduced SIP(L19) and biological studies.  
The porphyrin moiety required dual functionality: a single maleimide bioconjugatable 
group, enabling conjugation to a cysteine residue, and functionalities which could be 
further modified to provide hydrophilicity, facilitating the conjugation to SIP(L19) 
under aqueous conditions. The strategies used for the introduction of dual functionality 
were functionalisation of a symmetrical porphyrin, and incorporation of the different 
functional groups during porphyrin formation via a mixed condensation. The 
hypothesised porphyrinic products are depicted in Figure 6.  
Synthetically, the first major strategy decision was, at which point in the sequence of 
reactions leading to the target molecule was it most appropriate to switch the porphyrin 
from a hydrophobic to hydrophilic compound i.e. before or after addition of the 
maleimide. Due to difficulties in handling and purifying hydrophilic compounds, and 
the maleimide being susceptible to hydrolysis, it was hypothesised that the introduction 
of water solubility should be delayed as late into the synthetic sequence as possible. The 
quaternisation of pyridyl groups was selected as the method for inducing hydrophilicity, 
due to previous experience by members of the research group.   
 
 
 
Figure 6: Dual functional porphyrins. 
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Chapter 2: Functionalisation of symmetrical porphyrins 
 
2.1 Introduction 
 
In order to produce a dual functional porphyrin, two strategies can be adopted; 
functionalisation of a symmetrical porphyrin or incorporating the dual functionality 
during the formation of the porphyrin. The appeal of functionalising symmetrical 
porphyrins stems from the higher yields obtained, in relation to the „mixed 
condensation‟ porphyrins, using the most common synthetic methods. The strategy 
described here involved the mono-functionalisation of a porphyrin in the β-position, 
providing a single reactive functional group, which upon further modification, could 
potentially lead to a group suitable for bioconjugation; the second set of functional 
groups, already incorporated during porphyrins synthesis, could then be modified to 
render the macrocycle water soluble.  
 
2.2 Porphyrins  
 
Porphyrin derivatives are aromatic tetrapyrrolic macrocycles, consisting of four pyrrolic 
subunits connected by methine bridges. Porphyrin derivatives are described using 
specific IUPAC nomenclature; a system devised by Professor R. Bonnett and 
collaborators, to supersede the previously used Fischer numeration (Figure 7). There are 
two different regions on the porphine core referred to as β-positions: the outermost 
pyrollic carbons and meso-positions: the methine bridges joining the pyrroles together, 
and these are often used as “shorthand” to denote the reactive positions e.g. β-
substitution vs. meso substitution.
109
 
 
 
 
 
 
Figure 7: Porphyrin nomenclature.
109
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The porphyrin nucleus has a total of 22 π electrons, with 18 π electrons in a delocalised 
system, in compliance with Hückels rule of aromaticity. Generally, porphyrins 
participate in electrophilic and radical substitution reactions, due to the aromatic nature 
of the porphyrin core. The meso positions are the most electron dense and as such are 
the most reactive, however if the meso positions are occupied, the β positions can 
participate in electrophilic reactions.
110
 
Free base porphyrins have a UV/visible spectrum consisting of one intense absorption 
band, referred to as the Soret band, at 380-430 nm, and four less intense signals, known 
as the Q bands at higher wavelengths. This phenomena can be explained using the 
Gouterman molecular orbital theory by considering the four frontier orbitals present on 
the porphyrin macrocycle; the two π-orbitals (a1u/b1) and (a2u/b2) and the degenerate pair 
of π*-orbitals (egx/c1) and (egy /c2). The two highest molecular orbitals have a similar 
energy, therefore it might be expected that there would be two coincident absorption 
bands due to the two different transitions of (a1u/b1) to (egx/c1) and (a2u/b2) to (egy /c2). 
However these two transitions combine, resulting in the formation of two different 
bands; constructive interference leads to the generation of the Soret band, whereas 
destructive interferences lead to the Q-bands. Free base porphyrins are unsymmetrical, 
hence there are different transitions in the x and y directions, thus there are 2 transitions, 
in the x and y directions, for the destructive combination transition, leading to a total of 
4 bands being observed for the Q bands.
21
 The exact position and intensity of these 
absorption peaks are dependent on both the concentration and the nature of the solvent. 
The optical properties of different porphyrin derivatives are dependent on the functional 
groups present in the β and meso positions.22 
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2.3 Porphyrin synthesis 
 
From a retro-synthetic perspective, the porphyrin can be disconnected to four pyrrolic 
units and four bridging units (Figure 8). Correspondingly, porphyrins can be synthesised 
via a condensation reaction involving equimolar quantities of pyrrole and aldehyde.  
 
 
Figure 8: Retro-synthesis of porphyrin. 
 
Rothemund
111
 was the first to report the synthesis of a porphyrin using an aldehyde and 
pyrrole, by reacting benzaldehyde with pyrrole, in pyridine, in a sealed container, at 150 
°C for 24 hours. The rationale for this reaction was that aromatic compounds are stable, 
porphyrins are aromatic; therefore reacting pyrrole and benzaldehyde at high 
temperatures will result in the formation of a stable porphyrin. Although the potential 
for synthesising porphyrins was demonstrated, the yields were low due to the harsh 
reaction conditions; for example tetra(4-chlorophenyl)porphyrin was synthesised with a 
2.6 % yield,
112
 and the zinc(II) complex of tetra(4-pyridyl)porphyrin was produced, 
with a yield of about 10 %.
113
 Porphyrin research was therefore directed towards 
developing reaction conditions, enabling the production of a variety of meso-substituted 
porphyrins, with more reasonable reaction yields.    
 
2.3.1 Adler-Longo porphyrin synthesis
114
    
 
Adler and Longo
115
 were the first to rigorously evaluate the reaction conditions, 
facilitating the production of meso-substituted porphyrins. The reaction model 
investigated was the synthesis of tetraphenylporphyrin (TPP), via the reaction between 
pyrrole and benzaldehyde. The reaction was performed using a Dean-Stark trap, thus 
demonstrating that porphyrin formation results from a dehydration reaction, with the 
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reaction stoichiometry suggesting an oxidation process was occurring. The reaction was 
also investigated at different temperatures, using various solvents; including acetic acid, 
acetic acid with a metal salt and benzene containing chloroacetic acid or trifluoroacetic 
acid. The reactions performed at elevated temperatures, employing acidic solvents 
produced higher reaction yields, in comparison to those performed at lower 
temperatures, in the presence of metal salts. These observations, coupled with further 
investigation of the reaction conditions, led to the use of propionic acid, in place of 
acetic acid.
114
 It was observed that upon cooling, porphyrins synthesised in propionic 
acid can crystallise out of the reaction mixture, thus purification can be achieved simply 
by filtration and washing of the recovered crystals. Although the use of acetic acid 
produced TPP in higher yields, the additional chromatographic separation required was 
time consuming, and as such the reaction in propionic acid was considered to be more 
convenient. The optimised procedure, known as the Adler-Longo method
114
, involved 
reacting equimolar quantities of pyrrole and an aldehyde in refluxing propionic acid for 
30 min, in an open vessel. The Adler-Longo method produced TPP in a reproducible 
manner, with a yield of 20 %.  
Further mechanistic studies were conducted to evaluate the postulated role of molecular 
oxygen in the formation of a porphyrin. Using the synthesis of TPP as the reaction 
model, experiments were performed under various pressures and concentrations of 
oxygen, and in the absence of oxygen; with the reactions being monitored by UV-
visible spectroscopy. It was discovered that the oxidation processes was due to 
atmospheric oxygen, and therefore the overall reaction stoichiometry was determined, 
as shown in Figure 9, leading to a proposed mechanism shown in Scheme 18.
116
    
 
 
Figure 9: TPP reaction stoichiometry.
116
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Scheme 18: Mechanism for the formation of a porphyrin using Adler-Longo 
conditions.
116
 
 
The mechanism proposed by Adler and co-workers,
116
 proceeded via a carbinol 
intermediate. To test the theory, Little
117
 compared the reaction yields of porphyrins 
formed by either pyrryl carbinols, or corresponding aldehydes and pyrrole. The reaction 
yields were almost identical for the porphyrins evaluated, thus indicating that porphyrin 
formation occurs via a carbinol intermediate.  
The Adler-Longo conditions,
114
 for porphyrin synthesis can also lead to the presence of 
chlorin, resulting from the incomplete oxidation of the porphyrinogen. The chlorin 
impurities can be oxidised, forming the desired porphyrin, by treatment with 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ); or can be removed be column 
chromatography.
118
 
A wide variety of symmetrical porphyrins have been synthesised employing the Adler-
Longo method,
114
 including porphyrins synthesised by the addition of pyrrole to p-
chlorobebenzaldehyde
114
 or imidazole aldehydes,
119
 as illustrated in Scheme 19. 
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Scheme 19: Examples of symmetrical porphyrins synthesised under Adler-Longo 
condtions.
114,119
 
 
The synthesis of porphyrins using aldehydes with ionisable groups, yields porphyrin 
acid salts, which are soluble in propionic acid, thus isolating the porphyrin can be 
problematic.
114
 Research was therefore directed towards a more versatile porphyrin 
synthesis, to allow the incorporation of sensitive functional groups.  
 
2.3.2 Lindsey porphyrin synthesis
120
 
 
Lindsey et al.
120
 postulated that during the condensation reaction between pyrrole and 
benzaldehyde with catalytic amounts of Bronstead or Lewis acids, the 
thermodynamically favoured product would be 5,10,15,20-tetraphenylporphyrinogen. 
Hence, if the reaction were performed under appropriate reaction conditions, there 
would be an equilibrium favouring the formation of the porphyrinogen derivative. Once 
the equilibrium was established the 5,10,15,20-tetraphenylporphyrinogen could then be 
oxidised, immediately by addition of a chemical oxidant, to yield TPP. Lindsey also 
proposed that high temperatures were not required, as the pyrrole and benzaldehyde 
were already highly reactive molecules. Furthermore, the milder reaction conditions 
could enable the use of aldehydes bearing more sensitive functional groups for 
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producing porphyrins, which could not at the time be obtained using the Adler-Longo
114
 
procedure.  
The optimised Lindsey method for the production of TPP involved the addition of 
benzaldehyde, pyrrole and triethyl orthoacetate to anhydrous dichloromethane, under an 
inert atmosphere, at equimolar concentrations of 1 × 10
−2 
M. An aliquot of the acid 
catalyst: boron trifluoride etherate (1 × 10
−3 
M), was then added, and the reaction 
proceeded at room temperature for 1 hour. The acidic catalyst was neutralised by the 
addition of either potassium carbonate or triethylamine, followed by addition of the 
oxidant; either p-chloranil or DDQ. Once the reaction had been left at reflux for 1 hour, 
and cooled, the solvent was removed and flash chromatography afforded TPP, with a 
yield of 45-50 %. The reaction conditions were evaluated, and it was observed that the 
final porphyrin yield was influenced by the duration of the condensation period, the 
concentrations of the reagents, the presence of water in the solvent and the choice of 
acid catalyst and oxidant. 
A wide range of porphyrins have now been produced under Lindsey conditions,
119
 some 
of which are shown in Scheme 20.
121
 
 
 
R Group Acid Catalyst Yield (%) 
p-Tolyl TFA 41 
p-Tolyl BF3-etherate 17 
C6F5 TFA 11 
C6F5 BF3-etherate 23 
Hexyl TFA 16 
Hexyl BF3-etherate 12 
 
Scheme 20: Porphyrins synthesised under Lindsey condtions.
121
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2.4 Functionalising the β-position of a symmetrically substituted porphyrin 
 
2.4.1 Halogenation 
 
Giraudeau and co-workers,
122
 have reported the monochlorination of TPP at the β-
position, via treatment with N-chlorosuccinimide in 1,2-dichloroethane, at reflux for 2 
hours. Following chromatographic separation, the mono-substituted compound 
(TPP(Cl)) was isolated in 46 % yield, with the di-substituted compound (9 %) as the 
major impurity. 
The bromination of TPP has also been demonstrated using N-bromosuccinimide; TPP 
was treated with 1.1 equivalents of N-bromosuccinimide in a mixture of 
dichloromethane and methanol, at reflux for 5 minutes. The mono-brominated 
porphyrin was obtained with a yield of 48 %.
123
 Bromination using 
phenylselenyltribromide as the brominating agent has also been reported; 0.5 
equivalents of phenylselenyltribromide was reacted with the nickel(II) complex of TPP, 
producing a mixture of the mono and di-substituted porphyrins in 40-60 % yield.
124
  
    
2.4.2 Nitration 
 
The introduction of a nitro group at the β-position, of copper(II) TPP, can be achieved 
via treatment with copper(II) nitrate hexahydrate, in the presence of acetic anhydride, at 
35 °C, for 1 hour, as illustrated in Scheme 21.
122
 A similar methodology for nitrating 
porphyrins has been reported by Hombrecher el al.
125
; TPP was treated with copper(II) 
nitrate trihydrate and acetic anhydride, at room temperature for 48 hours. The reaction 
relied on the in situ insertion of copper into the porphyrin core, and subsequent 
nitration, affording the copper complex of the nitrated porphyrin with a yield of 86 %. 
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Scheme 21: Nitration of the copper(II) complex of TPP.
122
 
 
Treating certain metalloporphyrins with nitrogen dioxide gas, suspended in a suitable 
solvent can also result in mono-nitration at the β-position.126 It was observed that the 
choice of co-ordinated metal influenced the extent and position of the nitration. The 
copper(II), nickel(II) and palladium(II) chelates exclusively nitrate in the β-pyrrolic 
position, whereas, more electropositive metal complexes; including magnesium(II) and 
zinc(II) chelates, resulted in nitrations at the meso-positions, eventually leading to ring 
opening and the formation of non-porphyrinic products. The reaction conditions were 
refined, employing the dropwise addition of a dinitrogen tetroxide saturated solution of 
ether, to the copper(II) complex of TPP, with a reported yield of 88 %.
127
 Interestingly, 
it has been reported that a range of tetraheteroarylporphyrins have been nitrated using 
nitrogen dioxide, including tetra(4-pyridyl)porphyrin, as shown in Scheme 22.
128
  
 
 
Ar Yield 
4-quinolinyl quantitative 
6-quinolinyl quantitative 
3-pyridyl 70 % 
4-pyridyl 60 % 
 
Scheme 22: Nitration of tetraheteroarylporphyrins.
128
  
 
Catalano et al.
129
 demonstrated that 2-nitro-copper(II)TPP is susceptible to nucleophilic 
attack, via a reaction with sodium methoxide. A solution of the copper(II) complex of 2-
nitroTPP dissolved in anhydrous dimethylformamide, was treated with sodium 
methoxide for 18 hours at 0-25 
o
C, and after the reaction was quenched with water, the 
2,2-dimethoxy-3-nitro-2,3-dihyrdoporphyrin intermediate was isolated in 91 % yield. 
Denitration of the intermediate using Bu3SnH-AIBN in refluxing benzene, and 
subsequent elimination of methanol using aqueous oxalic acid, affords the copper(II) 
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complex of 2-methoxy-TPP in 90 % yield. It has also been illustrated that Grignard 
reagents react in a similar manner to oxygen nucleophiles, via a chlorin intermediate.
127
  
It has been reported that a nitro group on porphyrins can be reduced to an amino 
functionality, using various reductive treatments, including Sn/HCl, NaBH4/LiCl in 
tetrahydrofuran, and NH4O2CH-Pd/C or NaBH4/Pd/C in methanol. The amino 
functionality can then be converted into a diazonium salt, using sodium nitrite and 
sulphuric acid, which can subsequently react with an alcohol, producing the β-
substituted alkoxy-porphyrin.
125
     
    
2.4.3 Formylation 
 
The Vilsmeier complex, formed by the interaction between phosphorus oxychloride and 
dimethylformamide at 0 °C, has been used for the introduction of an aldehyde 
functionality, to the β-position of the copper (II) complex of TPP. The metal centre was 
required to prevent protonation of the inner nitrogens, and to direct the electrophilic 
attack of the chloromethyleneiminium salt towards the β-pyrrolic position.130 Once the 
intermediate iminium salt was hydrolysed, the formylated copper(II) complex of TPP 
was obtained in high yields (< 95 %). Demetallation of copper(II) complex of TPP was 
attempted using sulphuric acid, however the expected free base porphyrin was not 
produced, and the TLC of the reaction mixture revealed a mixture of porphyrinic 
fractions, and it was postulated that sulfonation and/or a secondary reaction of the 
formyl group had occurred.
131
 Further investigations led to the discovery that acidic 
treatment caused an intramolecular cyclisation reaction between the carbonyl group, and 
the ortho-postion of the adjacent phenyl ring.
132
 Bonfantini et al.
130
 overcame the 
intramolecular cyclisation problem by demonstrating that the intermediate iminium salt 
was stable to acidic demetallating conditions, therefore, by performing the demetallation 
in situ, prior to the hydrolysis of the iminium salt, it was possible to synthesise the free 
base formylated TPP (2-formyl TPP) in high yield (95 %), as depicted in Scheme 23. 
 
 64 
      
 
Scheme 23: Optimised formylation reaction conditions.
130
  
  
The conversion of the formyl group into a Wittig type reagent has been demonstrated by 
a series of high yielding synthetic steps. Reduction of the aldehyde group, using sodium 
borohydride, yields the reactive 1
o
 alcohol functionality (95 %), which upon further 
treatment with a mixture of pyridine/thionyl chloride, transforms the alcohol into a 
chloromethyl derivative (84 %). The final synthetic step involved formation of the 
phosphonium chloride salt (90 %), which was achieved via treatment with 
triphenylphosphine.
130
  
It has also been established that 2-formyl TPP, and the zinc analogue, can participate in 
a Horner-Wadsworth-Emmons reaction with a fullerene adduct, bearing an appropriate 
phosphonate group, as illustrated in Scheme 24. The yields for the porphyrin-C60 dyads 
were low to moderate, for reactions performed involving 2-formyl TPP (18 %) and the 
zinc derivative (41 %).
133
 
 
 
Scheme 24: Formation of porphyrin-fullerene dyad.
133
 
 
Stephenson et al.
134
 also performed a modified Horner-Wadsworth-Emmons reaction, 
using the zinc(II) complex of 2-formyl TPP and a variety of halophosphonates, leading 
to the formation of porphyrins bearing acetylene linked substituents at the β-position, as 
illustrated in Scheme 25. Generally, the Horner-Wadsworth-Emmons reaction requires 
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2 molar equivalents of base, however, when applied to this particular reaction, the major 
product formed was the halovinyl intermediate. In order to form the acetylene linkage, 
80 molar equivalents of base were required. The reaction yields varied considerably, 
and were dependent on the initial halophosphonate used.    
 
 
 
Scheme 25: Modified Horner-Wadsworth-Emmons reactions of 2-formyl TPP.
134
 
 
It has been reported that under appropriate conditions, metallated 2-formyl TPP can 
react with a 2
o
 amine, generating an azomethine ylide, which can participate in Diels-
Alder reactions. The nickel(II) complex of 2-formyl TPP was treated with N-
methylglycine in refluxing toluene, under an inert atmosphere. The resulting ylide, 
formed in situ, was reacted with a variety of dipolarophiles, including N-
phenylmaleimide, trans-β-nitrostyrene and dimethyl formate Due to the nature of the 
reaction, diastereoisomers were generated, and as such, chromatographic separation was 
required.
135
 
The nickel(II) complex of 2-formylTPP has also been shown to react with glycine 
methyl ester hydrochloride, using lanthanum(III) triflate as the catalyst, in the presence 
of a base; to deprotonate the 1
o 
amine. The crude imine, formed via the interaction 
between the amine and formyl groups, can be reduced leading to the formation of the 
stable 2
o
 amine linkage. The combined synthesis gave a reasonable yield, as illustrated 
Ar X Yield (%) 
Phenyl Cl 54 
4-Methoxyphenyl Cl 84 
4-Benzonitrile Br 26 
5,5-Dimethyl-2phenyl-[1,3]dioxane Br 88 
4-Pyridyl Cl 70 
4-Benzamide - 36 
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in Scheme 26. Demetallation can be achieved using sulphuric acid, producing the free 
base porphyrin in quantitative yield.
136
  
 
 
The reductive amination type reaction, catalysed by acetic acid, has also been applied to 
form adducts between free base 2-formyl TPP and a variety of 1
o
 amines, including 
aniline. Two distinct reaction procedures were described, with the reactions performed 
in either tetrahydrofuran or toluene, and addition of sodium cyanoborohydride, prior 
and post imine formation. The reactions performed in toluene used a Dean-Stark trap to 
remove water, driving the reaction towards formation of the imine intermediate. The 
reactions were then cooled, and sodium cyanoborohydride was used to reduce the imine, 
as shown in Scheme 27. The other procedure used tetrahydrofuran as the solvent; 
therefore a Dean-Stark trap could not be used as water and tetrahydrofuran are miscible. 
In this case all the reagents were added together in a one-pot synthesis, therefore as the 
imine formed, it was immediately reduced, driving the reaction towards formation of 
the product.
137
    
   
 
Scheme 27: Reductive amination of 2-formyl TPP.
137
 
 
The reaction yields ranged from 20-77 % and were mainly dependent on the 1
o
 amine 
used. The lower reaction yields were obtained for the cyclen adducts (20 and 52 %), 
whereas the less sterically hindered amines produced more reasonable yields (61-77 %), 
as shown in Figure 10. The article also described reactions involving the 2
o
 amino 
linkage and halogen electrophiles, under basic conditions. A range of unique 
 
Scheme 26: Reductive amination of the nickel(II) complex of 2-formyl TPP.
136
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compounds were synthesised, including a cyclen-porphyrin dimer; in spite of the steric 
hindrance involved.
137
 
 
 
Figure 10: Range of adducts produced via reductive amination of 2-formyl TPP.
137
 
 
2.5 Synthetic strategy 
 
Based on previous experience in our laboratory, the Adler-Longo
114
 method for 
synthesising porphyrins was selected for initial investigations. The literature suggested 
that the formylation and nitration reactions produced the highest yield of mono-
functionalised porphyrin, and as such, the formylation method was selected for this 
project. It was decided that a synthetic strategy using TPP should firstly be developed, 
due to the extensive literature describing reactions using 2-formyl TPP. Synthetic 
methodology could then be extended to formylation of porphyrins bearing water 
solubilising groups in the meso-positions. 
There did not appear to be any preferential, high yielding reaction involving 2-formyl 
TPP, with the Wittig and reductive amination type reactions producing similar yields. 
Due to the extra synthetic step required for the Wittig reaction, and the availability of 
chemical procedures recently developed by members of our research group; the 
reductive amination reaction was selected as the best route to further modify the 
porphyrin. As it was desirable for the porphyrin to ultimately have an amino 
functionality, which upon treatment with SMCC, would provided the maleimide 
bioconjugation handle; N-Boc-1,12-diaminododecane and N-Boc-1,3-diaminopropane 
hydrochloride were initially selected to react with 2-formyl TPP, as illustrated in 
Scheme 28. The Boc group is stable to the sodium cyanoborohydride reducing 
conditions,
138
 therefore no compatibility issues were anticipated.  
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Scheme 28: Reductive amination synthetic strategy for mono functionalisation of 
porphyrins. 
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2.5.1 2-Formyl-5,10,15,20-tetraphenylporphyrin (3) 
 
Following the synthetic strategy outlined in Scheme 28; TPP (1) was synthesised using 
the Adler-Longo method,
114
. Following a reported method,
130
 1 was then treated with a 
methanol/water solution of copper(II) acetate monohydrate, under reflux conditions. 
The hot solution was poured on to a silica pad, where the excess copper(II) acetate 
monohydrate was retained on top of the silica, while the product was recovered from the 
eluent. The copper(II) complex of TPP (2) was isolated in reasonable yield, 89 %, after 
precipitation from chloroform by the addition of methanol. Evidence that the reaction 
had proceeded as expected was provided by UV-visible spectroscopy and mass 
spectrometry. The UV-visible spectrum showed the typical transformation; 5 peaks for 
TPP, reducing to 3 peaks for the copper(II) complex, additionally, mass spectrometry 
revealed the expected mass signal of 678 m/z corresponding to the (M)
+
 ion, with a 
copper isotope distribution pattern being observed. Compound 2 was converted into 2-
formyl TPP (3), using the Vilsmeier-Haack formylation conditions, as previously 
reported by Bonfantini et al.
130
  
The 
1
H NMR spectrum of 3 was also in agreement with the previously reported data,
130
 
and exhibited the expected signal transformations from TPP; with the formation of 2 
singlet peaks at 9.41 ppm and 9.22 ppm, corresponding to the formyl and neighbouring 
β-pyrrolic protons. 
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 2.6 Reductive Amination 
 
The versatile reductive amination reaction involves the interaction between either a 
ketone or aldehyde; with ammonia, or a 1
o
 or 2
o 
amine; leading to the formation of a 
carbinol amine intermediate. In the presence of a proton source, dehydration of the 
hydroxylamine occurs, and the resulting imine can be reduced, furnishing the alkylated 
amino product (Scheme 29).
139
  
 
 
Scheme 29: Illustration of the reductive amination reaction.
139
 
 
Formation of the imine can be enhanced by using an acid catalyst, usually acetic acid 
and/or removal of water. The removal of water would shift the equilibrium of the 
reaction towards the formation of the imine; with the acid catalyst protonating the 
carbonyl group making it more susceptible to nucleophilic attack from the amine, as 
well as favouring dehydration of the hydroxylamine intermediate. However, it would be 
possible for the amine to become protonated under high concentrations of acid, 
therefore only a catalytic amount of acid should be used. Reduction of the imine can be 
performed in situ; or after the imine has been isolated. Sodium cyanoborohydride is a 
suitable reducing agent for in situ reductions as its stable to acidic conditions and it is 
soluble in hydroxylic solvents, furthermore, the rate at which sodium cyanoborohydride 
reduces the aldehyde or ketone starting material, is relatively slow, and at pH 6-8, the 
imine is protonated preferentially over the carbonyl functionality, facilitating the 
reductive process.
139
 Sodium borohydride can also be used for reducing imines, and is 
preferable to sodium cyanoborohydride due to a lower toxicity. However 2-formyl TPP 
can also be reduced using sodium borohydride, hence it can not be used for in situ 
reductions.  
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2.6.1 Reductive amination synthetic strategy 
 
The literature suggests that there are two distinct methodologies for performing 
reductive aminations employing formylated porphyrins. The first, one pot strategy, 
involves the acid catalysed reaction between the free base formyl porphyrin and amine; 
with the sodium cyanoborohydride reducing agent being added post or prior imine 
formation.
137
 The other procedure uses lanthanum(III) triflate to catalyse the reaction 
between the formylated porphyrin metal complex and amine, with isolation of the imine 
intermediate and subsequent reduction with sodium borohydride.  
The presence of water shifts the reaction equilibrium back towards the initial starting 
materials or the hydroxylamine intermediate, therefore removal of water using activated 
molecular sieves, or a Dean-Stark trap would result in shifting the reaction equilibrium 
towards product formation. Additionally, the reactions should be performed under an 
inert atmosphere to avoid exposure to moisture. 
       
2.6.2 Attempted reductive aminations involving alkyl diamines 
 
The first reductive amination attempts are shown in Scheme 28. Compound 3 and 1.2 
equivalents of either N-Boc-1,3-diaminopropane hydrochloride or N-Boc-1,12-
diaminododecane were dissolved in anhydrous toluene, a catalytic amount of acetic acid 
was added and the mixtures were heated at reflux, under an inert atmosphere (N2), while 
using a Dean-Stark trap to remove water. The reactions were monitored via TLC, over a 
16 hour period; the reaction employing N-Boc-1,12-diaminododecane showed no 
change, whereas a trace amount of a polar UV-active spot evolved during the reaction 
using N-Boc-1,3-diaminopropane hydrochloride, but nearly all the starting material 
remained unconsumed. Mechanistically, the formation of an imine is an equilibrium 
process, therefore excess sodium cyanoborohydride in methanol was added to the 
mixtures to observe whether there was a shift in the equilibrium, favouring product 
formation. After 14 hours (overnight) the TLC of the reaction mixture using N-Boc-
1,12-diaminododecane showed the presence of multiple UV-active fractions, including 
a significant amount of 3, therefore the reaction was discarded. The TLC of the reaction 
involving N-Boc-1,3-diaminopropane hydrochloride showed that the previous trace 
fraction (suspected imine) was present, with the development of another major UV-
active fraction (suspected product), and trace amounts of 3. The reaction employing N-
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Boc-1,3-diaminopropane hydrochloride was worked-up and applied to a preparative 
TLC plate, however decomposition was observed, hence the reaction was discarded.  
 The reactions were repeated in a similar manner using 10 equivalents of the alkyl 
diamines; to maximise the probability of interactions with the formylated porphyrin, 
and activated molecular sieves; to ensure removal of any water. The modified reaction 
conditions did not seem to enhance imine formation. Once excess reducing agent was 
added, the formation of the suspected product was more prominent, indicating an excess 
of amine favoured imine formation. The reaction using N-Boc-1,12-diaminododecane 
again produced a complex mixture of UV-active fractions, including a significant 
quantity of starting material; due to the high yielding criteria of the strategy, reductive 
aminations employing N-Boc-1,12-diaminododecane were deemed unsuitable for this 
particular reaction. 
The reaction was performed again using 5 equivalents of N-Boc-1,3-diaminopropane 
hydrochloride, with sodium cyanoborohydride being added with the starting reagents, 
prior to imine formation. The TLC of the reaction showed the development of a polar, 
UV-active fraction, with trace amounts of starting material being detected, however the 
reaction did appear to be cleaner than the previous attempts. The reaction was worked-
up, and the crude mixture was re-dissolved in dichloromethane and applied to a 
preparative TLC plate, then eluted with 5 % methanol/ dichloromethane. The relevant 
fraction was collected and the product was precipitated from dichloromethane by the 
addition of hexane. Once dried, acquisition of a 
1
H NMR spectrum was attempted, but it 
was apparent that the sample had decomposed; a hypothesis confirmed by comparing 
the TLC‟s of the sample over a period of time and by conducting a 2D TLC experiment. 
To determine whether the reaction had proceeded as postulated, 
1
H NMR analysis was 
conducted just after the suspected product was isolated via preparative TLC, and an 
attempt to assign the signals of the 
1
H NMR spectrum is shown in Figure 11. The 
1
H 
NMR spectrum possessed a signal at 1.41 ppm which could be attributed to the tert-
butyl region of the Boc group, and was used as the reference integral. Although the 
porphyrinic signals seemed to integrate correctly, in the expected positions; not all of 
the signals corresponding to the propyl protons were observed, potentially due to signals 
being beneath the solvent signals. The multiplet signal at 1.53-1.61 ppm had a quintet 
type appearance, corresponding to the middle CH2 of the propyl chain, however the 
peak was too poorly resolved to be assigned as a quintet. One of the CH2 units of the 
propyl chain was also observed as a quartet at 3.0 ppm. To ensure the proposed signal 
assignments were correct, 2D COSY and HMBC experiments were conducted, however 
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the solvent peaks were too prominent to obtain spectrum of suitable quality, and 
attempts to dry the sample led to decomposition; therefore there was no conclusive 
evidence that the 
1
H NMR signal assignment was correct and the reaction had 
proceeded as postulated. The broad singlet at 3.89 ppm, which appears to integrate to 
approximately 2, could potentially be an amino signal, as the assigned singlet at 4.11 
ppm does not have the typically broad appearance which would usually be observed. As 
the sample was not dried and decomposition was observed, all the signals in the alkyl 
region could potentially be solvent signals or other impurities, thus there was not any 
conclusive evidence for the proposed, newly formed 2
o
 amine, nor the methyl group 
which would be attached to the β-position of the porphyrin; although the sample did 
seem to posses signals for both the porphyrinic and diamine moieties. As the crude 
1
H 
NMR was inconclusive and the product was unstable, it was hypothesised that the 
suspected product could have been the iminium ion intermediate, therefore the sample 
was dissolved in anhydrous dichloromethane and treated with a methanolic solution of 
sodium borohydride at 0 °C, for 15 minutes; once acetic acid was added to neutralise 
the excess sodium borohydride and the porphyrin was worked-up and isolated, the 
suspected product remained unchanged as indicated by TLC.  
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Figure 11: Crude 
1
H NMR of suspected tert-butyl(3-((5,10,15,20-
tetraphenylporphyrin-2-ylmethyl)amino)propyl)carbamate.  
 
a 
c 
b or d f 
e 
DMSO H2O 
MeOH 
Ar-o-H 
Ar-m-p-H 
β-H 
g 
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 Further reductive amination attempts were conducted, as outlined in Scheme 30. The 
toluene solvent was replaced with tetrahydrofuran, to ascertain whether a change in 
solvent stabilised the suspected product. A lanthanum(III) triflate catalysed reaction was 
also attempted, to establish whether the different reaction conditions enabled imine 
formation.   
  
 
Scheme 30: Attempted reductive amination employing alkyl diamines. 
 
Acid catalysed reductive amination attempts were conducted as previously reported.
137
 
Experiments were performed under an inert atmosphere, in tetrahydrofuran containing 
activated molecular sieves. The experiments proceeded in exactly the same manner as 
those performed in toluene, therefore the acid catalysed synthetic strategy was deemed 
unsuitable. 
The other reductive amination methodology, reported by Silva et al.,
136
 used 
lanthanum(III) triflate to catalyse the formation of an imine between the nickel(II) 
complex of 2-formyl TPP and amine. Due to the low yield of 3 previously obtained, the 
formylation reaction was performed without the intermediate demetallation step, with 
the aim of producing the copper(II) complex of 2-formyl TPP in higher yield. The 
isolated yield of the copper(II) complex of 2-formyl TPP (4) was 74 %, which 
represented a slight improvement in yield in comparison to the 67 % obtained for 3. The 
lanthanum(III) triflate catalysed reactions between 4 and either N-Boc-1,12-
diaminododecane or N-Boc-1,3-diaminopropane hydrochloride were monitored over a 3 
day period, with no apparent reaction occurring as indicated by TLC, with only 
porphyrin starting material being recovered.   
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2.6.3 Reductive amination reaction involving aniline  
 
Due to the somewhat negative results concerning alkyl amines, it was prudent to 
perform a known reductive amination reaction using aniline, as shown in Scheme 31. 
 
 
Scheme 31: Reductive amination of 3 with aniline. 
    
The reaction was performed as formerly reported.
137
 The reaction was monitored after 2 
hours, with the TLC revealing the presence of two UV-active fractions corresponding to 
the starting material and a polar product, which was suspected to be the imine. After 24 
hours, the TLC of the reaction mixture showed that nearly all of 3 had been converted 
into the imine; therefore sodium cyanoborohydride dissolved in methanol was added. 
After 2 hours at reflux, the reaction mixture was cooled, and following aqueous work-
up, the mixture was chromatographically separated and, following precipitation, 5 was 
obtained with a yield of 67 %. The characterisation studies were in agreement with the 
literature determinations.
137
 Although lower than the literature yield of 77 %, the 
reported reductive amination reaction was successful, and indicated that a large excess 
of amine should not be required, as only 1.7 equivalents of aniline was used; imine 
formation also should be evident after only a few hours.        
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2.6.4 Reductive aminations involving aryl amine derivatives 
 
Due to the unsuccessful reductive amination attempts using alkyl amines, the synthetic 
strategy was modified to incorporate a phenyl moiety, directly attached to the amine, 
which would form an imine with the formylated porphyrin. The aryl amino derivative 
also possessed a protected amine, which could be transformed into the bioconjugation 
group, as previously postulated. Both the acetic acid and lanthanum(III) triflate 
catalysed reactions were attempted, as shown in Scheme 32.   
 
 
Scheme 32: Attempted reductive aminations using 3 and 4 with aryl linkers. 
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The synthesis of succinimdyl-4-aminobenzoate (6) was achieved using a modified 
procedure reported by Franek et al.
140
 Compound 6 contains an activated ester and 
amino group, therefore if the reaction were performed for extended time periods, under 
thermodynamically favourable conditions, the molecule would react with itself, leading 
to the production of oligomers. The succinimidyl group and activated ester are moisture 
sensitive; therefore the reaction was performed in anhydrous dimethylformamide, under 
an inert atmosphere. Equimolar equivalents of 4-aminobenzoic acid, NHS and DCC 
were dissolved in anhydrous dimethylformamide, under an inert atmosphere (N2). The 
mixture was stirred at 4 °C, for 16 hours (overnight) until all the 4-aminobenzoic acid 
starting material had been consumed, as indicated by TLC. The reaction mixture was 
filtered to remove the dicyclohexylurea by-product and dimethylformamide was 
removed by evaporation under reduced pressure, the crude mixture was re-dissolved in 
40 % dichloromethane/ethyl acetate, washed with water to remove residual 
dimethylformamide, and dried over anhydrous sodium sulphate. The crude product was 
isolated using column chromatography and precipitation, affording 6 as white 
crystalline needles, with a yield of 58 %. It was reported that 6 was synthesised in situ, 
prior to coupling with BSA, thus there was no published characterisation studies 
concerning 6.
140
 The 
1
H NMR and 
13
C NMR spectra for compound 6 are shown in 
Figure 12.  
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Figure 12: 
1
H NMR and 
13
C NMR spectrum‟s of compound 6. 
 
The NMR studies suggested the reaction had proceeded as expected; the 
1
H NMR 
exhibiting a distorted set of doublets (c) and (b), which had a „roof-top‟ (AB) 
appearance due to the phenyls 1,4 substitution pattern, a broad singlet (a) for the amino 
protons and a singlet (d) corresponding to the succinimidyl protons; the 
13
C NMR 
spectrum exhibited the expected number of signals, corresponding to each of the carbon 
environments. The mass spectrum gave the expected m/z signal, however the sample did 
b 
a 
c 
d 
CHCl3 
 
b 
c 
d 
CHCl3 
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appear to be impure, with a major signal corresponding to a dimeric intermediate, thus 
demonstrating the instability of the molecule. 
The initial attempt at synthesising compound 7 employed equimolar equivalents of 6 
and N-Boc-1,3-diaminopropane hydrochloride dissolved in dimethylformamide, in the 
presence of 2 mole equivalents of N,N-diisopropylethylamine; the base was required to 
neutralise the hydrochloric acid, ensuring the amine was available to react with the 
activated ester. It was hypothesised that the difference in reactivity between the 
different amines, i.e. the less reactive aromatic amine of 6, and the more reactive 
primary amine of N-Boc-1,3-diaminopropane hydrochloride, should favour the 
production of the target compound 7. 
The TLC of the reaction mixture showed the presence of 6, the formation of a major 
fraction corresponding to 7 and another more polar fraction located at the base line; 
which could be attributed to oligomers of 6. The solvent was removed in vacuo, the 
crude product was re-dissolved in ethyl acetate and washed with water to remove 
residual dimethylformamide and N-Boc-1,3-diaminopropane hydrochloride. 
Chromatographic separation and precipitation led to 7 being isolated with a yield of 35 
%. Isolation of compound 7 was problematic due to the presence 6 and other polar 
impurities, which accounts for the low yield. To suppress the production of oligomers, a 
2 mole equivalent of N-Boc-1,3-diaminopropane hydrochloride was employed, which 
resulted in complete consumption of 6 and trace polar impurities being observed by 
TLC. The solvent was again removed by evaporation in vacuo, re-dissolved in ethyl 
acetate and washed with water to remove residual dimethylformamide and N-Boc-1,3-
diaminopropane hydrochloride. Compound 7 was isolated as a yellow powder with a 
yield of 66 %, after chromatographic separation and precipitation. The 
1
H NMR 
spectrum gave the expected signals, which integrated correctly, however the sample 
exhibited the presence of methanol, as shown in Figure 13. Compound 8 was 
synthesised with yields of 56 % and 76 %, by applying the same reaction conditions 
used for the production of 7, using a slightly larger volume of dimethylformamide due 
to the solubility of N-Boc-1,12-diaminododecane. The 
1
H NMR spectrum for 8 had a 
similar appearance to that of 7, with a methanol peak being prominent, with the 
exception of the multiplet signal at 1.16-1.25 ppm, attributed to the middle section of 
the dodecyl alkyl chain. 
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Figure 13: 
1
H NMR spectrum of compound 7. 
 
The preliminary reductive amination attempts involving aryl linkers 7 and 8, followed 
the published acid catalysed strategy.
137
 Compounds 7 and 8 were poorly soluble in 
toluene, therefore anhydrous tetrahydrofuran was selected and the reactions were 
conducted under an inert atmosphere, in the presence of activated 3Å molecular sieves. 
The initial reaction was performed using 1.2 equivalents of 7, relative to 3, in the 
presence of the acetic acid catalyst. The reaction was monitored by TLC, with the 
development of a trace polar fraction located at the base line being observed after 12 
 82 
      
hours, with almost complete recovery of 3. A methanolic solution of sodium 
cyanoborohydride was added and, after 24 hours, TLC analysis indicated the presence 
of trace amounts of a newly formed porphyrinic fraction, the previous base line polar 
fraction and a significant amount of 3. The reaction may have failed due to too much 
acid catalyst being added, protonating the amine rendering it inactive; although 
literature suggests that 1-2 equivalents of acetic acid can be used to catalyse the 
reaction.
139
 As the formation of the imine was not evident, the reaction was repeated 
using 2 molar equivalents of 7, adding the sodium cyanoborohydride reducing reagent 
at the start of the reaction. The reaction was monitored by TLC, and after 24 hours, 
almost complete consumption of 3 had occurred. The solvent was removed, re-dissolved 
in dichloromethane, washed with water and chromatographically separated. After 
drying, the suspected product had decomposed in a similar manner to the reaction 
involving N-Boc-1,3-diaminopropane. The reaction was repeated in exactly the same 
manner, and to ensure reduction of any imine had occurred, additional sodium 
cyanoborohydride dissolved in methanol was added after the 24 hour period. After a 
further 4 hours, TLC analysis showed the reaction mixture remained unchanged, and 
following work-up and isolation the suspected product had decomposed in exactly the 
same manner. The initial reductive amination attempt concerning compound 8 was 
performed without the addition of the sodium cyanoborohydride in the first step; after 
24 hours TLC analysis revealed a trace, polar UV-active fraction, with almost all of 3 
remaining. Sodium cyanoborohydride dissolved in methanol was added and after 24 
hours the development of a variety of fractions including a major polar UV-active 
fraction with 3 also being detected. An additional methanolic solution of sodium 
cyanoborohydride was added and after 24 hours no additional change to the reaction 
mixture was observed by TLC. Once worked-up and chromatographically separated, the 
product exhibited decomposition. The reaction was repeated, adding the sodium 
cyanoborohydride dissolved in methanol at the beginning of the reaction. Following 24 
hours at reflux, no further consumption of 3 was observed, with the development of two 
other UV-active fractions. Sodium cyanoborohydride was again added and after 13 
hours, the composition of the reaction mixture remained unchanged. The reaction 
mixture was worked-up and the suspected product isolated via preparative TLC 
chromatography. Once dried the suspected product had decomposed, therefore the 
preparative TLC chromatography procedure was repeated and a crude 
1
H NMR analysis 
was conducted before suspected decomposition. The 
1
H NMR spectrum possessed a 
sharp singlet at 1.42 ppm, which could correspond to the tert-butyl group, a pair of 
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doublets at 6.42 and 7.42 ppm which might correspond to the phenyl group adjacent to 
the dodecyl chain, and a range of signals located in the aromatic and alkyl regions; none 
of which integrated correctly. Partial assignment of the 
1
H NMR spectrum was not 
attempted as the spectrum was not resolved well enough, although there were signals 
which could potentially be due to porphyrin and aryl linker components. Due to the 
instability of the suspected product, the acid catalysed strategy for the aryl linkers was 
abandoned. 
The lanthanum(III) triflate methodology was also attempted employing either 
compounds 7 and 8 with the copper(II) complex of the formylated porphyrin 4. The 
reactions were performed in tetrahydrofuran in the presence of activated 3Å molecular 
sieves and under an inert atmosphere (N2). Both sets of reactions were monitored over a 
3 day period with no apparent change to 4 being detected by TLC. 
 
2.6.5 Reductive amination using methyl 4-aminobenzoate 
 
As the reductive aminations using the novel aryl compounds 7 and 8 had failed, and the 
reaction using aniline was successful, it was decided that a different aniline derivative 
should be used, which possessed a different functionality, and upon further modification 
could be transformed into the reactive maleimide bioconjugation group. It has been 
reported that 2-formyl-TPP can participate in reductive aminations with ethyl-4-
aminobenzoate, producing ethyl-4-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)amino)benzoate with a good yield of 72 %.
137
 By performing a reaction using 
methyl 4-aminobenzoate, and hydrolysing the ester, this would provide a carboxyl 
group that could then be transformed in a similar manner to that of compound 6 
(Scheme 32), eventually terminating in an amino group which could be transformed into 
the maleimide functionality. The synthetic strategy involving methyl 4-aminobenzoate 
is outlined in Scheme 33.      
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Scheme 33: Synthetic strategy involving methyl 4-aminobenzoate. 
 
As compounds 3 and 4 were both available, two different routes for synthesising 
compound 10 were explored. Methyl 4-aminobenzoate appeared to be more soluble in 
tetrahydrofuran in comparison to toluene, although heating was required; therefore 
tetrahydrofuran was used for the reactions. By following a known procedure,
136
 
compound 4, methyl 4-aminobenzoate and lanthanum(III) triflate were added to 
tetrahydrofuran. The reaction was heated to reflux, under an inert atmosphere (N2) 
protected against light and in the presence of activated 3Å molecular sieves. After 44 
hours, TLC analysis of the reaction mixture showed no further change, with the 
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presence of a major, more polar UV-active fraction and compound 4. Once the solvent 
was removed by evaporation in vacuo, the mixture was re-dissolved in 
dichloromethane, filtered to remove the lanthanum(III) triflate catalyst and washed with 
water to remove excess methyl 4-aminobenzoate and tetrahydrofuran. The solution was 
dried over anhydrous sodium sulphate, the solvent was removed under reduced pressure 
and the crude mixture was dried under vacuum, to avoid the presence of water, which 
could react with sodium borohydride liberating flammable hydrogen gas. The crude 
mixture was dissolved in anhydrous dichloromethane and the imine reduced with a 
methanolic solution of sodium borohydride under an inert atmosphere. Acetic acid was 
added to neutralise the excess sodium borohydride. Once aqueous work-up had been 
performed the TLC of the reaction showed two major porphyrinic fractions, 
corresponding to 4 and 9. Compound 9 was isolated as a red powder, with a yield of 65 
%, after column chromatography and precipitation from dichloromethane by the 
addition of pentane. The initial mass spectrum showed a major 837 m/z peak (M+H)
+
, 
implying that the imine had been produced, therefore the reduction procedure using a 
methanolic solution of sodium borohydride was repeated. The high resolution mass 
spectrum provided the expected 861.2134 m/z signal, corresponding to the (M+Na)
+
 
ion; although fragmentation was prominent, as shown in Figure 13. 
 
 
Figure 13: Mass spectrum of 9. 
 
The demetallation of 9 was initially attempted using relatively mild acidic conditions, as 
previously reported.
141
 Dissolution of 9 in anhydrous dichloromethane was followed by 
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treatment with a 2 % sulphuric acid/trifluoroacetic acid solution, the mixture was stirred 
vigorously for 2 minutes, and once extracted and purified, the reaction only showed the 
presence of 9 as indicated by TLC. The reaction was repeated using 15 % sulphuric 
acid/trifluoroacetic acid, 50 % sulphuric acid/trifluoroacetic acid and 25 % 
trifluoroacetic acid/sulphuric acid, and by extending the reaction time to 5 minutes. The 
expected colour change to green; due to the protonation of the inner nitrogens, was not 
being observed. The procedure reported by Bonfantini et al.
130
 was therefore employed, 
with 9 dissolved in chloroform being treated with sulphuric acid for 5 minutes. The 
protonation of the porphyrin was observed, and basic work-up resulting in a colour 
change from green to purple in the organic layer. After work-up, chromatographic 
separation and precipitation in methanol over dichloromethane, 10 was afforded as a 
purple powder, with a yield of 62 %.   
Compound 10 was also synthesised via a published procedure.
137
 A solution of 3 
dissolved in anhydrous tetrahydrofuran was treated with 1.5 equivalents of methyl 4-
aminobenzoate in the presence of a catalytic amount of acetic acid. After 6 hours at 
reflux, TLC analysis detected the development of a minor polar fraction, as well as a 
substantial quantity of 3. A methanolic solution of sodium cyanoborohydride was added 
and the reaction was monitored by TLC. After 40 hours the reaction was not developing 
further, with porphyrinic fractions corresponding to 3 and 10 being detected. Following 
work-up and column chromatography, 10 was isolated with a yield of 26 %. The yield 
for 10 using the acetic acid catalysed reductive amination was significantly less than the 
combined yield for the lanthanum(III) triflate catalysed reaction, coupled with the 
copper demetallation, an overall yield of 40 %, thus the lanthanum(III) triflate approach 
was considered to be the preferred strategy. The 
1
H NMR spectrum of 10 is shown in 
Figure 14. The assignment of the signals was achieved using a combination of 
13
C NMR 
2D COSY and CH-correlation experiments. The assignment of the signals in the alkyl 
region was quite straight-forward, with a singlet corresponding to the methyl group of 
the ester (a) at 3.78 ppm and the methyl group (e) neighbouring the porphyrin core 
giving the expected doublet signal, which had the same coupling constant, J = 5 Hz, as 
the neighbouring triplet (d), corresponding to the amino group. The 2D COSY 
experiment showed that the doublet at 6.38 ppm coupled to the doublet at 7.74 ppm 
with the signals having a similar coupling constant, which gave an averaged value of J 
= 8.9 Hz, thus these signals were assigned to the phenyl ring directly attached to the 
amino group. The other signals were assigned by using a combination of the integrals 
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and considering the shielding effect of the porphyrin core. The mass spectrum gave the 
expected 778.3171 m/z signal, due to the (M+H)
+ 
ion. 
 
 
 
 
Figure 14: 
1
H NMR spectrum of 10. 
d 
e 
a 
f 
β-H 
c 
b 
Ar-m-p-H 
Ar-o-H CHCl3 
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 The hydrolysis of 10 was attempted using a modified known procedure.
142
 A solution 
of 10 dissolved in a 50 % ethanol/dichloromethane solution was treated with a 2 M 
potassium hydroxide solution, at reflux, while avoiding exposure to light. The reaction 
was monitored over a 3 day period, with no change to 10, as shown by TLC. The basic 
hydrolysis of the ester was also attempted using a method developed by Silva et al.,
136
 a 
1 M sodium hydroxide solution was added to 10 dissolved in tetrahydrofuran, and the 
resulting mixture was stirred at 50 
o
C. The reaction was monitored via TLC, with only 
10 being detected after 4 days. The reaction was repeated in a similar manner, using a 4 
M sodium hydroxide solution. After 16 hours, (overnight), TLC analysis showed full 
consumption of 10, the development of a trace polar UV-active fraction and another 
major porphyrinic fraction. Following work-up and chromatographic separation, 
1
H 
NMR analysis of the newly formed porphyrinic fraction showed that 3 had re-formed. 
Since the base hydrolysis of 10 had caused the reformation of 3, it suggested that the 
starting material could have been the iminium ion intermediate, although 
1
H NMR 
analysis of the starting material 10 showed the presence of the amino proton at 4.53 
ppm and the neighbouring methyl protons at 4.45 ppm. Two postulated mechanisms for 
the basic cleavage of methyl 4-aminobenzoate from 10 are illustrated in Scheme 34. 
Another basic hydrolysis of the ester was also attempted following a procedure devised 
by Stephenson et al.
134
 A solution of 10 dissolved in tetrahydrofuran, was treated with a 
20 molar excess potassium hydroxide in water and methanol (10:1), and the resulting 
mixture was heated to reflux under an inert atmosphere. After 46 hours, the TLC of the 
reaction mixture showed that all of 10 had been consumed, with the development of 
trace polar fractions and a significant quantity of 3. Following work-up and 
chromatographic separation, the 
1
H NMR confirmed the newly formed porphyrinic 
fraction was 3, thus the ester base hydrolysis strategy was abandoned. 
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Scheme 34: Hypothetical mechanisms for base cleavage of 10 leading to the formation 
of 3. 
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The carboxyl group can be deprotected using acidic hydrolysis conditions, as reported 
by Walter and co-workers.
143
 The article described the hydrolysis of a variety of meso-
carbomethoxyphenyl substituted porphyrins using a mixture of organosulfonic acid 
dissolved in 4 M sulphuric acid, under reflux conditions. Compound 10 dissolved in 4 
M sulphuric acid was treated with 4 molar equivalents of p-toluenesulfonic acid 
monohydrate and the mixture was heated under reflux conditions. After 20 hours, TLC 
analysis of the reaction mixture revealed complete consumption of 10 with a newly 
formed, polar fraction was detected. An ice cooled 1 M sodium hydroxide solution was 
added to the vigorously stirred reaction mixture, until a colour change from green to 
red/yellow was observed, indicating that the acid had been sufficiently neutralised. The 
crude product was extracted into dichloromethane, and washed with a saturated sodium 
hydrogen carbonate solution to remove any residual acid, and water to remove residual 
base. Once chromatography and precipitation procedures had been performed, 11 was 
furnished as a purple powder in a 73 % yield. The 
1
H NMR spectrum for 11, shown in 
Figure 15, exhibited a singlet at 12.02 ppm, due to the newly formed carboxyl proton 
and in comparison to the 
1
H NMR spectrum for 10, no signal for the methyl group of 
the ester was observed, providing evidence that hydrolysis of the ester had occurred. 
The signal for the amino proton adjacent to the porphyrin exhibited a shift from 4.53 
ppm to 7.27 ppm, although this was probably due to the different solvent systems used 
for the analysis. The doublet at 6.51 ppm had the same coupling constant, J = 8.8 Hz, as 
the doublet at 7.63 ppm, therefore these signals were assigned the phenyl group attached 
to the β-position of the porphyrin. The other signals were assigned by considering the 
shielding effect of the porphyrin and the signal integrals. The HRMS gave the expected 
764.3013 m/z peak due to the (M+H)
+
 ion. Therefore there was enough evidence to 
suggest that the reaction had proceeded as expected. 
The sequential yield of compound 11, from the initial aldehyde and pyrrole starting 
materials was 3.8 %, which is lower than what would be expected for a mixed 
condensation synthesis of an unsymmetrically substituted porphyrin. Therefore the 
synthetic route was abandoned as there was no obvious advantage relative to the 
porphyrin synthesis using a statistical mixture of aldehydes.     
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Figure 15: 
1
H NMR spectrum of compound 11. 
β-H 
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2.7 Formylation of porphyrins bearing water solubilising functionalities in the 
meso-positions  
 
Although the optimisation of conditions required for introducing a maleimide to TPP 
was unsuccessful, it was still interesting to ascertain whether the Vilsmeier formylation 
conditions could be applied to porphyrins bearing functionalities in the meso-positions, 
which could be further modified to induce water solubility. The porphyrins; tetra(4-
pyridyl)porphyrin (12) and tetra(3,5-dimethoxyphenyl)porphyrin (14) contain functional 
groups which can modified to render the porphyrins fully water-soluble. Compound 12 
possess pyridyl groups which can be methylated by treatment with methyl iodide, and 
the pyridinium ions provide hydrophilicity, whereas compound 14 has methoxy groups 
which can be de-methylated using boron tribromide, with the hydroxyl groups enabling 
water-solubility.
68
 Formylating these porphyrins, and performing a series of 
modifications to the formyl group, eventually leading to the expression of a 
bioconjugation “handle”, fits the overall strategy outlined in the introduction. The 
formylation attempts are shown in Scheme 35. 
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Scheme 35: Attempted formylation reactions involving porphyrins with water 
solubilising groups in the meso-positions. 
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2.7.1 Attempted formylation of tetra(4-pyridyl)porphyrin (12) 
 
Tetra(4-pyridyl)porphyrin (12) was synthesised as a purple crystalline solid with a yield 
of 11 % by following the Adler-Longo method.
114
 The yield of the porphyrin was quite 
low, with a significant quantity of the porphyrin being retained in the propionic acid, 
possibly due to ionization of the pyridyl groups under the acidic conditions which 
would lead to the formation of a porphyrin acid salt.
114
 The 
1
H NMR spectrum for 12 
gave the expected signals, which integrated correctly. The signal for the aromatic ortho-
protons, has a higher ppm value compared to the β and aromatic meta-protons, due to 
the inductive effect exerted by the nitrogen. The mass spectrum showed the 619 m/z 
peak due to (M+H)
+
, therefore there was sufficient evidence that 12 had been produced. 
Compound 12 was then treated with a methanol/water solution of copper(II) acetate 
monohydrate, under reflux conditions.
130
 During the purification of 13, a silica column 
was initially used which resulted in the entire product being retained on the silica, thus 
when the experiment was repeated a neutral alumina column was used, allowing 
efficient purification. This suggested that even the mild acidity of silica gel was 
sufficient to cause protonation of the pyridyl groups. Following work up compound 13 
was isolated as a red powder, with a yield of 93 % .The mass spectrum of 13 gave the 
expected 679 m/z peak and the typical copper isotope pattern. The UV-visible spectrum 
of 13 gave 3 signals, whereas the spectrum of 12 gave 5 signals. This was due to 13 
being more symmetrical. Compound 13 was treated with the Vilsmeier complex as 
previously reported.
130
 Following work-up, only compound 12 was detected by TLC. 
The reaction could have failed due to the electron deficient nature of the pyridyl groups 
drawing electron density more towards the meso-positions of the porphyrin, resulting in 
the β-position not being sufficiently nucleophilic towards the Vilsmeier reagent. 
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2.7.2 Attempted formylation of tetra(3,5-dimethoxyphenyl)porphyrin (14) 
 
The Adler-Longo method,
114
 was used for the production of tetra(3,5-
dimethoxyphenyl)porphyrin (14), which was furnished as a purple solid with a yield of 
15 %. The 
1
H NMR analysis, coupled with the mass spectrum, confirmed that 14 had 
been successfully synthesised, in a reasonable yield.  
Following a reported procedure
130
 14, dissolved in chloroform, was treated with a slurry 
of copper(II) acetate monohydrate in methanol-water, at reflux for 5 hours. After work-
up, 15 was isolated a red/purple solid with a yield of 95 %. The evidence provided by 
the different UV-visible spectra of 14 and 15, as well as the mass spectrum for 15, 
indicated that the metallation had occurred as postulated. 
Compound 15 was treated under Vilsmeier formylation conditions, as previously 
reported.
130
 Following work-up, TLC analysis indicated that the reaction mixture 
contained no UV-active fraction, with the product having a yellow/brown viscous 
appearance.  
 
2.8 Summary / further work 
 
 The development of a high yielding synthetic pathway, involving the mono-
functionalisation of a symmetrical porphyrin and further modification into a group 
suitable for bioconjugation was unsuccessful, mainly due to the instability, and yields of 
products from the reductive amination reactions. Time permitting, it should be possible 
to react the carboxyl group possessed by 11 with a Boc protected diamine, which could 
deprotected and react with SMCC.  
The formylations of the copper(II) complexes tetra(4-pyridyl)porphyrin (13) and 
tetra(3,5-dimethoxyphenyl)porphyrin (15) were also unsuccessful. The formylation of 
15 should be further explored, but without the in-situ demetallation and conducting 
reductive aminations on the formylated copper(II) complex. 
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Chapter 3: Synthesis of immunoconjugate bearing a linker between photosensitiser 
and targeting moiety. 
 
3.1 Introduction 
 
Due to the problems associated with functionalising a symmetrical porphyrin, an 
alternative strategy was adopted involving incorporation of the required functionally 
during formation of the porphyrin. The types of reaction associated with forming 
porphyrins with multiple functional groups, including mixed condensations, are 
generally lower yielding than those for symmetrical porphyrins, however, developing 
the chemistry associated with forming water soluble maleimido porphyrins, performing 
successful conjugation to SIP(L19), and evaluating the characteristics of the subsequent 
immunoconjugates, validates the overall strategy.  
Members of our group, had previously coupled the lysine reactive, 5-[4-(succinimidyl-
N-oxycarbonyl)phenyl]-10,15,20-tri-(4-N-methyl-pyridiniumyl)porphyrin triiodide 
(PS3) to SIP(L19). Alonso et al.
144
 had also conjugated the SIP(L19), to a cationic 
porphyrin bearing a maleimide group directly attached to the porphyrin core; 5-(4-
maleimidophenyl)-10,15,20-tri-(4-N-methyl-pyridiniumyl)porphyrin triiodide (PS4).  
Therefore, by conjugating the same antibody fragment (SIP(L19)), to a similar 
porphyrin, which possessed a linker between the porphyrin and the maleimide group, it 
would be possible to assess the influence the linker had on the conjugates immunogenic 
and photophysical properties. Additionally, it would also be possible to further evaluate 
the effect on the immunoconjugates characteristics, of having the photosensitiser 
coupled to either the lysine or cysteine residues. 
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3.2 Synthesis of unsymmetrical porphyrins 
 
3.2.1 Mixed condensation porphyrin synthesis 
 
The mixed condensation approach involves reaction between at least two different 
aldehydes, and pyrrole, and as such the approach can be applied to synthesising 
porphyrins under either Adler-Longo
114
 or Lindsey
120
 reaction conditions. In terms of 
producing a dual functional porphyrin, suitable for forming bioconjugates, two different 
aldehydes would be used; one bearing a functional group which can be transformed into 
the bioconjugatable group, and another which facilitates water solubility. From a 
statistical perspective, this can produce six different porphyrins (Figure 16); therefore 
exhaustive chromatographic separation is required. The yield of the porphyrin can be 
enhanced by using appropriate stoichiometry, while also considering the reactivates of 
the different aldehydes. 
  
 
Figure 16: Representation of porphyrins produced during a mixed condensation 
porphyrin synthesis. 
 
When performing a mixed condensation, using Adler-Longo conditions,
114
 a major by-
product is poly-pyrrole, therefore the crude material is usually first passed through a 
plug of silica to isolate the porphyrins from the tarry mixture. Although limited by the 
stability of the aldehyde to propionic acid, a wide variety of unsymmetrical porphyrins 
have been synthesised using this methodology, as shown in Scheme 36. Interestingly, it 
has been reported that boronic acids withstand the harsh acidic conditions.
145
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Scheme 36: Examples of unsymmetrical porphyrins synthesised using Adler-Longo 
conditions.
145,146
 
 
The yields of unsymmetrical porphyrins synthesised under Adler-Longo conditions
114
 
are usually lower than those synthesised via the Lindsey method,
120
 thus it would be 
appropriate to use Lindsey conditions,
120
 if the reagents and corresponding 
porphyrinogen intermediate are soluble in chlorinated solvents. In addition to producing 
porphyrins in higher yields, as demonstrated by the yields of TPP obtained during 
preliminary studies, Lindsey conditions
120
 are also more tolerant of acid sensitive 
functional groups. Würthner et al.
147
 reported the synthesis of an anthryl-bithienyl 
porphyrin using the Lindsey procedure (Scheme 37); in this case using Lindsey reaction 
conditions were advantageous, as it was unlikely that the thienyl functionality would 
withstand boiling acidic conditions. Furthermore, the Adler-Longo method,
114
 only 
produces low yields of meso-alkyl porphyrins, e.g. meso-tetrapropylporphyrin in 2.8 % 
yield.
148
 Lindsey conditions
120
 have also being used for the synthesis of 5,10,15- 
tris(4-[2,3,4,6-tetraacetyl-β-D-glucosyl]phenyl)-20-mono(2,3,4,5,6-
pentafluorophenyl)porphyrin (Scheme 37).
149
 Equimolar equivalents of the aldehydes 
were used for the synthesis; however the major porphyrinic product was the 
symmetrical glycosylated porphyrin (9.5 %), thus demonstrating the importance of 
considering the reactivates of the aldehydes, in order to obtain the optimum yield of the 
desired porphyrin.  
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Scheme 37: Unsymmetrical porphyrins synthesised using Lindsey conditions.
148,149
 
 
3.2.2 MacDonald porphyrin synthesis.
150
 
 
 The 2+2 porphyrin synthesis is often used referring to reactions pioneered by 
MacDonald and co-workers,
150
 as an alternative method for producing multi-
functionalised porphyrins. The procedure involved the acid catalysed reaction between 
two dipyrromethanes; one of which possesses formyl groups on the carbons 
neighbouring the pyrrolic nitrogens, leading to the formation of a porphyrinogen, which 
was oxidised by air to afford porphyrin, as depicted in Scheme 38.    
 
 
Scheme 38: Example of MacDonald porphyrin synthesis.
150
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A similar 2+2 methodology has also been applied to dipyrromethane-carbinols, enabling 
the expression of multiple substituents in the meso-positions, as shown in Scheme 39. 
The production of the dipyrromethane-carbinol is achieved by initial acylation of the 
dipyrromethane, via treatment with ethylmagnesium bromide; producing the 
dipyrromethane anion, which is nucleophilic towards the subsequent substituent bearing 
a carbonyl attached to a good leaving group e.g. chloride or thiolated pyridyl group. 
Generally, acylations using the pyridyl thiolate derivatives produce higher yields, in 
comparison to acid chlorides, using polar solvents. Additionally, mono and di-acylation 
can be controlled by using appropriate stoichiometry. Reduction of the carbonyls using 
sodium borohydride affords the carbinol, which can be condensed with a 
dipyrromethane in the presence of acid, to furnish the porphyrinogen, which is oxidised 
by DDQ to afford the porphyrinic product.
151
  
 
 
Scheme 39: Theoretical synthesis of multifunctional porphyrin using 2+2 carbinol 
strategy. 
  
There has been a wide variety of porphyrins synthesised using the carbinol intermediate, 
with a few examples illustrated in Scheme 40.  
The scope of the 2+2 carbinol strategy is restricted mainly by the acylation procedure, 
due to incompatibility between the basic Grignard reagent or sodium borohydride,  with 
the substituent which is to be appended to the dipyrromethane; for example, acylations 
using an acetamido substituted thioester were unsuccessful due to the acidity of the NH 
group.
152
 The synthesis of a mono-functionalised pyridyl porphyrin has been reported, 
as illustrated in Scheme 40; however the yield was significantly lower than previously 
reported porphyrins which were synthesised in a similar manner.
153
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Scheme 40: Porphyrins synthesised using the carbinol intermediate.
151,153
 
 
3.2.3 Polymer supported synthesis of mono-functionalised porphyrin 
 
A polymer support can also be employed for the synthesis of mono-functionalised 
porphyrins, as demonstrated by Borhan and co-workers.
154
 The procedure involved the 
anchoring of 4-carboxybenzaldehyde to a functionalised solid support bearing a reactive 
alkyl halide, resulting in the carboxylic group forming an ester with the solid support. 
The derivatised solid support was then reacted with benzaldehyde and pyrrole, under 
Adler-Longo
114
 conditions, leading to formation of the mono-functionalised porphyrin 
attached to the solid support, and TPP in solution. The solid support was isolated by 
filtration, washed, and base hydrolysis of the ester afforded the mono-functionalised 
porphyrin in a reasonable yield of 6 %, as shown in Scheme 41. A similar methodology 
was then applied to a derivatised polymer bearing an alkyl halide. The polymer in ethyl 
acetate, was treated with 4-carboxybenzaldehyde in the presence of triethylamine, in a 
sealed tube at 90 
o
C; which resulted in anchoring of the aldehyde to the polymer via an 
ester bond. The derivatised polymer was reacted with pyrrole and benzaldehyde, under 
Lindsey conditions.
120
 The polymer was collected, washed with methanol, and the ester 
was cleaved using sodium hydroxide. The 5-(4-carboxyphenyl)10,15,20-
tri(phenyl)porphyrin was isolated in an excellent yield of 30 %. Considering only the 
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reaction yields, the porphyrin synthesised under Adler-Longo conditions
114
 didn‟t 
exhibit an advantage over the mixed condensation approach, whereas the Lindsey 
conditions
120
 produced a substantially higher yield. The main advantage of using the 
solid support strategy is the absence of the undesirable di, tri or tetra substituted 
porphyrins, therefore reducing the amount of chromatographic separation required and 
making isolation of the product more efficient. 
 
 
Scheme 41: Polymer supported synthesis of mono-functionalised porphyrin.
154
 
 
 
 
 
 
 
 
 
 
 
 
 
 103 
      
3.3 Porphyrins bearing amino functionalities. 
 
The amino group is a nucleophilic species. Therefore if the amino group is to be 
integrated into the porphyrin structure during porphyrin formation it must be protected 
to avoid condensation with the aldehyde. During porphyrin formation, amino groups are 
generally introduced as acetamido, 
68,155,156
 or phthalimide groups,
157
 or as a nitro 
precursor.
157,158,159 
The acetamido functionality can be hydrolysed by either base or acid 
treatment, yielding the amino group. The hydrolysis of 5-(4-acetamidophenyl)-
10,15,20-tri-(4-methoxyphenyl)porphyrin has been demonstrated by Fungo et al.,
155
 via 
basic treatment with potassium hydroxide, yielding the amino derivative with a yield of 
75 %; whereas Boyle and co-workers,
68
 deprotected the same porphyrin under acidic 
conditions, employing aqueous hydrochloric acid, affording the amino porphyrin in 93 
% yield (Scheme 42). The nitro group can be reduced to the amino functionality, as 
shown by Liu et al.
158
; 5-(4-nitrophenyl)-10,15,20-tri(4-tert-butylphenyl)porphyrin was 
treated with a mixture of tin(II) chloride and hydrochloric acid, furnishing the amino 
derivative in 84 % yield, as illustrated in Scheme 42. The phthalimide functionality can 
be cleaved using hydrazine monohydrate, via nucleophilic attack at the phthalimide 
carbonyls, leading to the production of a stable cyclic by-product; for example, the 
amino analogue of 5-(4-phthalimidophenyl)-10,15,20-tri(4-
trifluoromethylphenyl)porphyrin was produced in a 85 % yield,
157
 as depicted in 
Scheme 42. 
 
 104 
      
 
Scheme 42: Amino porphyrins from acetamido,
68,155
 nitro,
158
 and phthalimide
157
 
analogues. 
 
It has been demonstrated that amino porphyrins can participate in DCC mediated 
couplings and a variety of nucleophilic substitution reactions. An article by Wang et 
al.
157
 has described the DCC mediated coupling between tetra(4-aminophenyl)porphyrin 
with Boc protected valine. The reaction was performed in dichloromethane in the 
presence of 4-dimethylaminopyridine for 72 hours at 6 
o
C, furnishing the product in 38 
% yield. Feng and Senge,
160
 have performed a DCC catalysed reaction involving (−)-
2,3:4,6-di-O-isopropylidene-L-gulo-hex-2-ulofuranosonic acid and 5-(4-aminophenyl)-
15-butyl-10,20-diphenylporphyrin in dichloromethane, for 3 hours at ambient 
temperature, affording the desired porphyrin in 70 % yield. Interestingly, it has been 
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reported that DCC couplings involving 5-(4-aminophenyl)-10,15,20-tri-(4-
pyridyl)porphyrin and Boc protected glutamic acid were unsuccessful; attributed to the 
amino group having a low nucleophilicity, due to the nitrogen‟s lone pair of electrons 
delocalising into the phenyl ring. However, the coupling was achieved by pre-activating 
the glutamic acid‟s carboxyl group with ethyl chloroformate, and the resulting 
anhydride was reacted with the amino porphyrin in situ, producing the adduct in 80 % 
yield.
161
  
5-(4-Aminophenyl)-15-butyl-10,20-diphenylporphyrin has also been shown to react 
with maleic anhydride, to furnish the maleic acid analogue. The porphyrin, dissolved in 
anhydrous tetrahydrofuran, was treated with aliquots of maleic anhydride, and the 
resulting mixture was stirred at ambient temperature for 30 minutes. The excess maleic 
anhydride was neutralised with an aqueous solution of sodium hydroxide, and the 
maleic acid derivative was isolated in 92 % yield, after aqueous washings and 
chromatographic separation.
160
 
 Flamigni et al.
159
 have shown that 5-(4-aminophenyl)-10,15,20-tri-(4-
trifluoromethylphenyl)porphyrin can react with a corrole bearing an acid chloride, as 
shown in Scheme 43. The corrole, bearing a carbomethoxy group, was treated with 
trifluoroacetic acid, acetic acid and sulphuric acid under an argon atmosphere, for 24 
hours at 100 °C. The carboxyl functionality was then converted into the acid chloride by 
dissolving the corrole in anhydrous tetrahydrofuran, and treatment with oxalyl chloride 
at 60 °C for 30 minutes. The solvent was removed, and the intermediate acid chloride 
was re-dissolved in a mixture of dry tetrahydrofuran and triethylamine. The amino 
porphyrin was subsequently added and the reaction was stirred at 50 °C over night; 
following work-up, the dyad was isolated in 48 % yield. 
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Scheme 43: Synthesis of porphyrin-corrole adduct.
159
 
 
 5-(4-Aminophenyl)-10,15,20-tri-(2,4,6-trimethoxyphenyl)porphyrin has been shown to 
participate in a nucleophilic substitution reaction with 1-chloro-2,6-dinitro-4-
trifluorometilbenzene. The reagents were dissolved in chloroform, and the reaction 
proceeded after potassium hydroxide was added to activate the amino group, and in the 
presence of the phase transfer catalyst tetrabutylammonium bromide, affording the 
product in 90 % yield.
156
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3.4 Porphyrins bearing carboxyl functionalities 
 
The carboxyl group doesn‟t require protection prior to porphyrin formation, however 
Yamaguchi et al.
142
 and Ishikawa et al.
162
 synthesised 5-(4-carboxyphenyl)-10,15,20-
tri-(4-pyridyl)porphyrin via the base hydrolysis of the methyl ester analogue. The 
reasons for this strategy are unknown, as the reaction yields of 1.4 %
142
 and 5 %,
162
 are 
not favourable, and there is no significant difference in cost between methyl 4-
formybenzoic acid and 4-carboxybenzaldehyde.
163
 
It has been reported that porphyrins bearing carboxyl groups can be utilised for 
reactions that require coupling reagents. An EDCI mediated reaction between 5-(4-
carboxyphenyl)-10,15,20-tri-(3,5-di-tert-butylphenyl)porphyrin and a fullerene which 
possessed a polyethylene glycol chain terminating in a hydroxyl group has been 
reported. The coupling proceeded in anhydrous dichloromethane and in the presence of 
4-dimethylaminopyridine. The mixture was stirred for 18 hours, and following work-up 
and isolation, the adduct was furnished in 51 % yield.
164
 It has also been shown that 
EDC and 4-dimethylaminopyridine can catalyse a coupling involving 5-(4-
carboxyphenyl)-10,15,20-tri-(2-pyridyl)porphyrin and an oligonucleotide possessing an 
amino functionality. The reaction was performed at room temperature, overnight, in dry 
dichloromethane, with the conjugate isolated in 73 % yield.
 165
 Habdas et al.
166
 have 
reported the DCC/4-dimethylaminopyridine coupling of aminophosphonates with 5-(4-
carboxyphenyl)-10,15,20-tri-(4-pyridyl)porphyrin. The amino phosphonate, 4-
dimethylaminopyridine and triethylamine were dissolved in anhydrous 
dichloromethane, which was subsequently added to a solution of the porphyrin and 
DCC, dissolved in dry dichloromethane. The mixture was stirred at 0 °C for 2 hours, 
and then at room temperature for a further 24 hours, with the porphyrin-phosphonate 
derivatives produced in 65 % and 70 % yields, as illustrated in Scheme 44.  
 
 
 108 
      
 
Scheme 44: DCC coupling of porphyrin and phosphonate derivatives.
166
 
 
Acridines bearing an alkyl chain, of varying lengths, terminating in an amino group, 
have been used for synthesising a library of porphyrin-acridine conjugates, via the 
carbonyldiimidazole catalysed coupling with 5-(4-carboxyphenyl)-10,15,20-tri-(4-
pyridyl)porphyrin. The porphyrin was pre-activated with carbonyldiimidazole, 
dissolved in a mixture of dimethylformamide and dimethylsulfoxide at 0 °C. The 
acridine, dissolved in the same solvent system was added, and the resulting solutions 
were stirred at 0 °C for 20-47 hours, affording the porphyrin-acridine conjugates in 22-
46 % yields.
162
 
Carboxyl groups can be transformed into an activated form, e.g. activated esters or acid 
chlorides, making them susceptible to nucleophilic attack. Frochot and co-workers,
167
 
converted 5-(4-carboxyphenyl)-10,15,20-tri-(phenyl)porphyrin into an activated ester 
via a DCC mediated reaction with N-hydroxysuccinimide in dry 1,4-dioxane, at room 
temperature for 4 hours, affording the N-hydroxysuccinimide activated porphyrin in 91 
% yield. The activated ester dissolved in anhydrous tetrahydrofuran was reacted with a 
PEG chain terminating in amino groups, one of which was Boc protected. The reaction 
mixture was stirred at room temperature for 18 hours, yielding the porphyrinic product 
in 75 % yield, as depicted in Scheme 45. The N-hydroxysuccinimide activated 
porphyrin was also treated with a folic acid derivative which possessed an amino 
functionality. The reaction was performed in a mixture of anhydrous dimethylsulfoxide 
and pyridine, for 24 hours at ambient temperature, giving the porphyrin-folic acid 
conjugate in 34 % yield. 
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Scheme 45: Reaction between N-hydroxysuccinimide activated porphyrin and PEG 
derivative.
167
 
 
5-(4-Carboxyphenyl)-10,15,20-tri-(4-pyridyl)porphyrin has also been converted into the 
N-hydroxysuccinimide activated ester derivative, as demonstrated by Tomé et al.
168
 A 
solution of the carboxyl porphyrin dissolved in dry pyridine was treated with thionyl 
chloride, and the mixture was stirred for 30 minutes at 50 °C. N-hydroxysuccinimide 
was subsequently added to the mixture, and the reaction was continued for a further 3 
hours. Once worked-up, 5-[4-(succinimide-N-oxycarbonyl)phenyl]-10,15,20-tri-(4-
pyridyl)porphyrin was isolated in 91 % yield. The porphyrin bearing the activated ester 
was then used to synthesise a porphyrin-polylysine conjugate. 
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3.5 Synthetic strategy involving addition of SMCC to 5-(4-aminophenyl)-10,15,20-
tri-(4-pyridyl)porphyrin (17) 
 
Previous experimental experience led to selection of the Adler-Longo method,
114
 for 
porphyrin synthesis. The overall aim was to produce a porphyrin bearing two different 
functional groups in the meso-positions; one functional group facilitating the addition of 
a linker; eventually terminating in a maleimide group, with the remaining meso-
positions occupied by functionalities, which upon further modification, could provide 
the hydrophilic character. It was decided that pyridyl groups, which upon methylation 
would provide hydrophilicity, with an amino group present in the remaining meso-
position, which could be further modified with SMCC, leading to the introduction of a 
short linker, terminating with a maleimide bioconjugatable group. The amino group had 
to be protected during porphyrin formation, and literature suggested that the highest 
yielding deprotection was the acid hydrolysis of the acetamido group. Therefore, the 
target porphyrin became the product of the mixed condensation between 4-acetamido-
benzaldehyde and 4-pyridinecarboxaldehyde, with pyrrole. The overall synthetic 
strategy is illustrated in Scheme 46. 
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Scheme 46: Synthetic strategy involving addition of SMCC to 5-(4-aminophenyl)-
10,15,20-tri-(4-pyridyl)porphyrin. 
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3.5.1 Attempted addition of SMCC to 5-(4-aminophenyl)-10,15,20-tri-(4-
pyridyl)porphyrin (17) 
 
Following a known procedure,
68
 5-(4-acetamidophenyl)-10,15,20-tri-(4-
pyridyl)porphyrin (16) was synthesised with a yield of 5 %. Characterisation studies 
were in agreement with the reported data, although the 
13
C NMR spectrum for 16 had 
16 signals when theoretically 23 signals should be observed. 
The acidic hydrolysis of the acetamido group was firstly performed by treating 16 with 
a 5 M hydrochloric acid solution, at reflux for 3 hours, as previously described.
68
 
Following removal of hydrochloric acid, the crude product was dissolved in a solution 
of triethylamine in dichloromethane, to neutralise the residual hydrochloric acid and 
deprotonate the porphyrins inner nitrogens. Following chromatographic separation and 
precipitation from chloroform by the addition of methanol, 17 was isolated with a yield 
of 82 %. The yield was lower than the published yield of 90 %, thus the hydrolysis was 
performed using a slightly modified procedure,
169
 with 16 being dissolved in ethanol 
prior to the acidic treatment, affording 17 with a yield of 91 %. The 
1
H NMR spectrum 
of 17 exhibited no singlet at 2.35 ppm corresponding to the methyl protons, however no 
signal for the newly formed amino protons was observed, possibly due to proton-
deuterium exchange. The mass spectrum gave the expected 633 m/z (M+H)
+
 peak, 
therefore there was sufficient evidence that the reaction had occurred as postulated.  
The addition of SMCC to 17 was then attempted by dissolving the two reagents in 
anhydrous dichloromethane, and the resulting solution was stirred at 30 
o
C for 2 hours. 
TLC analysis (silica, eluent: 10 % methanol/dichloromethane) of the reaction mixture 
showed only the presence of 17, therefore a drop of diisopropylethylamine was added to 
ensure the amine was not protonated. After 16 hours, the TLC of the reaction mixture 
showed that 17 remained unchanged, therefore the reaction mixture was discarded. The 
reaction was repeated, employing dry chloroform, and with the addition of portions of 
diisopropylamine successively after the SMCC. The reaction mixture was monitored 
over a 6 day period with no apparent change to 17. The reaction was also attempted in 
anhydrous pyridine, with no base being required, due to the basicity of the solvent. The 
reaction was monitored over a 4 day period by TLC, with only 17 being detected. 
It was hypothesised that the reactions had failed because the amino groups lone pair of 
electrons had delocalised into the phenyl ring, impairing nucleophilicity. 
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3.6 Synthetic strategy involving synthesis of porphyrin bearing an alkyl chain 
terminating with a maleimide bioconjugatable group. 
 
Since the addition of SMCC to the amino porphyrin 17 was unsuccessful, the synthetic 
strategy required modification, with the aim of producing a porphyrin bearing a more 
nucleophilic aliphatic amino functionality, enabling the reaction with the activated ester 
of SMCC. Due to the low reactivity of the aromatic
 
amino group of 17, it was postulated 
that if the porphyrin bore a different functionality, which facilitated a reaction with a 
aliphatic linker, terminating with an amino group, the reaction with SMCC could then 
occur. A porphyrin bearing a carboxyl and pyridyl groups, was selected for further 
modification, hence the target porphyrin was a product of the mixed condensation 
between 4-carboxybenzaldehyde, 4-pyridinecarboxaldehyde, with pyrrole. The 
literature suggested that coupling reagents such as DCC,
166
 EDC,
165
 and 
carbonyldiimidazole
162
 can be employed for coupling carboxyl porphyrins bearing 
pyridyl groups to derivatives bearing amino groups, with some reasonable yields being 
reported. The other predominant type of reaction concerning carboxyl porphyrins 
involved converting the carboxyl group into an activated N-hydroxysuccinimide ester, 
facilitating reactions with nucleophilic species, such as amino groups.
167,168
 There 
wasn‟t a preferential reaction involving carboxyl porphyrins, but since the synthesis of 
5-[4-(succinimidyl-N-oxycarbonyl)phenyl]-10,15,20-tri-(4-pyridyl)porphyrin, has been 
reported,
168
 and a reaction between a diamine and the activated ester had also being 
established,
167
 the activated ester strategy was selected. The next requisite was for the 
porphyrin to posses a terminal 1
o
 amino group, therefore N-Boc-1,6-diaminohexane 
hydrochloride was chosen to react with the activated ester. One of the amino groups was 
Boc protected, to prevent the porphyrin reacting at both ends of the alkyl linker, leading 
to the formation of a porphyrin dimer. Once the Boc group had been cleaved under 
acidic conditions, a subsequent reaction with SMCC resulted in introduction of the 
maleimide functionality. The final step of the reaction sequence involved quatenisation 
of the pyridyl groups to induce water-solubility, as illustrated in Scheme 47.
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Scheme 47: Synthesis of hydrophilic porphyrin bearing an alkyl chain terminating with 
a maleimide group. 
 
3.6.1 Synthesis of 5-(4-((6-tert-butylcarbamate)hexyl-1-amino-N-
carbonyl)phenyl)10,15,20-tri-(4-pyridyl)porphyrin (20) 
  
Following a literature procedure,
170
 18 was isolated in 6 % yield. The 
1
H NMR of 18 
was similar to the reported data, except the signal for the β and 10,15,20-meta-aromatic 
protons had merged into a multiplet at 8.74-9.09 ppm, which integrated to 14, and the 
signal corresponding to the carboxyl proton was not observed. 
Using a reported method,
168
 19 was synthesised in a 90 % yield. The 
1
H NMR spectrum 
of 19 was more resolved than the literature data, with the signal for the 10,15,20-
aromatic protons appearing as double doublets at 8.17 ppm and 9.06 ppm, and the signal 
for the β protons splitting into 2 signals; one doublet corresponding to 2 β-protons at 
8.85 ppm, with the remaining 6 β-protons appearing as a multiplet at 8.86-8.90 ppm.  
Both 19 and N-Boc-1,6-diaminohexane hydrochloride were soluble in 
dimethylsulfoxide, therefore it was deemed a suitable solvent for the synthesis of 20. 
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Furthermore, the dimethylsulfoxide solvent had to be dry, to avoid hydrolysis of the 
porphyrin‟s activated ester. The N-Boc-1,6-diaminohexane hydrochloride available 
amino group was in a protonated form with a chloride counter ion, thus to ensure the 
amino group was sufficiently nucleophilic towards the activated ester, the reaction was 
performed in the presence of base. Potassium carbonate was soluble in 
dimethylsulfoxide and was therefore selected for the reaction. Using a modified 
method,
167
 compound 20 was synthesised multiple times, using slightly different 
reaction conditions, as illustrated in Table 1. The synthesis of 20 was initially achieved 
by dissolving 19, N-Boc-1,6-diaminohexane hydrochloride (2.5 equivalents) and 
potassium carbonate (4.9 equivalents) in anhydrous dimethylsulfoxide (10 mL), and 
stirring the reaction mixture at 40 °C, while protected against light and moisture. The 
reaction was monitored by TLC (silica, eluent: 10 % methanol/dichloromethane), and 
after 40 minutes complete consumption of 19 was observed, with the development of a 
more polar UV-active fraction corresponding to 20. The product was extracted into 
dichloromethane and washed with copious amounts of water to remove the excess N-
Boc-1,6-diaminohexane hydrochloride, potassium carbonate, the 1-hydroxypyrrolidine-
2,5-dione by-product and dimethylsulfoxide. Anhydrous sodium sulphate was added to 
the organic layer, to remove residual water, and the filtrate was collected. The solvent 
was removed in vacuo, and the crude product was chromatographically separated 
(silica, eluent: 6 % methanol/dichloromethane) with 20 isolated in 57 % yield after 
precipitation from dichloromethane by the addition of hexane. The yield of 57 % 
seemed reasonable, therefore the reaction was repeated in the same manner, however a 
lower yield was obtained (49 %) and when the reaction was scaled up, using 98 mg of 
19, the yield diminished further, with 20 being produced in 40 % yield. The lower yield 
obtained for the scaled-up reaction meant that subsequent reactions were done using 
approximately 50 mg of 19. The reaction was repeated using a lower volume of 
dimethylsulfoxide, thus the concentration of 19 was increased to 6.8 mg/mL, from 5.9 
mg/mL for the initial reactions. 
As a large excess of base was used for the initial reactions, the reaction was performed 
using a lower amount of potassium carbonate (4.1 equivalents), which resulted in 20 
being produced in 46 % yield. Reducing the base, reduced the yield of 20, therefore the 
reaction was repeated using a higher amount of both potassium carbonate (6.9 
equivalents) and N-Boc-1,6-diaminohexane hydrochloride (2.8 equivalents), furnishing 
20 in 84 % yield. For the conditions evaluated, the quantity of base present in the 
reaction mixture seemed to have the most dramatic effect on the yield of 20. The 
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reaction was repeated in a similar manner, using a slightly lower amount of N-Boc-1,6-
diaminohexane hydrochloride (2.5 equivalents) and potassium carbonate (6.3 
equivalents), affording 20 in 82 % yield. 
 
19 
 
DMSO N-Boc-1,6-
diaminohexane 
hydrochloride 
Potassium 
carbonate 
20 
59 mg, 
78 μmol 
10 mL 50 mg, 197 μmol, 
2.5 equiv. 
53 mg, 
383 μmol, 4.9 equiv. 
38 mg, 
57 % 
59 mg, 
78 μmol 
10 m 50 mg, 197 μmol, 
2.5 equiv. 
53 mg, 
383 μmol, 4.9 equiv. 
33 mg, 
49 % 
98 mg, 
129 μmol 
18 mL 82 mg, 324 μmol, 
2.5 equiv. 
89 mg, 
644 μmol, 5 equiv. 
45 mg, 
40 % 
68 mg, 
90 μmol 
10 mL 57 mg, 225 μmol, 
2.5 equiv. 
62 mg, 
449 μmol, 5 equiv. 
39 mg, 
50 % 
68 mg, 
90 μmol 
10 mL 57 mg, 225 μmol, 
2.5 equiv. 
62 mg, 
449 μmol, 5 equiv. 
47 mg, 
61 % 
58 mg, 
76 μmol 
10 mL 50 mg, 197 μmol, 
2.5 equiv. 
43 mg, 
311 μmol, 4.1 equiv. 
30 mg, 
46 % 
47 mg, 
61 μmol 
8 mL 43 mg, 170 μmol, 
2.8 equiv. 
58 mg, 
420 μmol, 6.9 equiv. 
Combined 
with 
below 
reaction 
47 mg, 
61 μmol 
8 mL 43 mg, 170 μmol, 
2.8 equiv. 
58 mg, 
420 μmol, 6.9 equiv. 
88 mg, 
84 % 
51 mg, 
67 μmol 
9 mL 43 mg, 170 μmol, 
2.5 equiv. 
58 mg, 
420 μmol, 6.3 equiv. 
47 mg, 
82 % 
     
 
Table 1: Reaction conditions used for the synthesis of 20. 
 
The relevant sections of the 
1
H NMR spectrum for 20, is shown in Figure 17. The 
assignment of the signals was achieved using a combination of 
13
C NMR, 2D COSY 
and CH-correlation experiments. The assignment of the signals in the alkyl region was 
achieved by evaluating the 2D COSY experiment, depicted in Figure 18. 
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Figure 17:
 1
H NMR spectrum of 20. 
 
 
 
10,15,20-Ar-m-H 
and β-H 
5-Ar-o-m-H and 
10,15,20-Ar-o-H 
CHCl3 
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Figure 18: 
1
H NMR COSY of 20. 
 
The signal at 1.37-1.47 ppm which integrates to 11, is in the region which would be 
expected for the tert-butyl protons of the Boc group, however the 2D COSY shows 
coupling with a signal at 1.48-1.58 ppm, and theoretically the Boc protons should not 
couple with any other proton environment. Therefore the peak at 1.37-1.47 ppm 
corresponds to the 9 protons of the tert-butyl region of the Boc group (i), and 2 protons 
of a CH2, neighbouring a proton environment which produces the signal at 1.48-1.58 
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ppm. The multiplet signal at 1.48-1.58 ppm appears to couple with 3 other signals; the 
multiplet at 1.37-1.47 ppm, the quintet at 1.75 ppm and the multiplet at 3,06-3.18 ppm, 
therefore that peak must be from 2 different proton environments. As the multiplet at 
1.48-1.58 ppm integrates to 4, and couples to 3 other signals, and the multiplet at 1.37-
1.47 ppm only couples to 1 signal, the CH2 from the multiplet at 1.37-1.47 ppm must be 
in-between 2 CH2 environments from the signal at 1.48-1.58 ppm. The signal at 1.75 
ppm integrates to 2, and appears as a quintet, thus it must be from a CH2 located in the 
middle of the hexyl chain. The 2D COSY analysis showed that the quintet at 1.75 ppm 
couples with the triplet at 3.58 ppm, and as none of the amino protons were observed 
for that particular 
1
H NMR analysis, the peak at 3.58 ppm was assigned proton 
environment (b). Once (b) was determined, the other signals were subsequently 
assigned; the quintet at 1.75 ppm (c), the multiplet at 1.48-1.58 ppm (d) and (f), and the 
multiplet at 1.37-1.47 ppm (i) and (e). The remaining multiplet signal in the alkyl region 
at 3.06-3.18 ppm, integrated to 2, and coupled with proton environment (f), therefore it 
was assigned (g). The 
1
H NMR and 2D COSY experiments were repeated, to obtain 
amino proton signals, with the 2D COSY shown in Figure 18. The signal for proton 
environment (b) couples to a broad singlet at 7.68 ppm, which was assigned amino (a), 
and peak (g) couples with a broad singlet at 5.09 ppm, which was attributed to amino 
group (h). Although not well defined, the signals in the aromatic region integrated 
correctly and were subsequently assigned; a multiplet at 8.11-8.29 ppm corresponding 
to the 5-aromatic and 10,15,20-ortho-aromatic protons and another multiplet at 8.63-
9.08 attributed to the β and10,15,20-meta-aromatic protons. The mass spectrum gave 
the expected 860.4029 m/z peak due to the (M+H)
+ 
ion, so there was sufficient evidence 
that 20 had been produced. 
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3.6.2 Synthesis of 5-(4-(6-(4-(N-maleimidomethyl)cyclohexane-1-amido)hexyl-1-
amino-N-carbonyl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrin (21) 
 
The acid hydrolysis of the Boc protecting group of 20 was attempted using a modified 
published procedure.
157
 A solution of 20 dissolved in anhydrous dichloromethane was 
treated with trifluoroacetic acid for 50 minutes at room temperature, until complete 
consumption of 20 had occurred as indicated by TLC (silica, eluent: 10 % 
methanol/chloroform). The resulting mixture was poured onto an ice cooled aqueous 
solution of sodium hydrogen carbonate, to neutralise the trifluoroacetic acid; a colour 
change from green to red was observed in the organic layer, due to deprotonation of the 
porphyrin inner nitrogens. The product was extracted into dichloromethane, and the 
organic layer was washed with water to remove residual sodium hydrogen carbonate 
and dried over anhydrous sodium sulphate to remove residual water. Initial 
chromatographic separation was attempted (silica, eluent: 10 % 
methanol/dichloromethane), which resulted in the porphyrinic product being retained on 
top of the silica; a result of the extra polarity provided by the amino functionality, and 
subsequent ionic interactions with the polar hydroxyl groups from the silica gel. 
Therefore flash chromatography was attempted using neutral alumina and 10 % 
methanol/dichloromethane eluent. Once the relevant fraction had been collected, the 
TLC of the product revealed that decomposition had occurred, and the 
1
H NMR of the 
suspected deprotected 20 was inconclusive. Isolation of the amino porphyrin was also 
attempted using alumina coated preparative TLC plates, but decomposition of the 
product was again observed. Because isolation of deprotected 20 was problematic and 
the TLC of the reaction mixture indicated that complete amino deprotection had been 
achieved, the reaction was repeated, without the amino porphyrin been isolated and the 
crude intermediate was used in the next synthetic step.  
Reaction of SMCC with the crude amino porphyrin was achieved following a modified 
published procedure.
102
 A solution of the crude amino-porphyrin dissolved in anhydrous 
dimethylformamide was treated with SMCC (1.2 equivalents relative to 20) in the 
presence of diisopropylethylamine (2.2 equivalents relative to SMCC). The resulting 
mixture was stirred for 50 minutes at ambient temperature, while protected against 
moisture and light until the composition of the mixture exhibited no further change, as 
shown by TLC (silica, eluent: 10 % methanol/dichloromethane) with the presence of 
both the amino porphyrin intermediate and 21 being detected. An ice cooled solution of 
diethyl ether and hexane was added to the reaction mixture to initiate precipitation of 
 121 
      
the crude product, which was subsequently chromatographically separated (silica, 
eluent: 5 % methanol/chloroform). The relevant fraction was collected, with 21 isolated 
in 36 %, after precipitation from hexane over dichloromethane. The reaction yield was 
quite low, with the TLC of the reaction mixture indicating that not all of the amino-
porphyrin had reacted with the SMCC. Therefore it was postulated that a proportion of 
the amino groups were in a protonated form, hence were not nucleophilic towards the 
activated ester of SMCC. Therefore the reaction was repeated using 5 equivalents of 
diisopropylethylamine, to ensure complete deprotonation of the ammonium groups. 
After the reaction mixture had been stirred at room temperature for 50 minutes, the TLC 
of the reaction mixture showed almost complete consumption of the amino porphyrin 
intermediate, and following work-up, 21 was isolated in 85 %.    
The important regions of the 
1
H NMR spectrum for 21, are shown in Figure 19. Despite 
multiple attempts, 
1
H NMR spectrum where all the protons in the alkyl region were 
accounted for was not achieved. As the solvent peaks were prominent, it was possible 
that signals for proton environments corresponding to the hexyl chain and/or the 
cyclohexane ring, were beneath solvent signals, however drying the sample led to 
decomposition. A 2D COSY experiment was performed, however only partial 
assignment of the signals could be made due the complex nature of the spectrum and the 
presence of solvent peaks, and not all of the protons in the alkyl region were accounted 
for. Importantly, the alkyl region of the 
1
H NMR spectrum for 21 does not show the 
presence of the tert-butyl protons which were detected for 20 at 1.37-1.47 ppm. The 
aromatic region of the spectra provided conclusive evidence that 21 had been 
synthesised as envisaged, with the detection of a singlet at 6.62 ppm due to the 
maleimide protons. All the other peaks in the aromatic region were accounted for and 
assigned. The HRMS gave the expected 979 m/z peak due to the (M + H)
+ 
ion, therefore 
it was concluded that 21 had been synthesised. 
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Figure 19: 
1
H NMR spectrum of 21. 
 β-H 
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3.6.3 Synthesis of 5-(4-(6-(4-(N-maleimidomethyl)cyclohexane-1-amido)hexyl-1-
amino-N-carbonyl)phenyl)-10,15,20-tri-(4-N-methyl-pyridyniumyl)porphyrin 
triiodide (22) 
 
Following a published method,
68
 21 was quaternised via treatment with methyl iodide. 
Due to the volatile and harmful nature of methyl iodide, the reaction was performed in a 
vessel fitted with a reflux condenser which had tubing feeding into a triethylamine 
solution, in order to destroy any methyl iodide which could evaporate from the reaction 
mixture at 40 °C. A solution of 21 dissolved in anhydrous dimethylformamide was 
treated with a large excess of methyl iodide and the resulting mixture was stirred for 4 
hours at 40 °C. The reaction mixture was then cooled to ambient temperature over ice, 
with the addition of an ice cooled mixture of diethyl ether and hexane initiating 
precipitation of the product. The precipitate was collected, and the crude product was 
washed with warm diethyl ether to remove any residual dimethylformamide and methyl 
iodide, furnishing 22 in 80 % yield.  
The relevant regions of the 
1
H NMR spectrum for 22, is shown in Figure 20. A 
combination of 2D COSY, C-H correlation and HMBC experiments were used for 
assignment of the aliphatic signals. The two singlets at 4.72 ppm and 4.73 ppm, which 
gave a combined integral of 9, indicated that methylation of the pyridyl groups had 
occurred. The maleimide group, which produces a singlet at 6.97 ppm, was present, 
indicating that the maleimide bioconjugatable group had remained unaffected under the 
methylation conditions. 
The mass spectrum of 22, produced a 341 m/z signal which corresponded to the (M)
3+ 
ion. Therefore there was sufficient evidence that 21 had been successfully quaternised, 
affording the target photosensitiser (22).   
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Figure 20:
 1
H NMR spectrum of 22. 
6H of β-H 
10,15,20-Ar-o-H + 2H of β-H 
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3.7 Synthesis of photosensitisers PS3 and PS4 
 
Photosensitiser PS3 was synthesised by a literature method.
168
 During this research 
project, Alonso et al.,
144
 synthesised PS4, as depicted in Scheme 48. A solution of 5-4-
amino)-10,15,20-tri-(4-pyridyl)porphyrin in nitrobenzene, was treated with maleic 
anhydride, and the subsequent cyclodehydration of the maleic acid intermediate resulted 
in the formation of the single maleimide bioconjugatable group. Quaternisation of the 
pyridyl groups rendered the porphyrin fully water soluble, facilitating the conjugation to 
the antibody in aqueous media. 
 
 
Scheme 48: Synthesis of 5-(4-maleimidophenyl)-10,15,20-tri-(4-N-methyl-
pyridiniumyl)porphyrin triiodide (PS4).
144
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3.8 Photoimmunoconjugates 
 
3.8.1 Photoimmunoconjugate preparation 
 
The water-soluble porphyrins bearing either N-hydroxysuccinimide (PS3) or maleimide 
(PS4 and 22) bioconjugatable groups (Figure 21) , were investigated as components for 
the formation of photoimmunoconjugates of SIP(L19) in collaboration with the research 
group of Professor Dario Neri at the Swiss Federal Institute (ETH) based in Zurich. The 
synthesis of the immunoconjugates and subsequent biological studies were conducted 
by Alessandro Palumbo and Corinne Hutter, under the supervision of Professor Dario 
Neri. 
 
 
Figure 21: Hydrophilic porphyrins PS3, PS4 and 22.  
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3.8.1 Conjugation to SIP(L19) 
 
A solution of SIP(L19) in PBS (pH 7.4) was treated with a 30-fold excess of the mild 
reducing agent: TCEP to reduce the cysteine residues in the c-terminal region while 
leaving the intra-domain disulphide bridges intact; thus enabling site specific coupling. 
The resulting mixture was incubated for 12 hours at 4 °C. A 40 molar excess of the 
photosensitiser (PS3, PS4 or 22) dissolved in dimethylsulfoxide was added to the 
reduced SIP(L19), and the resulting mixture was incubated for 3 hours, at ambient 
temperature, with gentle shaking. The photoimmunoconjugate was purified by passing 
the crude mixture through a PD-10 gel permeation column, and then the relevant 
fraction was dialysed against PBS (pH 7.4) at 4 °C. 
   
3.8.2 Photoimmunoconjugate characterisation 
 
To ensure that covalent coupling between the photosensitiser and antibody had 
occurred, the photoimmunoconjugate was analysed by SDS-PAGE.  
SDS-PAGE is an electrophoresis separation technique where molecules, within a 
sodium dodecyl-sulphate (SDS) solution, migrate on a polyacrylamide gel solid support, 
with the rate of migration dependent on the size of the molecule and the 
electronic field strength applied. SDS is an anionic detergent which binds to proteins, 
causing them to denature, so when a protein solution is charged on to the 
polyacrylamide gel and the electric field is applied, different proteins separate based on 
molecular mass.
171
 The SDS-PAGE of photoimmunoconjugates PS4-SIP(L19) and 22-
SIP(L19) is shown in Figure 22. Visualisation of the antibody component on the 
polyacrylamide gel was achieved via staining with coomassie blue. The comassie blue 
dye binds to proteins mainly via electrostatic interactions between the dyes sulphonate 
groups, and the proteins protonated amino groups; with hydrophobic interactions, 
hydrogen bonding, van der Waals forces and electrostatic interactions also contributing 
to the dye-protein interaction.
172
 The photosensitiser moiety was detected more simply 
by fluorescence imaging.     
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Lanes 1 and 2: control reactions involving PS4 and 22 with SIP(L19) which has not 
been reduced. Lanes 4 and 5: PS4 and 22 coupling with reduced SIP(L19). Lanes 7-
10: SIP(L19) reference standards (0.8 mgL
−1
, 0.4 mgL
−1
, 0.2 mgL
−1
 and 0.1 mgL
−1
).
 
A: Stained with coomassie blue. B: Fluorescence imaging using a Cy5 filter lamp 
Figure 22: SDS-PAGE of SIP(L19), PS4-SIP(L19) and 22- SIP(L19). 
 
The purpose of the control reactions was to evaluate whether the photosensitisers 
coupled to the SIP(L19), when the cysteine residues were unavailable. Lanes 1 and 2 
did not produce a fluorescent signal, therefore the photosensitiser had not coupled to the 
non-reduced SIP(L19). Furthermore, when stained with coomassie blue, lanes 1 and 2 
both showed that the SIP(L19) homodimer, had a molecular weight of ≈ 80 KDa. Lanes 
4 and 5, which were stained with coomassie blue, shows that SDS-PAGE analysis 
detects the reduced SIP(L19) in the monomeric form, and that complete reduction of 
SIP(L19) had been achieved. The fluorescent signals produced by lanes 4 and 5, 
indicated that the photosensitisers had covalently coupled with the reduced antibody. 
The fluorescent signal at the base line of the polyacrylamide gel plate was due to the 
presence of bromophenol blue within the SDS loading buffer. 
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The SDS-PAGE analysis of PS3-SIP(L19) (data not shown), indicated that the 
photosensitiser covalently coupled to the antibody under both reducing and non-
reducing conditions, indicating that coupling had occurred through lysine residues.  
Under optimal conditions exactly two photosensitisers should couple to each intact 
SIP(L19), corresponding to the two available thiol reactive sites. To test the hypothesis, 
the photosensitiser: antibody loading ratio was calculated using both UV-visible 
spectroscopy and MALDI-TOF/TOF techniques. For the 22-SIP(L19) 
immunoconjugate: the UV-visible spectroscopy method for estimating the loading ratio 
involved producing a conjugate sample, which gave an absorbance of 1.4 units at 280 
nm, as it is known that the SIP is at a 1 mg/mL concentration at that reading. The 
conjugates absorbance was then measured at 424 nm. The porphyrin‟s extinction 
coefficient at 424 nm and the recorded absorbance were then used to calculate the 
concentration of the porphyrin in the conjugate sample using Beer-Lamberts law. The 
concentration of the porphyrin moiety was divided by the concentration of the antibody 
moiety, to give a photosensitiser:antibody loading ratio of 0.9. The theoretical 
photosensitiser:antibody loading ratio should be 2, because the reduced SIP(L19) has 
two thiol groups available for conjugations, therefore a MALDI-TOF/TOF technique 
was used to confirm the estimated loading ratio, shown in Figure 23. 
 
 
Figure 23: MALDI-TOF/TOF spectra for (A) SIP(L19), (B) 22-SIP(L19). 
 
The intact SIP(L19) is a homodimer which is covalently linked through a disulfide bond 
and has a molecular weight of approximately 80 KDa. The MALDI-TOF/TOF spectrum 
for the SIP(L19), prior to reduction, shows a signal of 38452 ± 31.25 m/z, which is 
equivalent to a molecular weight of 38 KDa, therefore the MALDI-TOF/TOF analysis 
detects the SIP(L19) as the (M)
2+
 ion or as two monomer fragments. The MALDI-
TOF/TOF of 22-SIP(L19) shows a signal of 39433 ± 80.49 m/z. If the mass signal of the 
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antibody is subtracted from the mass signal for the conjugate, the mass contribution 
from the photosensitiser is calculated:   
 
 Photosensitiser mass = Conjugate‟s mass − Antibody‟s mass 
                                   = 39433 ± 80.49 m/z − 38452 ± 31.25 m/z 
                                   = 981 ± 111.74 m/z 
 
Compound 22 has a molecular weight of 1404 gmol
−1
, however mass spectrometry does 
not detect the iodide counter ions, giving 22 an observed molecular weight of 1023 
gmol
−1
. The calculated photosensitiser mass, with the experimental error, showed that a 
single photosensitiser had coupled to the monomeric SIP(L19), thus the 
photosensitiser:antibody loading ratio was 2:1 for the SIP(L19) in the dimeric form. 
The loading ratios were calculated in a similar manner for PS3-SIP(L19) and PS4-
SIP(L19). UV-visible spectroscopy was used to estimate the loading ratios for the other 
immunoconjugates, 1.75 for PS3-SIP(L19) and 0.76 for PS4-SIP(L19), however the 
MALDI-TOF/TOF analysis indicated that a loading ratio of approximately 2 was 
obtained for both immunoconjugates. 
The conjugate was then analysed by size exclusion chromatography to assess whether 
once conjugated, the dimeric nature of SIP(L19) was retained under an aqueous 
environment, despite the absence of the disulfide linkage. The size exclusion 
chromatographic profiles of SIP(L19) and 22-SIP(L19), illustrated in Figure 24, were 
very similar, indicating that the conjugates antibody moiety was in a dimeric form.   
  
 
Figure 24: Size exclusion chromatography profile of SIP(L19) and 22-SIP(L19). 
 
Similar size exclusion chromatography profiles were observed for PS3-SIP(L19) and 
PS4-SIP(L19). 
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3.8.3 Photoimmunoconjugate Immunoreactivity 
 
BIAcore analysis uses surface plasmon resonance (SPR) biosensitisers to evaluate, in 
real time, interactions of binding biomolecules. The biosensor chip possesses one of the 
biomolecules immobilised on its surface, with a solution of the other biomolecule being 
passed over the chip. The SPR detector can monitor the amount of complex formed 
between the two biomolecules by measuring the change of refractive index of the 
solvent near the sensors surface, caused by the association and dissociation of the 
complex.
173,174
  
The experiment involved passing the immunoconjugates or SIP(L19); in a reduced or 
non-reduced state; at a concentration of 0.3 μM in PBS, over a biosensor chip which 
possessed immobilised EDB of fibronectin. Once the association equilibrium had been 
reached, the chip was washed with a constant stream of PBS, resulting in the 
exponential decay of the sensogram signal, due to dissociation of the 
immunoconjugate/SIP(L19)-EDB fibronectin complex. The dissociation BIAcore  
sensogram for the immunoconjugates and SIP(L19) is shown in Figure 25. The BIAcore 
analysis showed that the reduction of the SIP(L19) marginally improved the binding 
efficiency of the antibody fragment. The immunoconjugates which are produced via the 
cysteine residues, exhibited a similar sensogram profile in comparison to the 
unconjugated SIP(L19), indicating that the binding efficiency of the antibody moiety 
had been retained for those conjugates. The sensogram for PS3-SIP(L19) showed a 
decrease in immunoreactivity when compared to the other conjugates. Thus, 
conjugating the photosensitiser to the antibody fragment through a lysine residue, could 
result in the photosensitiser being attached to the binding region of the antibody, 
resulting in diminished binding efficiency for the antibody moiety. 
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Figure 25: BIAcore analysis of photoimmunoconjugates and SIP(L19). 
 
3.8.4 Photoimmunoconjugate photoactivity 
 
An in vitro photocytotoxicity assay was used to assess the photoactivity of the 
immunoconjugates. 96 Well plates, expressing antigen positive LM fibroblasts, were 
incubated with 50 μL of the immunoconjugate being evaluated, or the SIP(L19) control, 
dissolved in PBS at either a 35 or 3.8 μg/mL concentration, for 1 hour at 37 oC. The 
plates were washed with PBS, to remove any unbound immunoconjugate or antibody, 
and then each of the wells was covered with 50 μL of PBS. A KL 1500 electronic 
tungsten halogen light fitted with a 620/20 filter was used to irradiate the plates with a 
light dose of 60 J/cm
2
. Following the administration of light, the PBS was removed and 
100 μL of growth medium was added, the cells were subsequently incubated overnight, 
at 37 
o
C under a 5 % carbon dioxide atmosphere. In order to evaluate the photoactivity 
of the immunoconjugates, control experiments were also performed including the 
immunoconjugates in the absence of light, SIP(L19) only and light, and PBS only and 
light. The cell viability was then measured using a Cell Titer 96 Aqueous One Solution 
Cell Proliferation Assay. The cell death percentage was calculated from the cells 
detected for the treated experiment (cells treated with immunoconjugate plus light) 
divided by the cells detected from the control experiment (cells treated with 
immunoconjugate without light). The in vitro photocytotoxicity for 22-SIP(L19), PS3-
SIP(L19) and PS4-SIP(L19) is illustrated in Figure 26.        
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Figure 26: In vitro photocytotoxicity assay of photoimmunoconjugates on LM 
fibroblasts. 
 
The PS3-SIP(L19) conjugate, which contains porphyrins bound to the antibody 
fragment through lysine residues, had a lower immunoreactivity compared to PS4-
SIP(L19) and 22-SIP(L19), therefore it would be expected that the PS3-SIP(L19) would 
exhibit the lowest photocytotoxicity considering the photosensitiser moieties, and 
loading ratios for each of the immunoconjugates analysed were almost identical. 
However it was found that PS3-SIP(L19) had the highest photocytotoxicity, with 90.7 
% cell inhibition when administered at a concentration of 3.8 μg/mL, whereas 22-
SIP(L19) (73.7 %) and PS4-SIP(L19) (69.1 %) caused lower cell inhibition when tested 
under the same reaction conditions. As each of the conjugates possessed the same 
number of porphyrin moieties, and the immunoreactivity of 22-SIP(L19) and PS4-
SIP(L19) was higher than PS3-SIP(L19); it was postulated that the 22-SIP(L19) and 
PS4-SIP(L19) photosensitisers in the excited triplet state must be losing energy, leading 
to less energy being available for producing reactive oxygen species. When reduced, the 
SIP(L19) expresses two thiol reactive sites which are in close proximity, thus when the 
photosensitiser coupled to these thiol groups, they would also be next to each other. It is 
known that porphyrin aggregation influences the photophysical properties of the 
porphyrin, hence the production of reactive oxygen species.
175
 Therefore the close 
proximity of the porphyrin moieties on the SIP(L19) could lead to a quenching of the 
excited state energy, leading to diminished production of reactive oxygen species. 
Evidence that the quenching phenomena is occurring is provided by the photoactivity of 
22-SIP(L19) being greater than PS4-SIP(L19), as the porphyrin moieties are further 
apart, due to the presence of the alkyl chain, as shown in Figure 27. The quenching 
effect also explains why the loading ratios calculated for 22-SIP(L19) and PS4-
SIP μg/mL 
 
35 3.8 
 134 
      
SIP(L19) by UV-visible spectroscopy, were considerably lower than the MALDI 
TOF/TOF determination, and hypothetical model. 
 
 
Figure 27: Illustrations of the PS4-SIP(L19) and 22-SIP(L19). 
 
3.9 Summary / further work 
 
The synthesis of a hydrophilic porphyrin bearing a maleimide bioconjugatable group 
(22) has been demonstrated, with the photosensitiser being successfully conjugated to 
cysteine residues expressed by SIP(L19), in a quick, reproducible manner. The well 
characterised immunoconjugate (22-SIP(L19)) possessed no non-covalently bound 
photosensitiser and retained the targeting efficiency of the antibody moiety. The 
photoactivity of 22-SIP(L19) was lower than expected in comparison to PS3-SIP(L19), 
possibly due to quenching of the excited state. 
Time permitting, a library of photosensitiser analogues could be synthesised bearing 
alkyl chains of varying length. The effect of chain length on the immunoconjugates 
characteristics could then be evaluated. 
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Chapter 4: Preparation of immunoconjugate bearing a PEG linker. 
 
4.1 Introduction 
 
Although the presence of the alkyl chain reduced the quenching of the excited state for 
22-SIP(L19) in comparison to PS4-SIP(L19), the quenching effect was not completely 
abolished, as the phototoxicity of PS3-SIP(L19) was greater than that of 23-SIP(L19), 
as discussed in chapter 3. Therefore it was postulated that if the photosensitiser 
possessed a hydrophilic PEG chain connecting to the maleimide group, it could 
abrogate the quenching phenomena. In contrast to the hydrophobic alkyl chain, the 
hydrophilic polyethylene glycol chains would be less likely to interact with each other, 
or with hydrophobic regions of the antibody, thus decreasing the proximity of the 
porphyrin moieties, and reducing or preventing the quenching of the photosensitisers 
excited state. 
 
4.2 Polyethylene glycol (PEG) 
 
PEG is a linear or branched polyether, which is commonly synthesised by the 
polymerisation of ethylene oxide, initiated by the nucleophilic attack by either a 
hydroxide or alkoxide ion on the ethylene oxide methylene group. Termination of the 
propagating species can be achieved using an electrophile, e.g. proton, as shown in 
Figure 28.
176,177
 Polyethylene glycol oligomers possessing repeating ether units are 
relatively inert, therefore for derivatisation of PEG to take place, additional reactive 
terminal or pendent functionalities are required.
177
 
 
 
Figure 28: Hydroxide initiated anionic ring-opening polymerisation of ethylene 
oxide.
177
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4.3 Properties of PEGs 
 
In terms of biocompatibility, PEGs exhibit some favourable characteristics, such as low 
toxicity and low immunogenicity. Additionally PEG is non-reactive towards many 
chemical agents, stable against hydrolysis, and soluble in many organic and aqueous 
environments. Therefore PEG is deemed suitable for modifying biological 
macromolecules.
176-178
 Under aqueous conditions, PEG can bind to 2-3 water molecules 
per ethylene oxide unit, which effectively makes the PEG molecule behave as if it were 
10 times larger than a hydrophilic protein of a similar size. Hence, conjugating PEG to a 
biological molecule influences its pharmacological properties by increasing its apparent 
size, thereby altering its biodistribution, and reducing renal filtration. PEG has the 
ability to shield the antigenic and immunogenic epitopes expressed by proteins, as well 
as receptor-mediated uptake and clearance by the reticuloendothelial system; thus 
reducing the immunogenicity of the macromolecule and increasing its circulation time. 
Furthermore, PEG prevents recognition by proteolytic enzymes and inhibits subsequent 
degradation.
176
  
Savellano and Hasan,
50
 have demonstrated that the PEGylation of the C225 mAb, prior 
to conjugation with the N-hydroxysuccinimide ester analogue of benzoporphyrin 
derivative, significantly affects the solubility of the resulting immunoconjugate. The 
benzoporphyrin derivative-C225 PEGylated and non-PEGylated immunoconjugates 
were stored in a dimethylsulfoxide/ aqueous (1:1) solutions and, over extended periods 
of time, the non-PEGylated immunoconjugate exhibited aggregation, whereas the 
PEGylated immunoconjugate remained in solution. Furthermore, aggregation was also 
observed when a concentrated sample of the non-PEGylated immunoconjugate, in the 
same solvent mixture, was further diluted with water. Preliminary cellular uptake 
studies were performed comparing the PEGylated and non-PEGylated 
immunoconjugates by employing A-431 cells (epidermal growth factor receptor 
positive cells), NR6 cells (antigen negative) and J774 macrophage cells. The PEGylated 
immunoconjugate exhibited a 2-3 fold decrease in non-specific J774 macrophage 
uptake, attributed to the reduced aggregation. For experiments using A-431 cells, the 
PEGylated immunoconjugate showed slight lower uptake, however the presence of non-
covalently bound photosensitiser could have influenced the analysis. 
Hamblin et al.
179
 have incorporated PEG moieties into a chlorin e6-polylysine conjugate, 
and assessed the effect the PEGylation had on photoactivity and biodistribution of the 
conjugate. An in vitro photoactivity assay, using an ovarian cancer cell line (OVCAR-5) 
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and a macrophage cell line (J774) showed that PEGylation caused a nine-fold increase 
in phototoxicity towards the OVCAR-5 cells, while a four-fold reduction in 
photoactivity towards J774 cells was observed. The conjugates differing photo-activities 
towards the OVCAR-5 and J774 cell lines was attributed to localisation of the 
conjugates within the different cells, and/or the presence of antioxidant enzymes in the 
macrophage cell line. The conjugates photodynamically induced oxygen consumption 
was then evaluated, by activating the conjugates in an oxygenated medium. The 
PEGylated conjugate consumed substantially less molecular oxygen in comparison to 
the non-PEGylated conjugate, indicating that the PEGylated conjugate produced 
reactive oxygen species via a type I mechanism. The biodistribution of the conjugates 
was then analysed, in vivo, by injecting the conjugates into nude mice bearing OVCAR-
5 tumours. The PEGylated conjugate showed a 2-fold increase in accumulation in the 
tumour and exhibited considerably more favourable tumour to peritumoural ratios, for 
all organs harvested.     
TPP has been functionalised with 1 to 4 low weight PEG chains, each containing 6 
repeating ether units, as illustrated in Figure 29, and the effect the presence the PEG 
chains had on cellular uptake and phototoxicity was evaluated. Solubility and 
aggregation of the PEGylated porphyrins was assessed by comparing the fluorescence 
emission spectra from experiments conducted in either dimethylsulfoxide or HEPES 
buffer solution. Emission spectra for the porphyrin derivatives bearing 1 or 2 PEG 
chains were identical for both solvents. However, when the porphyrin was conjugated to 
3 or 4 PEG chains, the fluorescence emission was greater in dimethylsulfoxide 
compared to the buffer; therefore it was postulated that porphyrin aggregation was 
occurring in the buffer solution. The time dependent cellular uptake of the PEGylated 
porphyrins into HEp2 cells was then investigated over a 24 hour period. During the first 
2 hours, cellular uptake of the porphyrins was consistent. However after 2 hours, the 
uptake of the porphyrins bearing 3 or 4 PEG chains reached a plateau, while porphyrins 
functionalised with 1 or 2 PEG chains continued to accumulate in the cells. When the 
experiment was terminated, the porphyrins with 1 or 2 PEG chains showed a 12-fold 
increase in cellular accumulation in comparison to the porphyrins with 3 or 4 PEG 
chains, with the porphyrin bearing 2 PEG chains exhibiting the highest accumulation in 
the HEp2 cell line. The photocytotoxicity investigation involved exposing HEp2 cells to 
varying concentrations of the PEGylated porphyrins, and exposing them to a low light 
dose (1 J/cm
2
). The porphyrins with 3 or 4 PEG chains showed no toxicity, up to a 
concentration of 10 μM, whereas the porphyrins bearing 1 PEG chain (IC50 = 2 μM) and 
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2 PEG chains (IC50 = 1.8 μM) were phototoxic. Fluorescence microscopy studies 
indicated that the TPP functionalised with 1 or 2 PEG chains accumulated in the 
mitochondria and endoplasmic reticulum, while the porphyrin derivatives possessing 3 
or 4 PEG chains targeted the liposomal compartment.
180
         
     
 
Figure 29: PEGylated TPP derivatives.
180
 
 
4.4 Porphyrins functionalised with PEG moieties 
 
The addition of a PEG chain bearing an amino functionality to a porphyrin which 
possessed an N-hydroxysuccinimide ester has been reported by Frochot and co-
workers,
167
 and was summarised in chapter 3. The PEGylated porphyrin was 
synthesised in 75 % yield. 
An EDC mediated coupling between a fullerene derivative bearing a PEG chain 
terminating in a hydroxyl group and a porphyrin possessing a carboxyl group has been 
achieved, as discussed in chapter 3. The porphyrin-fullerene adduct was produced in 51 
% yield.
164
     
A TBTU coupling approach has been utilised for the synthesis of porphyrin-peptide 
conjugates, which contain a PEG chain between the photosensitiser and targeting 
moieties. 5-(4-Aminophenyl)-10,15,20-tri-(phenyl)porphyrin was treated with 
diglycolic anhydride, in dimethylformamide, for 24 hours. The functionalised porphyrin 
bearing a carboxyl group was produced quantitatively and was subsequently coupled to 
a PEG derivative; which had an amino group, and a carboxyl group protected as the 
tert-butyl ester, located at the termini; via a TBTU/ HOBt/ diisopropylamine mediated 
reaction. Once the mixture had been stirred for 48 hours at ambient temperature, the 
porphyrinic product was isolated in a 64 % yield, and the tert-butyl ester was cleaved, 
quantitatively, using trifluoroacetic acid. Finally, a TBTU catalysed reaction, in the 
presence of HOBt and diisopropylamine, led to the formation of an amide linkage 
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between the peptide and porphyrin derivative, and the conjugates were synthesised in 
46-52 % yield, as shown in Scheme 49.
181
 
 
 
Scheme 49: Porphyrin-peptide conjugates.
181
  
 
The synthetic strategy developed for the synthesis of the porphyrin-peptide conjugates 
was then transferred to the production of porphyrin-retinamide conjugates. A PEG 
derivative bearing amino groups located at either end, one of which was Boc protected, 
was used as a linker, with the coupling again mediated by TBTU/ HOBt/ 
diisopropylamine, giving the PEGylated porphyrin in 83 % yield. Trifluoroacetic acid 
was used to cleave the Boc protecting group quantitatively, and the same coupling 
conditions were used to form the porphyrin-retinamide conjugates, in 49-78 % yields.
182
 
Nawalany et al.
183
 have reported the covalent attachment of a modified single PEG 
chain of various molecular weights (350, 2000 or 5000) to 5,10,15,20-tetra(4-
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hydroxyphenyl)porphyrin, as illustrated in Scheme 50. For PEG(350), the methoxy-
PEG chains were activated by insertion of a mesyl group, via treatment with mesyl 
chloride in the presence of triethylamine, for 24 hours at room temperature, producing 
the activated PEG chain in 86 % yield. PEGylation was achieved by mixing the 
activated PEG chains, porphyrin and caesium carbonate in dimethylformamide, for 24 
hours at 100 °C. The reaction yields varied considerably: porphyrin-PEG(350) (40 %), 
porphyrin-PEG(2000) (87 %) and porphyrin-PEG(5000) (46 %).  
 
 
Scheme 50: PEGylated 5,10,15,20-tetra(4-hydroxyphenyl)porphyrin.
183
 
 
A carbonylruthenium(II)porphyrin bearing pentafluorophenyl substituents in the meso-
positions has been functionalised with a PEG chain, which possessed terminal hydroxyl 
functionality, via a nucleophilic substitution reaction at the para-position of one of the 
pentafluorophenyl moieties. The PEGylation proceeded by mixing the porphyrin 
derivative, methoxy-PEG and sodium hydride in dimethylformamide, affording the 
PEG functionalised porphyrin in 70 % yield.
184
 
The PEGylation of 5,10,15,20-tetra(2,3,4,5,6-pentafluorophenyl)porphyrin derivatives, 
with PEG chains of different molecular masses (164, 550 and 750) has also been 
reported by Mewis et al.
185
. Firstly, the monomethoxy PEG chains hydroxyl groups 
were converted into mono-halides. PEG(164) hydroxyl group was substituted with a 
chloride, via treatment with thionyl chloride, in pyridine, for 3 hours under reflux 
conditions and an inert atmosphere, furnishing the chlorinated PEG chain in 89 % yield. 
The longer PEG chains were brominated via treatment with phosphorous tribromide, in 
dichloromethane at 0 °C for 1.5 hours, affording the brominiated PEG chains, 
BrPEG550 (40 %) and BrPEG(750) (76 %). 5,10,15,20-Tetra(2,3,4,5,6-
pentafluorophenyl)porphyrin derivatives were PEGylated by adding the corresponding 
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halogenated PEG chain, sodium sulphide in dimethylformamide, and stirring the 
resulting mixture at ambient temperature, for 72 hours. The reaction yields were good to 
excellent, and depended on the PEG chain and porphyrin complex used, as illustrated in 
Scheme 51. 
 
 
X n M Yield (%) 
Cl 2 H2 75 
Br 11 H2 100 
Br 15 H2 87 
Cl 2 Ni(II) 62 
Br 11 Ni(II) 79 
Br 15 Ni(II) 95 
Cl 2 Ga(III)OPh 83 
Br 11 Ga(III)OPh 94 
Br 15 Ga(III)OPh 93 
 
Scheme 51: PEGylation of 5,10,15,20-tetra(2,3,4,5,6-pentafluorophenyl)porphyrin 
derivatives.
185
 
  
The PEGylation of 5-(4-pyridyl)-10,15,20-tri(4-methoxyphenyl)porphyrin has been 
reported, using di-halogenated PEG chains of various molecular weights (8000, 20000, 
and 35000). The reaction proceeded via quaternisation of the pyridyl group, using PEG 
chains that have chlorides located at the termini. The exact experimental conditions, and 
reaction yields were not discussed.
186,187
 
Kim et al.
188
 have synthesised a porphyrin dimer, with the porphyrin moieties connected 
through a short PEG chain. 5-(4-(Ethylcarbonyl)oxy)phenyl)-10,15,20-tri(4-
pyridyl)porphyrin dissolved in dimethylformamide was treated with triethylene glycol 
ditosylate in the presence of sodium hydroxide, furnishing the PEGylated porphyrin in 
34 % yield. The PEGylated porphyrin was added to a solution of 5-(4-
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(ethylcarbonyl)oxy)phenyl)-10,15,20-tri(4-pyridyl)porphyrin in dimethylformamide, 
and potassium hydroxide was added to initiate the conjugation. The mixture was stirred 
for several hours and the dimeric intermediate was isolated after re-crystallisation. The 
porphyrin dimer dissolved in dimethylformamide was methylated by the addition of a 
large excess of methyl iodide, affording the hydrophilic dimer in 35 % yield, as 
depicted in Scheme 52. 
 
 
Scheme 52: Synthesis of porphyrin dimer with PEG connection.
188
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4.5 Synthetic strategy: synthesis of a hydrophilic porphyrin bearing a PEG chain 
terminating in a maleimide group 
 
The aim was to produce a hydrophilic porphyrin bearing a PEG chain terminating with 
a maleimide group. In relation to the literature describing PEGylation of porphyrins, 
coupling strategies using EDC
164
 or TBTU
181,182
, and mesityl
183
 or tosyl
188
 PEG 
derivatives, produced the lowest yields. There does not appear to be any preference for 
the other PEGylation approaches, with the reactions using the porphyrin with an 
activated ester or pentafluorophenyl substituent‟s giving the highest PEGylation yields, 
62-100 %.
167,184,185
  
As the PEGylation strategy utilising the N-hydroxysuccinimide ester gave a high yield 
(75 %),
167
 the availability of 19 and the experimental experience gained from the 
synthesis of 22, it was deemed appropriate to use a similar approach for the synthesis of 
the target porphyrin. Therefore the PEG linker selected bore amino groups located  
at both termini, one of which was Boc protected; O-(2-Aminoethyl)-O‟-[2-(Boc-
amino)ethyl]-hexaethylene glycol. PEG derivatives have been shown to be to stable and 
inert in the presence of N-hydroxysuccinimide esters,
177,189
 trifluoroacetic acid,
189
 
diisopropylethylamine
189
, maleimide groups
177
 and methyl iodide;
188
 therefore no 
incompatibility issues were envisaged. The synthetic approach used for the synthesis of 
the target porphyrin 25, is shown in Scheme 53. 
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Scheme 53: Synthesis of the hydrophilic porphyrin bearing a PEG chain terminating 
with a maleimide group. 
 
 
 
 
 145 
      
4.5.1 Synthesis of 5-(4-(23-(tert-butylcarbamate)-3,6,9,12,15,16,21-
heptaoxadocosyl-1-amino-N-cabonyl)phenyl)-10,15,20-tri(4-pyridyl)porphyrin (23) 
 
 The O-(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-hexaethylene glycol linker and 19 
were both soluble in dimethylsulfoxide, hence it was selected as the initial solvent for 
the synthesis of 23. The free amino group of the PEG linker was not in a protonated 
form, thus, theoretically, the presence of base should not have been a requisite for the 
reaction to occur. However, to guarantee that the amino group was not protonated 
during the course of the reaction, base was added to the reaction mixture. Adapting a 
published procedure,
164
 the porphyrinic intermediate 23 was synthesised multiple times 
to optimise the method, as shown in Table 2.      
 
19 Solvent O-(2-Aminoethyl)-O’-[2-
(Boc-amino)ethyl]-
hexaethylene glycol 
Base 23 
45 mg, 
59 μmol 
DMSO, 
5 mL 
78 mg, 166 μmol,  
2.8 equiv. 
K2CO3, 38 mg, 275 
μmol, 4.7 equiv. 
21 mg, 
32 % 
68 mg, 
90 μmol 
DMSO, 
7 mL 
110 mg, 235 μmol,  
1.2 equiv.  
K2CO3, 50 mg, 362 
μmol, 4 equiv. 
54 mg, 
53 % 
56 mg, 
74 μmol 
DMF, 
6 mL 
85 mg, 181 μmol,  
2.4 equiv. 
DIEA, 63 μL, 360 
μmol, 4.9 equiv. (× 2)  
34 mg, 
41 % 
47 mg, 
62 μmol 
DMSO, 
5 mL 
71 mg, 152 μmol,  
2.5 equiv. 
K2CO3, 70 mg, 508 
μmol, 8.2 equiv.  
36 mg, 
52 % 
 
Table 2: Reaction conditions used for the synthesis of 23. 
 
The initial synthesis of 23 was achieved by treating a solution of 19 in anhydrous 
dimethylsulfoxide with O-(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-hexaethylene glycol 
(2.8 equivalents) in the presence of dry potassium carbonate (4.7 equivalents). The 
reaction mixture was protected from light and atmospheric moisture and was stirred at 
40 °C, for 5 days, until complete consumption of 19 was observed as shown by TLC 
(silica, eluent: 10 % methanol/dichloromethane). The reaction mixture was 
partitioned between dichloromethane and water, the organic layer was collected and 
washed with water to remove the excess O-(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-
hexaethylene glycol, residual dimethylsulfoxide, potassium carbonate and the 1-
hydroxypyrrolidine-2,5-dione by-product. The dichloromethane was removed under 
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reduced pressure, and the crude product was chromatographically separated (silica, 
eluent: 8 % methanol/dichloromethane). Compound 23 was isolated as a purple solid in 
32 % yield, after precipitation from dichloromethane by the addition of ethyl acetate and 
hexane. The initial yield of 23 was low, despite using a 2.8 fold excess of O-(2-
aminoethyl)-O‟-[2-(Boc-amino)ethyl]-hexaethylene glycol, and a 1.7 equivalents of 
base in relation to the PEG linker. Therefore the reaction was repeated using a lower 
proportion of O-(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-hexaethylene glycol, and a 3.3 
equivalence of base in relation to the PEG chain, to ensure the amino group was 
deprotonated. Under the modified conditions, 23 was isolated in 53 % yield. The 
increase in yield resulting from the extra base added in relation to the PEG derivative, 
indicated that under the experimental conditions, a proportion of the PEG chains amino 
groups were in an inactive, protonated form, thus base was required to facilitate 
PEGylation. TLC of the reaction mixtures suggested that all of 19 had been converted 
into 23, in a relatively clean reaction, hence the low yields obtained could be due to 
problems associated with isolating 23 from the dimethylsulfoxide solvent. Hence, the 
synthesis of 23 was attempted using dimethylformamide as an alternative solvent and 
diisopropylethylamine (2 equivalents relative to the PEG derivative) as the base. The 
reaction was monitored over a 3 day period by TLC, until the composition of the 
reaction mixture exhibiting no further change, however at this point both 19 and 23 
could still be detected. As the reaction had not reached completion, additional 
diisopropylethylamine (2 equivalents relative to the PEG derivative) were added. The 
reaction was monitored for a further 3 days by TLC, but the extra addition of base did 
not influence the progression of the reaction. Following work-up and chromatographic 
separation, 23 was produced in 41 % yield. The change in solvent did not improve the 
yield of 23, hence to further optimise the reaction conditions, a higher proportion of O-
(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-hexaethylene glycol was used to increase the 
availability of amino functionalities. After work-up and isolation, 23 was synthesised in 
52 % yield.  
The important sections of the 
1
H NMR spectrum for 23, is depicted in Figure 30.          
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Figure 30: 
1
H NMR spectrum of 23. 
 
 
 
 β-H 
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Assignment of the signals was achieved using a combination of 2D COSY and C-H 
correlation experiments. For the alkyl region, the signal at 1.40 ppm which integrated to 
9, did not couple with another signal, as indicated by the 2D COSY analysis, therefore it 
was assigned to the tert-butyl protons (h). Two broad singlets, with integrals of 1, were 
observed at 5.10 ppm and 7.55 ppm, with the 2D COSY showing that each peak 
coupled to one other signal in the alkyl region. By considering the shielding effect 
exerted by the porphyrin, these signals were assigned as the amino proton (a) at 7.55 
ppm, and (f) at 5.10 ppm; although theoretically these signals should appear as triplets. 
The amino proton (a) coupled to a multiplet at 3.81-3.90 ppm, which integrated to 4, 
therefore that multiplet was assigned proton environment (b). The 2D COSY 
experiment revealed that amino proton (f) coupled to a quartet at 3.24 ppm, which 
integrated to 2, and was subsequently assigned as (e). The triplet at 3.44 ppm was 
assigned as proton environment (d), as it integrated to 2, it coupled with (e) and both 
signals had the same coupling constant; J = 5 Hz. The remaining 5 multiplets at 3.47-
5.51 ppm, 3.52-3.58 ppm, 3.59-3.66 ppm, 3.67-3.73 ppm and 3.74-3.80 ppm, gave a 
total integral of 24, which corresponded to the remaining protons present in the PEG 
chain, and were assigned as proton environment (c). The assignment of the signals in 
the aromatic region was more straightforward. The doublet at 8.17 ppm integrated to 6 
and coupled to the doublet at 9.06 ppm, which also had an integral of 6, both signals 
had the same coupling constant, J = 5.9 Hz, and by considering the inductive effect 
exerted by the pyridyl group, these signals were assigned as the pyridyl-meta-protons at 
9.06 ppm and the pyridyl-ortho-protons at 8.17 ppm. The multiplet at 8.27-8.29 ppm 
had an integral of 4 and showed no coupling with any other signal, therefore it was 
assigned as the 5-aromatic-protons. The remaining signals; 2 doublets at 8.84 ppm and 
8.89 ppm, and a multiplet at 8.86-8.88 ppm, gave a combined integral of 8 and was 
therefore assigned as the β protons. The UV-spectrum for 23 was typical for a free-base 
porphyrin. The mass spectrum of 23 gave the expected 1112 m/z peak due to the (M + 
H)
+
 ion, therefore it was concluded that 23 had been successfully synthesised.      
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4.5.2 Synthesis of 5-(4-(23-(4-(N-maleimidomethyl)cyclohexane-1-amido)-
3,6,9,12,15,18,21-heptaoxadocosyl-1-amino-N-cabonyl)phenyl)-10,15,20-tri(4-
pyridyl)porphyrin (24) 
 
Adapting a published procedure,
157
 compound 23 dissolved in anhydrous 
dichloromethane, was treated with trifluoroacetic acid, while protected against moisture 
and light. The mixture was stirred for 50 minutes, at ambient temperature until complete 
cleavage of the Boc protecting group was observed, as shown by TLC (silica, eluent: 10 
% methanol/dichloromethane). The excess trifluoroacetic acid was neutralised by 
pouring the reaction mixture on to an ice cooled saturated sodium hydrogen carbonate 
solution; a colour change in the organic layer was observed from green to red, due to 
deprotonation of the porphyrin‟s inner nitrogens. The crude intermediate was extracted 
into dichloromethane, washed with water to remove residual sodium hydrogen 
carbonate, and dried over anhydrous sodium sulphate to remove residual water. As it 
was not possible to isolate the amino intermediate derived from 20, as discussed in 
chapter 3, isolation of the deprotected 23 was not attempted. 
The crude amino porphyrin was treated with SMCC, using the modified optimised 
conditions determined for the production of 21.
102
 SMCC (1.2 equivalents relative to 
23) and diisopropylethylamine (4.1 equivalents relative to SMCC) were added to a 
solution of the amino derivative of 23 dissolved in dry dimethylformamide. The 
resulting mixture was stirred at room temperature for 14 hours (overnight), until the 
composition of the reaction mixture exhibited no further change, as indicated by TLC 
(silica, eluent: 10 % methanol/dichloromethane).The crude porphyrinic product was 
precipitated by the addition of diethyl ether and hexane, and column chromatography 
was used to isolate 24. Precipitation was attempted by dissolving 24 in 
dichloromethane, and adding either methanol or hexane; in both cases 24 seemed to 
have an affinity towards the glass vessel, and could not be collected. Precipitation of the 
product was achieved in ethyl acetate/hexane (10:1) over dichloromethane, furnishing 
24 in 32 % yield. The yield of 24 was lower than expected, thus the reaction was 
repeated using a higher quantity of diisopropylethylamine (5.3 equivalents relative to 
SMCC). Following work-up and isolation, 24 was afforded in 55 % yield. The relevant 
sections of the 
1
H NMR spectrum of 24, is shown in Figure 31. 
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Figure 31: 
1
H NMR spectrum of 24. 
 
 
 
 
 
 β-H 
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The assignment of the peaks in the aliphatic region of the 
1
H NMR spectrum for 24 
corresponding to the cyclohexane ring substituent was achieved using a combination of 
2D COSY, C-H correlation and HMBC experiments. The 2D COSY analysis of the 
region containing the signals for the cyclohexane substituent for 24, is shown in Figure 
32, with the yellow crosses depicting solvent couplings. 
 
 
Figure 32: Aliphatic section of the 2D COSY of 24. 
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The signal at 1.88-1.95 ppm, had an integral of 1, and coupled with multiplets at 1.67-
1.80 ppm and 1.25-1.38 ppm, therefore it was a CH environment connecting to either 
the carbonyl or CH2-maleimide. The peak at 1.49-1.66 ppm, coupled with 3 other 
signals which had integrals of 2; 0.83-0.94 ppm, 1.25-1.38 ppm and 1.67-1.80 ppm; 
thus it was a signal from protons which were on opposite sides of the cyclohexane ring. 
However, the signal at 1.49-1.66 ppm had an integral of 3, thus a section of that signal 
must be due to a CH environment. By considering the shielding effect exerted by the 
porphyrin, the multiplet at 1.88-1.95 ppm was assigned (b) and a part of the multiplet at 
1.49-1.66 ppm was assigned (e). Signal (b) coupled with multiplets at 1.67-1.80 ppm 
and 1.25-1.38 ppm, which had a combined integral of 4, hence those signals were 
attributed to proton environments (c) and (g). The multiplet at 0.83-0.94 ppm and a 
proportion of the signal at 1.49-1.66 ppm were subsequently attributed to (d) and (f). 
The signal at 1.49-1.66 ppm exhibited coupling with the doublet at 3.19 ppm, thus the 
doublet at 3.19 ppm was assigned the CH2 environment neighbouring the maleimide 
group (h). A combination of HMBC and C-H correlation experiments confirmed the 
signal assignments. Despite multiple attempts, a clean spectrum where all the peaks for 
the PEG protons were well defined, was not obtained. It appeared that a proportion of 
the signals corresponding to the PEG protons were beneath the methanol solvent peak. 
Importantly, the signal for the tert-butyl protons from the Boc group, which was 
observed at 1.40 ppm for the 
1
H NMR spectrum for 23, is not present in the 
1
H NMR 
spectrum for 24, thus confirming that the Boc group had been removed. The aromatic 
region of the spectrum exhibited a singlet at 6.80 nm, which corresponded to the 
maleimide protons, indicating the presence of the maleimide group. Although not well 
defined, the peaks corresponding to the protons from the porphyrin core were observed.  
The UV-visible spectrum for 24 was typical for a free-base porphyrin. 
The HRMS spectrum gave the expected 1231 m/z signal due to the (M + H)
+ 
ion.  
The characterisation studies indicated that the reaction had proceeded as postulated 
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4.5.3 Synthesis of 5-(4-(23-(4-(N-maleimidomethyl)cyclohexane-1-amido)-
3,6,9,12,15,18,21-heptaoxadocosyl-1-amino-N-cabonyl)phenyl)-10,15,20-tri(4-N-
methyl-pyridyniumyl)porphyrin triiodide (25) 
 
Following Scheme 53, and using a modified literature method,
68
 a solution of 24 in 
anhydrous dimethylformamide was treated with a large excess of methyl iodide, at 40 
°C for 4 hours. Once the reaction had reached ambient temperature, the reaction mixture 
was cooled over ice and an ice cooled solution of diethyl ether and hexane (50:1) was 
added to promote precipitation of the porphyrinic product. The product was collected by 
filtration, with the filtrate, containing residual methyl iodide, being neutralised with a 
solution of triethylamine. The precipitate was rapidly washed with ice cooled diethyl 
ether, to remove the residual methyl iodide and dimethylformamide. The precipitate was 
collected and dried under vacuum, furnishing 25 in 75 % yield.  
The relevant sections of the 
1
H NMR of 25 is shown in Figure 33, with the assignment 
of the peaks achieved using a combination of 2D COSY and C-H correlation 
experiments. The pair of singlet‟s at 4.73 ppm and 4.74 ppm, which have a combined 
integral of 9, corresponded to the 3 methyl groups from quaternised pyridyl groups. All 
the signals due to the other proton environments were accounted for, a further indication 
that the methylation had proceeded as expected, and the structure of the porphyrin 
withstood the quaternisation conditions. 
The UV-visible spectrum for 25 was typical for a free-base porphyrin. 
The MALDI mass spectrum of 25 provided the expected 1276 m/z peak which was due 
to the [M+H] 
+
 -3I ion. It was concluded that the methylation of 24 had been achieved. 
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Figure 33: 
1
H NMR spectrum of 25. 
 β-H 
 10,15,20-Ar-o-H and 2H of β-H 
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4.6 Photoimmunoconjugates 
 
The conjugation of PS3, 22 or 25 (Figure 34) to SIP(L19) was achieved using the same 
conjugation method as described in Chapter 3. The synthesis of the immunoconjugates 
and subsequent biological studies were performed by Alessandro Palumbo and Corinne 
Hutter, under the supervision of Professor Dario Neri. 
 
 
Figure 34: Hydrophilic photosensitisers PS3, 22 and 25. 
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4.6.1 Photoimmunoconjugate characterisation 
 
The purity of 25-SIP(L19) was assessed by SDS-PAGE analysis, with the SDS-PAGE 
profile of 25-SIP(L19) being equivalent to 22-SIP(L19). It was concluded that the 
SIP(L19) was fully reduced, covalent attachment of 25 to cysteine residues expressed 
by the reduced SIP(L19) was achieved, and non-covalently bound photosensitiser could 
not be detected.   
The photosensitiser loading ratio was then determined by both UV-visible spectroscopy 
and MALDI TOF/TOF, in the same manner as described in Chapter 3 for 22-SIP(L19). 
For the UV-visible estimation, the conjugate sample was prepared and gave an 
absorbance of 1.4 absorbance units at 280 nm, corresponding to 1 mg/mL of SIP(L19) 
within the sample. The absorbance of the same solution was then measured at 425 nm, 
and the extinction coefficient of 25 (188,489 M
−1
 cm
−1
), was used to calculate the 
concentration of the photosensitiser in the sample. The concentration of the 
photosensitiser was divided by the concentration of SIP(L19) to give an estimated 
photosensitiser:antibody ratio of 1.75. 
The loading ratio was then confirmed using MALDI-TOF/TOF as shown in Figure 35. 
 
 
Figure 35: MALDI-TOF/TOF spectra for (A) SIP(L19), (B) 25-SIP(L19). 
 
The mass of the antibody in the monomeric form was subtracted from the 25-SIP(L19) 
in the monomeric form, to give the mass contribution of the photosensitiser from half of 
the complete immunoconjugate. 
 
Photosensitiser mass = Conjugate‟s mass − Antibody‟s mass 
                                   = 39720 ± 57.40 m/z − 38452 ± 31.25 m/z 
                                   = 1268 ± 88.65 m/z 
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Compound 25 had a molecular weight of 1656 gmol
−1
, however mass spectrometry does 
not detect the iodide counter ions, therefore, 25 had an observed molecular weight of 
1276 gmol
−1
. The calculated photosensitiser mass, with the experimental error, showed 
that one photosensitiser had coupled to the monomeric SIP(L19), thus 2 photosensitisers 
had coupled to the intact SIP(L19). The 25-SIP(L19) loading ratio calculated by UV-
visible spectroscopy, was similar to the loading ratio calculated by MALDI-TOF/TOF 
and the hypothetical model. The similarity of the loading ratios calculated for 25-
SIP(L19) by the 2 methods, suggests that the quenching effect was less prominent, 
when compared to the previous PS3-SIP(L19) and 22-SIP(L19) conjugates.  
The size exclusion chromatography profile of 25-SIP(L19) was then compared to the 
size exclusion profile of the non-reduced SIP(L19), to ascertain whether the dimeric 
nature of the immunoconjugate was retained after the reduction and subsequent 
coupling to 25, under aqueous conditions. The similar size exclusion profiles of non-
reduced SIP(L19) and 25-SIP(L19) is shown in Figure 36, which indicates that dimeric 
nature of the antibody was maintained, when subjected to an aqueous environment. 
 
 
Figure 36: Size exclusion chromatography profile of SIP(L19) and 25-SIP(L19). 
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4.6.2 Photoimmunoconjugate characterisation 
 
The immunogenicity of 25-SIP(L19) was evaluated by BIAcore analysis, which showed 
that the binding of the conjugate was similar to the native SIP(L19), suggesting that the 
targeting efficiency of the conjugates SIP(L19) moiety had been retained. 
A photocytotoxicity assay was performed employing antigen positive (LM fibroblasts) 
and antigen negative (CHO-S and HEK293T) cell lines, to evaluate the selectivity of the 
immunoconjugates. Each of the cell lines were grown in DMEM media enriched with 
10 % FCS and antibiotics, at 37 
o
C with 5 % CO2. The supernatant was removed and the 
cells were washed with PBS and incubated with a trypsin-EDTA solution. The cell 
suspension was collected and diluted with growth medium. The cell lines were then 
incubated at 37 °C for 20 minutes, before being stored. Each cell line (50 μl cells, 3 × 
10
4
 cells) was added to wells of a 96 well plate, and was subsequently incubated at 37 
o
C, under a 5 % CO2 atmosphere, overnight. The growth medium was removed and the 
cells were incubated with either 20 mg/mL of SIP(L19), or the immunoconjugates at a 
concentration of 50 μM with respect to the photosensitiser moiety, with DMEM 
medium, at 37 °C, under a 5 % CO2 atmosphere, for 1 hour. The unbound SIP(L19) or 
immunoconjugate was removed via PBS buffer washings, and the cells were covered 
with 50 μL of PBS and irradiated using a KL 1500 electronic tungsten halogen light 
fitted with a 620/20 filter. Control experiments were also performed involving the cells 
treated with the immunoconjugate or SIP(L19), without light activation. The PBS buffer 
was removed and the 100 μL of fresh growth medium was added, before the cells were 
incubated at 37 
o
C, under a 5 % CO2 atmosphere, overnight. The cell viability was then 
measured using a Cell Titer 96 Aqueous One Solution Cell Proliferation Assay. The cell 
death percentage was calculated from the cells detected for the treated experiment (cells 
treated with immunoconjugate plus light) divided by the cells detected from the control 
experiment (cells treated with immunoconjugate without light). The in vitro 
photocytotoxicity assay results, involving the administration of SIP(L19), PS3-
SIP(L19), 22-SIP(L19) or 25-SIP(L19) to LM fibroblast, CHO-S or HEK293T cell 
lines, are shown in Figure 37. The results illustrate the selectivity of the  
immunoconjugates, as significant phototoxicity was observed on the antigen positive 
LM fibroblast cell line, whereas the antigen negative cell lines were relatively 
unaffected by the PDT treatments; although 25-SIP(L19) did exhibit a low photoactivity 
against the antigen negative cell lines. The photoactivity assay performed on the LM 
fibroblasts showed the importance of the linker between the photosensitiser and 
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antibody moieties. The PS3-SIP(L19) caused ≈ 65 % cell death, which increased to ≈ 83 
% cell death for 22-SIP(L19), by the incorporation of a alkyl linker between the 
maleimide bioconjugatable handle and photosensitiser. The potency was further 
improved by using a longer, hydrophilic chain, as the photoactivity of 25-SIP(L19), 
which caused ≈ 98 % cell death, was substantially greater than that of 22-SIP(L19). 
Furthermore, the results also demonstrated that the un-conjugated SIP(L19) was not 
phototoxic towards the cell lines investigated.  
 
 
Figure 37: Phototoxicity of photoimmunoconjugates and SIP(L19) on antigen-positive 
(LM fibroblasts) and antigen-negative (CHO-S, HEK293T) cell lines. 
 
Another in vitro phototoxicity assay, employing LM fibroblasts, was used to evaluate 
the photoactivity of the immunoconjugates at different concentrations, as shown in 
Figure 38, enabling the determination of the half maximal inhibitory concentrations 
(IC50). The 25-SIP(L19) (IC50 = 7-8 × 10
−7
 M) immunoconjugate was considerable 
more potent than the 22-(SIP)L19 (IC50 = 7-8 × 10
−6
 M) which was more photoactive 
than PS3-SIP(L19) (IC50 = 5-6 × 10
−6
 M). These results are consistent with the 
quenching effect hypothesis, as increasing the chain length and hydrophilicity of the 
chain, would enable the conjugated porphyrins to have a greater freedom of movement, 
which would reduce the probability of the porphyrins quenching each other.   
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Figure 38: In vitro phototoxicity assay of PS4-SIP(L19) (black ▲), 22-SIP(L19) (red 
■) carried out on LM fibroblasts using MTS assay. 
 
4.7 Summary / further work 
 
The synthesis of a hydrophilic porphyrin bearing a maleimide group (25) has been 
demonstrated. The photosensitiser was conjugated to cysteine residues expressed by 
SIP(L19). The well characterised immunoconjugate (25-SIP(L19)) possessed no 
detectable non-covalently bound photosensitiser and retained the targeting efficiency of 
the antibody moiety. The photoactivity of 25-SIP(L19) was substantially greater than 
PS3-SIP(L19) and 22-SIP(L19), due to the presence of a hydrophilic linker in-between 
the antibody and photosensitiser moieties. It was postulated that the longer hydrophilic 
chain, provides the conjugated porphyrins with a greater freedom of movement, 
reducing the probability of the porphyrins coming together and quenching each others 
excited state, therefore improving the overall photoactivity. 
Time permitting, a library of photosensitiser analogues could be synthesised bearing 
hydrophilic chains of varying lengths. The influence of chain length and/or 
hydrophilicity of the chain, on the immunoconjugates characteristics could then be 
evaluated. 
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Chapter 5: Towards a bioconjugatable porphyrin dimer 
 
5.1 Introduction 
 
Enhancing the photoactivity of a photoimmunoconjugate can be achieved by increasing 
photosensitiser loading. Since the reduced SIP(L19) only has two cysteine residues 
available for bioconjugation, the only strategy available for increasing porphyrin 
loading would be to increase the number of photosensitisers connected to each thiol 
group. It was postulated that the production of porphyrin dimers, bearing a single 
maleimide functionality, could effectively double the photosensitiser to antibody 
loading, and thus increase the overall photoactivity of the immunoconjugate. 
 
5.2 Porphyrin dimers 
 
5.2.1 Porphyrin dimer synthetic aims 
 
From a retro-synthetic perspective, the target porphyrin dimer could be a product from 
the coupling of two different porphyrins, as illustrated in Figure 39. The proposed 
porphyrin would possess three functional groups in the meso-positions, which could be 
converted into hydrophilic moieties (X), with the remaining meso-position is occupied 
by a functional group (A) which could facilitate covalent attachment to another 
porphyrin. The second porphyrin would therefore have the complementary functionality 
(B), enabling attachment to the initial porphyrin via a reaction with functional group A. 
The second porphyrin would also possess a protected functional group (Y) that could be 
transformed into the bioconjugatable group, with the remaining meso-positions 
occupied by additional water solubilising groups (X). Thus in order to produce the 
porphyrin dimer, the initial porphyrin synthesised could be the product of a mixed 
condensation between aldehydes bearing groups A and X, and pyrrole. The trans-
porphyrin would be synthesised from the condensation of a dipyrromethane bearing 
functionality X, and aldehydes bearing groups B and Y.      
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Figure 39: Retro-synthesis of bioconjugatable porphyrin dimer. 
 
The literature describes a wide variety of approaches for coupling porphyrins together, 
including: reductive aminations;
136
 amide formation, resulting form the reaction 
between an acid chloride and amino groups;
190,191
 a nucleophilic substitution reaction, 
using an alkyl chain terminating in a halogen, and porphyrin bearing a hydroxyl 
group;
192
 Grubb‟s catalysis,193 imine formation,194 and Sonogashira coupling.194 Each of 
these techniques could be reviewed in there own right, however these approaches were 
not deemed appropriate for the purpose of synthesising the target porphyrin dimer 
required here, and will not be discussed further. 
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5.2.2 Suzuki coupling 
 
The Suzuki reaction refers to the palladium catalysed cross-coupling between organic 
halides or triflates with organoboron compounds, in the presence of an inorganic base, 
resulting in the formation of a carbon-carbon bond. The reaction proceeds regio- and 
stereo-selectively, under relatively mild conditions, tolerating a variety of sensitive 
functional groups.
195
 The organo-boron compound is generally stable under aqueous 
conditions, and an evaluation of the reaction, under both aqueous and anhydrous 
conditions, suggested that the presence of water did not influence the reaction yields.
196
  
The Suzuki catalytic cycle, depicted in Figure 40, initially involves the oxidative 
addition of the aryl halide to the palladium catalyst. The base then exhibits dual 
functions in the cycle; displacement of the halide by metastasis, and coordination with 
the boron atom, inducing nucleophilicity, so that the subsequent transmetallation with 
the palladium(II) complex can occur. Finally, reductive elimination yields the coupled 
product with re-generation of the palladium catalyst.
195,197
 The catalytic cycle involves 
the reduction and oxidation of the palladium catalyst, thus the reaction is generally 
performed in de-oxygenated solvents.  
 
 
Figure 40: Suzuki catalytic cycle.
195
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Zhou et al.
198
 have described the synthesis of a porphyrin dimer using Suzuki coupling 
conditions. The boronic ester porphyrin: 5-(4-boronatophenyl)-10,15,20-tetraphenyl 
porphyrin, was synthesised via the dehydration of benzaldehyde and 4-formylphenyl 
boronate with pyrrole, under Lindsey conditions,
120
 furnishing the porphyrin in 33 % 
yield. The porphyrin boronate, 2-bromo-TPP, tetra(triphenylphosphine)palladium(0) 
and anhydrous potassium carbonate were dissolved in degassed toluene, and the 
resulting solution was heated at 90-100 
o
C, for 48 hours, under an inert atmosphere. 
Following work-up and chromatographic separation the dimer was isolated with a yield 
of 88 %.  
A similar approach has been utilised for the production of a dimer between 5,15-bis(3,5-
di-tert-butylphenyl)-10-mesityl-20-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl)porphyrin and 5,15-bis(3,5-di-tert-butylphenyl)-10-iodo-20-mesitylporphyrin, 
as illustrated in Scheme 54. The boronic ester porphyrin was synthesised from the acid 
catalysed condensation of a carbinol, and dipyrromethane bearing the boronic ester, 
with the porphyrin isolated in 16 % yield. The boronic ester porphyrin, iodo-porphyrin, 
tetra(triphenylphosphine)palladium(0) and anhydrous potassium carbonate were 
dissolved in a mixture of toluene and dimethylformamide, and the mixture was purged 
with argon. The mixture was heated at 75 
o
C for 3 hours, at which time, additional 
catalyst was added. The resulting mixture was heated at 90 
o
C for a further 15 hours, 
and following chromatographic separation, the dimer was afforded in 70 % yield.
199
  
The incorporation of the boronic ester moiety during porphyrin formation has also been 
achieved under Adler conditions,
114
 via a mixed condensation reaction, although only a 
low yield (3 %) of the target porphyrin was obtained.
145
 
The zinc complex of 5-(3-iodophenyl)-10,15,20-tris(3,5-di-tert-butylphenyl)porphyrin 
has been used for the synthesis of a porphyrin trimer, using a tri(2,4,6-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl linker. The boronic ester linker, iodo-
porphyrin and sodium carbonate were dissolved in a mixture of toluene, ethanol and 
water, and the resulting solution was degassed. Tetra(triphenylphosphine)palladium(0) 
was added, and the reaction was heated at 80 
o
C, for 4 days, under an inert atmosphere. 
Following work-up and preparative TLC, the zinc porphyrin trimer was isolated in 80 % 
yield.
200
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Scheme 54: Porphyrin dimer synthesis.
199
  
 
Yu et al.
201
 have reported the addition of a boronic ester to the zinc(II) complex of 5-
bromo-10,20-dimesitylporphyrin, as illustrated in Scheme 55. A Schlenk flask was 
charged with 4,4,5,5-tetramethyl-1,3,2-dioxaborolane, triethylamine and 
dichlorobis(triphenylphosphine)palladium(II), under an inert atmosphere. 1,2-
Dichloroethane was added, and the mixture was heated at 85 
o
C for 1 hour, with the 
boronated porphyrin isolated in 93 % yield. The boronated porphyrin was added to bis-
(5-(4-iodophenyl)dipyrrinato)palladium(II), barium hydroxide octahydrate and 
tetra(triphenylphosphine)palladium(0). The reaction vessel was purged with argon and 
dimethoxyethane and water were added. The reaction was stirred at 80 
o
C, for 2 hours, 
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and following work-up and column chromatography, the target complex was furnished 
in 50 % yield. 
 
 
Scheme 55: Synthesis of bis(5-4-(5,15-dimesitylporphyrinatozinc(II)-10-
yl)phenyl)dipyrro)palladium (II).
201
 
 
The addition of a boronic ester to a pyridyl derivative bearing a bromo functionality, 
can be achieved using bis(pinacolato)diboron, as demonstrated by Aspley and 
Williams.
202 
Bis(pinacolato)diborone, 4-(4-bromophenyl)-2,2:6,2-terpyridine, potassium 
acetate and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) were added to 
a Schlenk flask, under an inert atmosphere. Dry, degassed dimethylsulfoxide was added, 
and the mixture was stirred at 80 
o
C, for 6 hours under an inert atmosphere. The product 
was extracted into toluene, and following work-up, the boronic ester derivative was 
isolated in 42 % yield. The reaction conditions were evaluated, with the rate of the 
reaction increasing in more polar solvents, and stronger bases, such as potassium 
carbonate, promote further coupling of the desired boronic ester product with the initial 
halide. Furthermore, the reaction is tolerant towards diverse functionalities such as 
nitro, cyano and ester groups.
197
 Additionally iodo-derivatives react more rapidly than 
bromo-analogues, producing the corresponding boronated derivatives in higher 
yields.
203
  
The Suzuki coupling strategy has been applied to pyridyl containing porphyrins. A 
solution of 5,10,15,20-tetra(5-bromo-3-pyridyl)porphyrin in toluene and methanol was 
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treated with 2-furanboronic acid, tetra(triphenylphosphine)palladium(0) and an aqueous 
solution of sodium carbonate. After the mixture was stirred at 70 
o
C for 20 hours, 
additional palladium catalyst and 2-furanboronic acid was added, and the reaction was 
continued for a further 15 hours. The porphyrinic product was isolated in 44 % yield, 
after work-up and flash chromatography.
170
 
Interestingly, a variety of Suzuki couplings has been achieved using metal complexes of 
5-(4-bromophenyl)-10,15,20-(4-pyridyl)porphyrin, as depicted in Figure 41. It was 
found that couplings with the non-metallated porphyrin were unsuccessful and the zinc 
porphyrin complexes gave the most favourable reaction times and yields.
204
 
 
 
M R Time (hours) Yield (%) 
Zn 4-methoxyphenyl 6 65 
Ni 4-methoxyphenyl 24 58 
Zn 4-acetylphenyl 5 75 
Ni 4-acetylphenyl 24 71 
Zn trans-1-hexen-1-yl 6 76 
 
Figure 41: Suzuki couplings involving metal complexes of 5-(4-bromophenyl)-
10,15,20-(4-pyridyl)porphyrin.
204
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5.2.3 Click chemistry 
 
The criteria describing the concept of „Click reaction‟ were first coined in 2001:  
 
‘ The reaction must be modular, wide in scope, give very high yields, generate only 
inoffensive by-products that can be removed by non-chromatographic methods, and are 
stereospecific (but not necessarily enantioselective). The required process 
characteristics include simple reaction conditions, readily available starting materials 
and reagents, the use of no solvents or a solvent which is benign or is easily removed, 
and simple product isolation.
205,206
 
 
At elevated temperatures, the Huisgen 1,3-dipole addition of azide to alkyne derivatives, 
leads to the formation of a triazole, in the 1,4 and 1,5 regioisomeric forms. It was 
discovered in 2001 that copper(I) salts accelerate the reaction and leads to the 
production of the 1,4-regioisomer exclusively, as shown in Figure 42.
205,207 
The catalytic 
cycle requires copper(I), which can be provided by using copper(I) salts or the in situ 
reduction of copper(II) salts, such as copper(II) sulphate pentahydrate using reducing 
agents such as sodium ascorbate, or the inexpensive copper on charcoal. The catalytic 
cycle starts with the formation of the active copper acetylide intermediate, thus the 
presence of base is required.
205
 It has been proposed that the [2+3] cycloaddition can 
then occur directly, or via the step-wise addition of the azide to the copper complex, 
which subsequently leads to the formation of the 6-membered-copper containing 
intermediate. A ring contraction then occurs, and protonation results in the production 
of the triazole product.
207,208
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Figure 42: Click catalytic cycle.
207
 
 
The azide moiety is stable towards dimerisation and hydrolysis, hence is considered to 
be a convenient 1,3 dipolar reagent. However, due to the general toxicity of azides, 
medicinal chemists utilise the reaction with caution.
206
 As azide and alkyne substituents 
can be incorporated into compounds via a variety of methods, the potential of the [2+3] 
cycloaddition of azide and alkyne as a Click reaction was realised.
205
 From a medicinal 
point of view, the triazole group is relatively stable due to its aromatic nature, and is 
therefore inert under many acid/base and oxidative/reductive conditions.
205
 
Furthermore, the triazole group is stable to hydrolytic cleavage and can therefore be 
used for biological applications.
208
 
Shen et al.
209
 have demonstrated that the amino group, of the nickel(II) complex of 2-
amino-TPP, can be transformed into an azide group, which can subsequently be coupled 
to a porphyrin which possesses an alkyne group in the meso-position. The amino-
porphyrin was dissolved in tetrahydrofuran and was treated with a saturated solution of 
sodium nitrite in a mixture of water and concentrated sulphuric acid, for 30 minutes at 
ambient temperature. A saturated solution of sodium azide in water was added drop-
wise to the stirred mixture. After 20 minutes, the product was extracted into 
dichloromethane and was chromatographically separated, affording the corresponding 
azido-porphyrin in 95 % yield. The nickel(II) complex of 5,15-di(phenyl)-10-
ethynylporphyrin was added to a mixture of the azido-porphyrin, 
copper(II) sulphate pentahydrate, sodium ascorbate dissolved in dimethylformamide, 
and the resulting mixture was stirred at 50 
o
C for 1.5 hours. The product was extracted 
into dichloromethane, washed with water, dried and purified by flash chromatography, 
furnishing the dimer in 98 % yield. Interestingly, an intramolecular cyclisation reaction 
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occurs if the azido-porphyrin is dissolved in toluene, and heated at reflux for 2 hours. A 
similar approach for synthesising an azido porphyrin has been described for the 
synthesis of the zinc(II) complex of 5-(4-azidophenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin, as illustrated in Scheme 56. The diazotisation of the free-base 
amino porphyrin dissolved in trifluoroacetic acid was achieved by the addition of 
sodium nitrite in water, and the diazonium salt was then converted into the azide 
functionality via treatment with sodium azide in water, affording the azido porphyrin in 
95 % yield, after purification. The azido porphyrin was then quantitatively converted 
into the zinc(II) complex, using zinc acetate. An evaluation of the reaction conditions 
leading to the formation of a porphyrin dimer was then described, using the zinc(II) 
complexes of the azido-porphyrin and 5-(4-ethynylphenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin, as shown in Scheme 56. It was reported that the typical click 
coupling conditions, using copper(II) sulphate pentahydrate and ascorbic acid were 
unsuccessful, and the coupling was only achieved using more novel copper catalytic 
systems. The couplings were attempted using free-base porphyrin precursors, which 
resulted in copper being inserted into the porphyrin core.
210
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Reaction Conditions Yield (%) 
CuSO4, 4H2O, ascorbic acid, DCM, Et3N (5:1), 60 
o
C, 12 h 0 
CuSO4, 4H2O, ascorbic acid, 40 
o
C, DMSO/DCM/ Et3N (10:5:1), 4 hrs 0 
CuI, 4H2O, 1,6-dimethyl-pyridine, CHCl3, 0 
o
C 12 hrs, then RT 72 hrs 0 
Cu(PPh3)3Br, DIEA/THF (1:5), 50 
o
C, 3 hrs 23 
Cu(P(OEt)3)I, DIEA/THF/H2O (1:1:5), 50 
o
C, 12 hrs 29 
(SIMes)CuBr, THF/H2O (3:1), 45 
o
C, 12 hrs 32 
(SIMes)CuBr, THF/H2O (3:1), 45 
o
C, 60 hrs 44 
 
Scheme 56: Evaluation of different reaction conditions for the synthesis of a porphyrin 
dimer.
210
  
 
The addition of an azide moiety to a pre-formed porphyrin can also be achieved by the 
nucleophilic substitution reaction between sodium azide and a alkyl halide bearing 
porphyrin, as reported by Punidha et al.
211
 A solution of 5-(4-hydroxyphenyl)-10,15,20-
tri(p-tolyl)porphyrin and potassium carbonate dissolved in dimethylformamide was 
treated with a large excess of 1,3-dibromopropane, and the resulting mixture was stirred 
at room temperature for 10 hours. The 5-(4-(3-bromo)- 
propyloxyphenyl)-10,15,20-tri(p-tolyl)porphyrin was isolated in 88 % yield , after 
purification. The porphyrin bearing an alkyl halide and sodium azide, were dissolved in 
acetone, and the mixture was stirred at 80 
o
C for 12 hours. Once the reaction mixture 
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has been washed with water, dried, and chromatographically separated, the azido 
porphyrin was isolated in 76 % yield. The article also described the synthesis of a 
dithiaporphyrin derivative which bore a hydroxyl functionality, which was modified to 
possess an alkyne group. The dithiaporphyrin and sodium hydride were dissolved in dry 
tetrahydrofuran. Once the mixture had stirred at ambient temperature for 30 minutes, 
DABCO and propargyl tosylate were added, and the mixture was stirred for a further 12 
hours. The alkyne porphyrin was produced in 52 % yield, after purification. The free-
base azido porphyrin and alkyne dithiaporphyrin were dissolved in a mixture of water 
and acetic acid and copper(II) sulphate pentahydrate and sodium ascorbate were 
subsequently added, the mixture was then stirred at 80 
o
C for 96 hours. The porphyrin-
dithiaporphyrin adduct was isolated in 46 % yield, after chromatographic separation, as 
depicted in Scheme 57.  
A hydroxyl group attached to a phenyl group can also be modified to bear an azide 
moiety. A solution of the hydroxyl/phenyl derivative dissolved in dimethylformamide 
was treated with potassium carbonate, lithium bromide and 3-azidopropyltosylate; and 
the reaction mixture was heated at 80 
o
C for 96 hours, yielding the azido compound in 
33 % yield.
212
 Although this approach for the introduction of azido functionality to a 
hydroxyl group has been achieved, this particular strategy has not been applied to 
porphyrin chemistry.  
Vicente and co-workers,
213
 have reported the mono-alkylation of 5,10,15,20-tetra(4-
hydroxylphenyl)porphyrin using 3-bromo-1-yne, with the reaction conducted in 
anhydrous dimethylsulfoxide in the presence of potassium carbonate, at 60 
o
C for 15 
minutes, under an inert atmosphere. The free base porphyrin was isolated, and 
converted into the zinc(II) complex, using zinc acetate, giving an overall yield of 28 %. 
Click reactions were then performed, employing carbohydrates which bore azide 
functionalities, with the reactions performed using copper(II) sulphate pentahydrate and 
sodium ascorbate in a mixture of tert-butanol and water, with the reaction heated at 70 
o
C for 24 hours. The porphyrin-carbohydrate compounds were produced in 92 % and 88 
% yields. It was found that the reaction had to be heated to at least 50 
o
C for the click 
reaction to occur. Furthermore, the reactions were attempted using the free-base 
porphyrin, but failed to produce the target compound.      
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Scheme 57: Syntheses of a porphyrin-thiaporphyrin adduct.
211
 
 
The mono-alkylation of 5,10,15,20-tetra(2,3,4,5,6-pentaflourophenyl)porphyrin has 
been reported, using propargyl alcohol in the presence of potassium carbonate. The 
reagents were dissolved in dimethylsulfoxide, and the resulting mixture was heated at 
50 
o
C for 4 hours, furnishing the alkylated porphyrin in 86 % yield. A variety of 
quinolone derivatives, which bore azide functionalities, were then used to form 
porphyrin-quinolone conjugates with the modified porphyrin. The porphyrin, quinolone, 
copper(II) sulphate pentahydrate and ascorbic acid were dissolved in 
dimethylformamide. The reactions were performed for 8-72 hours, affording the 
conjugates in 53-93 %.
214
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5.3 Trans-substituted porphyrins 
 
The synthesis of a trans-porphyrin could be achieved via a mixed aldehyde 
condensation reaction with pyrrole, using a 1:1 ratio of aldehydes, with pyrrole. Using 
aldehyde A and B, the statistical distribution of porphyrins produced under these 
conditions is: A4 (6.25 %), A3B (25 %), cis-A2B2 (25 %), trans- A2B2 (12.5 %), AB3 (25 
%), B4 (6.25 %), assuming the reactivity‟s of the aldehydes are the same and no 
scrambling occurs.
215
 Thus, assuming the total yield of the porphyrin is 20 %, only 2.5 
% would be the target trans-porphyrin.    
A 2+2 strategy, using a dipyrromethane-carbinol derivative and a dipyrromethane 
would also result in the production of a trans-porphyrin. However, reactions employing 
pyridyl-dipyrromethanes tend to lead to lower than expected yields, and the acetamido 
group is incompatible with the required Grignard reagent, as discussed in Chapter 
3.
152,153
  
Ravikanth et al.
216
 have reported the synthesis of 5,15-dimesityl-10-(3-(2-
(trimethylsilyl)ethynyl)phenyl)-20-(4-iodophenyl)porphyrin using a condensation 
reaction between 3-(2-(trimethylsilyl)ethynyl)benzaldehyde and 4-iodobenzaldehyde 
with 5-mesityldipyrromethane. Firstly, the 3-(2-(trimethylsilyl)ethynyl)benzaldehyde 
was prepared via a Sonogashira coupling reaction between 4-iodobenzaldehyde and 
(trimethylsilyl)acetylene, employing tri(dibenzylideneacetone)dipalladium(0) and 
triphenylarsine in triethylamine, affording the product in 81 % yield. The aldehydes and 
dipyrromethane were used to produce the porphyrin under Lindsey conditions,
120
 
affording the trans-porphyrin in 14 % yield after purification. Under these conditions, 
only 3 porphyrins are produced, thus in comparison to a mixed condensation using 
aldehydes and pyrrole, less chromatographic separation would be required. However, 
the reaction mixture did exhibit other trace porphyrinic fractions, attributed to 
scrambling of a polypyrrolic intermediate  
Littler et al.
217
 have investigated the acid catalysed rearrangement, of the poly-pyrrolic 
intermediate, which occurs during a dipyrromethane and aldehyde condensation, as 
shown in Figure 43. It was found that reactions employing dipyrromethanes which have 
sterically hindered substituents in the meso-position e.g. mesityl group, exhibit a lower 
degree of scrambling in comparison to reactions which use sterically unhindered 
groups, such as phenyl functionalities. The condensation reaction, between 5-
mesityldipyrromethane and various aldehydes, was investigated. It was discovered that 
scrambling can be circumvented if the reaction was performed at ambient temperature, 
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in dichloromethane, using trifluoroacetic acid at a concentration of 17.8 mM, with 5-
mesityldipyrromethane and aldehyde at a concentration of 10 mM. It was also observed 
that using anhydrous solvents did not affect the porphyrin yield. An extensive study was 
then conducted, to obtain reaction conditions which suppressed scrambling, for 
reactions involving sterically un-hindered dipyrromethanes. While analysing the 
reaction between 5-(4-iodophenyl)dipyrromethane and 4-(2-
(trimethylsilyl)ethynyl)benzaldehyde, two sets of reaction conditions were identified 
which resulted in reasonable yields, with little or no scrambling occurring: 
 
1. A solution of dipyrromethane (10 mM) and aldehyde (10 mM) in acetonitrile, 
was treated with boron trifluoride etherate (1.0 mM) and ammonium chloride 
(100 mmol/L) at 0 
o
C, for typically 4 hours. Following DDQ oxidation and 
column chromatography, the trans-porphyrin was isolated in 8 % yield.  
2.  The dipyrromethane (100 mM) and aldehyde (100 mM) was dissolved in 
dimethylsulfoxide, and in the presence of ammonium chloride (316 mmol/L), 
the reaction was heated at 90 
o
C, for 24 hours, while exposed to air. The 
porphyrin was insoluble in dimethylsulfoxide and was isolated in 5 % yield, by 
filtration. 
 
 
Figure 43: Scrambling of poly-pyrrolic intermediate.
217
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5.4 Synthetic strategy: porphyrin dimer via Suzuki coupling. 
 
A Suzuki coupling approach was selected for the synthesis of the porphyrin dimer, as 
shown in Scheme 58. One porphyrin would possess three functionalities which could be 
transformed into water-solubilising groups, e. g. methylated pyridyl groups, and a single 
functionality enabling coupling to the trans-porphyrin. The trans-porphyrin would 
require a functionality which could be transformed into a bioconjugatable group, e g. 
acetamido, two hydrophilic moieties, and a functionality which would facilitate dimer 
production. Since Suzuki couplings involving pyridyl porphyrins have been 
reported,
170,204
 it was selected as an appropriate strategy for coupling the two porphyrins 
together; thus one of the porphyrins would possess a boronic ester or acid, and the other 
porphyrin would possess a halide. The literature suggests that Suzuki couplings using 
pyridyl porphyrins requires the porphyrin to be metallated, highly reactive palladium 
catalysts and strong bases,
204
 therefore developing chemistry using TPP derivatives was 
not attempted, as it was unlikely that the optimised conditions could be transferred to 
pyridyl porphyrin derivatives. It seemed more relevant to assess the conditions required 
for the Suzuki coupling between bis(pinacolato)diboron and the zinc(II) complex of 5-
(4-bromophenyl)-10,15,20-tri(4-pyridyl)porphyrin. Although it was envisaged that these 
reaction conditions would not be directly used for coupling the two pyridyl porphyrins 
together, as a stronger catalytic systems would be required. If the boronic ester was on 
the tri-pyridyl porphyrin derivative, the trans-porphyrin would require a complementary 
halide, and an acetamido group which could be converted into the maleimide 
functionality using a literature method,
144
 with pyridyl groups in the remaining meso-
positions. Thus, the trans-porphyrin would be the product of the dehydration between 4-
acetamidobenzaldehyde and 4-bromobenzaldehyde, with 4-pyridyldipyrromethane, as 
illustrated in Scheme 58. As it has been reported that scrambling of the poly-pyrrolic 
intermediate occurs during trans-porphyrin formation, conditions which circumvent the 
scrambling phenomena were employed. Due to the extremely high cost of acetonitrile at 
this time, the reaction using dimethylsulfoxide, in the presence of ammonium chloride, 
at 90 
o
C, was employed.
217
 
 
 177 
      
 
Scheme 58: Proposed synthesis of porphyrin dimer using Suzuki coupling. 
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5.4.1 Synthesis of 5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-15-(4-
bromophenyl)porphyrin (27) 
 
The literature suggested that the synthesis of 5-(4-pyridyl)dipyrromethane (26) via the 
traditional trifluoroacetic acid catalysed reaction between 4-pyridinecarboxaldehyde and 
pyrrole, only produced the desired dipyrromethane in relatively low yields; 35 %
218
 and 
26 %.
219
 It has been reported that the reaction can be performed at elevated temperatures 
(85 
o
C), overnight, without the addition of the acid catalyst, and under these conditions 
26 has been isolated in 58 % yield.
153
 Following Scheme 58, and a known procedure,
153
 
26 was isolated in 48 % yield after purification. After 15 hours, the reaction was 
complete, as indicated by TLC (silica, 30 % hexane/ethyl acetate), thus the excess 
pyrrole was removed under reduced pressure, and the residue was purified by flash 
column chromatography (silica, 20 % hexane/ethyl acetate). The fraction containing the 
crude product was identified and pure 26 was isolated as a white powder, after 
precipitation from acetone by the addition of hexane. 
The assignment of the signals for the 
1
H NMR spectrum for 26, was achieved using a 
combination of 2D COSY and C-H correlation experiments, and was slightly different 
to reported determinations,
153
 although deuterated dimethylsulfoxide was employed for 
the analysis. The broad singlet at 8.10 ppm coupled to the multiplet at 6.72-6.77 ppm, 
which in turn coupled to a quartet at 6.17 ppm. Therefore, the broad singlet at 8.10 ppm 
was assigned the NH protons, the multiplet at 6.72-6.77 ppm was designated the 1 and 
9-CH environments and the quartet at 6.17 ppm was assigned to the 2 and 8-CH. The 
literature determination had the NH proton environment at 10.67 ppm.
153
 Apart from the 
position of the NH proton signal, the 
1
H NMR of 26 was in agreement with the 
published data. The mass spectrum gave the expected 223 m/z peak, therefore it was 
concluded that 26 had been produced.    
The synthesis of 27 was performed using a modified procedure.
217
 Appropriate 
stoichiometric quantities of 26, 4-acetamidobenzaldehyde, 4-bromobenzaldehyde and 
ammonium chloride were dissolved in dimethylsulfoxide and the resulting mixture was 
heated to 90 
o
C for 24 hours. Once cooled, the mixture was then stirred at ambient 
temperature for a further 3 hours to ensure that the porphyrinogen had been oxidised. 
The TLC (silica, eluent: 10 % methanol/dichloromethane) of the reaction mixture 
exhibited three distinct porphyrin fractions and poly-pyrrolic by-products. The 
porphyrins appeared to be soluble in dimethylsulfoxide as filtration did not yield any 
porphyrinic product and the TLC of the filtrate showed the presence of the porphyrins. 
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Therefore a 5 % methanol/dichloromethane solution was used to extract the porphyrin 
from the dimethylsulfoxide, which was subsequently washed with copious amounts of 
water to remove the residual dimethylsulfoxide and ammonium chloride. The crude 
product was dried over anhydrous sodium sulphate to remove the residual water and the 
crude mixture was chromatographically separated (silica, eluent: 3 % 
methanol/dichloromethane). Once the relevant fraction was collected, 27 was isolated as 
a purple solid in 1 % yield, after precipitation from dichloromethane by the addition of 
methanol. The concentration of the dipyrromethane used (76 mM) was lower than the 
optimal concentration of 100 mM, which could have contributed to the low reaction 
yield. However, isolating the porphyrins from dimethylsulfoxide was the most likely 
process which led to a diminished yield. The reaction was only attempted once, thus the 
optimum reaction conditions were not identified. 
The relevant section of the 
1
H NMR spectrum for 27 is shown in Figure 44. All of the 
proton environments were accounted for; however 2D HMBC, COSY and C-H 
correlation experiments would have to be performed to reveal the exact assignments. 
The doublets at 7.84 ppm and 8.00 ppm appear to have a roof-top appearance, as does 
the doublets at 7.92 ppm and 8.07 ppm; all of which have the same coupling constant: J 
= 8.36 Hz. However the 2D experiments would provide the conclusive evidence for the 
signal assignments.  
The mass spectrum for 27 is depicted in Figure 45 and shows a typical bromine isotope 
distribution pattern and exhibits the expected 752 m/z peak, therefore there was 
sufficient evidence that the reaction had occurred as postulated. 
The metallation of 27 was not attempted. 
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Figure 44: 
1
H NMR spectrum of 27. 
 
 
 
Figure 45: Mass spectrum of 27. 
10,20-Ar-m-H and β-H 
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5.4.2 Attempted synthesis of (5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborinan-2-
yl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
 
5-(4-Bromophenyl)-10,15,20-tri(4-pyridyl)porphyrin (28) was synthesised using 4-
bromobenzaldehyde, 4-pyridinecaroxaldehyde and pyrrole, under Adler-Longo 
conditions.
114
 Compound 28 was isolated in 4 % yield. Although the 
1
H NMR of 28 was 
not as refined as reported data,
220
 all the proton environments were accounted for, and 
the mass spectrum gave the 695 m/z 
79
Br(M)
+
 signal, and the expected isotope 
distribution pattern.  
The insertion of zinc into the free-base 28 was achieved using a modified procedure.
221
 
A solution 28 dissolved in 25 % methanol/chloroform was treated with zinc acetate 
dihydrate for 2 hours at 40 °C. The solution was subsequently washed with a saturated 
sodium hydrogen carbonate solution; to remove un-reacted zinc acetate dihydrate and 
the acetic acid by-product; and water, and the organic layer was dried over anhydrous 
sodium sulphate; to remove residual water. The solvent was removed under reduced 
pressure, with 29 isolated in 83 % yield, after precipitation from chloroform by the 
addition of methanol. The characterisation studies confirmed that 29 had been 
synthesised. 
The reaction between 29 and bis(pinacolato)diboron was attempted multiple times, as 
tabulated in Table 3, with the initial attempt following a published method.
197
 An oven 
dried Schlenk flask which was cooled under argon, was charged with 29, 
bis(diphenylphosphino)ferrocene]dichloropalladium(II), potassium acetate and 
bis(pinacolato)diborane under an argon atmosphere. The Schlenk flask was flushed with 
argon to remove residual oxygen. Anhydrous dimethylsulfoxide was degassed with 
argon to remove oxygen, and was added to the Schlenk flask under an argon 
atmosphere. The resulting mixture was sonicated to ensure the reagents were in 
solution. The reaction mixture was then heated at 80 °C, under an argon atmosphere 
while protected against light. The reaction was monitored over a 24 hour period, by 
working-up aliquots of the reaction mixture and subsequent analysis by TLC (silica, 
eluent: tetrahydrofuran), which indicated that no reaction was occurring and recovery of 
29. Therefore additional potassium acetate, bis(pinacolato)diborane and 
bis(diphenylphosphino)ferrocene]dichloropalladium(II) were added under argon. The 
reaction was monitored for a further 19 hours by TLC, but only 29 was observed. 
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The reaction was also attempted in a similar manner using dimethylformamide, heating 
the reaction at 80 °C, and tetrahydrofuran with heating the reaction at 50 °C. Both 
reactions were monitored over 48 hours, with 29 being recovered in both reactions, as 
indicated by TLC. 
The conditions required for the palladium catalysed reaction between 
bis(pinacolato)diborane and a halo-arene were evaluated, and it was found that stronger 
bases such as potassium phosphate and potassium carbonate, promoted further coupling 
with the initial halo-arene.
197
 As it appeared that no reaction was occurring between 29 
and bis(pinacolato)diborane using the weakly basic potassium acetate, stronger bases 
were employed. Thus the reaction was repeated substituting potassium acetate with 
potassium carbonate, with the reactions being conducted in either dimethylformamide 
or dimethylsulfoxide. The reactions were monitored by TLC over a 72 hour period, with 
almost complete recovery of 29, and trace polar fractions being observed in both cases. 
The trace fractions were more prominent for the reaction conducted in 
dimethylsulfoxide, thus subsequent reaction attempts were performed in 
dimethylsulfoxide.  
The reaction was repeated in a similar manner, employing caesium carbonate or 
potassium phosphate as the base. Both reactions were monitored by TLC over a 72 hour 
period, which revealed that mainly 29 had being recovered, and the development of 2 
polar trace fractions, which were more prominent for the reaction employing potassium 
phosphate.  
 
Porphyrin Palladium catalyst Base Solvent 
29 Pd(dppf)Cl2 KOAc DMSO 
29 Pd(dppf)Cl2 KOAc THF 
29 Pd(dppf)Cl2 KOAc DMF 
29 Pd(dppf)Cl2 K2CO3 DMF 
29 Pd(dppf)Cl2 K2CO3 DMSO 
29 Pd(dppf)Cl2 Cs2CO3 DMSO 
29 Pd(dppf)Cl2 K3PO4 DMSO 
 
Table 3: Attempted Suzuki coupling reactions involving bis(pinacolato)diborane and 
29. 
 
 
 183 
      
It has been reported that reactions between bis(pinacolato)diborane and iodo-derivatives 
are more rapid and produce the boronated product in higher yields, in comparison to 
reactions which used bromo-analogues.
197,203
 Thus the reaction was repeated employing 
the zinc(II) complex of 5-(4-iodophenyl)-10,15,20-tri(4-pyridyl)porphyrin in place of 
29, as illustrated in Scheme 59. 
 
 
Scheme 59: Attempted Suzuki coupling involving 31. 
 
Following the Adler procedure,
114
 5-(4-iodophenyl)-10,15,20-tri(4-pyridyl)porphyrin 
(30) was synthesised from the dehydration reaction between 4-iodobenzaldehyde, 4-
pyridinecaroxaldehyde and pyrrole. The 
1
H NMR spectrum of 30 possessed all the 
expected signals, the UV-visible spectrum was typical for a free-base porphyrin, and the 
mass spectrum gave the expected 744 m/z peak corresponding to the (M+H)
+
 ion. Thus 
there was sufficient evidence that 30 had been synthesised. The production of the 
zinc(II) complex of 30 (31), was achieved by a modified literature method,
221
 affording 
31 in 88 % yield, after precipitation form chloroform by the addition of methanol. The 
characterisation studies suggested that 31 had been produced as postulated. However, 
31 was poorly soluble in chlorinated solvents, dimethylsulfoxide and tetrahydrofuran, 
thus a 
13
C NMR spectrum was not obtained.   
The reaction between bis(pinacolato)diboron and 31 was attempted using a modified 
literature method,
197
 using a different base for each reaction, as shown in Table 4. The 
reactions were monitored by TLC (silica, eluent: tetrahydrofuran). 
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Porphyrin Palladium catalyst Base Solvent 
31 Pd(dppf)Cl2 KOAc DMSO 
31 Pd(dppf)Cl2 K3PO4 DMSO 
31 Pd(dppf)Cl2 Cs2CO3 DMSO 
 
Table 4: Attempted Suzuki coupling reactions involving bis(pinacolato)diborane and 
31. 
 
The reactions employing potassium acetate and caesium carbonate were monitored over 
a 96 hour period by TLC, which exhibited nearly total recovery of 31, with the 
development of trace polar fractions; hence those reactions were discarded. The reaction 
using potassium phosphate showed almost complete consumption of 31 within 5 hours, 
with the development of a newly formed polar fraction, with other more polar trace 
fractions also being observed; thus the porphyrinic products were extracted into 10 % 
methanol/dichloromethane. The porphyrinic product only appeared to be partially 
soluble in the 10 % methanol/dichloromethane solution; using a higher concentration of 
methanol was attempted, but resulted in dimethylsulfoxide being detected in the organic 
layer. The organic layer was washed with copious amounts of water, to remove 
dimethylsulfoxide and potassium phosphate, and dried over anhydrous sodium sulphate 
to remove residual water. The mixture was chromatographically separated (silica coated 
preparative TLC plates, eluent: 10 % methanol/chloroform) and the relevant fraction 
was isolated. The suspected product was isolated after precipitation form 10 % 
methanol/dichloromethane, by the addition of methanol.  
1
H NMR analysis of the suspected product proved to be problematic, as the product 
seemed to precipitate out of chloroform/ methanol solutions and dimethylsulfoxide. 
Therefore the sample was dissolved in deuterated dimethylsulfoxide, and the solution 
was filtered prior to the 
1
H NMR analysis. The relevant sections of the 
1
H NMR and 
11
B 
NMR spectrum‟s of suspected (5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborinan-2-
yl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II), are shown in Figure 46. The 
aromatic region of the suspected product was similar to the 
1
H NMR of 31, with both 
exhibiting a doublet at 8.85 ppm corresponding to a β-proton environment, with all the 
other proton environments accounted for in comparable positions. However, the 
1
H 
NMR spectrum of the suspected product did not show a peak in the alkyl region 
accounting for methyl groups of the boronic pinacol ester, which would be present if the 
reaction had occurred as postulated. Furthermore, the 
11
B NMR of the suspected 
product produced a very weak signal, thus it was inconclusive whether the suspected 
 185 
      
product possessed a boron moiety. The strength of the signals for 
11
B NMR and 
1
H 
NMR were similar, indicating that although the 
11
B NMR signal was extremely weak, it 
was comparable with the strength of the 
1
H NMR. As the 
11
B NMR of the suspected 
product was inconclusive and the 
1
H NMR did not have a signal for the methyl groups 
of the pinacol ester, it was concluded that the reaction had failed and no further 
characterisation studies were conducted.   
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Figure 46: 
1
H NMR and 
11
B NMR of spectra of suspected (5-(4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborinan-2-yl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II). 
 
 
 
 
 
1
H NMR 
11
B NMR 
 β-H 
 β-H 
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As the boronation attempts involving bis(pinacolato)diborane were unsuccessful, an 
alternative boronation strategy was adopted, employing pinacolborane, as depicted in 
Scheme 60. Following a modified literature procedure,
201
 an oven dried Schlenk flask 
was charged with 29 and bis(diphenylphosphino)ferrocene]dichloropalladium(II), and 
the residual oxygen was removed form the reaction, under reduced pressure. Under an 
inert atmosphere, degassed dimethylformamide and triethylamine were added, followed 
by pinacolborane. The resulting solution was heated at 80 °C overnight, with the TLC 
(silica, eluent: tetrahydrofuran) of the reaction mixture only showing the presence of 29. 
Since the reported reaction was complete after 1 hour,
201
 and similar reactions involving 
pinacolborane and aryl-bromo derivatives,
222
 and (5-bromo-10,20-
diphenylporphyrinato)zinc(II) the reaction,
223
 were complete in 2-6 hours and 45 
minutes respectively, it was deemed that the reaction had failed.  
     
 
Scheme 60: Attempted boronation of 29. 
 
It has been reported that Suzuki couplings involving 29 are successful when employing 
tris(dibenzylideneacetone)dipalladium(0), tri(tert-butyl)phosphine and caesium 
carbonate, however the exact experimental conditions were not published.
204
  
It has been reported that porphyrins bearing pyridyl groups can coordinate with zinc 
metalled porphyrins,
224
 and palladium(II),
225
 leading to the production of multi-
porphyrin systems. Additionally, porphyrins bearing both pyridyl and iodophenyl 
moieties, can form supramolecular assemblies, where the iodo functionality coordinates 
to the pyridyl group.
226
 The formation of these coordination complexes could hinder or 
prevent Suzuki reactions involving 29 or 31 from occurring.   
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5.5 Synthetic strategy: porphyrin dimer by click coupling. 
 
Since the Suzuki coupling attempts involving 29 and 31 were unsuccessful, a click 
coupling approach was adopted for producing the porphyrin dimer, as shown in Scheme 
61. The synthetic strategy was similar to the Suzuki coupling approach, with the 
exception of the functional groups which facilitate dimer formation; it was required for 
the porphyrin moieties to possess azido and alkyne groups. 
Since it has been reported that porphyrins bearing a single amino group, can be 
converted into the azido analogue in good yields (95 %),
209,210
 it seemed prudent to use 
similar reaction conditions for the conversion of 17 into the azido derivative. The 
zinc(II) complex of the azido porphyrin was then produced, as the literature suggested 
that click reactions involving azido porphyrins are favoured when the porphyrin is in a 
metalled form,
213
 and copper(II) is present in the click reaction mixture which could 
insert into the porphyrin.
210
 Although click reactions utilising a free-base porphyrin has 
been reported.
211
  
Alkyne functionalities can be incorporated into a trans-porphyrin structure during the 
condensation reaction between an alkyne bearing aldehyde and dipyrromethane.
216
 The 
alkyne bearing aldehyde can be produced via the Sonogashira reaction between 4-
bromobenzaldehyde and ethynyltrimethylsilane.
227
 The literature suggested that there 
were two sets of reaction conditions which resulted in little or no scrambling of the 
poly-pyrrolic intermediate prior to trans-porphyrin formation.
217
 Due to the high cost of 
acetonitrile, the synthesis of the trans-porphyrin was performed in dimethylsulfoxide in 
the presence of ammonium chloride. Thus, the trans-porphyrin was the product of the 
condensation between 4-((trimethylsilyl)ethynyl)benzaldehyde, 26 and 4-
acetamidobenzaldehyde, which was subsequently converted into the zinc(II) complex. 
The trimethylsilyl protecting group could be removed via treatment with 
tetrabutylammoniumfluoride, enabling the alkyne to participate in a click reaction with 
an azido derivative. Once the porphyrin dimer formed, the acetamido group could be 
removed under acidic conditions, and the amino functionality could then be converted 
into the maleimide group by a published procedure.
144
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Scheme 61: Proposed synthesis of porphyrin dimer using „click‟ chemistry. 
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5.5.1 Synthesis of (5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-15-(4-
((trimethylsilyl)ethynyl)phenyl)porphyrinato) zinc(II) (34) 
 
Following the synthetic sequence outlined in Scheme 61 and a known procedure,
227
 a 
vessel was charged with 4-bromobenzaldehyde, palladium(II) acetate and 
triphenylphosphine. Freshly distilled triethylamine, which had been degassed with 
argon, was added and the resulting solution was degassed with argon for a further 5 
minutes. Ethynyltrimethylsilane was then added to the solution, which was 
subsequently heated at reflux for 2 hours. Once the reaction had reached ambient 
temperature, the mixture was filtered to remove the triethylamine hydrobromide by-
product, and the filtrate was collected. The solvent was removed in vacuo and the crude 
thick oil was re-dissolved in 50 % dichloromethane/hexane and was 
chromatographically separated (silica, eluent: 50 % dichloromethane/hexane). 4-
((Trimethylsilyl)ethynyl)benzaldehyde (32) was isolated as white/yellow crystals in a 
reasonable 72 % yield, after recrystalisation from isopropanol. The characterisation 
studies conducted on 32 were comparable to published data,
228
 hence it was concluded 
that 32 had been produced. 
Following a modified reported method,
217
 5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-
15-(4-((trimethylsilyl)ethynyl)phenyl)porphyrin (33) was synthesised via the 
condensation reaction between 32 and 4-acetamidobenzaldehyde, with 26.  
A solution of 32, 26, 4-acetamidobenzaldehyde and ammonium chloride dissolved in 
dimethylsulfoxide, was heated to 90 °C for 24 hours. Once cooled to ambient 
temperature, the mixture was stirred for a further 3 hours, open to air to ensure that the 
porphyrinogen had been oxidised. The porphyrinic products were extracted into a 5 % 
methanol/dichloromethane solution and the organic layer was isolated, and washed with 
copious amounts of water, to remove residual dimethylsulfoxide and ammonium 
chloride. The organic layer was dried over anhydrous sodium sulphate and the solvent 
was removed under reduced pressure. The crude product was chromatographically 
separated (silica, eluent: 3 % methanol/dichloromethane), with 33 isolated as a purple 
solid after precipitation from dichloromethane by the addition of methanol. The yield of 
33 was particularly low (1 %), which could have been due to the extraction from 
dimethylsulfoxide procedure.  
The alkyl region of the 
1
H NMR spectrum of 33 exhibited a singlet at 0.38 ppm, 
corresponding to the trimethyl proton environment, and another singlet at 2.38 ppm, 
from the acetamido protons. The aromatic region showed a pair of doublets at 7.88 ppm 
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and 7.93 ppm, with both signals having the same coupling constants, J = 8.44 Hz. 
However, 2D COSY analysis showed that both of the doublets at 7.88 ppm and 7.93 
ppm, coupled with the multiplet at 8.11-8.18 ppm, but not with each other. By 
considering the shielding effect exerted by the porphyrin core, the doublets at 7.88 ppm 
and 7.93 ppm were assigned the 5,15-meta-aromatic protons, with the 5,15-ortho-
aromatic protons within the 8.11-8.18 ppm multiplet. The 2D COSY also showed that 
the a proportion of the multiplet at 8.11-8.18 ppm coupled with the multiplet at 8.99-
9.07, thus by considering the inductive effect of the pyridyl groups, the multiplet at 
8.99-9.07 was assigned the 10,20-meta-aromatic protons and a proportion of the 
multiplet at 8.11-8.18 was assigned the 10,20-ortho-aromatic protons. The pair of 
doublets at 8.86 ppm and 8.93 ppm had J values which were typical for β-protons (J = 
4.8 Hz), and the 2D COSY analysis showed that those doublets and the multiplet at 
8.78-8.83 ppm exhibited coupling with each other; thus the doublets at 8.86 ppm and 
8.93 ppm, and the multiplet at 8.78-8.83 ppm were assigned the β-protons. The UV-
visible spectrum of 33 was typical for a free-base porphyrin and the mass spectrum gave 
the expected 770 m/z peak due to the (M+H)
+
 ion. There was substantial evidence 
suggesting that 33 had been synthesised as hypothesised. 
Following Scheme 61 and a modified reported method,
221
 the zinc(II) complex of 33 
(34) was produced in 84 % yield. The relevant sections of the 
1
H NMR spectrum of 34, 
is shown in Figure 47. The alkyl region of the 
1
H NMR spectrum of 34 has a singlet at 
0.25 ppm (a) which corresponds to the trimethyl group, and another singlet at 2.09 ppm 
(b), corresponding to the methyl protons from the acetamido group. The aromatic 
region of the spectrum contains doublets at 7.72 ppm and 8.04 ppm, both of which 
having the same coupling constant (J = 7.96 Hz). The 2D COSY analysis indicated that 
those doublets coupled with each other, thus those doublets were attributed ortho-meta-
aromatic-protons, located at either the 5 or 15 positions on the porphyrin core. The 2D 
COSY also showed that the multiplet at 7.88-7.98 ppm coupled with the multiplet at 
8.56-8.68 ppm. By considering the inductive effect of the pyridyl groups, the multiplet 
at 8.56-8.68 ppm was assigned 10,20-meta-aromatic-protons and a proportion of the 
multiplet at 7.88-7.98 was assigned 10,20-ortho-aromatic-protons. The multiplet at 
7.88-7.98 had an integral of 8, thus the remaining 4 protons were assigned as ortho-
meta-aromatic-protons, located at either the 5 or 15 positions on the porphyrin core. The 
remaining signals were assigned as the β-protons. The UV-visible spectrum of 34, was 
typical for a metallated porphyrin, and the mass spectrum gave the 832 m/z peak; thus it 
was concluded that 34 had been successfully produced. 
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The removal of the trimethylsilyl group from 34, via treatment with 
tetrabutylammoniumfluoride, was not attempted. 
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Figure 47: 
1
H NMR spectrum of 34. 
 
β-H 
4H of β-H and  
4H of 10,20-Ar-m-H 
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5.5.2 Synthesis of (5-(4-azidophenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
(35) 
 
Following Scheme 61 and a modified published procedure,
169
 a solution of 17 in 
trifluoroacetic acid was cooled to 0 °C, and was subsequently treated with sodium 
nitrite dissolved in water. After 15 minutes, sodium azide dissolved in water was added 
and the reaction mixture was stirred for a 1 hour. Water was added to the reaction 
mixture and the porphyrinic product was extracted into dichloromethane, with the un-
reacted reagents and trifluoroacetic acid retained in the aqueous layer. The organic layer 
was collected, washed with water to remove residual impurities, and dried over 
anhydrous sodium sulphate, to remove residual water. TLC analysis (silica, 10 % 
methanol/dichloromethane) indicated that 17 had been quantitatively converted into the 
azido analogue. The azido porphyrin intermediate was re-dissolved in dichloromethane 
and zinc acetate dihydrate dissolved in methanol was added. The resulting mixture was 
heated at 40 °C for 2 hours. Once cooled to room temperature, the reaction mixture was 
washed with water to remove zinc acetate dihydrate, dried over anhydrous sodium 
sulphate to remove residual water, and the solvent was removed under reduced pressure, 
affording (5-(4-azidophenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) (35) as a 
black solid in 94 % yield. Once the solvent was removed, compound 35 was insoluble 
in chloroform, acetone, methanol, 5-20 % methanol/chloroform; and was only partially 
soluble in tetrahydrofuran, dimethylsulfoxide and dimethylformamide, after sonicating 
the suspensions. Preparative TLC (silica coated prep TLC plates, eluent: 
tetrahydrofuran) was attempted, but resulted in the porphyrin precipitating on the silica, 
thus purification of 35 was not achieved. The 
1
H NMR of 35 was performed in 
deuterated dimethylsulfoxide, with the sample requiring filtration prior to the analysis.  
The aromatic region of the 
1
H NMR spectrum of 35 is depicted in Figure 48. The alkyl 
region of the spectrum did not possess a broad singlet corresponding to the amino 
protons of starting material 17. The aromatic region of the spectrum contained signals 
for all the proton environments. The sample was not concentrated enough to obtain a 
13
C NMR. The UV-visible spectrum of 35 was typical for a metalled porphyrin. The 
mass spectrum of 35 produced a 694.1 m/z signal which could be attributed to the 
(M+2H−2N)+ ion, however the HRMS gave a 695.1645 m/z peak, which did not 
correspond to the possible ions which 35 could produce. Although the 
1
H NMR of 35 
indicated that the reaction had occurred as postulated, the mass spectrum was 
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inconclusive, thus there was not sufficient evidence that the reaction had occurred as 
hypothesised.       
 
 
 
Figure 48: 
1
H NMR spectrum of 35. 
 
During the synthesis of 35, the TLC analysis of the reaction mixture indicated that 17 
had been converted into the azido analogue. Hence to ensure the amino group was 
transformed into the azido functionality, the reaction was repeated without the insertion 
of zinc, as shown in Scheme 62.  
 
β-H 
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Scheme 62: Synthesis of 36. 
 
The synthesis of 5-(4-azidophenyl)-10,15,20-tri-(4-pyridyl)porphyrin (36) was achieved 
in a similar manner as described for 35, except for the zinc dihydrate treatment. The 
aromatic region of the 
1
H NMR spectrum of 36 is shown in Figure 49, and was 
comparable to the 
1
H NMR spectrum of 35. The mass spectrum of 36 exhibited a 
659.2408 m/z peak due to the (M+H)
+
 ion, thus it was concluded that 36 had being 
successfully produced. As 36 had been synthesised, it was likely the zinc(II) complex 
(35) had also been produced as postulated. 
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Figure 49: 
1
H NMR spectrum of 36. 
 
 
 
 
 
 
 
 
 
 
β-H 
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5.5.3 Attempted synthesis of 5-(4-((4-trimethylsilyl)-1,2,3-triazole)phenyl)-10,15,20-
tri-(4-pyridyl)porphyrin 
 
Before attempting a click reaction using 35 and deprotected 34, a trial reaction was 
attempted involving 35 and ethynyltrimethylsilane, as illustrated in Scheme 63. 
Following a modified procedure,
213
 a solution of 35 in dimethylsulfoxide (10 mL) was 
charged with sodium L-ascorbate and copper(II) sulphate pentahydrate suspended in 
water. It has been reported that additives such as tris((1-benzyl-1H-1,2,3-triazol-4-
yl)methyl)amine enhances the click reaction by reducing the required copper 
concentration, or increasing the efficiency of the reaction.
205
 Thus tris((1-benzyl-1H-
1,2,3-triazol-4-yl)methyl)amine was then added to the reaction mixture, which was than 
heated to 80 °C. The reaction was monitored by TLC (silica, eluent: tetrahydrofuran) 
over 4 days, with only 36 being detected.  
 
 
Scheme 63: Attempted „click‟ reaction. 
 
Compound 35 was poorly soluble in dimethylsulfoxide, thus the reaction could have 
failed due to the low concentration of 35 within the reaction mixture. Click reactions 
have been performed in acetic acid solutions,
211
 and as pyridyl groups can be 
protonated, it would have been prudent to investigate the click reaction using acetic acid 
in the solvent system.  
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5.6 Summary/further work  
 
Both the Suzuki and click coupling strategies for producing a porphyrin dimer were 
unsuccessful. For the Suzuki coupling approach, the zinc(II) complexes of the bromo 
and iodo pyridyl porphyrins were poorly soluble in the solvent systems used, possibly 
due to zinc-pyridyl or halide-pyridyl coordination. To suppress the formation of the 
possible coordination complexes, porphyrins could be produced which have the pyridyl 
nitrogens located in the 2-postion, opposed to the 4. Suzuki coupling attempts involving 
the free-base porphyrins should also be attempted.  
The click coupling attempt was hindered by the solubility of 35, thus time permitting, 
different solvent systems should be investigated, initially using weakly acidic solutions.  
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Chapter 6: Experimental 
 
Starting reagents were purchased from Fisher Scientific UK (Fisher Scientific UK, 
Bishop Meadows Road, Loughborough, Leicestershire), Sigma Aldrich (YorLab, 9 The 
Crescent, Blossom Street, York, Yorkshire) and Strem Chemicals (Strem Chemicals 
UK, 48 High Street, Orwell, Royston, Hertfordshire) and were used as received unless 
otherwise stated. Solvents, of either analytical of HPLC grade, were obtained from 
Fisher Scientific UK. Solvents were dried according to published procedures.
229
  
 
TLC analysis was preformed using aluminium-backed silica gel 60 F254, (Merck plates) 
or aluminium-backed aluminium oxide 60 F254, (Merck plates) purchased from Sigma 
Aldrich. 
 
 Silica gel chromatography was preformed with silica gel 60 Å (Davisil), bought from 
Sigma Aldrich. Alumina chromatography was preformed using aluminium oxide 150, 
purchased from Sigma Aldrich. 
 
NMR studies were conducted using either a JEOL-ECP 400 MHz FT-NMR 
spectrometer or JEOL-JNM-LA400 FT NMR spectrometer. The chemical shifts were 
quoted in ppm, with the coupling constants (J) quoted in hertz (Hz). The solvent peaks 
were assigned using literature determinations.
230
  
 
UV-Vis absorption spectra were recorded on Agilent 8453 spectrometer. 
. 
Mass spectrometry was performed using either a Bruker Reflex IV MALDI TOF 
mass spectrometer, or a Perkin-Elmer Turbomass quadrupole GC/MS, with a 
Perkin-Elmer Autosystem XL GC and autosampler. 
 
High resolution mass spectra were provided by: 
 
EPSRC National Mass Spectrometry Service Centre 
Chemistry Department  
University of Swansea 
Wales 
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With the analyses performed using the following instrumentation: 
 
Applied Biosystems Mariner (Electrospray) 
Applied Biosystems Voyager (MALDI-TOF) 
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6.1 Synthesis of 5,10,15,20-tetraphenylporphyrin (1) 
 
 
 
Benzaldehyde (10.6 mL, 100 mmol) was dissolved in propionic acid (400 mL) and the 
resulting mixture was heated to reflux. Pyrrole (7.9 mL, 100 mmol, 1 equiv. relative to 
benzaldehyde) was added drop-wise to the refluxing mixture and the resulting solution 
was heated under reflux conditions for a further 30 minutes, while protected against 
light. Once cooled to ambient temperature, the dark mixture was filtered to yield a 
purple solid, which was washed with methanol and hot water to afford 1 (2.7 g, 18 %) 
as a purple crystalline solid. Rf = 0.82 (silica, CH2Cl2:C6H12; 3:2); m.p. = >350 °C 
decomp.  
  
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.77 (s, 2H, NH), 7.71-7.81 (m, 12H, 
5,10,15,20-Ar-m-p-H), 8.19-8.25 (m, 8H, ,10,15,20-Ar-o-H), 8.84 (br s, 8H, β-H) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 120.1, 126.7, 127.7, 131.3, 134.6, 142.2 
UV/Vis (CH2Cl2, nm) λmax = 417, 514, 549, 590, 646  
MS (MALDI) m/z = 614 (M)
+
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6.2 Synthesis of (5,10,15,20-tetraphenylporphyrinato)copper(II) (2) 
 
 
 
A slurry of copper (II) acetate monohydrate (3.2 g, 16 mmol, 10 equiv. relative to 1) in 
methanol-water (50 mL; 6:1) was added to a solution of 1 (1 g, 1.6 mmol) dissolved in 
chloroform (250 mL) and the resulting mixture was heated at reflux, for 5 hours. The 
hot solution was applied to a warm neutral alumina oxide pad, and eluted using warm 
chloroform. The organic layer was collected, dried over magnesium sulphate and the 
solvent was removed under reduced pressure. The purple product was isolated (1.07 g, 
97 %), after precipitation from methanol over chloroform. Rf = 0.94 (silica, 
CH2Cl2:C6H12; 3:2); m.p. = >350 °C decomp. 
 
 UV/Vis (CH2Cl2, nm) λmax = 414, 538, 616 
 MS (MALDI) m/z = 675 
63
Cu(M)
+ 
, 676 
63
Cu(M+H)
+ 
, 677 
65
Cu(M)
+ 
and 
63
Cu(M+2H)
+
, 
678 
65
Cu(M+H)
+ 
, 679 
65
Cu(M+2H)
+  
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6 .3 Synthesis of 2-formyl-5,10,15,20-tetraphenylporphyrin (3) 
 
 
 
Phosphorus oxychloride (7.91 mL, 84 mmol) was added drop-wise to ice cooled 
anhydrous dimethylformamide (10 mL, 129 mmol), under an argon atmosphere, while 
avoiding exposure to moisture. An ice cooled solution of 2 (900 mg, 1.3 mmol) 
dissolved in anhydrous 1,2-dichloroethane (90 mL) was added to the viscous Vilsmeier 
complex. The mixture was then allowed to reach room temperature and then was 
subsequently heated at reflux for 7 hours. Once the reaction mixture had cooled to 
ambient temperature over night, sulphuric acid (18 M, 17.3 mL, 300 mmol) was added 
to the stirred solution. The mixture was then poured onto a stirred, ice-cooled solution 
of sodium hydroxide (0.72 M, 900 mL), and chloroform was added. The organic layer 
was separated, washed with a saturated solution of sodium hydrogen carbonate and 
water, and was then dried over anhydrous sodium sulphate. The solvent was removed 
under reduced pressure and the crude product was isolated by column chromatography 
(silica, eluent: dichloromethane). Compound 3 (575 mg, 67 %) was isolated as a purple 
solid after precipitation from dichloromethane by the addition of hexane. Rf = 0.51 
(silica, CH2Cl2); m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.55 (s, 2H, NH), 7.66-7.86 (m, 12H, 
5,10,15,20-Ar-m-p-H), 8.13-8.27 (m, 8H, 5,10,15,20-Ar-o-H ), 8.67-9.02 (m, 6H, β-H), 
9.22 (s, 1H, β-H), 9.41 (s, 1H, CHO) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 120.0, 120.3, 120.6, 122.6, 126.85, 126.88, 
127.4, 128.0, 128.2, 129.0, 134.5, 134.6, 134.7, 135.0, 141.6, 141.8, 142.4, 189.4 
UV/Vis (CH2Cl2, nm) λmax = 430, 525, 566, 605, 663 
MS (MALDI) m/z = 642 (M)
+ 
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6.4 Attempted synthesis of tert-butyl(3-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)amino)propyl)carbamate 
 
 
 
Method 1 
 
A solution of 3 (50 mg, 77 μmol) in anhydrous toluene (35 mL), was charged with N-
Boc-1,3-diaminopropane hydrochloride (19.6 mg, 93 μmol, 1.2 equiv. relative to 3), and 
1 drop of acetic acid, and the reaction vessel was fitted with a Dean-Stark trap. The 
reaction mixture was heated to reflux, under an inert atmosphere (N2), while avoiding 
exposure to light. After 16 hours, a trace, polar, UV-active fraction was observed by 
TLC (silica, eluent: 5 % methanol/dichloromethane), with almost all the starting 
material remaining. A solution of sodium cyanoborohydride (6 mg, 95 μmol, 1.2 equiv. 
relative to 3) dissolved in dry methanol (7 mL) was added to the reaction mixture, and 
heating was continued for a further 14 hours (overnight), until the TLC of the reaction 
mixture showed almost complete consumption of 3, and the development of another 
UV-active fraction (suspected product). Once cooled to room temperature, the solvent 
was removed under reduced pressure. The crude mixture was re-dissolved in 
dichloromethane, washed with water, and the organic layer was dried over anhydrous 
sodium sulphate. Chromatographic separation (silica coated prep TLC plates, eluent: 5 
% methanol/dichloromethane) isolated the relevant fractions, however TLC analysis 
showed the suspected product had decomposed. 
 
The reaction was repeated, with the exception of using a 10 molar excess of N-Boc-1,3-
diaminopropane hydrochloride (164 mg, 778 μmol, 10 equiv. relative to 3), and in the 
presence of activated 3 Å molecular sieves. The reaction proceeded in exactly the same 
manner as previously described. Decomposition of the suspected product was observed, 
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following chromatographic separation (silica coated prep TLC plates, eluent: 5 % 
methanol/dichloromethane).   
 
Method 2 
 
Compound 3 (200 mg, 311 μmol) dissolved in anhydrous toluene (50 mL), was charged 
with N-Boc-1,3-diaminopropane hydrochloride (327 mg, 1.56 mmol, 5 equiv. relative to 
3), 1 drop of acetic acid and activated 3 Å molecular sieves; and the reaction vessel was 
fitted with a Dean-Stark trap. Sodium cyanoborohydride (23 mg, 370 μmol, 1.2 equiv. 
relative to 3) dissolved in dry methanol (15 mL) was added to the reaction mixture, 
which was subsequently heated to reflux, under an inert atmosphere (N2) while avoiding 
exposure to light. After 24 hours (overnight) no further consumption of 3 was observed, 
as indicated by TLC (silica, eluent: 5 % methanol/dichloromethane), with the reaction 
mixture exhibiting the presence of a major UV-active fraction (suspected product), and 
multiple trace UV-active fractions. Once cooled to room temperature, the solvent was 
removed in vacuo, the crude mixture was re-dissolved in dichloromethane and washed 
with a saturated sodium hydrogen carbonate solution, brine and then water. The organic 
layer was dried over anhydrous sodium sulphate and chromatographic separation (silica 
coated preparative TLC plates, eluent: 5 % methanol/dichloromethane) isolated the 
relevant fraction. The suspected product was precipitated from dichloromethane by the 
addition of hexane. Once dried, the suspected product had degraded as indicated by 
TLC, therefore the chromatographic and precipitation procedures were repeated. Once 
isolated, 
1
H NMR analysis of the suspected product was inconclusive, with the TLC of 
the 
1H NMR sample exhibiting decomposition. The suspected product (11 mg, 14 μmol-
assuming suspected product was the imine) was dissolved in anhydrous 
dichloromethane (5 mL), and was treated with a solution of sodium borohydride (2 mg, 
55 μmol, 4. equiv. relative to suspected product) in dry methanol (1 mL). The resulting 
solution was stirred for 15 minutes, at 0 °C, under an inert atmosphere (N2). Acetic acid 
(0.1 mL) was added, and the resulting mixture was washed with water and then dried 
over anhydrous sodium sulphate. TLC analysis indicated that the sodium borohydride 
treatment had not affected the suspected product.  
    
 
 
 
 207 
      
Method 3 
 
A solution of sodium cyanoborohydride (6 mg, 93 μmol, 1.2 equiv. relative to 3) 
dissolved in dry methanol (6 mL) was added to 3 (50 mg, 77 μmol), N-Boc-1,3-
diaminopropane hydrochloride (82 mg, 39 μmol, 5 equiv. relative to 3), 1 drop of acetic 
acid and activated 3 Å molecular sieves in anhydrous tetrahydrofuran (30 mL). The 
reaction was heated to reflux, under an inert atmosphere (N2), while protected against 
light. After 24 hours (overnight), the TLC (silica, eluent: 5 % 
methanol/dichloromethane) of the reaction mixture revealed the presence of a major 
UV-active fraction (suspected product), a minor polar fraction (suspected imine) and a 
trace amount 3, therefore the reaction was stopped to avoid possible decomposition. 
Once cooled to ambient temperature, the solvent was removed under reduced pressure, 
the crude mixture was re-dissolved in dichloromethane and washed with water. The 
organic layer was dried over anhydrous sodium sulphate and chromatographic 
separation (silica coated prep TLC plates, eluent: 5 % methanol/dichloromethane) 
isolated the relevant fraction. The suspected product was precipitated in hexane over 
dichloromethane. The suspected product had degraded as indicated by TLC. 
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6.5 Attempted synthesis of tert-butyl(12-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)-amino)dodecyl)carbamate 
 
 
 
A solution of 3 (50 mg, 77 μmol) in anhydrous toluene (35 mL), was charged with N-
Boc-1,12-diaminododecane (28 mg, 93 μmol, 1.2 equiv. relative to 3), 1 drop of acetic 
acid and activated 3 Å molecular sieves. The reaction vessel was fitted with a Dean-
Stark trap and was heated to reflux, under an inert atmosphere (N2), while avoiding 
exposure to light. After 16 hours, the reaction mixture showed no change as indicated 
by TLC (silica, eluent: 5 % methanol/dichloromethane), with recovery of the starting 
material. A methanolic solution of sodium cyanoborohydride (6 mg, 95 μmol, ≈ 1.2 
equiv. relative to 3) was added to the refluxing mixture. After 14 hours (overnight) the 
TLC of the reaction mixture exhibited multiple UV-active fractions, including a 
substantial quantity of 3, therefore the reaction was discarded.  
 
The reaction was repeated, with the exceptions of using a 10 molar excess of N-Boc-
1,12-diaminododecane (133 mg, 778 μmol, 10 equiv. relative to 3) and in the presence 
of activated 3 Å molecular sieves. The reaction proceeded in exactly the same manner 
as previously described, with the formation of multiple UV-active fractions, including a 
substantial quantity of 3, therefore the reaction mixture was discarded.   
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6.6 Synthesis of (2-formyl-5,10,15,20-tetraphenylporphyrinato)copper(II) (4) 
 
 
 
Phosphorus oxychloride (8.8 mL, 96 mmol) was added drop-wise to ice cooled 
anhydrous dimethylformamide (11.2 mL, 145 mmol), under an argon atmosphere while 
avoiding exposure to moisture. A cooled solution of 3 (1 g, 1.55 mmol) dissolved in 
anhydrous 1,2-dichloroethane (100 mL), was then added to the viscous Vilsmeier 
complex, and the mixture was then allowed to reach ambient temperature, and was then 
heated at reflux for 7 hours. Once the reaction mixture had cooled to room temperature 
overnight, it was poured onto a stirred, ice-cooled solution of sodium hydroxide (0.72 
M, 1 L). Chloroform was then added, the organic layer was collected, washed with 
water, dried over anhydrous sodium sulphate and the solvent was removed under 
reduced pressure. The crude product was isolated by column chromatography (silica, 
eluent: dichloromethane) and precipitation from dichloromethane by the addition of 
hexane, affording 4 (771 mg, 74 %) as a red solid. Rf = 0.67 (silica, CH2Cl2); m.p. = 
>350 °C decomp. 
 
 UV/Vis (CH2Cl2, nm) λmax = 427, 550, 591 
 MS (MALDI) m/z = 703 
63
Cu(M)
+
 ,705 
65
Cu(M)
+ 
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6.7 Attempted synthesis of tert-butyl(3-((((5,10,15,20-
tetraphenylporphyrinato)copper(II))-2-ylmethyl)-amino)propyl)carbamate 
 
 
 
A solution of 4 (50 mg, 71 μmol) in anhydrous toluene (30 mL), was charged with N-
Boc-1,3-diaminopropane hydrochloride (73 mg, 350 μmol, 5 equiv. relative to 4), and 
lanthanum(III) triflate (8 mg, 1.4 μmol, 0.2 equiv. relative to 4); and the reaction vessel 
was fitted with a Dean-Stark trap. The reaction was heated to reflux, under an inert 
atmosphere (N2), while avoiding exposure to light. The reaction was monitored over a 3 
day period by TLC (silica, eluent: dichloromethane), with a trace, polar, UV-active 
fraction located at the base line being observed, with almost all the starting material 
remaining. Once cooled to room temperature, the reaction mixture was diluted with 
dichloromethane, filtered, washed with water and the organic fraction was dried over 
anhydrous sodium sulphate. The TLC of the reaction mixture revealed that 4 had been 
recovered, and trace fractions which couldn‟t be characterised. 
 
The reaction was repeated in a similar manner, in the presence of potassium carbonate 
(48 mg, 350 μmol, 1 equiv. relative to N-Boc-1,3-diaminopropane hydrochloride). The 
reaction was monitored by TLC (silica, eluent: dichloromethane) over a 3 day period, 
with the starting material being recovered. 
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6.8 Attempted synthesis of tert-butyl(12-((((5,10,15,20-
tetraphenylporphyrinato)copper(II))-2-ylmethyl)-amino)dodecyl)carbamate 
 
 
 
N-Boc-diaminododecane (105 mg, 350 μmol, 5 equiv. relative to 4), and lanthanum(III) 
triflate (8 mg, 1.4 μmol, 0.2 equiv. relative to 4) were added to 4 (50 mg, 71 μmol) 
dissolved in anhydrous toluene (30 mL). The reaction vessel was fitted with a Dean-
Stark trap and was heated to reflux, under an inert atmosphere (N2), while avoiding 
exposure to light. The reaction was monitored over a 3 day period, by TLC (silica, 
eluent: dichloromethane), a trace, polar, UV-active fraction located at the base line was 
observed with almost all the starting material remaining. Once cooled to room 
temperature, the reaction mixture was diluted with dichloromethane, filtered, the filtrate 
was washed and dried over anhydrous sodium sulphate. The TLC of the worked-up 
reaction mixture revealed that 4 had been recovered. 
 
The reaction was repeated in a similar manner, in the presence of potassium carbonate 
(48 mg, 350 μmol, 1 equiv. relative to N-Boc-1,3-diaminododecane). The reaction was 
monitored over a 3 day period by TLC (silica, eluent: dichloromethane), with the 
starting material being recovered. 
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6.9 Synthesis of phenyl-(5,10,15,20-tetraphenylporphyrin-2-ylmethyl)amine (5) 
 
 
 
Aniline (0.1 mL, 100 mg, 1.1 mmol, 1.7 equiv. relative to 3) and 1 drop of acetic acid 
were added to a solution of 3 (40 mg, 62 μmol) dissolved in anhydrous toluene (30 mL). 
The reaction vessel was fitted with a Dean-Stark trap and was heated to reflux, under an 
inert atmosphere (N2), while avoiding exposure to light. After 24 hours, the reaction 
mixture showed no further change as indicated by TLC (silica, eluent: 
dichloromethane), with almost complete consumption of the starting material. A 
methanolic solution of sodium cyanoborohydride (5 mg, 80 μmol, 1.3 equiv. relative to 
3) was then added to the refluxing mixture. Following 2 hours at reflux, the TLC of the 
reaction mixture revealed that the reaction had gone to completion. Once cooled to 
ambient temperature, the solvent was removed under reduced pressure and the crude 
product was re-dissolved in dichloromethane, washed with water and dried over 
anhydrous sodium sulphate. The organic layer was concentrated in vacuo and was 
purified by column chromatography (silica, eluent: dichloromethane). The purified 5 
(30 mg, 67 %) was isolated as a purple powder after precipitation from dichloromethane 
by the addition of pentane. Rf = 0.31 (silica, CH2Cl2); m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = not observed (s, 2H, NH), 4.26 (br s, 1H, 
PhNH), 4.51 (s, 2H, CH2NH), 6.51-6.56 (m, 2H, NH-Ar-m-H), 6.68-6.73 (m, 1H, NH-
Ar-p-H), 7.09-7.15 (m, 2H, NH-Ar-o-H), 7.65-7.80 (m, 12H, 5,10,15,20-Ar-m-p-H), 
8.09- 8.16 and 8.18-8.23 (2m, 8H, 5,10,15,20-Ar-o-H), 8.65 (d, J = 4.77 Hz, 1H, β-H), 
8.75-8.87 (m, 6H, β-H)   
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 44.2, 113.3 (NH-Ar-m-C), 117.6, 119.4, 
120.2, 120.6, 126.6, 127.3, 127.6, 127.7, 128.5, 129.0 (NH-Ar-o-C), 133.2, 134.5 
(5,10,15,20-Ar-o-C), 134.58 (5,10,15,20-Ar-o-C), 134.64 (5,10,15,20-Ar-o-C), 141.9, 
142.0, 142.2, 142.3, 148.1 
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UV/Vis (CH2Cl2, nm) λmax = 419, 515, 549, 590, 645 
MS (MALDI) m/z = 720 (M+H)
+
 
 
6.10 Synthesis of succinimidyl-4-aminobenzoate (6) 
 
 
 
4-Aminobenzoic acid (2.0 g, 15 mmol), N-hydroxysuccinimide (1.68 g, 15 mmol, 1 
equiv. relative to 4-aminobenzoic acid), N,N’-dicyclohexylcarbodiimide (3.0 g, 15 
mmol, 1 equiv. relative to 4-aminobenzoic acid) were dissolved in dry 
dimethylformamide (18 mL). The reaction mixture was cooled using an ice bath and 
was stirred for 24 hours, while protected against moisture, until complete consumption 
of 4-aminobenzoic acid was observed by TLC (silica, eluent: 40 % 
dichloromethane/ethyl acetate). The reaction mixture was filtered, the filtrate was 
collected and the solvent was removed in vacuo. The crude mixture was dissolved in 
ethyl acetate, washed with water, dried over anhydrous sodium sulphate, and the solvent 
was removed under reduced pressure. The crude mixture was re-dissolved in 40 % 
dichloromethane/ethyl acetate and was chromatographically separated (silica, eluent: 40 
% dichloromethane/ethyl acetate). Once the relevant fraction had been collected, the 
solvent was removed under reduced pressure. The white crystalline 6 (2.04 g, 58 %) 
was precipitated from 40 % dichloromethane/ethyl acetate by the addition of hexane. Rf 
= 0.25 (silica, C2H5CO2CH3:C6H12; 1:1); m.p. = 177-180 °C. 
  
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = 2.89 (br s, 4H, 2 x CH2), 4.27 (br s, 2H, NH2), 
6.66 and 7.93 (AB, J = 8.77 Hz, 4H, Ar-H )  
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 25.8 (2 x CH2), 113.7, 114.0 (Ar-C), 133.1 
(Ar-C), 152.6, 161.7, 169.7 
HRMS (ES): calculated for C11H10N2O4Na (M+Na)
+
 257.0533, found: 257.0536 
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6.11 Synthesis of tert-butyl(3-(4-aminobenzamido)propyl)carbamate (7) 
 
 
 
N-Boc-1,3-diaminopropane hydrochloride (135 mg, 640 μmol, 2 equiv. relative to 6) 
and diisopropylethylamine (0.2 mL, 1.28 mmol, 2 equiv. relative to N-Boc-1,3-
diaminopropane hydrochloride) were added to 6 (75 mg, 320 μmol) dissolved in 
anhydrous dimethylformamide (20 mL). The reaction mixture cooled with an ice-water 
mixture and was stirred under an inert atmosphere (N2) for 24 hours (overnight), until 
complete consumption of 6 was observed, as indicated by TLC (silica, 40 % 
dichloromethane/ethyl acetate). The solvent was removed under reduced pressure, the 
crude mixture was dissolved in ethyl acetate, washed with water, dried over anhydrous 
sodium sulphate, and the solvent was removed under reduced pressure. The crude 
product was re-dissolved in a mixture of 25 % dichloromethane/ 0.5 % methanol/ 75 % 
ethyl acetate and was chromatographically separated (silica, eluent: 25 % 
dichloromethane/ethyl acetate). The product 7 (62 mg, 66 %) was isolated as a yellow 
powder after precipitation in hexane over ethyl acetate. Rf = 0.23 (silica, 
C2H5CO2CH3:C6H12; 7:3); m.p. = 155-156 °C .  
 
1
H N.M.R. [400 MHz, (CD3)2SO], δ (ppm) = 1.37 (s, 9H, 3 × CH3), 1.56 (quintet, J = 
6.5 Hz, 2H, -CH2CH2CH2-), 2.94 (q, J = 6.5 Hz, 2H, NHCH2CH2), 3.18 (q, J = 6.5 Hz, 
2H, NH-CH2-CH2), 5.59 (br s, 2H, NH2), 6.52 and 7.54 (AB, J = 8.43 Hz, 4H, Ar-H), 
6.81 (t, J = 5.6 Hz, 1H, NH), 7.96 (t, J = 5.6 Hz, 1H, NH)  
13
C N.M.R. [100 MHz, (CD3)2SO], δ (ppm) = 28.3 (3 × CH3), 29.9 (-CH2-CH2-CH2-), 
36.6 (NH-CH2-CH2), 37.7 (NH-CH2-CH2), 77.5, 112.5 (Ar-C), 121.2, 128.6 (Ar-C), 
151.5, 155.6, 166.2  
HRMS (ES): calculated for C15H24N3O3 (M+H)
+
 294.1812, found: 294.1815 
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6.12 Synthesis of tert-butyl(12-(4-aminobenzamido)dodecyl)carbamate (8) 
 
 
 
A solution of 6 (100 mg, 427 μmol) in dry dimethylformamide (50 mL) was charged 
with N-Boc-1,12-diaminododecane (256 mg, 854 μmol, 2 equiv. relative to 6) and 
diisopropylethylamine (0.3 mL, 1.71 mmol, 2 equiv. relative to N-Boc-1,12-
diaminododecane). The reaction mixture was cooled using ice-water and was stirred 
under an inert atmosphere (N2), for 24 hours (overnight), until complete consumption of 
6 was observed as shown by TLC (silica, 40 % dichloromethane/ethyl acetate). The 
solvent was removed under reduced pressure, and the crude product was re-dissolved in 
a mixture of 25 % dichloromethane/ 75 % ethyl acetate, and was chromatographically 
separated (silica, eluent: 25 % dichloromethane/ethyl acetate). Compound 8 (135 mg, 
76 %) was isolated after precipitation from ethyl acetate by the addition of hexane. Rf = 
0.53 (silica, C2H5CO2CH3:C6H12; 7:3); m.p. = 122-123 °C. 
 
1
H N.M.R. [400 MHz, ((CD3)2SO)], δ (ppm) = 1.16-1.25 (m, 18H, 9 × CH2), 1.35 (s, 
9H, 3 × CH3), 1.45 (quintet, J = 6.60 Hz, 2H, CH2CH2CH2), 2.94 (q, J = 6.60 Hz, 2H, 
CH2), 3.16 (q, J = 6.60 Hz, 2H, CH2), 5.55 (br s, 2H, NH2), 6.51 (d, J = 8.61 Hz, 2H, 
Ar-H), 6.75 (t, J = 5.41 Hz, 1H, NH), 7.53 (d, J = 8.61 Hz, 2H, Ar-H), 7.93 (t, J = 5.5 
Hz, 1H, NH)  
13
C N.M.R. [100 MHz, ((CD3)2SO)], δ (ppm) = 26.2, 26.5, 28.2, 28.7, 28.8, 28.95, 29.0, 
29.4, 29.5, the signals corresponding to the NH-CH2 were not observed, 77.3, 112.5, 
121.5, 128.6, 151.4, 155.5, 166.0 
HRMS (ES): calculated for C24H42N3O3 (M+H)
+
 420.3221, found: 420.3221 
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6.13 Attempted synthesis of tert-butyl(3-(4-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)-amino)benzamido)propyl)carbamate 
 
 
 
A solution of sodium cyanoborohydride (6 mg, 95 μmol, 1.6 equiv. relative to 3) in 
methanol (3 mL), was added to 3 (38 mg, 59 μmol), 7 (35 mg, 119 μmol, 2 equiv. 
relative to 3), 1 drop of acetic acid and activated 3 Å molecular sieves in anhydrous 
tetrahydrofuran (15 mL). The reaction was heated to reflux, under an inert atmosphere 
(N2), while protected against light. 
After 24 hours, the reaction was not progressing any further, with the TLC (silica, 
eluent: 5 % methanol/dichloromethane) of the reaction mixture revealing the presence 
of a newly formed UV-active fraction (suspected product) and 3. A solution of sodium 
cyanoborohydride (6 mg, 95 μmol, 1.6 equiv. relative to 3) in methanol (3 mL), was 
added. After 4 hours, the composition of the reaction mixture had remained unchanged 
as indicated by TLC. Once cooled to room temperature, the solvent was removed under 
reduced pressure, the crude mixture was re-dissolved in dichloromethane, washed with 
water and the organic layer was dried over anhydrous sodium sulphate. 
Chromatographic separation (silica coated prep TLC plates, eluent: 5 % 
methanol/dichloromethane) isolated the relevant fraction. The TLC of the suspected 
product exhibited decomposition, therefore the reaction was discarded. 
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6.14 Attempted synthesis of tert-butyl(12-(4-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)-amino)benzamido)dodecyl)carbamate 
 
 
 
Compound 3 (80 mg, 124 μmol) dissolved in anhydrous tetrahydrofuran (30 mL), was 
charged with 8 (104 mg, 247 μmol, 2 equiv. relative to 3), 1 drop of acetic acid and 
activated 3 Å molecular sieves. Sodium cyanoborohydride (12 mg, 190 μmol, 1.5 equiv. 
relative to 3) dissolved in dry methanol (7 mL) was added to the reaction mixture, 
which was subsequently heated to reflux, under an inert atmosphere while avoiding 
exposure to light. After 24 hours (overnight) no further consumption of 3 was observed, 
as indicated by TLC (silica, eluent: 5 % methanol/dichloromethane), thus an additional 
methanolic solution of sodium cyanoborohydride (12 mg, 190 μmol, 1.5 equiv. relative 
to 3) was added. After 13 hours (overnight) the reaction mixture had remained 
unchanged as indicated by TLC. Once cooled to room temperature, the solvent was 
removed in vacuo, the crude mixture was re-dissolved in dichloromethane and washed 
with a saturated sodium hydrogen carbonate solution and water. The organic layer was 
collected and dried over anhydrous sodium sulphate and chromatographic separation 
(silica coated prep TLC plates, eluent: 5 % methanol/dichloromethane) isolated the 
relevant fraction. The suspected product had degraded, therefore the suspected product 
was isolated again by chromatography (silica coated prep TLC plates, eluent: 5 % 
methanol/dichloromethane) and a crude 
1
H NMR was conducted. The suspected product 
had decomposed and was discarded.  
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6.15 Attempted synthesis of tert-butyl(3-(4-((((5,10,15,20-
tetraphenylporphyrinato)copper(II))-2-ylmethyl)-
amino)benzamido)propyl)carbamate 
 
 
 
Compound 7 (17 mg, 57 μmol, 2 equiv. relative to 4), and lanthanum(III) triflate (2 mg, 
3.4 μmol, 8 equiv. relative to 4) were added to a solution of 4 (20 mg, 28 μmol) 
dissolved in anhydrous tetrahydrofuran (15 mL). Activated molecular sieves were added 
and the reaction mixture was heated to reflux, under an inert atmosphere (N2), while 
avoiding exposure to light. The reaction was monitored over a 3 day period by TLC 
(silica, eluent: dichloromethane), with only the starting material being observed. 
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6.16 Attempted synthesis of tert-butyl(12-(4-((((5,10,15,20-
tetraphenylporphyrinato)copper(II))-2-ylmethyl)-
amino)benzamido)dodecyl)carbamate 
 
 
 
 
A solution of 4 (20 mg, 28 μmol) in anhydrous tetrahydrofuran (15 mL), was charged 
with 8 (24 mg, 57 μmol, 2 equiv. relative to 4), lanthanum(III) triflate (2 mg, 3.4 μmol, 
8 equiv. relative to 4) and activated 3 Å molecular sieves. The reaction was heated to 
reflux, under an inert atmosphere (N2), while avoiding exposure to light. The reaction 
was monitored over a 3 day period by TLC (silica, eluent: dichloromethane), which 
revealed that no reaction had occurred, with recovery of 4.  
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6.17 Synthesis of methyl 4-((((5,10,15,20-tetraphenylporphyrinato)copper(II))-2-
ylmethyl)amino)benzoate (9) 
 
 
 
Compound 4 (500 mg, 711 μmol) dissolved in anhydrous tetrahydrofuran (150 mL) was 
charged with methyl 4-aminobenzoate (315 mg, 2 mmol, 2.9 equiv. relative to 4), 
lanthanum(III) triflate (80 mg, 136 μmol, 0.19 equiv. relative to 4) and activated 3 Å 
molecular sieves. The reaction was heated to reflux, under an inert atmosphere (N2), 
while avoiding exposure to light. The reaction was monitored over a 44 hour period 
until the reaction mixture showed no further change as indicated by TLC (silica, eluent: 
dichloromethane). Once cooled to room temperature, the solvent was removed under 
reduced pressure and the crude mixture was re-dissolved in dichloromethane. The 
solution was passed through a silica plug column, washed with water and the organic 
layer was dried over anhydrous sodium sulphate. The volume was reduced (100 mL) in 
vacuo, and was added to a stirred, ice cooled solution of sodium borohydride (108 mg, 
2.8 mmol, 4 equiv. relative to 4) in dry methanol (100 mL), under an inert atmosphere 
(N2), while protected against light. After 15 minutes, acetic acid (1.3 mL) was added, 
and the resulting mixture was washed with water and then dried over anhydrous sodium 
sulphate. The solvent was removed under reduced pressure and the crude product was 
re-dissolved in dichloromethane and was then chromatographically separated (silica, 
eluent: dichloromethane). Compound 9 (388 mg, 65 %) was isolated as a red powder 
after precipitation from dichloromethane by the addition of pentane. Rf = 0.18 (silica, 
CH2Cl2:C6H12; 6:4); m.p. = >350 
o
C decomp. 
 
UV/Vis (CH2Cl2, nm) λmax (log ) = 415 (5.63), 539 (4.72) 
MS (MALDI) m/z = 838 (M)
+
 
HRMS (ESI): calculated for C53H37CuN5O2Na (M+Na)
+
 861.2135, found: 861.2134 
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6.18 Synthesis of methyl 4-((5,10,15,20-tetraphenylporphyrin-2-
ylmethyl)amino)benzoate (10) 
 
 
 
Method 1  
 
Methyl 4-aminobenzoate (50 mg, 331 μmol, 1.5 equiv. relative to 3) and 1 drop of 
acetic acid were added to a solution of 3 (142 mg, 221 μmol) dissolved in anhydrous 
tetrahydrofuran (60 mL). The reaction mixture was heated to reflux, under an inert 
atmosphere (N2), while avoiding exposure to light. After 6 hours, sodium 
cyanoborohydride (21 mg, 339 μmol, 1.5 equiv. relative to 3) dissolved in dry methanol 
(12 mL) was added to the reaction. After 40 hours, the composition of the reaction 
mixture exhibited no further change, as indicated by TLC (silica, eluent: 
dichloromethane). Once cooled to ambient temperature, the solvent was removed under 
reduced pressure and the crude product was re-dissolved in dichloromethane, washed 
with water and dried over anhydrous sodium sulphate. The organic layer was 
concentrated in vacuo and was purified by column chromatography (silica, eluent: 
dichloromethane). The purified 10 (45 mg, 26 %) was isolated as a purple powder after 
precipitation from dichloromethane by the addition of methanol. 
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Method 2 
 
A stirred solution of 9 (172 mg, 204 μmol) dissolved in chloroform (20 mL), was 
treated with concentrated sulphuric acid (20 mL) for 5 minutes, while protected against 
light. The solution was carefully poured onto a vigorously stirred, ice cooled saturated 
sodium hydrogen carbonate solution (500 mL). Dichloromethane was added, and the 
organic layer was washed with water and was then dried over anhydrous sodium 
sulphate. The solvent was removed under reduced pressure, the crude product was re-
dissolved in dichloromethane and was chromatographically separated (silica, eluent: 
dichloromethane). The purified 10 (98 mg, 62 %) was isolated as a purple powder after 
precipitation in methanol over dichloromethane. Rf = 0.33 (silica, CH2Cl2); m.p. = >350 
°C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.84 (s, 2H, NH), 3.78 (s, 3H, OCH3), 4.45 
(d, J = 5 Hz, 2H, CH2NH), 4.53 (t, J = 5 Hz, 1H, CH2NH), 6.38 (d, J = 8.9 Hz, 2H, NH-
Ar-m-H), 7.56-7.71 (m, 12H, 5,10,15,20-Ar-m-p-H), 7.74 (d, J = 8.9 Hz, 2H, NH-Ar-o-
H), 8.01-8.07 and 8.10-8.16 (2m, 8H, 5,10,15,20-Ar-o-H ), 8.58 (d, J = 4.69 Hz, 1H, β-
H), 8.66-8.78 (m, 6H, β-H) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 42.5 (CH2NH), 50.5 (OCH3), 110.9 (NH-Ar-
m-C), 117.5, 118.3, 118.5, 119.3, 119.6, 125.61, 125.64, 125.7, 126.2, 126.70, 126.74, 
127.5, 130.3 (NH-Ar-o-C), 132.2 (5,10,15,20-Ar-o-C), 133.5 (5,10,15,20-Ar-o-C) , 
133.6 (5,10,15,20-Ar-o-C), 140.8, 140.9, 141.1, 141.2, 150.7, 166.4  
UV/Vis (CH2Cl2, nm) λmax (log ) = 419 (5.84), 515 (4.58), 550 (4.09), 591 (4.05), 645 
(3.81) 
HRMS (ESI): calculated for C53H40N5O2 (M+H)
+
 778.3177, found: 778.3171 
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6.19 Synthesis of 4-((5,10,15,20-tetraphenylporphyrin-2-ylmethyl)amino)benzoic 
acid (11) 
 
 
 
p-Toluenesulfonic acid monohydrate (30 mg, 160 μmol, 4.equiv. relative to 10) was 
added to 10 (31 mg, 40 μmol) dissolved in sulphuric acid (4 M, 25 mL) and the 
subsequent mixture was heated to reflux. After 20 hours, complete consumption of 10 
was observed by TLC (silica, eluent: dichloromethane) and the reaction mixture was 
cooled to ambient temperature. The vigorously stirred reaction mixture was cooled 
further on ice, and sodium hydroxide (1 M) was carefully added until neutralisation had 
occurred. The crude product was extracted with dichloromethane, which was 
subsequently washed with a saturated sodium hydrogen carbonate solution, then water, 
and the organic layer was dried over anhydrous sodium sulphate. The solvent was 
removed in vacuo and column chromatography (silica, eluent: 3 % 
methanol/dichloromethane) was used to isolate the relevant fraction. Product 11 (22 mg, 
73 %) was isolated as a purple powder after precipitation from dichloromethane by the 
addition of hexane. Rf = 0.55 (silica, CH2Cl2:CH3OH; 10:1); m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, (CD3)2SO], δ (ppm) = −2.92 (br s, 2H, NH), 4.41 (d, J = 5 Hz, 
2H, CH2NH), 6.51 (d, J = 8.8 Hz, 2H, NH-Ar-m-H), 7.27 (t, J = 5 Hz, 1H, CH2NH), 
7.63 (d, J = 8.8 Hz, 2H, NH-Ar-o-H), 7.65-7.89 (m, 12H, 5,10,15,20-Ar-m-p-H), 8.03-
8.09 and 8.19-8.26 (2m, 8H, 5,10,15,20-Ar-o-H ), 8.64 (d, J = 4.7 Hz, 1H, β-H), 8.70-
8.89 (m, 6H, β-H), 12.02 (br s, 1H, CO2H) 
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 43.1, 111.3, 111.7, 126.45, 126.52, 
126.6, 127.2, 127.6, 128.4, 131.5, 133.0, 134.4, 151.9, 169.2 
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax (log ) = 418 (5.5), 515 (4.22), 549 (3.75), 589 
(3.73), 645 (3.48) 
HRMS (ESI) calculated for C52H38N5O2 (M + H)
+
 764.3020, found: 764.3013 
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6.20 Synthesis of 5,10,15,20-tetra-(4-pyridyl)porphyrin (12) 
 
 
 
4-Pyridinecarboxaldehyde (4 mL, 42 mmol) was dissolved in propionic acid (100 mL) 
and the resulting pale yellow mixture was heated to reflux. Pyrrole (2.9 mL, 42 mmol, 1 
equiv. relative to 4-pyridinecarboxaldehyde) was added drop-wise to the refluxing 
mixture and the resulting solution was left under reflux conditions for 30 minutes, while 
protected against light. Once cooled to ambient temperature, the mixture was filtered to 
yield a dark purple solid. The crude product was washed with methanol and hot water to 
afford a purple solid. 
The propionic acid solvent was removed under reduced pressure and the black tarry 
crude mixture was dissolved in dichloromethane and methanol, which was subsequently 
washed with a saturated sodium hydrogen carbonate solution and water. The organic 
layer was dried over magnesium sulphate and the solvent was removed by evaporation 
in vacuo. The crude product was re-dissolved in 5 % methanol/dichloromethane and 
was purified by gravitational column chromatography (silica, eluent: 5 % 
methanol/dichloromethane), the relevant fraction was collected and was combined with 
the previously isolated purple solid. The purple crystalline 12 (0.75 g 11 %) was 
isolated after precipitation from chloroform by the addition of methanol. Rf = 0.55 
(silica, CH2Cl2:CH3OH; 10:1); m.p. = >350 °C decomp.  
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = −2.92 (s, 2H, NH), 8.16 (dd, J = 1.68 
Hz, J = 4.21 Hz, 8H, 5,10,15,20-Ar-o-H), 8.87 (br s, 8H, β-H), 9.07 (dd, J = 1.68 Hz, J 
= 4.21 Hz, 8H, 5,10,15,20-Ar-m-H)  
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 117.1, 129.3, 147.2, 150.3 
UV/Vis (CH2Cl2, nm) λmax = 416, 513, 546, 587, 643  
MS (MALDI) m/z = 619 (M+H)
+
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6.21 Synthesis of (5,10,15,20-tetra(4-pyridyl)porphyrinato) copper(II) (13) 
 
 
 
A slurry of copper(II) acetate monohydrate (770 mg, 39 mmol) in methanol-water (10 
mL; 6:1) was added to compound 12 (600 mg, 971 μmol) dissolved in chloroform (100 
mL), and the resulting mixture was heated to reflux. After 5 hours, the hot solution was 
poured onto a warm neutral alumina oxide pad and eluted using hot chloroform. The red 
band was collected and dried over magnesium sulphate, and the solvent was removed 
under reduced pressure yielding 13 as a red powder (612 mg, 93 %); Rf = 0.60 (silica, 
CH2Cl2:CH3OH; 10:1); m.p. = >350 °C decomp.  
 
UV/Vis (CH2Cl2, nm) λmax = 415, 495, 538  
MS (MALDI) m/z = 679 
63
Cu(M)
+ 
, 681 
65
Cu(M)
+
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6.22 Attempted synthesis of 2-formyl-5,10,15,20-tetra(4-pyridyl)porphyrin 
 
 
 
Phosphorus oxychloride (0.95 mL, 10 mmol) was added drop-wise to ice cooled, dry 
dimethylformamide (15 mL, 15 mmol), under an argon atmosphere while avoiding 
exposure to moisture. An ice cooled solution of 13 (100 mg, 147 μmol) dissolved in 
anhydrous 1,2-dichloroethane (10 mL), was then added to the viscous Vilsmeier 
complex, and the mixture was then allowed to reach room temperature, and was then 
heated at reflux for 7 hours. Once cooled to room temperature over night, the reaction 
mixture was poured onto an ice-cooled, stirred solution of sodium hydroxide (0.29 M, 
300 mL). Chloroform was then added, the organic layer was collected, washed with 
saturated sodium hydrogen carbonate solution and then water. The organic layer was 
then dried over anhydrous sodium sulphate and the solvent was removed under reduced 
pressure. TLC analysis (silica, eluent: 5 % methanol/dichloromethane) of the reaction 
mixture showed only the presence of 12. 
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6.23 Synthesis of 5,10,15,20-tetra(3,5-dimethoxyphenyl)porphyrin (14) 
 
 
 
3,5-Dimethoxybenzaldehyde (18.46 g, 111 mmol) was dissolved in propionic acid (300 
mL) and the resulting colourless mixture was heated to reflux. Pyrrole (7.69 mL, 111 
mmol, 1 equiv. relative to 3,5-dimethoxybenzaldehyde ) was added drop-wise to the 
refluxing mixture and the resulting dark solution was left under reflux conditions for 30 
minutes, while protected against light. Once the dark mixture was cooled to room 
temperature, the mixture was filtered to yield a purple solid product. The crude product 
was washed with methanol and hot water; and was then dried under vacuum to afford 
the purple crystalline 14 (3.54 g, 15 %). Rf = 0.81 (silica, CH2Cl2:CH3OH; 150:1); m.p. 
= >350 °C decomp.  
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.84 (s, 2H, NH), 3.96 (s, 24H, 8 × OCH3), 
6.90 (t, J = 2.15 Hz, 4H, 5,10,15,20-Ar-p-H ), 7.40 (d, J = 2.15 Hz, 8H, 5,10,15,20-Ar-
o-H ), 8.94 (br s, 8H, β-H)  
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 55.7, 100.2, 113.9, 119.8, 144.0, 158.9 
UV/Vis (CH2Cl2, nm) λmax = 421, 516, 549, 589, 645 
MS (MALDI) m/z = 855 (M+H)
+
  
 
 
 
 
 
 
 228 
      
6.24 Synthesis of (5,10,15,20-tetra(3,5-dimethoxyphenyl)porphyrinato) copper(II) 
(15) 
 
 
 
Compound 14 (350 mg, 409 μmol) dissolved in chloroform (40 mL) and a slurry of 
copper(II) acetate monohydrate (326 mg, 1.64 mmol, 4. equiv. relative to 14) in 
methanol-water (7 mL, 6:1) was heated to reflux for 5 hours. The hot solution was 
poured onto a warm silica pad and eluted using hot chloroform. The red band was 
collected, dried over magnesium sulphate and the solvent was removed in vacuo. The 
red-purple crystalline product 15 (356 mg, 95 %) was precipitated in methanol over 
chloroform. Rf = 0.86 (silica, CH2Cl2:CH3OH; 150:1); m.p. = >350 °C decomp. 
 
UV/Vis (CH2Cl2, nm) λmax = 417, 485, 539 
MS (MALDI) m/z = 915.348 
63
Cu(M)
+ 
, 917.352 
65
Cu(M)
+ 
and 
63
Cu(M+2H)
+
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6.25 Attempted synthesis of 2-formyl-5,10,15,20-tetra(3,5-
dimethoxyphenyl)porphyrin 
 
 
 
A Vilsmeier complex, formed by the drop-wise addition of phosphorus oxychloride 
(0.95 mL, 10 mmol) to ice cooled, anhydrous dimethylformamide (1.15 mL, 15 mmol), 
under an argon atmosphere while avoiding exposure to moisture, was added to a cooled 
solution of 15 (140 mg, 153 μmol) in dry 1,2-dichloroethane (15 mL). The reaction 
mixture was then allowed to reach room temperature, and then heated at reflux for 7 
hours, while protected against moisture and light. Once the reaction mixture had cooled 
to ambient temperature over night, it was poured onto a stirred, ice-cooled solution of 
sodium hydroxide (0.29 M, 300 mL). Chloroform was then added, the organic layer was 
collected, washed with saturated sodium hydrogen carbonate solution and then water. 
The organic layer was then dried over anhydrous sodium sulphate. The TLC (silica, 
eluent: dichloromethane) of the reaction mixture exhibited no UV-active fraction.  
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6.26 Synthesis of 5-(4-acetamidophenyl)-10,15,20-tri(4-pyridyl)porphyrin (16) 
 
 
 
4-Acetamidobenzaldehyde (4.08 g, 25 mmol) and 4-pyridinecarboxaldehyde (7.2 mL, 
75 mmol, 3 equiv. relative to 4-acetamidobenzaldehyde) were dissolved in propionic 
acid (400 mL), and the resulting pale yellow mixture was heated to reflux. Pyrrole (6.9 
mL, 100 mmol, 4 equiv. relative to 4-acetamidobenzaldehyde) was added drop-wise to 
the refluxing mixture and the resulting solution was left under reflux conditions for 60 
minutes, while avoiding exposure to light. Once the dark mixture was cooled to room 
temperature, the propionic acid was removed under reduced pressure to yield a crude 
dark purple, tarry solid. Gravitation column chromatography (silica, eluent: 5 % 
methanol/dichloromethane) was used to isolated the relevant fraction, and 16 was 
furnished a purple solid (849 mg, 5 %) after precipitation from dichloromethane by the 
addition of methanol. Rf = 0.24 (silica, CH2Cl2: CH3OH; 10:1); m.p. = >350 °C 
decomp. 
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = −2.90 (br s, 2H, NH), 2.35 (s, 3H, 
NHCOCH3), 8.00 and 8.15 (AB, 4H,
 
J = 8.55 Hz, 5-Ar-m-o-H), 8.19-8.23 (m, 6H, 
10,15,20-Ar-o-H), 8.71-9.08 (m, 14H, 8H of β-H and 6H of 10,15,20-Ar-m-H), 9.49 (br 
s, NHCOCH3) 
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 24.2, 116.8, 117.3, 117.7, 118.3, 
118.4, 121.7, 129.8, 135.2, 137.0, 138.7, 147.9, 148.0, 150.7, 150.8, 170.3 
UV/Vis (CH2Cl2, nm) λmax = 418, 514, 549, 589, 646 
MS (MALDI) m/z = 675(M+H)
+
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6.27 Synthesis of 5-(4-aminophenyl)-10, 15, 20-tri-(4-pyridyl)porphyrin (17) 
 
 
 
Hydrochloric acid (5 M, 100 mL) was added to 16 (136 mg, 833 μmol) in ethanol (14 
mL) and the mixture was heated to reflux for 3 hours. Once the solution had cooled to 
room temperature, the hydrochloric acid was removed in vacuo. The crude was 
dissolved in a mixture of chloroform (20 mL) and triethylamine (2 mL), and the 
resulting solution was stirred at room temperature for 10 minutes. The solution was 
washed with a dilute citric acid solution and water. The organic layer was collected, 
dried over magnesium sulphate and the solvent was reduced in vacuo. Gravity 
percolation chromatography (silica, eluent: 5 % methanol/dichloromethane) was used to 
purify the crude product, with 17 (116 mg, 91 %) isolated as a purple/red solid after 
precipitation from chloroform by the addition of methanol. Rf = 0.35 (silica, 
CHCl3:CH3OH; 19:1); m.p. = >350 °C decomp.  
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = −2.84 (s, 2H, NH), not observed 
(NH2), 7.13 (d, J = 8.4 Hz, 2H, 5-Ar-m-H), 7.99 (d, J = 8.4 Hz, 2H, 5-Ar-o-H), 8.17-
8.22 (m, 6H, 10,15,20-Ar-o-H) 8.74-9.07(m, 14H, 8H of β-H and 6H of 10,15,20-Ar-m-
H) 
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 113.7, 116.5, 117.1, 122.8, 129.6, 
131.6, 135.9, 146.5, 147.99, 148.04, 148.1, 150.5, 150.6 
UV/Vis (CH2Cl2, nm) λmax = 420, 516, 554, 591, 648 
MS (MALDI) m/z = 633 (M+H)
+
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6.28 Attempted synthesis of 5-(4-((N-maleimidomethyl)cyclohexane-1-
amido)phenyl)-10,15,20-tri(4-pyridyl)porphyrin 
 
 
 
SMCC (10 mg, 30 μmol, ≈ 2 equiv. relative to 17) was added to 17 (10 mg, 16 μmol) 
dissolved in dry dichloromethane (10 mL), and the resulting solution was stirred at 30 
°C, while protected against light and moisture. After 2 hours, TLC analysis (silica, 
eluent: 10 % methanol/dichloromethane) indicated only the presence of 17, therefore a 
drop of diisopropylethylamine was added. After 16 hours (overnight) the TLC of the 
reaction mixture remained unchanged. 
 
The reaction was repeated in a similar manner, employing chloroform (5 mL), with 
diisopropylethylamine being added at the start of the reaction. The reaction was 
monitored over a 6 day period, with no reaction occurring, as shown by TLC.  
 
The reaction was also repeated using pyridine (4 mL) as solvent, without the addition 
diisopropylethylamine. The reaction was monitored over a 4 days, with no reaction 
being observed, as indicated by TLC. 
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6.29 Synthesis of 5-(4-carboxyphenyl)-10,15,20-tri-(4-pyridy)porphyrin (18) 
 
 
 
Pyrrole (4 mL, 58 mmol) was added drop-wise to a refluxing mixture of 4-
carboxybenzaldehyde (2.54 g, 17 mmol, 0.29 equiv. relative to pyrrole) and 4-
pyridinecarboxaldehyde (4 mL, 42 mmol, 0.72 equiv. relative to pyrrole) dissolved in 
propionic acid (250 mL), while avoiding exposure to light. After 30 minutes at reflux, 
the reaction mixture was cooled to room temperature and the propionic acid was 
removed in vacuo. Gravity column chromatography (silica, eluent: 7 % 
methanol/dichloromethane) was used to obtain the relevant fraction and precipitation 
from dichloromethane, by the addition of methanol afforded the purple crystalline 18 
(516 mg, 6 %). Rf = 0.42 (silica,CH2Cl2: CH3OH; 9:1); m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = −2.89 (s, 2H, NH), 8.23-8.27 (m, 6H, 
10,15,20-Ar-o-H), 8.31 and 8.49 (AB, J = 8 Hz, 2H, 5-Ar-m-o-H), 8.74-9.09 (m, 14H, 
6H of 10,15,20-Ar-m-H and 8H of β-H), not observed (CO2H) 
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 116.7, 117.0, 120.3, 128.1, 129.5, 
130.2, 134.2, 145.7, 147.3, 150.6, 168.6 
UV/Vis (CHCl3, nm) λmax = 418, 514, 548, 588, 657 
MS (MALDI) m/z = 662 (M+H)
+ 
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6.30 Synthesis of 5-(4-(succinimidyl-N-oxycarbonyl)phenyl)-10,15,20-tri-(4-
pyridyl)porphyrin (19)  
 
 
 
Thionyl chloride (0.1 mL, 1.37 mmol, 18 equiv. relative to 18) was slowly added to a 
stirred solution of 18 (51 mg, 77 μmol) in anhydrous pyridine (5 mL) and the reaction 
was then stirred at 50 °C, while protected from light and atmospheric moisture. After 30 
minutes, N-hydroxysuccinimide (200 mg, 1.74 mmol, 22.6 equiv. relative to 19) was 
added, and the mixture was stirred for a further 3 hours. Once cooled to room 
temperature, the solvent was removed in vacuo, and the crude mixture was re-dissolved 
in dichloromethane and washed with a saturated solution of sodium hydrogen carbonate 
and then water. The organic layer was dried over anhydrous sodium sulphate and the 
solvent was removed under reduced pressure. The pure 19 (52 mg, 90 %) was isolated 
as a brown/red solid after precipitation in hexane over chloroform. Rf = 0.82 (Silica, 
CH2Cl2: CH3OH; 9:1). m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3],  (ppm) = −2.90 (br s, 2H, NH), 3.03 (br s, 4H, 2 x 
CH2), 8.17 (dd, J = 1.6 Hz, J = 4.3 Hz, 6H, 10,15,20-Ar-o-H), 8.37 (d, J = 6.5 Hz, 2H, 
5-Ar-m-H), 8.57 (d, J = 6.5 Hz, 2H, 5-Ar-o-H), 8.85 (d, J = 4.8 Hz, 2H, β-H), 8.86-8.90 
(m, 6H, β-H), 9.06 (dd, J = 1.6 Hz, J = 4.3 Hz, 6H, 10,15,20-Ar-m-H) 
13
C N.M.R. [100 MHz, CDCl3],  (ppm) = 25.8 (2xCH2), 117.7, 117.8, 119.2, 124.9, 
129.1, 129.3, 131.5, 134.8, 148.5, 149.8, 162.0, 169.3 (2 x CO) 
UV/Vis (CH2Cl2), max (log ) = 418 (5.66), 513 (4.43), 547 (3.93), 588 (3.91), 644 
(3.50) 
 HRMS (ESI): calculated for C46H31N8O4 (M + H)
+
 759.2463, found: 759.2446 
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6.31 Synthesis of 5-(4-((6-tert-butylcarbamate)hexyl-1-amino-N-
carbonyl)phenyl)10,15,20-tri-(4-pyridyl)porphyrin (20) 
 
 
 
To a stirred solution of 19 (51 mg, 67 μmol) in anhydrous dimethylsulfoxide (6 mL) it 
was added N-Boc-1,6-diaminohexane hydrochloride (43 mg, 170 μmol, 2.5 equiv. 
relative to 19) and potassium carbonate (58 mg, 420 μmol, 2.5 equiv. relative to N-Boc-
1,6-diaminohexane hydrochloride ). The reaction mixture was stirred at 40 °C, while 
protected against atmospheric moisture and light. After 40 minutes, full consumption of 
the starting porphyrin was achieved as indicated by TLC (silica, eluent: 10 % 
methanol/dichloromethane) and the reaction mixture was diluted with dichloromethane 
and washed with water. The organic layer was dried over anhydrous sodium sulphate 
and the solvent was removed under reduced pressure. The pure 20 was obtained (47 mg, 
82 %) after purification by flash chromatography (silica, eluent: 6 % 
methanol/dichloromethane) and precipitation from dichloromethane by the addition of 
hexane. Rf = 0.67 (Silica, CH2Cl2: CH3OH; 9:1); m.p. = >350 °C decomp.   
 
1
H N.M.R. [400 MHz, CDCl3],  (ppm) = −2.94 (br s, 2H, NH), 1.37-1.47 (m, 11H, -
CO2C(CH3)3 and 6‟-CH2), 1.48-1.58 (m, 4H, 5‟-CH2 and 7‟ -CH2), 1.75 (quintet, J = 6.9 
Hz, 2H, 4‟-CH2), 3.06-3.18 (m, 2H, 8‟-CH2), 3.58 (t, J = 6.9 Hz, 2H, -NHCH2 (3‟-CH2), 
5.09 (br s, 1H, 9‟-NH), 7.68 (br s, 1H, 2‟-NH), 8.11-8.29 (m, 10H, 5-Ar-o-m-H and 
10,15,20-Ar-o-H), 8.63-9.08 (m, 14H, 10,15,20-Ar-m-H and β-H) 
13
C N.M.R. [100 MHz, CDCl3],  (ppm) = 25.9, 26.1, 28.2 (3 x CH3), 29.1, 29.5, 29.7, 
39.7, 39.8, 116.6, 117.0, 120.1, 120.7, 125.5, 129.7 (10,15,20-Ar-o-C), 134.2, 134.4, 
142.2, 146.9 (10,15,20-Ar-m-C), 151.2, 151.3, 156.5 (-NHCO2
tBu), 167.9 (1‟-C)  
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UV/Vis (CH2Cl2, nm), max (log ) = 417 (5.66), 513 (4.38), 547 (3.89), 589 (3.87), 644 
(3.51) 
HRMS (ESI): calculated for C53H50N9O3 (M + H)
+
 860.4031, found: 860.4029 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 237 
      
6.32 Synthesis of 5-(4-(6-(4-(N-maleimidomethyl)cyclohexane-1-amido)hexyl-1-
amino-N-carbonyl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrin (21) 
 
 
 
Trifluoroacetic acid (6 mL) was added to a stirred solution of porphyrin 20 (35 mg, 41 
μmol) in dry dichloromethane (6 mL). The mixture was then kept under stirring at room 
temperature, while protected against light and moisture, for 50 minutes, until complete 
consumption of 20 had occurred as indicated by TLC (silica, eluent: 10 % 
methanol/chloroform). The mixture was then poured into an ice cooled aqueous solution 
of sodium hydrogen carbonate containing ice and the organic layer was collected, then 
washed with water and dried over anhydrous sodium sulphate. The solvent was then 
removed under reduced pressure and the resulting mixture was promptly dissolved in 
anhydrous dimethylformamide (4 mL). To the resulting solution was added SMCC 
(16.5 mg, 48 μmol, 1.2 equiv. relative to 20) and diisopropylethylamine (35 µL, 204 
μmol, 4.1 equiv. relative to SMCC) and the reaction mixture was stirred for 1 hour, at 
ambient temperature, while protected against light and moisture. After this period, the 
porphyrinic material was precipitated with diethyl ether and hexane. The precipitate was 
dissolved in dichloromethane and purified by flash chromatography (silica, eluent: 5 % 
methanol/chloroform). Precipitation from dichloromethane by the addition of hexane 
furnished porphyrin 21 (34 mg, 85 %). Rf = 0.52 (Silica, CH2Cl2: CH3OH; 9:1); m.p. = 
>350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3],  (ppm) = −2.90 (s, 2H, NH), 0.94-1.09 (m, 2H, 1H of 
13‟-CH2 and 1H of 15‟-CH2); 1.40-1.51, 1.52-1.63 and 1.64-1.88 (3m, 11H, 5 x CH2 + 
1CH); 1.89-1.99 (m, 2H, CH2), 2.00-2.11 (m, 1H, 11‟-H), 3.28-3.42 (m, 4H, 8‟-CH2, 
CH2-mal), 3.63 (q, J = 6.1 Hz, 2H, 3‟-CH2), 5.62 (t, J = 5.9 Hz, 1H, 9‟-NH), 6.62 (s, 
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2H, COCH=CHCO), 6.89 (t, J = 6.1 Hz, 1H, 2‟-NH), 8.10-8.21 (m, 6H, 10,15,20-Ar-o-
H), 8.23 and 8.29 (AB, J = 8.1 Hz, 4H, 5-Ar-o-m-H), 8.84 (d, J = 4.6 Hz, 2H, β-H), 
8.85-8.87 (m, 4H, β-H), 8.88 (d, J = 4.6 Hz, 2H, β-H), 8.98-9.16 (m, 6H, 10,15,20-Ar-
m-H)  
13
C N.M.R. [100 MHz, CDCl3],  (ppm) = 25.6 (CH2), 25.8 (CH2), 29.0 (13‟and 15‟ 
CH2), 29.5, 29.6, 29.7, 29.9, 36.4, 38.5 (CH2), 39.5 (CH2-mal), 43.6, 45.4, 117.4, 117.6, 
120.3, 125.5 (5-Ar-m-C), 129.4 (10,15,20-Ar-o-C), 131.3 (β-C), 133.9 
(COCH=CHCO), 134.5, 134.6 (5-Ar-o-C), 144.6, 148.4(10,15,20-Ar-m-C), 149.9, 
167.5 (1‟-CO), 171.0 (COCH=CHCO), 175.8(10‟-CO) 
UV/Vis (CH2Cl2, nm), max (log ) = 417 (5.51), 513 (4.23), 547 (3.83), 588 (3.81), 644 
(3.43)  
HRMS (ESI) calculated for C60H55N10O4 (M + H)
+
 979.4402, found: 979.4398 
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6.33 Synthesis of 5-(4-(6-(4-(N-maleimidomethyl)cyclohexane-1-amido)hexyl-1-
amino-N-carbonyl)phenyl)-10,15,20-tri-(4-N-methyl-pyridyniumyl)porphyrin 
triiodide (22) 
 
 
 
A solution of porphyrin 21 (21 mg, 20 μmol) in anhydrous dimethylformamide (2.6 
mL) was charged with a large excess of methyl iodide (0.2 mL, 3.21 mmol, 160 equiv. 
relatively to 21) and the resulting mixture was stirred at 40 °C for 4 hours, while 
protected against light. Once cooled to room temperature, the porphyrinic material was 
precipitated with ice cooled diethyl ether and hexane (50:1) and washed thoroughly with 
cold diethyl ether. The methylated porphyrin was obtained as a lustrous purple solid (24 
mg, 80 %). m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, (CD3)2SO],  (ppm) = −3.03 (s, 2H, NH), 0.83-0.97 (m, 2H, 1H 
of 13‟-CH2 and 1H of 15‟-CH2), 1.20-1.36 (m, 2H, 1H of 12‟-CH2 and 16‟-CH2), 1.37-
1.54 (m, 7H, 3 x CH2 and 14‟-H), 1.59-1.78 (m, 6H, 4‟-CH2 and 1H of 12‟-CH2, 1H of 
16‟-CH2, 1H of 13‟-CH2 and 1H of 15‟-CH2 ), 1.98-2.10 (m, 1H, 11‟-H), 3.02-3.10 (m, 
2H, 8‟-CH2), 3.23 (d, J = 6.9 Hz, 2H, CH2-mal), 3.41-3.47 (m, 2H, 3‟-CH2), 4.72 and 
4.73 (2s, 6H+3H, 3 × CH3), 6.97 (s, 2H,-COCH=CHCO-), 7.72 (t, J = 5.5 Hz, 1H, 9‟-
NH), 8.32 and 8.35 (AB, J = 8.4 Hz, 4H, 5-Ar-o-m-H), 8.87 (t, J = 5.6 Hz, 1H, 2‟-NH), 
8.95-9.06 (m, 8H, 2H of β-H and 6H of 10,15,20-Ar-o-H), 9.06-9-08 (m, 2H, β-H), 
9.19-9.24 (m, 4H, β-H), 9.48 (d, J = 6.9 Hz, 6H, 10,15,20-Ar-m-H)  
13
C N.M.R. [100 MHz, ((CD3)2SO)],  (ppm) = 26.1 (12‟-CH2 and 16‟-CH2), 26.2 (14‟-
CH2), 28.6 (CH2), 29.2, 29.4 (13‟-CH2 and 15‟-CH2), 36.1 (14‟-CH), 43.1 (8‟-CH2), 
43.8 (CH2-mal), 47.9 (CH3), 48.5, 114.7, 115.3 (10,15,20-C), 126.0 (5-Ar-m-C), 132.1 
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(10,15,20-Ar-o-C), 134.1 (5-Ar-o-C), 134.3 (-COCH=CHCO-), 134.6, 142.9, 144.2 
(10,15,20-Ar-m-C), 156.5, 165.8 (1‟-CO), 171.2 (-COCH=CHCO-), 174.8 (10‟-CO)  
UV/Vis (H2O, nm), max (log ): 424 (5.32), 519 (4.18), 555 (3.81), 588 (3.78), 643 
(3.31)  
HRMS (ESI) calculated for [C63H63N10O4 (M)
3+
 −3.I] 341.1672, found: 341.1675 
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6.34 5-(4-(23-(tert-butylcarbamate)-3,6,9,12,15,16,21-heptaoxadocosyl-1-amino-N-
cabonyl)phenyl)-10,15,20-tri(4-pyridyl)porphyrin (23)  
 
 
 
Compound 19 (68 mg, 89 μmol), O-(2-aminoethyl)-O‟-[2-(Boc-amino)ethyl]-
hexaethylene glycol (110 mg, 230 μmol, 2.6 equiv. relative to 19) and anhydrous 
potassium carbonate (50 mg, 360 μmol, 1.6 equiv. relative to the O-(2-aminoethyl)-O‟-
[2-(Boc-amino)ethyl]-hexaethylene glycol) were dissolved in dry dimethylsulfoxide (7 
mL). The reaction mixture was protected from light and atmospheric moisture, and kept 
under stirring at 40 
o
C, for 5 days, until complete consumption of 19 was observed as 
shown by TLC (silica, eluent: 10 % methanol/dichloromethane). The reaction was 
allowed to cool to ambient temperature, diluted with dichloromethane and the organic 
layer was washed with copious amounts of water, and dried over anhydrous sodium 
sulphate. The solvent was then removed under reduced pressure and the mixture was 
purified by flash column chromatography (silica, eluent: 8 % 
methanol/dichloromethane). Porphyrin 23 was obtained as a purple solid (54 mg, 53 %), 
after precipitation from hexane over dichloromethane and ethyl acetate. Rf = 0.43 
(Silica, CH2Cl2: CH3OH; 9:1); m.p. = >350 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3],  (ppm) = −2.89 (br s, 2H, NH), 1.40 (s, 9H, -
CO2C(CH3)3), 3.24 (q, J = 5.0 Hz, 2H, -OCH2CH2NHCO2
t
Bu), 3.44 (t, J = 5.0 Hz, 2H, -
OCH2CH2NHCO2
t
Bu); 3.47-5.51, 3.52-3.58, 3.59-3.66, 3.67-3.73 and 3.74-3.80 (5m, 
24H, -(OCH2CH2)6-), 3.81-3.90 (m, 4H, -CONHCH2CH2O-), 5.10 (br s, 1H, -
OCH2CH2NHCO2
t
Bu), 7.55 (br s, 1H, -CONHCH2CH2O-), 8.17 (d, J = 5.9 Hz, 6H, 
10,15,20-Ar-o-H), 8.27-8.29 (m, 4H, 5-Ar-o-m-H), 8.84 (d, J = 4.7 Hz, 2H, β-H), 8.86-
8.88 (m, 4H, β-H), 8.89 (d, J = 4.7 Hz, 2H, β-H), 9.06 (d, J = 5.9 Hz, 6H, 10,15,20-Ar-
m-H)  
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13
C N.M.R. [100 MHz, CDCl3],  (ppm) = 28.4 (3 x CH3), 40.1 (-CONHCH2CH2O-), 
40.3 (-OCH2CH2NHCO2
t
Bu); 70.11, 70.13, 70.2, 70.3, 70.4, 70.47, 70.50, 70.53, 70.59 
and 70.61 (-CONHCH2CH2(OCH2CH2)6OCH2CH2NHCO2
t
Bu); 117.4, 117.6, 120.4, 
125.8 (5-Ar-m-C), 129.4 (10,15,20-Ar-o-C), 131.3 (β-C), 134.4, 134.5 (5-Ar-o-C), 
144.6, 148.4 (10,15,20-Ar-m-C), 149.9, 156.0 (-NHCO2
t
Bu), 167.4 (-CONHCH2CH2O-
)  
UV/Vis (CH2Cl2, nm), max (log ): 417 (5.90), 513 (4.52), 548 (3.98), 588 (3.95), 644 
(3.56)  
HRMS (ESI) calculated for C63H70N9O10 (M + H)
+
 1112.5240, found: 1112.5228   
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6.35 5-(4-(23-(4-(N-maleimidomethyl)cyclohexane-1-amido)-3,6,9,12,15,18,21-
heptaoxadocosyl-1-amino-N-cabonyl)phenyl)-10,15,20-tri(4-pyridyl)porphyrin (24)  
 
 
 
Trifluoroacetic acid (9 mL) was added to a solution of 23 (99 mg, 89 μmol) dissolved in 
dry dichloromethane (9 mL). The mixture was stirred at room temperature for 50 
minutes, while avoiding exposure to light and moisture. Once the reaction was complete 
as indicated by TLC (silica, eluent: 8 % methanol/dichloromethane), the reaction 
mixture was poured onto a saturated sodium hydrogen carbonate solution containing 
ice. The organic layer was washed with water and dried over anhydrous sodium 
sulphate. The solvent was removed under reduced pressure to afford the porphyrin 
intermediate. 
SMCC (36 mg, 108 μmol, 1.2 equiv. relative to 23) and diisopropylethylamine (0.1 mL, 
574 μmol, 5.3 equiv. relative to SMCC) were added to a stirred solution of the 
porphyrin intermediate dissolved in anhydrous dimethylformamide (10 mL). The 
solution was stirred at ambient temperature for 14 hours (overnight), while protected 
from moisture and light. After this period, the porphyrinic material was precipitated 
with diethyl ether (50 mL) and hexane (5 mL). Compound 24 (60 mg, 55 %) was 
isolated by flash chromatography (silica, eluent: 8 % methanol/dichloromethane) and 
precipitation in diethyl ether and hexane over dichloromethane. Rf = 0.35 (Silica, 
CH2Cl2:CH3OH; 9:1); m.p. = >350 °C decomp. 
 
 
1
H N.M.R. [400 MHz, CDCl3],  (ppm) = the singlet corresponding to the 2H of the 
inner NH groups was not observed, 0.83-0.94 (m, 2H, 1H of 3‟-CH2 and 1H of 5‟-CH2), 
1.25-1.38 (m, 2H, 1H of 2‟-CH2 and 1H of 6‟-CH2), 1.49-1.66 (m, 3H, 4‟-CH, 1H of 3‟-
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CH2 and 1H of 5‟-CH2), 1.67-1.80 (m, 2H, 1H of 2‟-CH2 and 1H of 6‟-CH2), 1.88-1.95 
(m, 1H, 1‟-CH), 3.19 (d, J = 7.0 Hz, 2H, CH2-mal), 3.24 (t, J = 5.0 Hz, 2H, PEG-CH2), 
3.38 (t, J = 5.0 Hz, 2H, PEG-CH2), 3.42-3.53 (m, 20H, 10 x PEG-CH2), 3.53-3.59 (m, 
4H, 2 x PEG-CH2), 3.60-3.66 (m, 4H, 2 x PEG-CH2), 6.56 (s, 2H, COCH=CHCO), 
8.15-8.25 (m, 10H, 4H of 5-Ar-o-m-H and 6H of 10,15,20-Ar-o-H), 8.62-8.91 (m, 8H, 
β-H), 8.97 (d, J = 5.5 Hz, 6H, 10,15,20-Ar-m-H)  
13
C N.M.R. [100 MHz, CDCl3],  (ppm) = 28.5 (2‟-CH2 and 6‟-CH2), 29.6 (3‟-CH2 and 
5‟-CH2), 38.8 (4‟-CH), 43.4 (CH2-mal), 44.7 (1‟-CH); 69.6, 69.8, 69.9, 70.0, 70.16, 
70.22, 70.25, 70.29 and 70.30(CH2-PEG); 116.7, 117.0, 120.7, 125.7 (5-Ar-m-C), 
129.7(10,15,20-Ar-o-C), 133.8 (COCH=CHCO), 134.1, 134.4 (5-Ar-o-C), 144.3, 146.9 
(10,15,20-Ar-m-C), 151.3, 167.98 (1‟‟-CO), 171.0 (COCH=CHCO), 176.5 (10‟‟-CO) 
UV/Vis (CH2Cl2, nm), max (log ):417 (5.75), 513 (4.40), 548 (3.94), 588 (3.91), 644 
(3.61) 
HRMS (ESI) calculated for C70H75N10O11 (M + H)
+
 1231.5611, found: 1231.5575 
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6.36 5-(4-(23-(4-(N-maleimidomethyl)cyclohexane-1-amido)-3,6,9,12,15,18,21-
heptaoxadocosyl-1-amino-N-cabonyl)phenyl)-10,15,20-tri(4-N-methyl-
pyridyniumyl)porphyrin triiodide (25) 
 
 
 
Methyl iodide (1.5 mL, 2.4 mmol, 100 equiv. relative to 24) was added to a stirred 
solution of 24 (30 mg, 24 μmol) dissolved in anhydrous dimethylformamide (3 mL). 
The reaction mixture was stirred at 40 
o
C for 4 hours, whilst avoiding exposure to 
moisture and light. Ice cooled diethyl ether and hexane (50:1) was added to promote 
precipitation, yielding the crude methylated porphyrin product, which was washed with 
cold diethyl ether to afford 25 (30 mg, 75 %) as a lustrous purple solid. m.p. = >350 °C 
decomp. 
 
1
H N.M.R. [400 MHz, (CD3)2SO],  (ppm) = −3.02 (s, 2H, NH), 0.76-0.92 (m, 2H, 1H 
of 3‟-H and 1H of 5‟-H), 1.22-1.28 (m, 2H, 1H of 2‟-H and 6‟-H), 1.40-1.52 (m, 1H, 4‟-
H), 1.52-1.60 (m, 2H, 1H of 3‟-H and 1H of 5‟-H), 1.61-1.70 (m, 2H, 1H of 2‟-H and 
6‟-H), 1.94-2.06 (m, 1H, 1‟-H), 3.07-3.13 (m, 2H, -NHCH2CH2O-), 3.15 (d, J = 7.3 Hz, 
2H, CH2-mal), 3.29-3.33 (m, 2H, -NHCH2CH2O-), 3.44-3.75 (m, 28H, PEG- CH2), 4.73 
and 4.74 (2s, 6H + 3H, 3 × CH3), 6.80 (s, 2H,-COCH=CHCO-), 7.72 (t, J = 5.6 Hz, 1H, 
9 NH), 8.35 and 8.38 (AB, J = 8.4 Hz, 4H, 5-Ar-o-m-H), 8.98 (t, J = 5.6 Hz, 1H, NH), 
9.00-9.06 (m, 8H, 2H of β-H and 10,15,20-Ar-o-H), 9.07-9.12 (m, 2H, β-H), 9.14-9.25 
(m, 4H, β-H), 9.50 (d, J = 6.6 Hz, 6H, 10,15,20-Ar-m-H)  
13
C NMR [100 MHz, (CD3)2SO],  (ppm) = 28.5, 29.4, 34.4 (4‟-CH), 38.3 (CH2-mal), 
 43.0 (-NHCH2CH2O-), 47.8 (3 x CH3); 69.0, 69.5, 69.6, 69.70, 69.72, 69.74, 69.75, 
69.80, and 69.82 (CH2-PEG); 114.7, 115.4, 121.9, 126.1 (5-Ar-m-C), 132.1 (10,15,20-
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Ar-o-C), 134.2, 134.3 (-COCH=CHCO-), 143.0 (5-Ar-o-C), 144.2 (10,15,20-Ar-m-C), 
156.5, 166.0 (CO), 171.2 (-COCH=CHCO-), 175.0 (CO). 
UV/Vis (H2O), max (log ): 425 (5.28), 519 (4.16), 556 (3.77), 589 (3.74), 645 (3.29) 
MS (MALDI) m/z = 1276.5 (M+H)
+
 -3I 
 
6.37 Synthesis of 5-(4-pyridyl)dipyrromethane (26) 
 
 
 
A mixture of a large excess of pyrrole (60 mL, 865 mmol) and pyridine-4-
carboxaldehyde (1.9 mL, 20 mmol) was stirred and degassed (N2) for 20 minutes. The 
mixture was then heated to 85 °C, for 15 hours, under an inert atmosphere (N2), while 
avoiding exposure to light. The excess pyrrole was removed in vacuo and the resulting 
crude mixture was chromatographically separated (silica, 20 % hexane/ethyl acetate). 
Precipitation of the crude product from acetone by the addition of hexane yields 26 
(2.14 g, 48 %) as a white powder. Rf = 0.94 (Silica, CH3CO2CH3: C6H12; 8:2); m.p. = 
137-140 °C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = 5.46 (s, 1H, 5-CH), 5.87-5.93 (m, 2H, 3 and 
7-CH), 617 (q, J = 2.9 Hz, 2H, 2 and 8-CH), 6.72-6.77 (m, 2H, 1 and 9-CH), 7.13 (dd, J 
= 1.63 Hz, J = 4.4 Hz, 2H, Ar-o-H), 8.10 (br s, 2H, NH2), 8.48-8.55 (dd, J = 1.63 Hz, J 
= 4.4 Hz, 2H, Ar-m-H) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 43.5 (5-CH), 107.8 (3 and 7-CH), 108.8 (2 
and 8-CH), 118.0 (1 and 9-CH), 123.7 (Ar-o-C), 130.7, 150.1 (Ar-m-C), 151.2 
MS (GC-MS) m/z = 223 (M)
+ 
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6.38 Synthesis of 5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-15-(4-
bromophenyl)porphyrin (27) 
 
 
 
Compound 26 (850 mg, 3.8 mmol), 4-acetamidobenzaldehyde (310 mg, 1.9 mmol), 4-
bromobenzaldehyde (352 mg, 1.9 mmol) and ammonium chloride (850 mg, 16 mmol) 
were dissolved in dimethylsulfoxide (50 mL) and the resulting mixture was heated to 
100 °C for 24 hours, while avoiding exposure to light. Once cooled, the mixture was 
stirred at ambient temperature for a further 3 hours. A 5 % methanol/dichloromethane 
solution was added, and the organic layer was washed with copious amounts of water. 
The organic layer was dried over anhydrous sodium sulphate and the solvent was 
removed under reduced pressure. The crude product was obtained by chromatographic 
separation (silica, eluent: 3 % methanol/dichloromethane). The crude product was re-
dissolved in dichloromethane and addition of methanol initiated precipitation, affording 
27 (35 mg, 1 %) as a purple solid. Rf = 0.66 (Silica, CH2Cl2: CH3OH; 9:1); m.p. = >350 
°C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.88 (br s, 2H, NH), 2.34 (s, 3H, 
NHCOCH3), 7.84 (d, J = 8.36 Hz, 2H, Ar-m-H), 7.92 (d, J = 8.36 Hz, 2H, Ar-H), 8.00 
(d, J = 8.36 Hz, 2H, Ar-H), 8.07 (d, J = 8.36 Hz, 2H, Ar-H), 8.17 (d, J = 5.78 Hz, 4H, 
10,15-Ar-o-H), 8.53-9.02 (m, 12H, 4H of 10,15-Ar-m-H and 8H of β-H), 9.67 (br s, 1H, 
NHCOCH3) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 23.6 (NHCOCH3), 116.4, 118.0, 119.1, 
120.9, 122.6, 129.6, 129.8, 134.8, 135.6, 136.7, 138.4, 140.2, 147.1, 151.1, 170.3 
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax (log ) = 418 (5.6), 514 (4.3), 549 (3.9), 590 
(3.8), 645 (3.5) 
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MS (MALDI) m/z = 753 
79
Br(M+2H)
+ 
and/or 
81
Br(M)
+
 
HRMS (ESI): calculated for C44H31N7O
79
Br (M+H)
+
 752.1786, found: 752.1763 
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6.39 Synthesis of 5-(4-bromophenyl)-10,15,20-tri-(4-pyridyl)porphyrin (28)  
 
 
 
4-Bromobenzaldehyde (6.62 g, 36 mmol) and 4-pyridinecarboxaldehyde (10.2 mL, 108 
mmol, 3 equiv. relative to 4-bromobenzaldehyde) were added to propionic acid (400 
mL) while avoiding exposure to light. Pyrrole (10 mL, 144 mmol, 4 equiv. relative to 4-
bromobenzaldehyde) was added drop-wise to the refluxing mixture. After 40 minutes at 
reflux, the reaction mixture was cooled to room temperature, and the propionic acid was 
removed in vacuo. Gravity column chromatography (silica, eluent: 2 % 
methanol/dichloromethane) was used to obtain the crude product. Precipitation of the 
crude product from dichloromethane by the addition of methanol, furnished 28 (1.03 g, 
4 %). Rf = 0.91 (silica, CH2Cl2: CH3OH; 9:1); m.p. = >350 °C decomp. 
  
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = −2.92 (br s, 2H, NH), 7.94 and 8.08 
(AB, 4H, J = 8.28 Hz, 5-Ar-o-m-H), 8.19-8.25 (m, 6H, 10, 15, 20-Ar-o-H), 8.75-9.11 
(m, 14H, 6H of 10,15,20-Ar-m-H and 8H of β-H) 
13
C N.M.R. [100 MHz, CDCl3/CD3OD], δ (ppm) = 116.8, 117.1, 120.0, 122.7, 129.5, 
129.9, 135.6, 140.1, 147.5, 150.5 
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax = 417, 513, 547, 588, 644 
MS (MALDI) m/z = 695 
79
Br(M)
+
, 696.142 
79
Br(M+H)
+
, 697.142 
79
Br(M+2H)
+ 
and/or 
81
Br(M)
+ 
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6.40 Synthesis of (5-(4-bromophenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
(29) 
 
 
 
Compound 28 (167 mg, 239 μmol) and zinc acetate dihydrate (1.26 g, 5.7 mmol, 24 
equiv. relative to 28) were dissolved in chloroform (30 mL) and methanol (10 mL) and 
the resulting mixture was stirred at 40 
o
C for 2 hours, while avoiding exposure to light. 
The solvents where removed under reduced pressure and the crude product was re-
dissolved in chloroform (30 mL) and methanol (10 mL), and was washed with a 
saturated sodium hydrogen carbonate solution and water. The organic layer was dried 
over anhydrous sodium sulphate and the solvent was removed in vacuo. The crude 
product was dissolved in the minimum volume of chloroform and methanol was added 
to initiate precipitation, furnishing the purple crystalline product (151 mg, 83 %). Rf = 
0.63 (Silica, C4H8O); m.p. = >350 °C decomp.   
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = = 7.82 and 7.99 (AB, J = 8.3 Hz, 4H, 
5-Ar-o-m-H), 8.03-8.07 (m, 6H, 10,15,20-Ar-o-H), 8.50-8.63 (m, 6H, 10,15,20-Ar-o-
H), 8.68-8.73 (m, 6H, β-H), 8.83 (d, J = 4.69 Hz, 2H, β-H)  
13
C N.M.R. [100 MHz, (CD3)2SO], δ (ppm) = 111.2, 114.2, 117.0, 119.9, 130.3, 132.4, 
132.6, 133.0, 133.2, 133.8, 136.4, 140.1, 148.6, 148.8, 149.0, 150.5, 158.4, 158.8, 
159.1, 159.5 
UV/Vis (C4H8O, nm) λmax = 423, 555, 595 
MS (MALDI) m/z = 759 (M+2H)
+
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6.41 Synthesis of 5-(4-iodophenyl)-10,15,20-tri-(4-pyridyl)porphyrin (30) 
 
 
 
Pyrrole (4.7 mL, 68 mmol, 4 equiv. relative to 4-iodobenzaldehyde) was added drop-
wise to a stirred refluxing solution of 4-iodobenzaldehyde (4.00 g, 17 mmol) and 
pyridine-4-carboxaldehyde (4.7 mL, 49 mmol, 3 equiv. relative to 4-iodobenzaldehyde) 
dissolved in propionic acid 250 mL. The mixture was stirred under reflux conditions for 
40 minutes, while avoiding exposure to light. Once the reaction had reached ambient 
temperature, the solvent was removed in vacuo. Compound 30 (539 mg, 4 %) was 
isolated as a dark purple solid after gravity column chromatography (silica, 2 % 
methanol/dichloromethane) and precipitation form chloroform by the addition of 
methanol. Rf = 0.88 (silica, CH2Cl2:CH3OH; 9:1); m.p. = >350 °C decomp.  
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.91 (br s, 2H, NH), 7.84-7.96 (m, 2H, 5-
Ar-m-H), 8.02-8.20 (m, 8H, 5,10,20,15-Ar-o-H), 8.74-8.95 (m, 8H, β-H), 8.95-9.10 (m, 
6H, 10,15,20-Ar-m-H) 
13
C N.M.R. [400 MHz, CDCl3], δ (ppm) = 94.6, 117.3, 117.6, 120.0, 129.3, 131.2, 
136.06, 136.07, 141.0, 148.4, 149.85, 149.87 
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax = 417, 513, 547, 588, 643  
MS (MALDI) m/z = 744 (M+H)
+
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6.42 Synthesis of (5-(4-iodophenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
(31)  
 
 
 
Zinc acetate dihydrate (100 mg, 456 μmol, 6.8 equiv. relative to 30) and compound 30 
(50 mg, 67 μmol) were dissolved in chloroform (15 mL) and methanol (5 mL), and the 
resulting mixture was stirred at 40 °C for 2 hours, while avoiding exposure to light. The 
solution was subsequently washed with a saturated sodium hydrogen carbonate solution 
and then water. The organic layer was dried over anhydrous sodium sulphate and the 
solvent was removed in vacuo. Precipitation from chloroform by the addition of 
methanol afforded 31 (48 mg, 88 %). Rf = 0.63 (Silica, C4H8O); m.p. = >350 °C 
decomp. 
 
1
H N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = 7.86 and 8.02 (AB, 4H, J = 8.13 Hz, 
5-Ar-m-o-H), 8.10 (d, J = 5.32 Hz, 6H, 10,20,15-Ar-m-H), 8.67-8.76 (m, 12H, 6H of 
10,20,15-Ar-o-H and 6H of β-H), 8.85 (d, J = 4.69 Hz, 2H, β-H) 
13
C N.M.R. [400 MHz, CDCl3/CD3OD], δ (ppm) = (sample was not concentrated 
enough to obtain a complete spectrum) 
UV/Vis (C4H8O, nm) λmax = 422, 555, 595 
MS (MALDI) m/z = 805 (M)
+
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6.43 Attempted synthesis of (5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborinan-2-
yl)phenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
 
 
 
General method 1 
 
An oven dried, argon flushed Schlenk flask was charged with porphyrin, 
bis(pinacolato)diborane, bis(diphenylphosphino)ferrocene]dichloropalladium(II) and 
base, under an inert atmosphere (Ar). Degassed (Ar), anhydrous solvent was added, and 
the mixture was degassed (Ar) and sonicated. The stirred reaction mixtures were heated, 
under an inert atmosphere, while protected against light. The reactions were monitored 
by TLC (silica, eluent: tetrahydrofuran).  
The series of reactions attempted are tabulated in Table 5.  
For the reaction employing 31 and potassium phosphate: the porphyrinic product was 
extracted into 10 % methanol/dichloromethane and the solution was then washed with 
water, dried over anhydrous sodium sulphate, and the solvent was removed in vacuo. 
The mixture was chromatographically separated (silica coated prep TLC plates, eluent: 
10 % methanol/dichloromethane) and the relevant fraction was isolated.
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Porphyrin bis(pinacolato)diborane Palladium Catalyst Base Solvent Temperature Reaction 
time 
29 (50 mg, 
66 μmol) 
1) 18 mg 1.05 equiv. 
relative to 29 
2) 18 mg 1.05 equiv. 
relative to 29 
1) Pd(dppf)Cl2 (4 mg, 
0.03 equiv. relative to 
29)  
2) Pd(dppf)Cl2 (4 mg, 
0.03 equiv. relative to 
29) 
1) KOAc (20 mg, 3 
equiv. relative to 
29) 
2) KOAc (20 mg, 3 
equiv. relative to 
29) 
DMSO (7 
mL) 
80 °C 1) 24 hrs 
 
2) 19 hrs 
29 (30 mg, 
39 μmol) 
11 mg, 1.05 equiv. 
relative to 29 
Pd(dppf)Cl2 ( 3 mg, 
0.03 equiv. relative to 
29) 
KOAc (12 mg, 3 
equiv. relative to 
29) 
THF (4 mL) 50 °C 48 hrs 
29 (30 mg, 
39 μmol) 
11 mg, 1.05 equiv. 
relative to 29 
Pd(dppf)Cl2 ( 3 mg, 
0.03 equiv. relative to 
29) 
KOAc (12 mg, 3 
equiv. relative to 
29) 
DMF (4 mL) 80 °C 48 hrs 
29 (30 mg, 
39 μmol) 
12 mg, 1.2 equiv. relative 
to 29 
Pd(dppf)Cl2 (1.5 mg, 
0.05 equiv. relative to 
29) 
K2CO3 (27 mg, 5 
equiv. relative to 
29) 
DMF (5 mL) 80 °C 72 hrs 
29 (30 mg, 
39 μmol) 
12 mg, 1.2 equiv. relative 
to 29 
Pd(dppf)Cl2 (1.5 mg, 
0.05 equiv. relative to 
29) 
K2CO3 (27 mg, 5 
equiv. relative to 
29) 
DMSO (5 
mL) 
80 °C 72 hrs 
29 (30 mg, 
39 μmol) 
30 mg, 3 equiv. relative 
to 29 
Pd(dppf)Cl2 (3 mg, 0.1 
equiv. relative to 29) 
Cs2CO3 (128 mg, 
10 equiv. relative 
DMSO (5 
mL) 
80 °C 72 hrs 
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to 29)  
29 (30 mg, 
39 μmol) 
30 mg, 3 equiv. relative 
to 29 
Pd(dppf)Cl2 (3 mg, 0.1 
equiv. relative to 29) 
K3PO4 (84 mg, 10 
equiv relative to 
29) 
DMSO (5 
mL) 
80 °C 72 hrs 
31 (20 mg, 
24 μmol) 
8 mg, 1.2 equiv. relative 
to 31 
Pd(dppf)Cl2 (2 mg, 0.1 
equiv. relative to 31) 
KOAc (24 mg, 10 
equiv. relative to 
31) 
DMSO (4 
mL) 
80 °C 96 hrs 
31 (30 mg, 
37 μmol) 
12 mg, 1.2 equiv. relative 
to 31 
Pd(dppf)Cl2 (3 mg, 0.1 
equiv. relative to 31) 
K3PO4 (77 mg, 10 
equiv. relative to 
31) 
DMSO (5 
mL) 
80 °C 5 hrs 
31 (20 mg, 
24 μmol) 
8 mg, 1.2 equiv. relative 
to 31 
Pd(dppf)Cl2 (2 mg, 0.1 
equiv. relative to 31) 
K2CO3 (34 mg, 10 
equiv. relative to 
31) 
DMSO (4 
mL) 
80 °C 96 hrs 
       
 
Table 5: Attempted boronation reactions involving 29 or 31 and bis(pinacolato)diborane. 
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Method 2 
 
A dried, degassed (Ar) Schlenk flask was charged with 29 (30 mg, 39 μmol), and 
bis(diphenylphosphino)ferrocene]dichloropalladium(II) (3 mg, 4.1 μmol, 0.1 equiv. 
relative to 29) under an inert atmosphere (Ar), while protected against light. The 
residual moisture/air was then removed under reduced pressure. Degassed (Ar), 
dimethylformamide (8 mL), triethylamine (240 μL, 1.7 mmol, 415 equiv. relative to 
bis(diphenylphosphino)ferrocene]dichloropalladium(II)) and 4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (100 μL, 690 μmol, 17.7 equiv. relative to 29) were added under an inert 
atmosphere. The resulting reaction mixture was stirred at 80 °C overnight. The TLC 
(silica, eluent: tetrahydrofuran) of the reaction mixture only exhibited 29, thus the 
reaction was discarded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 257 
      
6.45 Synthesis of 4-((trimethylsilyl)ethynyl)benzaldehyde (32) 
 
 
 
4-Bromobenzaldehyde (6.37 g, 22 mmol), palladium(II) acetate (78 mg, 0.01 equiv. 
relative to 4-bromobenzaldehyde) and triphenylphosphine (260 mg, 991 μmol, 2.9 
equiv. relative to palladium(II) acetate) were added to freshly distilled and degassed 
(Ar) triethylamine (80 mL), and the resulting solution was degassed (Ar) for a further 5 
minutes. Ethynyltrimethylsilane (7.6 mL, 53 mmol, 1.6 equiv. relative to 4-
bromobenzaldehyde) was added and the mixture, which was subsequently heated to 
reflux for 2 hours. Once the reaction had reached ambient temperature, the mixture was 
filtered, the filtrate was collected and the solvent was removed in vacuo. The crude 
mixture was dissolved in dichloromethane/hexane (1:1) and was chromatographically 
separated (silica, eluent: 50 % dichloromethane/hexane). Compound 32 (5.05 g, 72 %) 
was isolated as white/yellow crystals after recrystalisation from isopropanol. Rf = 0.4 
(Silica, CH3CO2CH3: C6H12; 8:2); m.p. = 69-70 °C.  
 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = 0.27 (s, 9H, Si(CH3)3), 7.60 (d, J = 8.3 Hz, 
2H, Ar-H), 7.82 (d, J = 8.3 Hz, 2H, Ar-H), 10.0 (s, 1H, CHO) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 99.2, 104.0, 129.6, 129.7, 132.7, 135.8, 
191.7 
MS (GC-MS) m/z = 202 (M)
+
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6.46 Synthesis of 5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-15-(4-
((trimethylsilyl)ethynyl)phenyl)porphyrin (33) 
 
 
 
A solution of 32 (1.01 g, 5 mmol), and 4-acetamidobenzaldehyde (815 mg, 5 mmol, 1 
equiv. relative to 32) dissolved in dimethylsulfoxide (100 mL) was charged with 26 
(2.23 g, 10 mmol, 2 equiv. relative to 32) and ammonium chloride (1.69 g, 31.6 mmol, 
6 equiv. relative to 32) and the resulting mixture was heated to 90 °C for 24 hours, 
while avoiding exposure to light. Once cooled, the mixture was stirred at room 
temperature for a further 3 hours. A 5 % methanol/dichloromethane solution was added, 
and the organic layer was washed with copious amounts of water. The organic layer was 
dried over anhydrous sodium sulphate and the solvent was removed under reduced 
pressure. The crude product was chromatographically separated (silica, eluent: 3 % 
methanol/dichloromethane). Compound 33 (46.4 mg, 1 %) was isolated as a purple 
solid after precipitation from dichloromethane by the addition of methanol. Rf = 0.68 
(silica, CH2Cl2:CH3OH; 9:1); m.p. = >350
 
°C decomp. 
 
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.87 (br s, 2H, NH), 0.38 (s, 9H, Si(CH3)3), 
2.38 (s, 3H, NHCOCH3), 7.59 (br s, 1H, NHCOCH3, 7.88 (d, J = 8.44 Hz, 2H, Ar-m-H), 
7.93 (d, J = 8.44 Hz, 2H, Ar-m-H), 8.11-8.18 (m, 8H, 5,10,15,20-Ar-o-H), 8.78-8.83 
(m, 4H, β-H), 8.86 (d, J = 4.8 Hz, 2H, β-H), 8.93 (d, J = 4.8 Hz, 2H, β-H), 8.99-9.07 (m, 
4H, 10,20-Ar-m-H)  
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13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 1.1 (Si(CH3)3, 25.0 (NHCOCH3), 96.0, 
104.9, 117.3, 118.2, 120.0, 120.6, 123.0, 129.4, 130.5, 134.5, 135.2, 137.6, 138.0, 
141.8, 142.0, 148.4 (10,20-Ar-m-C), 148.5, 150.0, 150.2, 168.7 
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax (log ) = 419 (5.63), 514 (4.327), 549 (3.97), 
590 (3.84), 645 (3.59) 
MS (MALDI) m/z = 769 (M)
+
  
HRMS (ESI) calculated for C49H40N7OSi (M+H)
+
 770.3058, found: 770.3052 
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6.47 Synthesis of (5-(4-acetamidophenyl)-10,20-di-(4-pyridyl)-15-(4-
((trimethylsilyl)ethynyl)phenyl)porphyrinato) zinc(II) (34) 
 
 
 
Compound 33 (21 mg, 27 μmol) and excess zinc acetate dihydrate (40 mg, 182 μmol, 
6.7 equiv. relative to 33) were dissolved in dichloromethane (9 mL) and methanol (3 
mL), and the resulting mixture was stirred at 40 °C for 2 hours, while avoiding exposure 
to light. The crude product was washed with a saturated sodium hydrogen carbonate 
solution and water. The organic layer was dried over anhydrous sodium sulphate and 
the solvent was removed in vacuo. TLC analysis (silica, eluent: 20 % 
methanol/dichloromethane) indicated complete consumption of 33. The crude product 
was dissolved in the minimum volume of chloroform and methanol was added to 
initiate precipitation, yielding 34 (19 mg, 84 %). Rf = 0.73 (Silica, C4H8O); m.p. = >350 
°C decomp.  
 
1
H N.M.R. [400 MHz, (CD3)2SO], δ (ppm) = 0.25 (s, 9H, Si(CH3)3), 2.09 (s, 3H, 
NHCOCH3), 7.72 (d, J = 7.96 Hz, 2H, Ar-H), 7.88-7.98 (m, 8H, 4H of 10,20-Ar-o-H 
and 4H of Ar-H) 8.04 (d, J = 7.96 Hz, 2H, Ar-H), 8.56-8.68 (m, 4H, 10,20-Ar-m-H), 
8.69-8.71 (m, 4H of β-H), 8.74 (d, J = 4.69 Hz, 2H, β-H), 8.82 (d, J = 4.69 Hz, 2H, β-
H), 9.32 (br s, 1H, NHCOCH3)     
13
C N.M.R. [100 MHz, (CD3)2SO], δ (ppm) = 1.0, 24.0, 95.5, 116.8, 118.0, 120.6, 
121.5, 122.4, 129.5, 130.2, 130.8, 131.0, 132.3, 132.7, 134.5, 135.0, 138.2, 138.5, 
143.4, 145.4, 148.6, 148.7, 150.1, 150.7, 152.4, 170.5 
UV/Vis (C4H8O, nm) λmax = 425 (5.85), 557 (4.45), 597 (3.96) 
HRMS (ESI): calculated for C49H38N7OSiZn (M+H)
+
 832.2193, found: 832.2187 
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6.48 Synthesis of (5-(4-azidophenyl)-10,15,20-tri-(4-pyridyl)porphyrinato) zinc(II) 
(35) 
 
 
 
Sodium nitrite (7 mg, 101 μmol, ≈ 2.2 equiv. relative to 17) dissolved in water (0.2 mL) 
was added to a stirred solution of 17 (30 mg, 47 μmol) in trifluoroacetic acid (0.8 mL) 
at 0 °C, while avoiding exposure to light. After 15 minutes, sodium azide (10 mg, 153 
μmol, ≈ 3.3 equiv. relative to 17) dissolved in water (0.2 mL) was added. After 1 hour, 
the reaction mixture was partitioned between water and dichloromethane, and the 
organic layer was collected, washed with water and dried over anhydrous sodium 
sulphate. Complete consumption of 17 had occurred as indicated by TLC (silica, 10 % 
methanol/dichloromethane). The porphyrinic intermediate was re-dissolved in 
dichloromethane and an excess of zinc acetate dihydrate (250 mg, 1 mmol) dissolved in 
methanol was added. The resulting mixture was heated at 40 °C for 2 hours. Once 
cooled to room temperature the reaction mixture was washed with water, dried over 
anhydrous sodium sulphate and the solvent was removed under reduced pressure; 
affording 35 (32 mg, 94 %) as a black solid. Rf = 0.63 (Silica, C4H8O); m.p. = >350 °C 
decomp.  
 
1
H N.M.R. [400 MHz, (CD3)2SO], δ (ppm) = 7.55 (d, J = 8.44 Hz, 2H, 5-Ar-m-H), 8.18-
8.22 (m, 8H, 5,10,15,20-Ar-o-H), 8.80-8.86 (m, 8H, β-H), 8.98-9.02 (m, 6H, 10,15,20-
Ar-m-H)  
13
C N.M.R. [100 MHz, (CD3)2SO], δ (ppm) = spectrum not obtained 
UV/Vis ((CH3)2SO, nm) λmax = 428 (5.63), 560 (4.33), 600 (3.84) 
MS (MALDI) m/z = 694 (M+2H−2N)+  
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6.49 Synthesis of 5-(4-azidophenyl)-10,15,20-tri-(4-pyridyl)porphyrin (36) 
 
  
 
Compound 17 (38 mg, 60 μmol) dissolved in trifluoroacetic acid (1.5 mL) was treated 
with a solution of sodium nitrite (12 mg, 174 μmol, 2.9 equiv. relative to 17) dissolved 
in water (0.3 mL). The resulting mixture was stirred at 0 °C, while avoiding exposure to 
light, for 15 minutes. Sodium azide (18 mg, 277 μmol, ≈ 4.6 equiv. relative to 17) 
dissolved in water (0.3 mL) was then added and the reaction was stirred for a further 1 
hour. The reaction mixture was partitioned between water and dichloromethane and the 
organic layer was dried over anhydrous sodium sulphate. Compound 36 (26 mg, 73 %) 
was isolated after gravity column chromatography (silica, eluent: 10 % 
methanol/dichloromethane) and precipitation from hexane over dichloromethane. Rf = 
0.58 (Silica, CH2Cl2: CH3OH; 9:1); m.p. = >350 °C decomp. 
  
1
H N.M.R. [400 MHz, CDCl3], δ (ppm) = −2.89 (s, 2H, NH), 7.45 (dd, J = 2.05 Hz, J = 
6.45 Hz, 2H, 5-Ar-m-H ), 8.14-8.17 (m, 6H, 10,15,20-Ar-o-H), 8.19 (dd, J = 2.05 Hz, J 
= 6.45 Hz, 2H, 5-Ar-o-H ), 8.81-8.93 (m, 8H, β-H), 9.03-9.07 (m, 6H, 10,15,20-Ar-m-
H) 
13
C N.M.R. [100 MHz, CDCl3], δ (ppm) = 117.2, 117.55, 117.63, 120.4, 129.3 (5-Ar-o-
C), 131.2 (β-C), 135.7, 138.2, 140.4, 148.4, 148.5, 149.86, 149.9     
UV/Vis (CH2Cl2:CH3OH; 2:1, nm) λmax (log ) = 417 (5.79), 513 (4.37), 548 (3.86), 588 
(3.82), 644 (3.46) 
HRMS (ESI): calculated for C41H27N10 (M+H)
+
 659.2415, found: 659.2408 
 
 
 
 263 
      
6.50 Attempted synthesis of 5-(4-((4-trimethylsilyl)-1,2,3-triazole)phenyl)-10,15,20-
tri-(4-pyridyl)porphyrin 
 
 
 
A solution of 35 (20 mg, 28 μmol) and ethynyltrimethylsilane (20 μL, 144 μmol, 5 
equiv. relative to 35) in dimethylsulfoxide (10 mL) was charged with sodium L-
ascorbate (2.7 mg, 13.8 μmol, 0.5 equiv. relative to 35) and copper(II) sulphate 
pentahydrate (1.7 mg, 6.9 μmol, 0.25 equiv. relative to 35) suspended in water (1 mL). 
A micro-spatula of tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)amine was added to the 
stirred mixture which was subsequently was heated to 80 °C. The reaction was 
monitored by TLC (silica, eluent: tetrahydrofuran) over 4 days, with only 35 being 
detected.  
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